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RESUMEN 
 
  
 
 
 
 
 
 
 
 
La enfermedad Inflamatoria Intestinal es una enfermedad crónica, recidivante, 
de carácter sistémico que afecta principalmente al tracto gastrointestinal. Esta patología 
engloba dos entidades clínicas, la Enfermedad de Crohn y la Colitis Ulcerosa, que 
difieren en algunos aspectos pero comparten la disrupción de la barrera epitelial y la 
respuesta exacerbada del sistema inmunológico a la flora bacteriana. La etiología de la 
enfermedad es desconocida pero se sabe que factores genéticos, ambientales, flora 
intestinal y sistema inmunológico contribuyen al desarrollo de la enfermedad. En los 
últimos años se ha evidenciado que la adecuada recuperación de la mucosa dañada 
constituye un objetivo clave del tratamiento ya que permite prolongar de forma 
significativa los periodos de remisión clínica.  
En la presente tesis nos planteamos como principal objetivo analizar la 
relevancia de la inmunidad innata, en particular de los macrófagos, en la regeneración 
de la mucosa intestinal en la EII. Nuestros resultados demuestran la co-existencia de 
diferentes fenotipos macrofágicos, un fenotipo pro-inflamatorio M1 y un fenotipo 
antiinflamatorio M2, tanto en la mucosa de pacientes crónicos con EII como en un 
modelo murino de colitis aguda. El análisis de la expresión de mediadores 
específicamente implicados en los mecanismos de regeneración en las criptas 
intestinales reveló que la expresión de ligandos Wnt es selectiva de macrófagos M2 y la 
de ligandos Notch se asocia a macrófagos M1 con lo que estas células parecen modular 
de forma diferencial las rutas de señalización Wnt y Notch en la mucosa.  
A pesar de la similitud encontrada en la expresión de receptores de superficie en 
el fenotipo M2 entre la colitis crónica y la aguda, la función desempeñada por este 
fenotipo macrofágico parece diferir dependiendo de la fase del proceso inflamatorio, 
probablemente como consecuencia de una diferente producción de citocinas. En la 
mucosa de pacientes con EII observamos una prevalencia de macrófagos M2 sobre 
macrófagos M1 asociada a la activación de la ruta Wnt y la inhibición de la ruta Notch 
lo que determina una inhibición de la autofagia epitelial y una dañada diferenciación 
enterocítica. Por el contrario, en el modelo agudo de colitis los macrófagos M2 parecen 
desempeñar un papel fundamental en la regeneración de la mucosa a través de la síntesis 
de ligandos Wnt y la activación de la ruta Wnt en el epitelio.  
En conclusión, el presente trabajo demuestra la relevancia de los macrófagos en 
la regeneración de la mucosa intestinal en la EII. Estas células, de manera fenotipo-
dependiente, se asocian con la inducción de ligandos Wnt y Notch que al señalizar sobre 
las células epiteliales de las criptas intestinales regulan los procesos de proliferación, 
diferenciación y autofagia, fundamentales en los mecanismos de regeneración mucosa. 
Una mejor caracterización funcional de los fenotipos macrofágicos en la mucosa de 
pacientes con EII ayudará a establecer nuevas aproximaciones celulares en la terapia de 
la enfermedad inflamatoria intestinal. 
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1. - INFLAMMATORY BOWEL DISEASE (IBD) 
 
Inflammatory Bowel Disease (IBD) is a chronic intestinal pathology caused by 
several complex interactions between the intestinal environment, genetics and gut 
microbiota. Both Ulcerative Colitis (UC) and Crohn’s Disease (CD) are included under 
the term IBD, but they present several differences. UC is characterized by ulcerations 
and inflammation mainly in the colon, specifically in the mucosal and submucosal 
layers, and it can also be present in the large intestine. The incidence of the localization 
of the damaged tissue varies; in fact, over 20-30% of UC occurs in the entire colon - 
named pancolitis - another 20-30% occurs in left-side pancolitis, and the most frequent - 
with 40-60% of all cases of inflammation - is localized in the rectosigmoid area. On the 
other hand, CD does not affect the whole length of the intestine, since ulcerations can 
co-exist with healthy areas. It mainly affects the terminal ileum, but can also manifest 
itself in all segments of the GI tract, and is characterized by transmural lymphoid 
aggregates, fissuring and non-necrotic granulomas (Sobczak M. et al., 2014).  
 
1.1. - EPIDEMIOLOGY OF IBD 
 
Despite the progress made in the past few decades, the etiology of IBD is not 
well known and there is no complete cure for it. Moreover, both the incidence and 
prevalence of IBD are rising every year. In fact, since 1980 the incidence of IBD has 
increased by 75% and 60% in the case of UC and CD, respectively (Molodecky N. et 
al., 2012). Specifically, in Europe the incidence of UC is 0.6-24.3 per 100.000 people 
and that of CD is 0.3-12.7 per 100.000, while the prevalence of UC is 4.9-505 per 
100000 and that of CD is 26-199 per 100.000 (Ananthakrishan A.N., 2015). Several 
studies have revealed that IBD usually appears between the second and fourth decade of 
life, although there are some studies that reveal a second peak of incidence between the 
sixth and seventh decades (Ananthakrishan A.N., 2015). Regarding the influence of 
gender, it has been described that in high-rate areas in Europe and North America CD is 
present 20-30% more frequently in women, whereas UC affects slightly more men. 
However, the incidence of pediatric IBD is opposite to that observed in adults, with CD 
being more frequent in boys and UC in girls (Cosnes J. et al., 2011).  
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Traditionally, IBD has been associated with white and Jewish people rather than 
in Asian and non-white populations, particularly African Americans. Nevertheless, there 
are recent studies that report an equal incidence of IBD among these populations and 
explained the lower incidence in black populations due to limitations in access to 
epidemiological studies. Furthermore, some studies have reported an increasing 
frequency of IBD in countries such as Saudi Arabia, Japan, Hong Kong and Korea, 
where a similar trend to that seen in Western Europe and North America Countries has 
been reported, supporting a lack of differences in the incidence of IBD between ethnic 
races (Ananthakrishan A.N., 2015). 
 
According to the meta-analysis performed by Duricova D. et al. 2010, the 
mortality of CD patients is higher - 40% - than in the normal population, mainly due to 
intestinal and lung cancers, postoperative complications and malnutrition. In contrast, 
the mortality of UC patients is not significantly higher than that of the general 
population. Nevertheless, mortality is higher among patients with extensive disease due 
to a higher risk of colorectal carcinoma or liver disease (Domènech E. et al., 2014). 
Therefore, despite the huge number of published studies about IBD, its etiology is still 
poorly understood and, as a consequence, no curative treatment exists, which makes 
further investigation essential in order to understand better the ethiopathogenesis of 
IBD.  
 
1.2. - ETIOLOGY OF IBD 
  
Several factors have been reported that may contribute to the development of 
IBD, such as immunological, genetic and environmental factors, such as diet, stress, 
free radicals, smoking and sleep. There are even some hypotheses that associate a 
higher risk of IBD with urban living and lack of exposure to agents. All of these 
environmental factors are crucial to the apparition of IBD, though with different grades 
of importance (Soon I.S. et al., 2012).  
 
1.2.1. - GENETIC FACTORS 
 
The importance of genetics in IBD emerged with familial aggregation, and twin 
studies have been an essential tool to determine the contribution of genetics and 
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environmental factors to the etiology of UC and CD. In fact, around 2% and 14% of the 
patients with IBD present a family history with more relatives affected. Therefore, the 
risk of suffering IBD for first-degree relatives is around 5%. Specifically, in CD, twin 
studies have also revealed that the concordance for monozygotic twins was between 
20% and 50%, while for dizygotic twins with the same environment it was less than 
10%. However, this may not be determinant for disease behavior, such as fistulizing or 
structuring type, or extent of the disease. On the other hand, in UC, the concordance 
observed was lower than in CD, being 16% in monozygotic twins and 4% in dizygotic 
twins. In line with this, phenotypic characteristics of UC are less consistent than those 
of CD (Halme L. et al., 2006). 
 
Large Genome-wide Association Studies (GWAS) meta-analyses of CD and UC 
have identified a large number of alterations in specific genes associated with a higher 
risk of suffering IBD. At the moment, there are 163 loci that have been related with 
IBD. Most of these genes have been associated with both CD and UC, but there are 
some, such as NOD2 and ATG16L1, that are specifically linked to CD and others only 
to UC, such as HNF4A, CDH1, LAMB1 or GNA12. All of these genes have a huge 
influence in key processes of the pathology, including innate immune responses, 
autophagy, maintenance of the epithelial barrier function, microbial defense, restitution 
and injury repair and antimicrobial activity (Ek W.E. et al., 2014).  
 
One of the most well-known and important genes associated with CD is NOD2. 
This gene encodes a protein responsible for the secretion of antimicrobial proteins and 
cytokines from Paneth cells. It was identified for the first time in 2001 with three 
variants, its homozygosity being responsible for a 20-40 fold increase the risk of 
developing CD, while heterozygosity is responsible for a 2-4 fold increase in that risk. 
The importance of this gene has been strongly reinforced with murine models of IBD 
with different NOD2 variants predisposed to CD in which autophagy has been shown to 
be impaired (Sobczak M. et al., 2014). 
 
Alterations in locus CARD15/NOD2 (IBD1) have also been associated with 
IBD. This gene encodes an intracellular monocyte receptor whose function is to bind 
bacterial toxins and to activate NF-Κβ. More than 30 mutations have been identified in 
this gene, the most common of which are G908R and 1007finsC (Cavanaugh J., 2006). 
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Furthermore, over 50% of CD patients have one mutation and over 17% of CD patients 
have two mutations in this gene and the rate of the progression and symptoms are 
associated with the number of mutations (Sobczak M. et al., 2014). 
 
Another pivotal gene that has been associated with IBD is ATG16L1. This gene 
plays an essential role in autophagy; specifically, it codifies a protein that forms a 
complex with two proteins (ATG5 and ATG12) in order to allow the conjugation of 
LC3 to a functional autophagophore. In addition, it regulates innate immune signaling 
and controls viral replication. The most common alteration of this gene is a single-
nucleotide polymorphism (SNP) at rs2241880 which encodes a Thr300Ala substitution. 
This variant determines the pathogen clearance with a modification in the cytokine 
production, and is also associated with endoplasmic reticulum stress and unfolded 
protein response (Salem M. et al., 2015). 
 
Other crucial genetic alterations that have also been associated with IBD are 
located in different loci, such as IRGM, which cause an impaired xenophagy, or E-
cadherin (CDH1) in which its polymorphism deregulates the intestinal permeability that 
triggers uncontrolled entrance of the bacteria into the mucosa. A missense mutation in 
Muc2 gene has been associated with a higher level of endoplasmic reticulum stress, 
causing an overproduction of Th17, Th1 and Th2 cytokines (Sobczak M. et al., 2014). 
 
Finally, miRNAs have recently emerged as possible factors involved in the 
development of IBD. Several functional studies have reported an association between 
the miRNA miR-21 and a higher risk of IBD. Indeed, it has been reported that miR-21 
promotes Th2 cell differentiation (Kalla R. et al., 2015) and also alters epithelial barrier 
function. Murine miR-21 knock-out models with DSS-induced colitis have higher 
survival rates and less tissue inflammation than wild type mice due to the regulation of 
its target gene Rhob, which regulates intestinal permeability (Shi C. et al., 2013). 
Furthermore, some miRNAs have been shown to regulate essential autophagy-related 
gene expression such as NOD2, ATG16L1 or IRGM, including miR-192, miR-122, 
miR-29 and miR-146a, which have been associated with a higher risk of development 
of the pathology (Kalla R. et al., 2015). 
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1.2.2. - ENVIRONMENTAL FACTORS 
  
 Several environmental factors have been strongly associated with the 
development of IBD. Although there is still not a direct connection between diet and 
development of IBD due to limitations in the design of epidemiological studies and 
interindividual variation in the gut microbiota, there are some components of the diet 
(high amount of sugar and animal fat and few proteins, fruit or vegetables) that have 
been associated with IBD. Hence, diet should be taken into account in clinical practice 
in order to control the problem of malnutrition and anemia in IBD (Halmos E.P. et al., 
2014). An inverse association has been reported between fiber and development of IBD, 
and has been explained by the fact that fiber helps to maintain epithelial barrier integrity 
and can inhibit pro-inflammatory cytokines when is metabolized by intestinal bacteria 
into short-chain fatty acids. Regarding micronutrients, vitamin D may have a protective 
role in the pathogenesis and course of IBD, since damage has been reported to be higher 
in vitamin D receptor knock-out mice treated with DSS. Furthermore, lower levels of 
vitamin D correlate with a higher risk of CD surgery, while higher levels of vitamin D 
correlate with lower risk of CD development. Zinc and iron have also been associated 
with IBD due to the fact that the former modulates immunological functions of 
macrophages, neutrophils and natural killer T cells by inhibiting the NF-Κβ pathway 
and myeloperoxidase activity, while iron induces intestinal inflammation due to 
activation of the IL-6-IL-11-STAT3 pathway and an enhancement of oxidative stress 
(Ananthakrishan A.N., 2015). 
 
 In addition to diet, some life habits can also influence in the development or 
course of IBD. Stress can affect gut inflammation, causing higher levels of pro-
inflammatory cytokines, activation of macrophages, and alteration of intestinal 
permeability and gut microbiota through the hypothalamus-pituitary-adrenal axis. In a 
study by Sonnenberg et al. sedentary lives were associated with a higher risk of IBD 
and more physical activity with a lower risk of IBD (Ananthakrishan A.N., 2015).  
 
 Smoking seems to play a dual role in the contribution of IBD development, since 
it increases the risk of CD, though it ameliorates the symptoms of UC. This has been 
explained by the differential effects of nicotine in the small and large intestine; nicotine 
increases the activity of NOS in the small intestine, contributing to formation of reactive 
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oxygen species (ROS), whereas in the large intestine it decreases the activity of NOS 
(Sobczak M. et al., 2014). 
 
 Another factor that has been associated with IBD is the presence of reactive 
oxygen species (ROS). These molecules are present in several pathologies, such as 
metabolic and cardiovascular disorders, cancer and IBD. Specifically, T and B 
lymphocytes are increased in the intestine in order to eliminate pathogens by increasing 
the levels of ROS. Nevertheless, the accumulation of ROS affects the polymerization of 
the intestine mucus, diminishing its protective effects. Moreover, in presence of ROS 
species, a higher amount of proteases, elastase, collagenase and cathepsin G are secreted 
by macrophages, mast cells and also T and B lymphocytes, thus triggering an 
impairment of intercellular connections and intestinal damage. This helps the 
penetration of bacteria into the lamina propria, which worsens IBD. Recent studies have 
supported the influence of ROS in the development of IBD, since oxidative stress 
products are significantly higher in active CD than in a remission stage (Sobczak M. et 
al., 2014).  
 
 Finally poor quality of sleep can alter the function of the immune system and 
have an influence in the inflammation process. In fact, a higher probability of 
recurrence of IBD has been reported in individuals with sleep disturbances (Ali T. et al., 
2013). 
 
2. - IMMUNOPATHOGENESIS 
 
 A dysfunction of epithelial barrier function and alterations of innate and adaptive 
immune responses are observed in IBD (Figure 1). The immunopathogenesis of IBD is 
characterized by: 
 
- penetration of the luminal content into underlying tissues, which can be 
facilitated by environmental factors or inherent alterations in mucosal 
barrier,  
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- alteration of the clearance of all the foreign material of the intestinal wall 
probably due to a defect in the secretion of pro-inflammatory cytokines by 
macrophages, 
 
- activation of the adaptive immune response, triggering a chronic 
inflammatory response and causing the injuries characteristic of IBD. 
 
Figure 1: Disruption of the epithelial barrier occurs in IBD due to genetic and 
environmental factors. The enhanced interactions between commensal bacteria 
and the immune system cause tissue destruction, triggering an uncontrolled 
immune response and mucosal inflammation (obtained from Neurath M.F. et al., 
2014). 
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2.1. - DYSRUPTION OF EPITHELIAL BARRIER 
 
 The intestinal epithelium is formed by a single layer of cells organized into 
crypts and villi, and is the largest surface area of all the body’s parts, which is 
continually renewed due to the presence of intestinal epithelial stem cells that have the 
ability to proliferate and differentiate into several specific cells: specialized intestinal 
epithelial cells (IECs), goblet cells, absorptive cells, enteroendocrine cells, M cells and 
Paneth cells. Each cell type has a specific function and all of them are essential in order 
to control the interaction between intestinal microbiota and immune cells. This 
epithelium, due to the presence of a net of tight junctions (TJs), is a physical defense 
mechanism against harmful microenvironment which, at the same time, allows selective 
permeability and absorption of nutrients. Alterations in the intestinal TJ proteins have 
been observed in IBD patients. It has been reported that permeability regulated by TJs is 
also increased by pro-inflammatory cytokines such as tumor necrosis factor (TNF-α) 
and interferon-γ in both CD and UC. Such an increase causes an impaired epithelial 
barrier function, triggering epithelial damage with ulcers characteristic of mucosal 
inflammation (Coskun M. et al., 2014). 
 
 In addition to TJs, epithelial cells, as a consequence of the continuous interaction 
with intestinal microbiota, identify pathogenic bacterial components through receptors 
such as TLR (Toll-like receptors), NLR (NOD-like receptors), NOD2 receptor, 
CARD15 receptor, etc. The TLR family is constituted by at least 13 members that 
recognize different pathogen-associated molecular patterns (PAMPs), like 
lipopolysaccharide (LPS), peptidoglycan (PGN), muramyl dipeptide (MDP), 
lipoteichoic acids (LTAs), and bacterial DNA due to an extracellular domain with 
several leucine-rich repeats. The interaction between the receptor and PAMPs causes an 
activation of NF-Κβ, triggering the activation of both innate and adaptive immune 
responses. Several alterations have been reported in these genes, and they increase the 
risk of chronic gut inflammation and, ultimately, IBD (Pastorelli L. et al., 2013). 
 
 Paneth cells are specialized cells located in the intestinal crypt that synthesize 
antimicrobial peptides (APM), such as α-defensins or β-defensins, in order to ensure an 
effective immunity. These APMs prevent contact between bacteria and the epithelium 
due to the presence of the mucosal layer. In CD patients, a defective expression of these 
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peptides has been observed (Coskun M. et al., 2014). Furthermore, the number of 
mucus-secreting-cells is reduced in these patients and the mucus layer is impaired. This 
has been strongly reinforced by studies with Muc2-deficient mice (the main protein 
secreted by goblet cells) which have shown a diminished mucosal layer, higher levels of 
pro-inflammatory cytokines, and development of spontaneous colitis. Furthermore, 
levels of mucin proteins have been reported to be significantly lower in the ileum and 
colon of IBD patients than in those of healthy people (Van der Sluis M. et al., 2006). 
 
2.2. - INFLAMMATORY RESPONSE 
 
 
 As previously mentioned, due to the weakening of the defense mechanisms, the 
permeability of the intestinal epithelium is altered, which triggers more frequent contact 
between the intestinal microbiota and the immune system. An excess of these 
interactions can cause a loss of tolerance to the intestinal flora, thereby provoking the 
activation and a perpetuation of the inflammatory cascade, leading to chronic intestinal 
inflammation, which causes the apparition of intestinal complications associated with 
IBD patients, such as fibrosis, stenosis, fistula and cancer (Neurath M. et al., 2014). The 
immune response is the effector axis that mediates inflammation. In IBD patients, an 
activation of both innate and adaptive responses is observed, as well as a loss of 
tolerance of enteric bacteria. In the following sections, the most important cells of each 
immune response with their specific functions and their relevance in IBD are described. 
 
 
 2.2.1. - INNATE IMMUNE RESPONSE 
 
 
 Intestinal epithelial cells (IECs) express several molecules that activate both the 
innate and adaptive immune response. The main cells of innate immune response are 
dendritic cells (DCs) and macrophages. Intestinal DCs are antigen-presenting cells and 
transport the antigens into secondary lymphoid tissue, generating an antigen-specific T-
cell response that stimulates primary T-cells, and triggering tolerogenic responses 
against commensal bacteria antigens or immunogenic responses against invading 
pathogens. In this way they play a dual role: they protect and stimulate intestinal 
immunity and generate a tolerogenic response towards intestinal microbiota. In mice, 
DCs can be subdivided depending on how they express combinations of CD11b, CD103 
INTRODUCTION 
12 
 
and CD8α. It has been reported that CD8α+ DC, in the presence of TGF-β, can promote 
T-reg generation and the migration of CD103+ DC towards mesenteric lymph nodes, 
triggering a specific T-cell response for luminal antigens (Elizabeth R. et al., 2014). 
 
Several murine models of colitis strongly support the accumulation of active 
DCs, whose origin may be newly recruited precursors or tissue-resident in situ dendritic 
cells. Furthermore, in IBD patients an accumulation of active DC has also been 
described, specifically in areas with inflammation. In fact, an amelioration of colitis has 
been observed in those mice in which DCs were suppressed during DSS administration; 
however, when DCs were suppressed before DSS administration, the mice showed an 
exacerbated colitis, which suggests a dual function of DCs (Abe K. et al., 2007).  
 
Macrophages are the other pivotal cells in innate response. They are located 
mainly in the lamina propria of the mucosa of the gastrointestinal tract, and also in the 
smooth muscle of the intestine. Intestinal macrophages have a wide range of functions, 
such as contributing to immune tolerance and a protective immune response and 
inflammation. Tissue macrophages regulate basal functions such as clearance of 
apoptotic cells and tissue remodeling. Unlike DCs, macrophages do not migrate to 
lymphoid tissue; however, they can regulate adaptive response due to the presentation 
of antigens to T-cells in situ in lamina propria. Intestinal macrophages can be identified 
as F4/80, CD68 and CD64, and also CX3CR1hi, although a subset of DCs expressing 
intermediate levels of CX3CR1hi has been reported (Bain C.C. et al., 2014).  
 
The functions of intestinal macrophages differ notably between inflammation 
and the steady stage. During inflammation, cellular infiltration is produced and 
macrophages, with a higher expression of TLR and inflammatory receptors, secrete high 
levels of pro-inflammatory cytokines and mediators. Resident intestinal macrophages 
are highly phagocytic and bactericidal. Due to their close proximity to the epithelium 
monolayer, they capture and destroy all of the foreign components and express lower 
levels of CD80, CD86 and CD40. They regulate immune tolerance due to a constitutive 
expression of the anti-inflammatory cytokine IL-10 (Elizabeth R. et al, 2014). A 
classification of intestinal CX3CR1+ macrophages has recently been reported: a) 
CX3CR1hi resident macrophages which produce constitutively IL-10 and are resistant 
to TLR; b) a smaller population that accumulates during colitis with intermediate levels 
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of CX3CR1, which respond with a TLR-triggering secretion of pro-inflammatory 
cytokines. The co-existence between resident regulatory macrophages and pro-
inflammatory macrophages in the gut has been reported (Bain C.C. et al., 2013).  
 
 2.2.2. - MACROPHAGE POLARIZATION 
 
 The wide range of functions are macrophages regulate is due to the fact these 
cells have a remarkable plasticity which, depending on the microenvironment, allows 
them to change their phenotype in a process known as macrophage polarization. 
Different macrophage phenotypes can be identified depending on the cell surface 
markers and cytokine profile, which confer to each phenotype specific functions in the 
homeostasis of the tissue (Figure 2) (Murray M.J. and Wynn T.A.,, 2011).  
 
 
 
Figure 2: Diagram of macrophage phenotypes and specific functions due to their 
plasticity (obtained from Arango-Duque G. and Descoteaux A., 2014). 
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The main phenotypes that have been described to date in vitro are classified as a 
pro-inflammatory phenotype referred to as “classically activated”, or M1, and an anti-
inflammatory phenotype named “alternative activated”, or M2 phenotype. The M1 
phenotype is stimulated by pro-inflammatory cytokines such as IFN-γ, LPS, TNF-α, IL-
1β, IL-6, and even by PAMPs, hypoxia present in the tissue, or abnormalities in the 
matrix with an altered collagen deposition. In the latter case, M1 macrophages are able 
to synthesize enzymes that degrade matrix components, like matrix metalloproteinases 
(MMPs), in order to migrate to the injured area. M1 macrophages produce high levels 
of pro-inflammatory cytokines like TNF-α, IL-1, IL-6, IL-12 and IL-23, which induce a 
Th1 response and synthesize oxygen and nitrogen radicals, whereas they do not express 
anti-inflammatory cytokines such as IL-10. Several transcription factors have been 
reported to be essential for polarization towards the M1 phenotype, such as STAT1 and 
IRF5 (Martinez F.O. et al., 2008). The main functions of this phenotype are the killing 
of intracellular pathogens, making them essential for host defense, and activation of 
inflammation (Van Loon S.L.M. et al., 2013). 
 
 M2 macrophages are involved in immunoregulation, tissue repair and wound 
healing. These macrophages express high levels of anti-inflammatory cytokines, such as 
IL-10, lower levels of pro-inflammatory cytokines, and regulate mannose receptors 
essential for matrix remodeling due to foreign body giant cell (FBGC) formation. This 
phenotype can be subdivided into three subsets: M2a, M2b and M2c. M2a macrophages 
are stimulated by IL-4 and IL-13 released by mast cells, granulocytes and Th2 cells. In 
this case, the transcription factors reported to be essential in vitro for polarization 
towards this phenotype are IRF4 and STAT6 (Martinez F.O. et al., 2008). These 
macrophages are involved in the Th2 type immune response against parasites, and also 
promote wound healing due to stimulation of extracellular matrix formation (ECM) 
proteins. Regulatory M2b macrophages are stimulated by a huge variety of signals; for 
instance, immune complexes, apoptotic cells, glucocorticoids, IL-10 and TLR agonists. 
They can secrete high levels of IL-10, limitating the inflammation and controlling the 
immune response, thus restoring homeostasis (Labonte A.C. et al., 2014). M2c 
macrophages are induced by IL-10, TGF-β and glucocorticoids, and they promote the 
development of Th2 lymphocites and Tregs. These macrophages stimulate tissue 
regeneration and angiogenesis (Arango-Duque G. and Descoteaux A., 2014). 
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 Recently, M2 macrophages have been subdivided into several further subsets 
depending on the specific signals that activate them and the cytokine profile that express 
each phenotype. An M2d phenotype has been described which accumulates in the tumor 
microenvironment but shares some properties with M1 macrophages, such as the 
expression of IFN-γ-induced chemokines, and even M4, Mhem an MOx, which differ in 
their gene expression, cytokines and chemokines (Labonte A.C. et al., 2014).  
 
Despite the huge amount of information about macrophage polarization in vitro, 
little is currently known about this process in vivo, but evidence strongly supports that 
infiltrating macrophages do not conform to defined M1 or M2 phenotypes during 
inflammation and adopt a continuum spectrum of functional phenotypes depending on 
the microenvironment. 
 
 2.2.3. - ADAPTIVE IMMUNE RESPONSE 
 
 The adaptive immune response is mainly mediated by T cells and B cells. As a 
consequence of the antigen-presenting by dendritic cells to T cells helper CD4+ in 
secondary lymphoid tissues, effector T cells travel to the intestine in order to induce a 
tolerogenic or inflammatory response. Once they arrive, mature T cells regulate the 
maintenance and function of intestinal epithelial cells. While in the past it was thought 
that mainly T-helper (Th) cells 1 and 2 were implicated in IBD, recent studies have 
revealed a newer subpopulation of T cells (Th17) that play an essential role in the 
defense against bacteria and fungi at mucosal interfaces and which are increased in IBD 
patients (Gerner R.R. et al., 2013). On the other hand, tissue-resident T cells rapidly 
respond during the ongoing inflammation and infection, specifically due to CD8+ T 
cell-dependent memory responses. These cells promote the retention of epithelial cells 
and other cells through CD103, which binds E-cadherin to intestinal epithelial cells. 
Furthermore, in IBD an absence of Treg is also observed, which contributes to the 
development of an immune response towards commensal bacteria, which are normally 
tolerated by the immune system due to periphery tolerance. Hence, due to a loss of that 
tolerance, the inflammation is perpetuated until it becomes chronic. 
 
A subpopulation of specialized cells known as intraepithelial lymphocytes 
(IELs) has been identified, and they regulate immune homeostasis at the intestinal 
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barrier (Edelblum K. L. et al., 2012). Although the influence of the microenvironment 
on T cells has not been studied in depth, it is well known that IELs regulate the 
maintenance and function of epithelial cells due to close interactions between them 
(Peterson L.W. et al., 2014).  
 
 In the adaptive immune response, B cells also play an important role. Depending 
on the signals that are present in the mucosa, they are able to express pro-inflammatory 
or anti-inflammatory cytokines. A specific B cell subset that affects autoreactive 
responses has been identified and is thought to regulate B regulatory cells (Breg) in 
autoimmune diseases. The maturation of B cells into mature IgA-secreting plasma cells 
is regulated by dendritic cells that carry antigen and bacteria from the intestine through 
a recombination in their heavy chain class-switch (CSR). In addition to that which 
occurs in T cells, B cells are also regulated by intestinal epithelial cells signals due to 
the production of nitric oxide (NO), IL-10 and retinoic acid. Furthermore, CD4+ T cells 
can also act as an essential signal for B cell CSR through CD40L. When T cells are not 
present, it has been reported that intestinal epithelial cells can support this process 
through NF-κβ signaling in response to commensal bacteria (He B. et al., 2007). A 
diminished production of IgA in IBD patients due to decreased expression of J-chain 
plays a pivotal role at mucosal effector sites in the secretion of antibodies (IgA and 
IgM) as a first defense. The pattern of antibody production differs between CD and UC, 
especially in regard to IgG production; whereas in UC there is a huge increase in IgG1 
secretion, in CD there is an increase in IgG1, IgG2 and IgG3. However, in all cases it 
has been observed that such an accumulation of IgG triggers a lack of tolerance in the 
intestine. Furthermore, B cells are also able to express immunomodulatory cytokines 
such as IL-10 or TGF-β (Gerner R.R. et al., 2013). 
 
 
3. - MUCOSAL HEALING 
 
 Mucosal healing has recently been highlighted as a key target for IBD treatment, 
since it is associated with a better and more effective disease control, longer periods of 
clinical remission, lower number of surgeries and a better quality of life. Basically, the 
main objective of mucosal healing is to reconstitute the barrier function of the intestinal 
epithelium and avoid the persistent immune cell activation due to the transfer of 
commensal bacteria into the mucosa and submucosa (Neurath M.F. et al., 2012). 
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 In normal and physiological conditions, intestinal epithelial cells are 
continuously renovated due to the presence of stem cells in the base of the crypts. These 
cells proliferate into transit amplifying cells, which in turn proliferate and differentiate 
into enterocyte, goblet, Paneth or enteroendocrine cells in order to ensure the presence 
of all lineages essential to the intestinal epithelium (Figure 3). This continuous renewal 
must be controlled in order to avoid an uncontrolled growth, which can cause intestinal 
hyperplasia, an inflammatory process or even cancer. Several stimuli, such as growth 
factors and soluble proteins, are able to induce epithelial proliferation and 
differentiation of IECs (Neurath M.F. et al., 2012). 
 
Figure 3: Schematic representation of different cell lineages present in a crypt of 
the colon (adapted from Barker N., 2014). 
 
 After an injury, IECs that are close to the wounded area lose their polarity and 
are able to migrate to the damaged area in order to initiate the wound healing in a 
process that is called “epithelial restitution”. This process is crucial for repair of the 
mucosa and has been described to take place a few minutes after damage. It can be 
activated by several cytokines, such as transforming growth factor, epidermal growth 
factor, interleukin-1β (IL-1β) and interferon-γ (IFN-γ), due to an induction of TGF-β 
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activation. Nevertheless, TGF-β-independent pathways have been reported, which also 
mediate epithelial restitution. Indeed, trefoil peptides, galectin-2 and galectin-4 can 
promote epithelial restitution without changing TGF-β expression (Neurath M.F. et al., 
2012). 
 
 Epithelial restitution is followed by several processes involved in wound 
healing, such as an increased epithelial proliferation and differentiation. Cell 
proliferation is essential to maintain a sufficient number of IECs available to cover the 
injury. Specifically, IECs receive a huge amount of several stimuli, such as epidermal 
growth factor, IL-6, IL-22, TLR ligands and LPS, which regulate cell survival and 
proliferation through the activation of transcriptional factors like NF-κβ or STAT3 
(Neurath M.F. et al., 2014). On the other hand, differentiation is also essential for a 
complete recovery of the wound in order to ensure that the new epithelium is able to 
perform all the functions that normally develop in physiological conditions (Collu G.M. 
et al., 2014).  
 
 Wnt signaling and Notch signaling pathways play crucial roles in regulating both 
proliferation and differentiation. There are several studies that reveal a crosstalk 
between Wnt and Notch pathways. Specifically, in the intestine, both pathways are vital 
for a correct maintenance of the stem cell niche at the base of the crypts. However, in 
the upper part of the crypts, where differentiated epithelial cells are present, both 
pathways are not required, since secretory cells need high Wnt and low Notch, while 
absorptive cells need the opposite, low Wnt and high Notch signals. It has been 
demonstrated that the canonical Wnt pathway without the Notch pathway promotes 
proliferation of stem cells and differentiation of secretory cell lineage. In contrast, when 
the Notch pathway is also active, both pathways regulate maintenance of the stem cells 
and a differentiation of progenitors into the absorptive lineage. Indeed, it has been 
reported that a pharmacological inhibition of Notch pathway with γ-secretase inhibitors 
causes an imbalance of the differentiation increasing secretory cells (Milano J. et al., 
2004). There are many studies which have revealed that both signaling pathways are 
essential in order to obtain a correct proliferation and differentiation of the intestinal 
epithelium after an injury (Nakamura T. et al., 2007; Lee G. et al., 2010; Liu S. et al., 
2013; Vanuytsel T. et al., 2013). 
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3.1. - WNT SIGNALING PATHWAY 
 
 Wnt signaling pathway is a conserved pathway that determines essential 
processes, such as cell migration, cell polarity, motility, fate proliferation and 
organogenesis, during embryonic development. This pathway is activated by Wnt 
ligands, a group of glycoproteins that, once secreted, are able to bind to the Frizzled 
receptor family. In humans, 19 members of the Wnt family ligands and 10 Frizzled 
receptors have been described.  
 
Before Wnt ligands are secreted, they are glycosylated and also palmitoilated in 
the endoplasmic reticulum due to the action of a protein called porcupine. Once it is 
modified, some Wnt proteins are involved in secretory vesicles and are secreted, 
operating over a short distance, like neuromuscular junction or stem cell niches. There 
is little evidence which suggest that Wnt ligands are also able to act over long distances 
(Komiya Y. and Habas R., 2008). 
 
Once Wnt ligands are secreted and delivered to their target cells, they are able to 
bind through their palmitate group into the cysteine-rich extracellular N-terminal 
domain of Frizzled receptors. They also bind to Lrp5/6 protein, forming a complex with 
Frizzled receptors (Figure 4). This complex triggers a conformational change in the 
receptor that allows the phosphorylation of the complex by kinases, which permits the 
release of β-catenin and its translocation into the nucleus. Both Wnt ligands and 
Frizzled receptors have been subdivided into canonical or non-canonical depending if 
they activate β-catenin or not, respectively. The hallmark of the canonical Wnt pathway 
is the translocation of the cytoplasmicβ-catenin into the nucleus and transcriptional 
regulation of genes (Clevers H. et al., 2014).  
 
When Wnt ligands are not present, there is a continuous degradation of the β-
catenin. The complex Axin and adenomatous polyposis coli (APC), protein phosphatase 
2A (PP2A), glycogen synthase kinase 3 (GSK3) and casein kinase 1α (CK1α) induce 
the phosphorylation of β-catenin. Such modification of β-catenin enables the 
ubiquitination and subsequent proteolytic destruction by proteasome. In this situation, 
the binding of the nuclear proteins Groucho to Tcf inhibits the transcription of β-catenin 
target genes. When Wnt ligands are present, such degradation of the β-catenin is 
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prevented and β-catenin is accumulated in the cytoplasm and translocates into the 
nucleus, where it controls several genes transcriptionally due to the association with Tcf 
and Lef transcription factors. This canonical pathway plays an essential role in cell fate 
decisions during early embryogenesis (Clevers H. et al., 2014). 
. 
Figure 4: Schematic representation of Wnt signaling pathway (obtained from 
Baron R. et al., 2013). 
 
 Several inhibitors have been described in the canonical Wnt pathway. On the 
one hand, the secreted Dickkopf (Dkk) proteins inhibit this pathway by directly binding 
to LRP5/6. DKK1 plays an important role by inhibiting the canonical Wnt pathway due 
to a negative-feedback loop, since it is a Wnt/β-catenin target gene. This protein has a 
C-terminal cysteine-rich domain responsible for the Wnt inhibitory function. DKK1 
inhibits the formation of the complex of LRP, Frizzled receptor and Wnt ligand through 
the interaction at the cell surface with LRP5/6, thereby promoting the internalization 
and inactivation of this receptor (Grumolato L. et al., 2010). On the other hand, there 
are some inhibitors that sequester Wnt ligands, thus triggering the inhibition of this 
pathway.Soluble Frizzled-Related Proteins (SFRPs) resemble the ligand-binding CRD 
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domain of the Frizzled family of Wnt receptors. WIF proteins are secreted molecules 
similar to the extracellular portion of the Derailed/RYK class of transmembrane Wnt 
receptors. SFRPs and WIFs work as extracellular Wnt inhibitors due to Wnt ligand 
sequestration (Clevers H., 2006). 
 
The non-canonical Wnt pathway (β-catenin independent) can be subdivided into 
two different branches: the Planar Cell Polarity pathway (PCP pathway) and the 
Wnt/Ca+2 pathway. The PCP pathway regulates both cell polarity and motility, is 
mediated through Frizzled receptors and is independent from the LRP5/6 receptor. The 
specific Frizzled co-receptors that participate in this pathway have not yet been 
identified. When Wnt ligands are present, the signal is transduced to Dsh, which 
activates Rho, actin polymerization and Rac. All of them cause cytoskeletal changes to 
cell motility and polarization during gastrulation. Regarding the Wnt/Ca+2 pathway, it 
has been reported that the Frizzled receptor activates Dsh through activation of G-
proteins that activate IP3, which produced a release of intracellular Ca+2, triggering a 
molecular pathway that ends in an inhibition of β-catenin/Tcf function. This pathway is 
involved in tissue separation and cell movements (Komiya Y. and Habas R., 2008). 
 
Among Wnt ligands, Wnt1, Wnt3a, or Wnt8 are canonical ligands, since they 
are able to activate β-catenin, whereas Wnt5a or Wnt11 are best known for non-
canonical Wnt signaling. However, it has been reported that Wnt5a and Wnt11 can also 
activate β-catenin. Therefore, the specificity of each Wnt ligand for each receptor and 
their involvement in canonical or non-canonical pathway are still unclear (Grumolato L. 
et al., 2010). 
 
3.2. - NOTCH SIGNALING PATHWAY 
 
 Notch signaling pathway is essential for the correct development of the organs 
during both embryogenesis and adult life. In addition to Wnt signaling pathway, the 
Notch pathway controls the fate of proliferation and differentiation of intestinal 
epithelial cells.  
 
Unlike Wnt ligands, Notch signaling pathway needs direct contact between 
adjacent cells. Therefore, Notch ligands are transmembrane proteins that interact 
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directly with the receptor due to a cell-cell contact. Five single-pass transmembrane 
ligands Delta-like (Dll) -1, 3 and 4 and Jagged 1 and 2- and four single-pass 
transmembrane Notch receptors (Notch 1-4) have been identified. Specifically in the 
gut, Notch1 and Notch2 are expressed in intestinal crypts, while Notch3 and Notch4 are 
expressed in mesenchymal and endothelial cells. Regarding to the expression of Notch 
ligands in the intestine, Jagged 1, Jagged 2, Dll2 and Dll4 have also been identified 
(Koch U. et al., 2013).  
 
After binding to the receptor, two proteolytic cleavages of the Notch receptor are 
detected. The first one is produced by the metalloproteases of the ADAM family (such 
as ADAM10/17) and the second by the γ-secretase complex. As a consequence of both 
cleavages, a free intracellular domain of the Notch receptor - called NICD- is generated 
and translocates into the nucleus of the target cell, where it binds with some co-
activators (such MAML1 or p300), allowing the complex the binding to the promoter 
regions of Notch target genes and activating their expression. NICD binds with RBPJ in 
the nucleus, forming a complex which activates the expression of primary target genes 
of Notch signaling such as Hes1, the main target gene of this pathway (Figure 5). When 
Notch signaling is not present and there is no NICD, a repressor complex is formed with 
additional co-repressors (such as N-CoR), which maintain the silent expression of these 
genes (Koch U. et al., 2013).  
 
Notch receptors and ligands can be influenced by a range of post-transcriptional 
modifications and other cellular processes that regulate this pathway during 
development. This pathway has been shown to be essential in differentiation, 
proliferation, apoptosis, stem cell fate and maintenance in embryonic and adult tissues. 
In recent years, there more evidence that Notch signaling pathway plays an important 
role in intestinal stem cell function. Indeed, it has been reported with animal models that 
this pathway is activated in intestinal stem cells and it is able to renew the whole crypt. 
The specific role of Notch pathway in gut homeostasis has been demonstrated with 
knock-out mice, which reveal that silencing Notch1 or Notch2 triggers a discrete 
increase of goblet cell lineage and reduced number of proliferative cells (Vanuytsel T. et 
al., 2013). 
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Figure 5: Notch signaling pathway (obtained from Amsen D. et al., 2009). 
  
 Notch signaling pathway is also crucial to determine the cell-fate decision of 
secretory or non-secretory lineage development. There are several studies that reveal a 
direct effect of this pathway on differentiation. Furthermore, Hes-1 knock-out mice 
have excessive numbers of secretory lineage cells and induce goblet cell metaplasia, 
suggesting a central role of this pathway in the regulation of the number of goblet cells. 
However, no direct effect of the Notch pathway over Paneth cells or enteroendocrine 
cells has been reported (Vooijs M. et al., 2007; Wu Y. et al., 2010). 
 
 This pathway has been studied specifically in IBD patients. UC patients showed 
an increase of proliferation, expression of NICD and a loss of goblet cells in active UC 
(Zheng X. et al., 2011). Murine models of colitis revealed contradictory results. 
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Induction of this pathway was associated with an increase in the severity of the 
pathology, weight loss and mortality. In contrast, other authors have reported that 
impairment of this pathway in an early stage of colitis reduces the damage. Of interest, 
it was reported a significant increase in Notch-1 was reported in the inflamed versus 
non-inflamed mucosa of CD patients (Vanuytsel T. et al., 2013).  
 
4. - HYPOXIA 
 
 The intestinal epithelium is anatomically positioned in order to act as a physical 
barrier between an anaerobic lumen and lamina propria, which has a high fate of 
metabolism. As a consequence, intestinal epithelial cells operate in a physiological 
oxygen gradient different to that of other cell types. In IBD, metabolic alterations 
associated with inflammation cause changes in oxygen levels, triggering hypoxia in the 
tissue. Furthermore, the intestine of IBD patients is characterized by the presence of 
several injuries that cause damage to the blood vessels, triggering an interrupted blood 
flow. The presence of hypoxia was first reported in a murine model of colitis using 
nitroimidazol, a colorant which reacts with cellular proteins to form adducts (R-NH2) 
that can be detected with labeled antibodies. The main transcription factors that are 
activated under hypoxic conditions are the Hypoxia Inducible Factors (HIF) (Colgan 
S.P. et al., 2010). 
 
 4.1. - HYPOXIA INDUCIBLE FACTORS (HIF) 
 
 Hypoxia inducible factors (HIFs) are heterodimer transcription factors composed 
of two different subunits: one α-subunit, which is oxygen sensitive, and another β-
subunit, which is expressed constitutively. Both subunits are of the Helix-Loop-Helix 
PER-ARNT-SIM (bHLH-PAS) transcription factor family. The HIF-α subunits contain 
several domains, such as an oxygen-dependent degradation (ODD) and two 
transactivation domains, which play an important role in the regulation of HIF target 
genes (Figure 6). Three different isoforms of the α-subunit have been identified in 
mammals - HIF-1α, HIF-2α and HIF-3α - which are expressed in three different 
proteins due to the presence of three splice variants. Regarding the β-subunit, three 
different subunits have also been reported - ARNT1, ARNT2 and ARNT3 -though only 
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ARNT1 is the primary HIF-1β subunit involved in hypoxia conditions (Nauta T.D. et 
al., 2014).  
 
 
 
 
Figure 6: Schematic representation of the domain structures of the HIFs (obtained 
from Nauta T.D. et al., 2014).  
 
 The oxygen-sensitive HIF-α subunits constitutively transcribed and translated; 
however, they have a really short half-life of 5 minutes due to a constitutive 
degradation. In normoxia conditions, they are hydroxylated by prolyl-hydroxilase 
enzymes (PHDs) on two proline residues in the ODD domain and in an asparagine 
residue in the C-TAD domain. As a consequence of proline hydroxylation, a binding 
site for the protein von Hippel Lindau tumor suppressor (pVHL) and for E3 ubiquitin 
ligase is formed, which triggers ubiquitination of the HIF-α subunit and its degradation 
due to the proteasome (Figure 7). On the other hand, the hydroxylation in the asparagine 
residue avoids the interaction of HIF-α and co-factors p300 and CBP, inhibiting the 
transcription of C-TAD-regulated genes. Otherwise, in hypoxic conditions, HIF-α 
subunits do not suffer hydroxylation and translocate to the nucleus, where they form a 
heterodimer with HIF-β. This complex binds to target genes due to hypoxia-responsive 
elements (HREs). It has been reported that HIF target genes regulate essential processes 
such as proliferation, apoptosis, autophagy, DNA damage response, cell migration, 
metabolism, inflammation, etc. (Nauta T.D. et al., 2014). 
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Figure 7: Regulation of HIF- subunit in normoxic and hypoxic conditions 
(obtained from Mimura I. et al., 2010).  
 
 Although HIF-1 and HIF-2 share several target genes, they also have specific 
targets. This is due to the high conservation of both sequence and domains, allowing 
them to regulate similar genes synergistically and partly compensate each other. In fact, 
C-TAD is highly homologous in HIF-1α and HIF-2α, promoting the regulation of 
several common target genes, such as GLUT1, while N-TAD is less homologous and is 
responsible for specific target genes, such as PGK or LDHA, which are regulated 
specifically only by HIF-1α, or Oct-4, cyclin D1 and transforming growth factor α 
(TGF-α) which are regulated specifically by HIF-2α (Hu C.J. et al., 2007). On the other 
hand, despite HIF-3α splice variants are homologous with HIF-1α and HIF-2α subunits, 
the lack of C-TAD and N-TAD domains of the splice variant HIF-3α363aa makes it 
incapable of inducing gene expression and act as an inhibitor of HIF-1 and HIF-2 
induced gene expression. The rest of the splice variants - HIF-3α667aa and HIF-3α669aa- 
can induce gene expression due to the presence of the C-TAD domain, but only very 
weakly (Nauta T.D. et al., 2014).  
 
 Despite the fact that HIF-1 and HIF-2 respond towards similar stimuli, they 
normally control different pathways. Indeed, whereas HIF-1 promotes the expression of 
glucose transporters and glycolytic enzymes and ROS liberation from mitochondria, 
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HIF-2 suppresses ROS accumulation by activating the expression of antioxidant 
enzymes, like superoxide dismutase-2 (SOD2) and hemeoxygenase 1 (HMOX1). In 
particular, in some processes during adult and embryonic angiogenesis, antagonistic 
effects have been reported (Nauta T.D. et al., 2014). 
 
 4.2. - HIF IN IBD 
 
 The presence of HIF in IBD has been demonstrated both in murine models of 
UC and in studies of gene expression in patients with IBD. Specifically in humans, it 
has been demonstrated that HIF1 is significantly overexpressed in the lesions of 
ischemic colitis compared with non-damaged region in the same patient or with the 
normal descending colon tissues of healthy controls (Okuda T. et al., 2005). However, 
the role of HIF in the development of this pathology is still not well understood, and, 
depending on the cell, this transcription factor can play a protective or a harmful role in 
this pathology. 
 
 In epithelial cells HIF1 plays a protective role due to the induction of genes 
which codify proteins such as mucin3, and several trefoil factors (TFF1, TFF2 and 
TFF3) that mediate defense mechanisms and tissue repair (Sturm A. and Dignass A.U., 
2008; Hernandez C. et al., 2009). Furthermore, it has been reported that mice lacking 
prolyl hydroxylase-1 in intestinal epithelial cells are less susceptible and respond better 
to an induction of colitis due to a decrease in epithelial cell apoptosis and an 
improvement of intestinal epithelial barrier function (Tambuwala M.M. et al., 2010). In 
line with this, a better function of intestinal epithelium has been reported with an 
administration of a novel hypoxia-inducible factor hydroxylase inhibitor in both DSS 
and TNBS colitis, since it ameliorated body weight loss, the survival rate and 
histological score of the intestines (Gupta R. et al., 2014). Therefore, taking into 
account all of these studies, HIF1 expressed in epithelial cells would seem to play a 
protective role in the development of IBD. 
 
 In contrast, the role of this transcription factor in cells of the lamina propria, 
such as macrophages and lymphocytes, is not well defined. In leukocytes, HIF1 
promotes leukocyte-endothelium adhesion, increasing the expression of β2 integrin. In 
contrast, the expression of HIF1 in these cells triggers an imbalance of cytokine 
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expression, thus allowing an improvement of the colitis (Higashiyama M. et al., 2012). 
In macrophages, HIF1 has been linked with the expression of pro-inflammatory 
cytokines such as TNF, iNOS or free radical species (Takeda N. et al., 2010), while it 
has also been reported that it induces the expression of molecules that mediate the 
phagocytosis of apoptotic cells, promoting the resolution of the inflammation (Dehne N. 
and Brune B., 2009). A better knowledge of the specific role of HIF1 in each cell type is 
essential in order to modulate this transcription factor in IBD. 
 
5. - AUTOPHAGY 
 
 In recent years, alterations in autophagy-related genes have been associated with 
a higher risk of IBD, which suggests autophagy as a possible target in the treatment of 
the pathology. 
 
 5.1. - BIOLOGICAL PROCESS 
 
 Autophagy is a highly conserved process that plays an important role in 
removing misfolded or aggregated proteins, intracellular pathogens and damaged 
organelles such as peroxisomes, mitochondria or endoplasmic reticulum. Furthermore, 
it can promote cell surface antigen presentation and cellular senescence, and protects 
against genome instability and necrosis. In line with this, alterations in autophagy have 
been observed in several diseases, including cancer neurodegeneration, diabetes, liver 
disease, infections and autoimmune diseases (Mizushima N. et al., 2011).  
 
 Depending on the mechanisms involved, physiological functions and the specific 
components that are degraded, there are three different types of autophagy: macro-
autophagy, micro-autophagy and chaperone-mediated autophagy (CMA). In macro-
autophagy cytosolic organelles and cytoplasmatic components are involved by a double 
membrane forming a vesicle that fuses with a lysosome and everything inside the 
vesicle is degraded. On the other hand, in micro-autophagy small components of the 
cytoplasm are directly engulfed by the lysosome. In both cases, components are 
degraded by selective and non-selective mechanisms. Finally, in CMA, only proteins 
that have a KFERQ-like pentapeptide sequence are recognized by cytosolic Hsc70 and 
cochaperones and are translocated into the lysosomal lumen due to the actuation of 
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lysosomal Lamp-2A. In all cases, the products that are obtained after degradation can be 
re-used for different purposes such as energy production, gluconeogenesis or new 
protein synthesis (Mizushima N. et al., 2011). 
 
Autophagy occurs in most cells and plays a role in maintaining cellular 
homeostasis and the integrity of cellular organelles and proteins. However, this process 
can be enhanced when nutrients are unavailable, since it promotes the survival of the 
cells under these conditions. The most important sensor of nutrients and cellular growth 
is the target of rapamycin TOR kinase, which is a sensor of numerous stimuli, including 
growth factor, ATP, insulin signaling or hypoxia. It is activated downstream of Akt 
kinase when nutrients are present, triggering the inhibition of autophagy. On the other 
hand, when the cell senses nutrient deprivation TOR kinase is repressed, thus enhancing 
the levels of autophagy. It has also been reported that hypoxia activates autophagy in a 
HIF-independent TOR inhibition downstream of AMPK. Furthermore, under hypoxia, 
autophagy may be increased in order to eliminate the excess of unfolded proteins and 
reduce the mitochondrial mass present in these conditions (Semenza G. et al., 2009). 
 
 This complex self-degradative process comprises several steps that are 
represented in figure 8. Autophagy starts with an isolation membrane, known as 
phagophore, which comes from the lipid bilayer by the endoplasmic reticulum, 
endosomes or Golgi apparatus. This phagophore expands itself and evolve the 
intracellular components that cells need to degrade, forming a double-membrane 
structure called autophagosome. The phagophore formation is regulated by energy-
sensing TOR kinase, which phosphorylates Atg13, avoiding its interaction with Atg1 
and triggering an inhibition of autophagy when nutrients are available. Next, the protein 
LC3 is processed and inserted into the extending phagophore membrane. LC3B is 
expressed in most cell types and is proteolitically cleaved by Atg4 under induction of 
autophagy, forming LC3B-I, which is activated in an ATP-dependent manner by Atg7. 
This activated LC3B-I is transferred to Atg3 and processed generating LC3B-II, which 
is integrated into the elongating phagophore in both surface membranes; hence the 
increase of LC3B-II expression under autophagic conditions (Fleming A. et al., 2011). 
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Figure 8: Schematic representation of autophagy (obtained from Fleming A. et al., 
2011). 
 
After the phagophore is elongated and has engulfed the cellular components that 
should be degraded, it fuses with a lysosome forming a structure called autophagosome, 
in which a degradation of the autophagosomal contents occurs, due to the action of 
lysosomal acid proteases. It was thought that this process is random, since 
autophagophores seem to engulf cytosolic components randomly. Nevertheless, there is 
growing evidence that the phagophore is able to recognize selectively some organelles 
or proteins. In fact, LC3B-II can interact selectively with some tag molecules, thereby 
promoting their selective degradation. One of the most important molecules that is a tag 
or adaptor is the protein p62/SQSTM1. p62 mediates the formation of protein 
aggregates destined for their degradation through autophagy due to its function as an 
adaptor, binding proteins that are ubiquitylated and delivering them to autophagosomes. 
There are other molecules, such as NBR1, which have a similar function to that of p62 
(Jiang T. et al., 2015; Fleming A. et al., 2011). 
 
The fusion of the phagophore with the lysosome forming the autophagosome 
triggers a delivery of components of the membrane fusion machinery, a decrease in the 
pH of the vesicles, and a release of lysosomal acid proteases. In this process, the 
cytoskeleton plays an important role, since its blockade with chemical agents such as 
nocadazole avoids the fusion of the phagophore with the lysosome (Webb J.L. et al., 
2004). The presence of lysosomal permeases and transporters allows the exportation of 
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amino acids and other products of degradation to the cytoplasm, where they can be used 
in cellular metabolism; hence, autophagy is thought as a kind of recycling machinery 
(Glick D. et al., 2010). 
 
 5.2. - AUTOPHAGY IN IBD 
 
 Autophagy has recently emerged as a possible target in the treatment of IBD. 
Taking into account results obtained in the GWAS studies, a defective autophagy may 
be present in these patients, which causes an impaired engulfing of the correct bacteria, 
thereby triggering a persistent inflammation characteristic of IBD patients. 
 
 The complete process of autophagy has been studied in several murine models 
of colitis by using pharmacological tools or knock-out mice. It has been recently 
reported that celastrol improves experimental colitis by activating autophagy (Zhao J. et 
al., 2015). In line with this, it has been reported that conditional Atg7-knock-out mice 
present a more severe acute and chronic colitis than WT mice due to the role played by 
autophagy in the maintenance of the gut microbiota and mucus secretion (Tsuboi K. et 
al., 2015). Therefore, there is strong evidence which confirms that autophagy is 
necessary for the correct homeostasis of the intestine and a defect in this process can 
lead to more severe inflammation, thus triggering the development of IBD. 
 
 The first autophagy-related gene associated with CD was ATG16L1, published 
in 2007 by Fujita et al. It is well known that the most frequent variant in this gene - 
rs2241880, which leads a T300A conversion - is responsible for a higher risk of CD due 
to the fact that it plays an important role in pathogen clearance, triggering an 
imbalanced cytokine production, or increasing endoplasmic reticulum stress and an 
unfolded protein response. Another autophagy-related gene associated with IBD is 
NOD2. This gene functions at the sites of bacteria entrance and recognizes pathogens 
through associated molecular patterns (AMPs), which are exposed when there is a 
breakdown of the epithelial intestinal barrier. Several genetic modifications have been 
identified in both genes and, depending on the cell type, the consequences are different. 
In myeloid cells, a defective ATG16L1 or defective NOD2 causes an enhanced 
inflammasome activation after stimulation with microbial patterns, increasing caspase-1 
activation and consecutively increasing the secretion of IL-1β and IL-18. In dendritic 
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cells and epithelial cells, this defect is associated with a profound defect in autophagy 
induction. In Paneth cells, their morphology and function is impaired, thus undermining 
granule biogenesis and the expression of α-defensin (Fritz T. et al., 2011). 
 
In addition to ATG16L1 and NOD2, other autophagy-related genes have been 
identified, such as IRGM, LRRK2, MTMR3, PTPN2 and NCF4 and ULK1, which are 
defective in IBD patients and trigger an alteration of essential processes such as 
phagosome maturation, virus-induced autophagy, bacterial killing, control of lysosomal 
store pH, autophagosome formation, phagocytosis and mTOR regulation (Henderson P. 
et al., 2012). Thus, all these genetic alterations point to a defective autophagy present in 
IBD patients. 
 
 Despite the huge amount of research carried out to date on genetic susceptibility, 
much is still not known regarding the whole process of autophagy in IBD and the 
precise molecular mechanisms that are altered which may be responsible for the 
development of this pathology. Therefore, further knowledge and research of the 
proteins involved in autophagy is required in order to take into consideration the 
autophagy as a possible target in the treatment of IBD. Furthermore, functional work is 
also needed in order to determine the potential beneficial effects that autophagy 
modulation might have in these patients. 
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&RS\ULJKW&RVtQ5RJHUHWDO7KLVLVDQRSHQDFFHVVDUWLFOHGLVWULEXWHGXQGHUWKHWHUPVRIWKH&UHDWLYH&RPPRQV$WWULEXWLRQ/LFHQVHZKLFK
SHUPLWVXQUHVWULFWHGXVHGLVWULEXWLRQDQGUHSURGXFWLRQLQDQ\PHGLXPSURYLGHGWKHRULJLQDODXWKRUDQGVRXUFHDUHFUHGLWHG
)XQGLQJ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&RPSHWLQJLQWHUHVWV7KHDXWKRUVKDYHGHFODUHGWKDWQRFRPSHWLQJLQWHUHVWVH[LVW
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GRORUHVEDUUDFKLQD#XYHV
,QWURGXFWLRQ
,QIODPPDWRU\ ERZHO GLVHDVH ,%' LV DVVRFLDWHG ZLWK
GLVUXSWLRQ RI WKH HSLWKHOLDO EDUULHU IXQFWLRQ 7KH FRQWURO RI
LQIODPPDWLRQ KDV EHHQ IRU \HDUV WKHPDLQ IRFXV RI UHVHDUFK
EXW WKHUH LV JURZLQJ DZDUHQHVV WKDW FRPSOHWH UHSDLU RI WKH
HSLWKHOLDOOD\HUPXVWEHDFKLHYHGIRUORQJWHUPUHPLVVLRQRI,%'
>±@5HJHQHUDWLRQRIWKHPXFRVDGHSHQGVRQWKHFRRUGLQDWHG
UHJXODWLRQ EHWZHHQ SUROLIHUDWLRQ DQG GLIIHUHQWLDWLRQ LQWR
HSLWKHOLDOFHOOOLQHDJHVRIWKHSURJHQLWRUFHOOVDSURFHVVWKDWLV
PDLQO\ UHJXODWHG E\ WKH :QW VLJQDOOLQJ SDWKZD\ >±@ 7KLV
SDWKZD\ LQFOXGHV D JURXS RI OLJDQGV WKDW DFW DV LQWHUFHOOXODU
VLJQDOOLQJPROHFXOHVUHJXODWLQJWKHFHOOXODUIDWHDORQJWKHFU\SW
LQ QRUPDO JXW HSLWKHOLXP DQG LQ UHVSRQVH WR HSLWKHOLDO LQMXU\
8SRQELQGLQJWRWKHLUUHFHSWRUVFDQRQLFDO:QWOLJDQGVLQGXFHG
LQDFWLYDWLRQ RI *6Nȕ DQG DFFXPXODWLRQ DQG QXFOHDU
WUDQVORFDWLRQ RI ȕFDWHQLQ ZKHUH LW HQJDJHV '1$ ERXQG 7&)
WUDQVFULSWLRQ IDFWRUV >±@ $FWLYDWLRQ RI WKH FDQRQLFDO :QW
SDWKZD\ LVREVHUYHG LQFHOOV ORFDWHGDW WKHEDVHRI WKHFU\SWV
DQG LW IXQFWLRQV WR PDLQWDLQ WKH FU\SW FHOO SRSXODWLRQ LQ D
SUROLIHUDWLYH VWDWH ZKLOH GRZQ UHJXODWHV WKH GLIIHUHQWLDWLRQ
SURFHVV
7KHUH LV VWURQJ HYLGHQFH WKDW WKH LQIODPPDWRU\
PLFURHQYLURQPHQWPRGXODWHV LQWHVWLQDOZRXQGKHDOLQJ >@
0DFURSKDJHV FRQVWLWXWH RQH RI WKH FHQWUDO FRPSRQHQWV RI
LQIODPHG WLVVXH DQG DUH FRQVLGHUHG DQ HVVHQWLDO HOHPHQW RI
UHJHQHUDWLYHUHVSRQVHV>@6HYHUDOVWXGLHVKDYHUHSRUWHG
V\QWKHVLV RI:QW OLJDQGVE\PDFURSKDJHV >@7KHVH FHOOV
H[KLELWJUHDWSODVWLFLW\DQGLWKDVEHHQSURSRVHGWKHH[LVWHQFH
RI WZRPDFURSKDJHVXEVHWVZKLFKGLIIHUVXEVWDQWLDOO\ LQ WHUPV
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RI UHFHSWRU H[SUHVVLRQ HIIHFWRU IXQFWLRQ DQG F\WRNLQH
SURGXFWLRQ >@ 0 RU FODVVLFDOO\ DFWLYDWHGPDFURSKDJHV
DUH FKDUDFWHUL]HG E\ WKH H[SUHVVLRQ RI KLJK OHYHOV RI SUR
LQIODPPDWRU\ F\WRNLQHV DQG PHGLDWH DQWLWXPRU LPPXQLW\ DQG
GHIHQFHRI WKHKRVW IURPPLFURRUJDQLVPV2Q WKHRWKHUKDQG
0 RU DOWHUQDWLYHO\ DFWLYDWHG PDFURSKDJHV H[SUHVV KLJK
OHYHOV RI DQWLLQIODPPDWRU\ F\WRNLQHV DQG VFDYHQJLQJ
PROHFXOHV ZKLOH H[HUWLQJ DQWLLQIODPPDWRU\ DFWLRQV DQG
UHJXODWLQJZRXQGKHDOLQJ'HVSLWHWKHVHLPSRUWDQWGLIIHUHQFHV
WKHSRODUL]DWLRQRIPDFURSKDJHVLVQRWGHILQLWLYHDVWKH\UHWDLQ
WKHFDSDFLW\WRFRQYHUWLQWRWKHRWKHUSKHQRW\SHLQDFFRUGDQFH
ZLWK WKH ORFDO PLFURHQYLURQPHQW 0XFRVDO PLFURHQYLURQPHQW
FDQ YDU\ GUDPDWLFDOO\ GHSHQGLQJ RQ WKH IRUP RI KXPDQ ,%'
8OFHUDWLYH FROLWLV 8&RU&URKQ
VGLVHDVH &' WKH FKURQLFLW\
RUWKHVWDJHRIWKHGLVHDVH+RZHYHUWKHUHLV OLWWOHNQRZOHGJH
RIWKHDFWLYDWLRQSDWWHUQRIPDFURSKDJHVLQWKLVSDWKRORJ\DQG
LWVVLJQLILFDQFHIRULQWHVWLQDOPXFRVDOKHDOLQJ
7KHSXUSRVHRIWKLVVWXG\ZDVWRDQDO\VHWKHLQYROYHPHQWRI
WKHPDFURSKDJHSKHQRW\SH LQ WKHDFWLYDWLRQRI:QW VLJQDOOLQJ
SDWKZD\V LQ LQWHVWLQDO HSLWKHOLDO FHOOV DQG WR HYDOXDWH LWV
UHOHYDQFH LQ WKH PXFRVD RI 8& SDWLHQWV :H IRXQG WKDW LQ
FRQWUDVWWR0PDFURSKDJHV0PDFURSKDJHVRYHUH[SUHVVHG
:QWOLJDQGVDQGDFWLYDWHG:QWVLJQDOOLQJSDWKZD\VLQHSLWKHOLDO
FHOOVZKLFKUHGXFHGPDUNHUVRIGLIIHUHQWLDWLRQ,QWKHGDPDJHG
PXFRVD RI 8& SDWLHQWV WKH QXPEHU RI 0 PDFURSKDJHV
LQFUHDVHGZLWKFKURQLFLW\DQG LWZDVDVVRFLDWHGZLWKDFWLYDWLRQ
RI :QW VLJQDOOLQJ SDWKZD\V DQG GLPLQXWLRQ LQ HQWHURF\WH
GLIIHUHQWLDWLRQ
0DWHULDODQG0HWKRGV
&HOOFXOWXUH
&DFR FHOOV $PHULFDQ 7\SH &XOWXUH &ROOHFWLRQ 9$ 86$
ZHUH FXOWXUHG LQ0(0PHGLXP 6LJPD$OGULFK VXSSOHPHQWHG
ZLWK LQDFWLYDWHGERYLQH IRHWDO VHUXP8POSHQLFLOOLQ
 ȝJPO VWUHSWRP\FLQ  P0 /JOXWDPLQH  P0 VRGLXP
S\UXYDWH DQG  RI QRQHVVHQWLDO DPLQR DFLGV +7
$PHULFDQ7\SH&XOWXUH&ROOHFWLRQ9$86$ZHUHFXOWXUHGLQ
0F&R\¶V0HGLXP0RGLILHG 6LJPD$OGULFKVXSSOHPHQWHGZLWK
 LQDFWLYDWHG ERYLQH IRHWDO VHUXP 8PO SHQLFLOOLQ 
ȝJPOVWUHSWRP\FLQDQGP0/JOXWDPLQH:KHQDSSURSULDWHG
HSLWKHOLDO FHOOV ZHUH WUHDWHG ZLWK H[RJHQRXV :QW QJPO
6LJPD$OGULFK
8 KXPDQ PRQRF\WHV (XURSHDQ &ROOHFWLRQ RI &HOO
&XOWXUH6DOLVEXU\8.ZHUHFXOWXUHGLQ530,PHGLXP6LJPD
$OGULFK&26W/RXLV02ZLWK LQDFWLYDWHGERYLQH IRHWDO
VHUXP )%6 /RQ]D %DVHO 6ZLW]HUODQG  8PO SHQLFLOOLQ
DQG  ȝJPO VWUHSWRP\FLQ 8 PRQRF\WHV ZHUH
GLIIHUHQWLDWHG LQWR PDFURSKDJHV E\ FXOWXULQJ WKHP LQ WKH
SUHVHQFH RI SKRUEROP\ULVWDWHDFHWDWH 30$ 6LJPD
$OGULFK IRU  K>@ 8GHULYHG PDFURSKDJHV ZHUH
VWLPXODWHGZLWK/36JPO(FROL%DQG,)1Ȗ
QJPORUZLWK,/QJPOLQRUGHUWRSRODUL]HWKHPWRZDUGV
0 RU 0 SKHQRW\SHV UHVSHFWLYHO\ 7R GHWHUPLQH WKH PRVW
HIIHFWLYH SHULRG IRU SRODUL]DWLRQ WKH H[SUHVVLRQ RI VHYHUDO
PDUNHUVZDVDQDO\]HGDWGLIIHUHQWWLPHSRLQWV
DQGKRXUV
51$LQWHUIHUHQFHDQGFHOOXODUWUDQVIHFWLRQ
8GHULYHG PDFURSKDJHV FHOOV ZHUH WUDQVIHFWHG ZLWK D
YHFWRUWDUJHWLQJ KXPDQ :QW PL:QW WDUJHWLQJ VHTXHQFH
¶7*$&77*77$$$&$*$&7*&*$$¶ *HQ%DQN $FFHVVLRQ
1R 10B RU D QRQWDUJHWLQJ FRQWURO YHFWRU PRFN
/LSRIHFWDPLQH ,QYLWURJHQ /LIH 7HFKQRORJLHV %DUFHORQD
6SDLQ ZDV HPSOR\HG DV D WUDQVIHFWLRQ UHDJHQW DQG XVHG DV
SUHYLRXVO\ UHSRUWHG >@ 6L[WHHQ KRXUV SRVWWUDQVIHFWLRQ
PDFURSKDJHV ZHUH SRODUL]HG LQWR 0 PDFURSKDJHV DV
GHVFULEHGDERYH7KHHIILFLHQF\RIWUDQVIHFWLRQZDVGHWHUPLQHG
E\DQDO\]LQJWKH:QWP51$H[SUHVVLRQE\T3&5
&RFXOWXUH
&DFRFHOOVZHUHFRFXOWXUHGZLWK8PDFURSKDJHVXVLQJ
7UDQVZHOO LQVHUWV&RUQLQJ,QFRUSRUDWHG0$86$ZLWKD
P SRURXVPHPEUDQH >@ 8GHULYHGPDFURSKDJHV ZHUH
VHHGHG RQ WKH LQVHUWV DQG GLIIHUHQWLDWHG SURSHUO\ $IWHUZDUGV
WKH LQVHUWV ZHUH SODFHG RQ WRS RI &DFR FHOOV DQG ZHUH
PDLQWDLQHG LQ FRFXOWXUH IRU  KRXUV :KHQ DSSURSULDWHG
&DFRFHOOVZHUHWUHDWHGZLWKWKHLQKLELWRURIWKH:QWSDWKZD\
;$906LJPD$OGULFKRUZLWK:QWQJPO6LJPD
$OGULFK
,VRODWLRQRIPRQRQXFOHDUFHOOV
+XPDQ SHULSKHUDO EORRG PRQRQXFOHDU FHOOV ZHUH LVRODWHG
IURPKHDOWK\GRQRUVDQG8&SDWLHQWVE\)LFROOGHQVLW\JUDGLHQW
FHQWULIXJDWLRQ DW J GXULQJ  PLQXWHV 0RQRF\WHGHULYHG
PDFURSKDJHV 0'0V ZHUH REWDLQHG IURP PRQRF\WHV ZKLFK
ZHUH VHHGHG LQ ZHOO WLVVXH FXOWXUH SODWHV DQG GLIIHUHQWLDWHG
LQWR PDFURSKDJHV E\ FXOWXULQJ WKHP LQ ;9LYR  PHGLXP
/RQ]D %DVHO 6ZLW]HUODQG VXSSOHPHQWHG ZLWK  KXPDQ
VHUXP8POGHSHQLFLOOLQȝJPOVWUHSWRP\FLQDQG
QJPOUHFRPELQDQWKXPDQ0&6)3HSURWHFK/RQGRQ8.DW
& LQ  &2 IRU  GD\V ,Q RUGHU WR REWDLQ DQ 0
SRODUL]DWLRQ FHOOV ZHUH LQFXEDWHG ZLWK JPO /36 IURP
(VFKHULFKLD FROL % SOXV  QJPO KXPDQ UHFRPELQDQW
,)1Ȗ IRU WKH ODVW  KRXUV 0 SRODUL]DWLRQ ZDV REWDLQHG E\
WUHDWLQJ FHOOVZLWK QJPO RI KXPDQ UHFRPELQDQW ,/ IRU WKH
ODVWKRXUVRIWKHFXOWXULQJSHULRG
3DWLHQWV
$ JURXS RI FKURQLF SDWLHQWV ZLWK XOFHUDWLYH FROLWLV 8& DQG
QHZO\ GLDJQRVHG 8& SDWLHQWV XQGHUZHQW D FRORQRVFRS\ RU
VLJPRLGRVFRS\ GXULQJ ZKLFK PXOWLSOH ELRSV\ VSHFLPHQV ZHUH
WDNHQ IURP GDPDJHG DQG QRQGDPDJHG PXFRVD 7DEOH 6
&OLQLFDO GLVHDVH DFWLYLW\ ZDV GHWHUPLQHG E\ WKH 0D\R &OLQLF
,QGH[ DQG LQ DOO FDVHV DFWLYH GLVHDVH ZDV REVHUYHG
+LVWRORJLFDODQDO\VLVRIWKHGDPDJHGPXFRVDZDVSHUIRUPHGLQ
UHSUHVHQWDWLYH  P VHFWLRQV RI SDUDIILQHPEHGGHG WLVVXH
VWDLQHG ZLWK KHPDWR[LOLQ DQG HRVLQH 6HFWLRQV ZHUH VFRUHG
KLVWRORJLFDOO\ E\ SHUVRQQHO EOLQGHG WR WKH FOLQLFDO LQIRUPDWLRQ
DFFRUGLQJ WR D VFDOH RI  LQWDFW PXFRVD DQG QRUPDO YLOORXV
PXFRVDO VXUIDFH  GLODWHG FU\SWV EUDQFKLQJ FU\SWV 
LQFUHDVHG LQWHUFU\SW GLVWDQFH RU  QHDU DEVHQFH RI FU\SWV
&RORQLF VXUJLFDO UHVHFWLRQV IURP ERWK GDPDJHG DQG QRQ
GDPDJHGPXFRVDZHUHDOVRREWDLQHGIURP8&SDWLHQWVQ 
00DFURSKDJHV$FWLYDWH(SLWKHOLDO:176LJQDOLQJ
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,PPXQRKLVWRFKHPLFDOVWXGLHV
,PPXQRVWDLQLQLJ IRU &' &' &' ȕFDWHQLQ :QW
DQG F0\F ZDV SHUIRUPHG LQ  P VHFWLRQV RI SDUDIILQ
HPEHGGHGFRORQLFWLVVXHV7DEOH$KRUVHDQWLPRXVHUDEELW
ELRWLQ\ODWHG DQWLERG\ 9HFWRU /DERUDWRULHV &$ 86$ 
ZDV XVHG DV D VHFRQGDU\ DQWLERG\ 7KH 9(&7$67$,1 HOLWH
$%&V\VWHP.LW9HFWRU/DERUDWRULHVZDVHPSOR\HGIRUVLJQDO
GHYHORSPHQW$OOWLVVXHVZHUHFRXQWHUVWDLQHGZLWKKHPDWR[\OLQ
DQGWKHVSHFLILFLW\RIWKHLPPXQRVWDLQLQJZDVFRQILUPHGE\WKH
DEVHQFH RI SULPDU\ RU VHFRQGDU\ DQWLERGLHV 4XDQWLWDWLYH
DQDO\VLVRIPDFURSKDJHVZDVSHUIRUPHGLQDQDUHDRIPP
7KHVRIWZDUH ,PDJH- 1DWLRQDO ,QVWLWXWHVRI+HDOWK%HWKHVGD
0' 86$ ZDV XVHG WR TXDQWLI\ WKH LQWHQVLW\ RI ȕFDWHQLQ
VWDLQLQJ 7KUHH UHSUHVHQWDWLYH FU\SWV RI HDFK VDPSOH ZHUH
HYDOXDWHG DQG UHVXOWV ZHUH QRUPDOL]HG WR WKH DUHD RI HDFK
FU\SW
'RXEOH,PPXQRKLVWRFKHPLVWU\
$IWHU YLVXDOL]DWLRQ RI WKH H[SUHVVLRQ RI WKH ILUVW SULPDU\
DQWLERG\:QWZLWK'$%VHFWLRQVZHUHZDVKHG LQ3%6DQG
H[FHVVRIELRWLQDQGDYLGLQZHUHEORFNHGZLWK'DNR&\WRPDWLRQ
%LRWLQ%ORFNLQJ6\VWHP'DNR%DUFHORQD6SDLQ7LVVXHVZHUH
EORFNHGDQGZHUH LQFXEDWHGZLWKWKHVHFRQGSULPDU\DQWLERG\
&' $IWHU LQFXEDWLRQ ZLWK WKH VHFRQGDU\ DQWLERG\ WKH
VHFRQG VLJQDO ZDV GHYHORSHG ZLWK 9HFWRU 3XUSOH 9HFWRU
/DERUDWRULHV 7KH VSHFLILFLW\ RI WKH LPPXQRVWDLQLQJ ZDV
FRQILUPHGE\WKHDEVHQFHRIERWKSULPDU\DQWLERGLHV
7DEOH  6SHFLILF DQWLERGLHV XVHG IRU ERWK
LPPXQRKLVWRFKHPLFDOVWXGLHVDQG:HVWHUQEORWDQDO\VLV
$QWLERG\ ,PPXQRKLVWRFKHPLVWU\ 
:HVWHUQ
EORW
 $QWLJHQ5HWULHYDO
$QWLERG\
GLOXWLRQ
$QWLERG\
GLOXWLRQ
&'%LROHJHQG
0DGULG6SDLQ ĮFK\PRWU\SVLQ&PLQ  
F0\F6DQWD&UX]
%LRWHFKQRORJ\
+HLGHOEHUJ*HUPDQ\
VRGLXPFLWUDWHEXIIHUS+ 
&PLQ  
:QW6LJPD$OGULFK
&26W/RXLV02
VRGLXPFLWUDWHEXIIHUS+ 
&PLQ  
&'
(SLWRPLFV
%XUOLQJDPH &$
86$
ĮFK\PRWU\SVLQ&PLQ  
&'6LJPD$OGULFK VRGLXPFLWUDWHEXIIHUS+ &PLQ  
ȕFDWHQLQ6LJPD
$OGULFK
VRGLXPFLWUDWHEXIIHUS+ 
&PLQ  
ȕDFWLQ6LJPD$OGULFK   
1XFOHROLQ6LJPD
$OGULFK   
GRLMRXUQDOSRQHW
3URWHLQH[WUDFWLRQZHVWHUQEORWDQDO\VLVDQG
LPPXQRSUHFLSLWDWLRQ
(TXDO DPRXQWV RI SURWHLQ IURP8PDFURSKDJHV&DFR
FHOOV RU FRORQLF WLVVXHZHUH ORDGHGRQWR6'63$*(JHOV DQG
DQDO\]HG E\ :HVWHUQ EORW DV GHVFULEHG SUHYLRXVO\ >@ 7R
GHWHUPLQH QXFOHDU ȕFDWHQLQ SURWHLQV ZHUH H[WUDFWHG E\
VRQLFDWLRQ RI QXFOHDU SHOOHWV IROORZHG E\ FHQWULIXJDWLRQ
0HPEUDQHV ZHUH LQFXEDWHG RYHUQLJKW DW & ZLWK GLIIHUHQW
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SURWHLQ H[SUHVVLRQ RI QXFOHDU ȕFDWHQLQ E\ ZHVWHUQ EORW Q  DQG P51$ H[SUHVVLRQ RI /JU Q  DQG F0\F Q  7ZR
UHSUHVHQWDWLYH ZHVWHUQ EORWV VKRZLQJ QXFOHDU ȕFDWHQLQ LQ &DFR FHOOV %DUV UHSUHVHQW PHDQ6(0 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SRODUL]HGPDFURSKDJHV3YV0PDFURSKDJHVWUDQVIHFWHGZLWKPRFNDQG	3DQG		3YV&DFRFHOOVFRFXOWXUHG
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&' GHPRQVWUDWLQJ WKH H[SUHVVLRQ RI :QW E\ 0
PDFURSKDJHVLQWKHPXFRVDRI8&SDWLHQWV)LJXUH%
,PPXQRKLVWRFKHPLVWU\IRUȕFDWHQLQVKRZHGWKHSUHVHQFHRI
QXFOHDUVWDLQLQJLQHSLWKHOLDOFHOOVRIWKHPXFRVDORFDWHGDWWKH
EDVHRIWKHFU\SWVDQGLWGHFUHDVHGDVFHOOVPRYHWRZDUGVWKH
WRS RI WKH FU\SWV )LJXUH & 7KH GHWHFWLRQ RI QXFOHDU
LPPXQRVWDLQLQJRIF0\FLQHSLWKHOLDOFHOOVRIWKHVDPHFU\SWLQ
FRQVHFXWLYHVOLGHV)LJXUH&VXJJHVW WKDW WKH:QWVLJQDOOLQJ
SDWKZD\LVDFWLYHLQHSLWKHOLDOFHOOVRIWKHGDPDJHGPXFRVDRI
8& SDWLHQWV $ TXDQWLWDWLYH DQDO\VLV UHYHDOHG D VLJQLILFDQW
LQFUHDVH LQ ERWK WRWDO DQG QXFOHDU SURWHLQ OHYHOV RI ȕFDWHQLQ
)LJXUH ' DQG P51$ H[SUHVVLRQ RI /JU DQG F0\F LQ
GDPDJHG PXFRVD YV QRQGDPDJHG PXFRVD )LJXUH ) ,Q
DGGLWLRQ LPPXQRSUHFLSLWDWLRQ H[SHULPHQWV UHYHDOHG DQ
LQFUHDVH RI ȕFDWHQLQ ERXQG WR 7FI LQ GDPDJHGPXFRVD YV
QRQGDPDJHG )LJXUH ( IXUWKHU UHLQIRUFLQJ WKDW :QW
VLJQDOOLQJSDWKZD\LVVWLPXODWHGLQWKHGDPDJHGWLVVXH
7KHVSHFLILFVWXG\RI:QWVLJQDOOLQJLQWKHGDPDJHGPXFRVD
KLJKOLJKWHG D UHODWLRQVKLS EHWZHHQ 0 PDFURSKDJHV DQG
HSLWKHOLDO :QW SDWKZD\ 4XDQWLILFDWLRQ RI ȕFDWHQLQ VWDLQLQJ
UHYHDOHG D KLJKHU LQWHQVLW\ LQ WKH GDPDJHG WKDQ LQ WKH QRQ
GDPDJHGPXFRVD DQG UHVXOWV VKRZD SRVLWLYH DQG VLJQLILFDQW
FRUUHODWLRQ EHWZHHQ WKH QXPEHU RI0PDFURSKDJHV DQG WKH
LQWHQVLW\RIHSLWKHOLDOȕFDWHQLQVWDLQLQJ)LJXUH*
'LVFXVVLRQ
7KH SUHVHQW VWXG\ GHPRQVWUDWHV WKH VHOHFWLYH LQGXFWLRQ RI
:QW OLJDQGVE\0PDFURSKDJHVDQGWKHDELOLW\RI WKHVHFHOOV
WRDFWLYDWH:QWVLJQDOOLQJSDWKZD\VDQGWRGHFUHDVHHQWHURF\WH
GLIIHUHQWLDWLRQLQDGMDFHQWHSLWKHOLDOFHOOV
7KH :QW VLJQDOOLQJ SDWKZD\ SOD\V D IXQGDPHQWDO UROH LQ
LQWHVWLQDO HSLWKHOLDO SUROLIHUDWLRQ DQG GLIIHUHQWLDWLRQ >±@ DQG
WKH LQGXFWLRQ RI :QW OLJDQGV E\ PDFURSKDJHV KDV UHFHQWO\
EHHQ UHSRUWHG WREH FULWLFDO IRU WKH UHSDLU DQG UHJHQHUDWLRQRI
RWKHUWLVVXHV>@2XUGDWDHQGRUVHWKLVFRQFHSWDQGH[SDQGLW
E\ UHYHDOLQJ D VHOHFWLYH SURILOH RI H[SUHVVLRQ RI :QW DQG
:QWD E\ 0 PDFURSKDJHV DQG QRW E\ 0 FHOOV RU QRQ
SRODUL]HGPDFURSKDJHV7KLVLVDFRQVLVWHQWREVHUYDWLRQVLQFH
LW LVREVHUYHG LQPRQRF\WHGHULYHGPDFURSKDJHV IURPKHDOWK\
GRQRUV DQG ,%' SDWLHQWV DVZHOO DV LQ D KXPDQ FHOO OLQH DQG
VXJJHVWVWKDWDVLJQDOOLQJSDWKZD\VSHFLILFDOO\DFWLYDWHGE\WKH
LQGXFWRURI0SRODUL]DWLRQ ,/ LQPDFURSKDJHVUHJXODWH WKH
LQGXFWLRQ RI :QW OLJDQGV ,Q WKLV OLQH D SUHYLRXV VWXG\ KDV
UHSRUWHGDFWLYDWLRQE\ ,O RI62; >@ D WUDQVFULSWLRQ IDFWRU
WKDWKDVEHHQUHODWHGWRWKHLQGXFWLRQRI:QW>@7KHSUHVHQW
VWXG\GHPRQVWUDWHV IRU WKH ILUVW WLPH WKDW WKH LQGXFWLRQRI:QW
OLJDQGV E\ PDFURSKDJHV LV VHOHFWLYHO\ PRGXODWHG E\ WKHLU
SKHQRW\SH
,Q WKH LQWHVWLQDO PXFRVD PDFURSKDJHV DUH VWUDWHJLFDOO\
SRVLWLRQHG WR PDLQWDLQ FRPPXQLFDWLRQ ZLWK HSLWKHOLDO FHOOV
)LJXUH  0PDFURSKDJHV GHFUHDVH DONDOLQH SKRVSKDWDVH DFWLYLW\ WKURXJK:QW VLJQDOOLQJ SDWKZD\V  $ *UDSKV VKRZ
DONDOLQHSKRVSKDWDVHDFWLYLW\LQ&DFRFHOOVFRFXOWXUHGZLWKPDFURSKDJHVRUZLWKDQHPSW\LQVHUWQ 6RPHFHOOVZHUHWUHDWHG
ZLWK;$90Q %DUVUHSUHVHQWPHDQ6(03YV&DFRFHOOVFRFXOWXUHGZLWKDQHPSW\LQVHUWDQG3YV
&DFRFHOOVFRFXOWXUHGZLWK0PDFURSKDJHV%*UDSKVVKRZDONDOLQHSKRVSKDWDVHDFWLYLW\LQ&DFRFHOOVDQG+7FHOOVK
DIWHUWUHDWPHQWZLWK:QWQJPO%DUVUHSUHVHQWPHDQ6(0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>@ ,Q WKH SUHVHQW VWXG\ FRFXOWXUH RIPDFURSKDJHV LQ
FORVH SUR[LPLW\ ZLWK HSLWKHOLDO FHOOV UHYHDOHG WKDW WKH IRUPHU
PRGXODWHWKHODWWHU LQZKDWDSSHDUHGWREHDSDUDFULQHDFWLRQ
6SHFLILFDOO\ 0 PDFURSKDJHV DQG QRW 0 RU QRQSRODUL]HG
PDFURSKDJHVVLJQLILFDQWO\LQFUHDVHGWKHQXFOHDUH[SUHVVLRQRI
ȕFDWHQLQ WKH FHQWUDO FRPSRQHQW RI WKH FDQRQLFDO :QW
SDWKZD\ WKURXJK:QW ,QWHUHVWLQJO\ WKHDPRXQWRIȕFDWHQLQ
ERXQG WR 7FI WKH PDLQ WUDQVFULSWLRQ IDFWRU LQYROYHG LQ WKH
H[SUHVVLRQ RI :QW WDUJHW JHQHV ZDV DOVR LQFUHDVHG E\ 0
FHOOVDVZHOODVWKHP51$H[SUHVVLRQRI/JUDQGF0\F>@
ZKLFK VWURQJO\ VXJJHVWV WKDW 0PDFURSKDJHV DUH DFWLYDWLQJ
WKH :QW VLJQDOOLQJ SDWKZD\ LQ HSLWKHOLDO FHOOV ,W KDV EHHQ
SURSRVHGDUROHIRUWKH:QWF0\FSDWKZD\DVDQLQWUDFHOOXODU
PROHFXODU VZLWFK EHWZHHQ SUROLIHUDWLRQ DQG GLIIHUHQWLDWLRQ >@
2XU UHVXOWV UHYHDOHG WKDW 0 PDFURSKDJHV SURIRXQGO\
GHFUHDVHG$3DFWLYLW\ LQ&DFRFHOOVZKLFKSURSRVHVWKDWWKH
VSRQWDQHRXVGLIIHUHQWLDWLRQRI WKHVHFHOOVDORQJWKHDEVRUSWLYH
FHOO OLQHDJH >@ LV LPSDLUHG E\ 0 PDFURSKDJHV
)XUWKHUPRUHWKLVHIIHFWZDVPHGLDWHGWKURXJKWKHDFWLYDWLRQRI
FDQRQLFDO :QW SDWKZD\V VLQFH LW ZDV SUHYHQWHG E\
GHVWDELOL]DWLRQRIHSLWKHOLDOȕFDWHQLQZLWK;$9>@7KHUROH
RI :QW VLJQDOOLQJ LQ GLPLQLVKLQJ HQWHURF\WH GLIIHUHQWLDWLRQ LV
IXUWKHU UHLQIRUFHG E\ VKRZLQJ WKDW WKH H[RJHQRXV
DGPLQLVWUDWLRQRI:QW WR WZRGLIIHUHQW FHOO OLQHV&DFRFHOOV
DQG+7 FHOOV VLJQLILFDQWO\ UHGXFHG$3 DFWLYLW\ $V DZKROH
RXUUHVXOWVVXJJHVWWKDWDFWLYDWLRQRIȕFDWHQLQLQHSLWKHOLDOFHOOV
UHSUHVV WKHH[SUHVVLRQRI JHQHVDVVRFLDWHGZLWK WKHRQVHW RI
FHOOGLIIHUHQWLDWLRQ>@
:H IXUWKHU DQDO\VHG WKH SDWKRSK\VLRORJLFDO UHOHYDQFH RI
WKHVHSDWKZD\V LQ WKHPXFRVDRI8&SDWLHQWV$FRPSDUDWLYH
DQDO\VLV SHUIRUPHG LQ WKH GDPDJHG PXFRVD RI QHZO\
GLDJQRVHGDQGFKURQLF8&SDWLHQWVUHYHDOHGWKDWWKHQXPEHURI
&'SRVLWLYHFHOOVZDVVLJQLILFDQWO\KLJKHULQWKHODWWHUWKDQLQ
WKH IRUPHU 7KHVH UHVXOWV VXJJHVW WKDW WKH QXPEHU RI
PDFURSKDJHVLQWKHPXFRVDRI8&SDWLHQWVLQFUHDVHVZLWKWKH
FKURQLFLW\DQGLWLVQRWRQO\UHODWHGZLWKWKHVHYHULW\RIGDPDJH
VLQFH ERWK FKURQLF DQG QHZO\ GLDJQRVHG SDWLHQWV H[KLELWHG D
VLPLODUKLVWRORJLFDOGDPDJH,QERWKJURXSVRISDWLHQWVDVOLJKW
LQFUHDVH LQ WKH QXPEHU RI &' FHOOV ZDV REVHUYHG LQ WKH
GDPDJHG DUHD ZKLFK VHHPV WR EH WKH FRQVHTXHQFH RI WKH
LQFUHDVH LQ WKH WRWDO DPRXQW RI PDFURSKDJHV VLQFH QR
GLIIHUHQFHVLQWKHSURSRUWLRQ&'&'FHOOVZHUHGHWHFWHG
EHWZHHQWKHQRQGDPDJHGDQGGDPDJHGPXFRVD+RZHYHUD
VLJQLILFDQWLQFUHDVHLQERWKWKHQXPEHURI&'FHOOVDQGWKH
SURSRUWLRQ RI &'&' PDFURSKDJHV ZDV LGHQWLILHG LQ
WKH GDPDJHGPXFRVD RI FKURQLF SDWLHQWV FRPSDUHG ZLWK WKH
QRQGDPDJHG WLVVXH 7KLV HIIHFW ZDV QRW REVHUYHG LQ WKH
PXFRVD RI QHZO\ GLDJQRVHG SDWLHQWVZKLFK VXJJHVWV WKDW WKH
QXPEHU RI &' FHOOV LQ WKH GDPDJHG PXFRVD LQFUHDVHV
ZLWKWKHFKURQLFLW\RIWKHGLVHDVH7KHVHUHVXOWVVHHPWREHLQ
DSSDUHQW FRQWUDGLFWLRQZLWK SUHYLRXV VWXGLHV VKRZLQJ WKDW WKH
SHUFHQWDJH RI &'&' FHOOV GHFUHDVHV DV GDPDJH
)LJXUH +LVWRORJLFDOVFRUH LQ WKHPXFRVDRISDWLHQWVZLWK8& $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LQFUHDVHV >@ ,Q RQH RI WKRVH VWXGLHV FRPSDULVRQV ZHUH
SHUIRUPHG EHWZHHQ DFWLYH DQG LQDFWLYH &URKQ
V GLVHDVH
SDWLHQWVDQG LQ WKHRWKHURQH LQ WKHVDPH ,%'SDWLHQWEHIRUH
DQGDIWHUUHFHLYLQJSKDUPDFRORJLFDOWUHDWPHQW+RZHYHUDVIDU
DVZHNQRZ WKHSUHVHQW VWXG\FRPSDUHV IRU WKH ILUVW WLPH WKH
GDPDJHGDQGQRQGDPDJHGPXFRVDRI WKHVDPHSDWLHQWDQG
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Abstract
Macrophage infiltration is a negative prognostic factor for most cancers but gastrointestinal tumors seem to be an
exception. The effect of macrophages on cancer progression depends on their phenotype, which may vary between M1
(pro-inflammatory, defensive) to M2 (tolerogenic, pro-tumoral). Gastrointestinal cancers often become an ectopic source of
gastrins and macrophages present receptors for these peptides. The aim of the present study is to analyze whether gastrins
can affect the pattern of macrophage infiltration in colorectal tumors. We have evaluated the relationship between gastrin
expression and the pattern of macrophage infiltration in samples from colorectal cancer and the influence of these peptides
on the phenotype of macrophages differentiated from human peripheral monocytes in vitro. The total number of
macrophages (CD68+ cells) was similar in tumoral and normal surrounding tissue, but the number of M2 macrophages
(CD206+ cells) was significantly higher in the tumor. However, the number of these tumor-associated M2 macrophages
correlated negatively with the immunoreactivity for gastrin peptides in tumor epithelial cells. Macrophages differentiated
from human peripheral monocytes in the presence of progastrin showed lower levels of M2-markers (CD206, IL10) with
normal amounts of M1-markers (CD86, IL12). Progastrin induced similar effects in mature macrophages treated with IL4 to
obtain a M2-phenotype or with LPS plus IFNc to generate M1-macrophages. Macrophages differentiated in the presence of
progastrin presented a reduced expression of Wnt ligands and decreased the number and increased cell death of co-
cultured colorectal cancer epithelial cells. Our results suggest that progastrin inhibits the acquisition of a M2-phenotype in
human macrophages. This effect exerted on tumor associated macrophages may modulate cancer progression and should
be taken into account when analyzing the therapeutic value of gastrin immunoneutralization.
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Introduction
Macrophages are a significant component of tumors and display
a variety of functions depending on the local environment. They
can be pro-inflammatory and help to generate adaptive immune
responses (classically activated macrophages, M1) or tolerogenic/
anti-inflammatory (alternatively activated macrophages, M2)
[1,2]. Tumor associated-macrophages (TAMs) often resemble
M2-macrophages and, therefore, instead of fighting against
cancerous cells, these leukocytes promote tumor growth by
dampening the immune response and through the secretion of
growth and angiogenic factors as well as the enzymes necessary for
cell invasion. As a consequence, the presence of TAMs has been
correlated with a decreased survival in patients with e.g.
melanoma, breast, kidney or bladder cancer. The situation seems
to be different in some cancerous processes affecting the
gastrointestinal tract. In patients with colorectal or gastric cancers
a higher macrophage infiltration correlates with a better prognosis
[3]. The reasons for this differential role of macrophages in these
particular diseases is far from clear, but from the current
knowledge one can infer that the colorectal/gastric tumor
microenvironment marks a different equilibrium in the function
of infiltrated M1 and M2 macrophages, with M2 macrophages
exerting a defective opposition to the accompanying M1-
phagocytes [4,5]. However, the mechanisms responsible for this
effect are unknown.
Most adenomatous polyps, colorectal and gastric tumors express
ectopically the gastrin gene. However, these cancer cells are not of
an endocrine nature and mainly synthesize the hormone precursor
progastrin [6–8], which has proliferative action on cancer cells [9].
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Although progastrin may bind with low affinity to gastrin CCK-2
receptors and this interaction may contribute to some extent to its
biological activity [10], progastrin’s growth-promoting effect
appears to be mainly mediated by a non-conventional receptor
recently identified as annexin II [9]. We have observed that gastrin
exerts a pro-inflammatory activity through CCK-2 receptors [11–
13], which are expressed in macrophages and endothelial cells,
while annexin II is highly expressed on the surface of
macrophages, where it serves as a pathogen recognition element
and mediates macrophage activation [14].
Our hypothesis was that gastrin peptides locally produced in
colonic tumors can influence the function of infiltrated macro-
phages and, in this way, modulate the immune response to disease.
We observed that the expression of gastric peptides in colorectal
tumor cells correlates with a reduced infiltration of M2-macro-
phages and showed that progastrin modulates the maturation
process of human macrophages in vitro, and represses the
acquisition of a M2-phenotype. Progastrin also reduced the
secretion of Wnt ligands by M2-macrophages and increased their
ability to induce apoptosis of colon cancer epithelial cells.
Methods
Patients
Twenty-one curatively resected colorectal carcinoma patients
(Table 1) were selected randomly from patients operated at the
Hospital de Manises. None of them had any preoperative radio/
chemotherapy. Immediately after resection, a piece containing
tumor and surrounding normal tissue was fixed in buffered
formalin and embedded in paraffin. Experienced pathologists
documented the histopathological characteristics of the tumors,
including tumor stage, differentiation grade, size, lymph/angioin-
vasion, perineural invasion and lymph node involvement. Tumor
Table 1. Characteristics of patients and tumors.
N (%)
Sex Female 7 (33)
Male 14 (67)
Age 50–60 years 2 (10)
60–70 years 9 (43)
70–80 years 7 (33)
.80 years 3 (14)
Site of primary tumor Colon 15 (71)
Rectum 6 (29)
Tumor differentiation Grade 1 3 (14)
Grade 2 17 (81)
Grade 3 1 (5)
TNM stage T2N0M0 3 (14)
T3N0M0 10 (48)
T3N1M0 1 (5)
T3N1M1 1 (5)
T3N2M0 2 (10)
T3N2M1 1 (5)
T4N0M0 1 (5)
T4N1M0 1 (5)
T4N2M0 1 (5)
doi:10.1371/journal.pone.0098458.t001
Table 2. Antibodies used in immunohistochemistry (IHC) and static cytometry studies.
Antigen Technique Primary antibody Antigen retrieval treatment*
CD68 IHC Monoclonal Mouse Anti-Human CD68 Clone PG-M1 (Dako) a-Chymotrypsin (Sigma), 20 min, 37uC
CD86 IHC B7-2/CD86 (Epitomics) Target Retrieval Solution pH 6 (Dako), 20 min, 95uC
Static cytometry FITC Mouse Anti-Human CD86 (BD Pharmingen) -
CD206 IHC Anti-MRCI (Sigma) Target Retrieval Solution pH 9 (Dako), 20 min, 95uC
Static cytometry PE Mouse Anti-Human CD206 (BD Pharmingen) -
Gastrin IHC FLEX Polyclonal Rabbit Anti-Human Gastrin (Dako) Target Retrieval Solution pH 9 (Dako), 20 min, 95uC
Wnt1 IHC Polyclonal Rabbit Anti-Wnt1 (Sigma) Target Retrieval Solution pH 6 (Dako), 20 min, 95uC
*Procedure to unmask the antigen.
doi:10.1371/journal.pone.0098458.t002
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Table 3. Primer sequences of specific PCR products for each gene analyzed.
Human Gene Sense Antisense Length (bp)
Wnt1 59-CGCCCACCCGAGTACCTCCA-39 59-TTCATGCCGCCCCAGGCAAG-39 110
Wnt3a 59-TACTCCTCTGCAGCCTGAAGCA-39 59-ATGGCGTGGACAAAGGCCGAC-39 322
Wnt5a 59-CTGCCCCAACTCGGGAGTCCAGG-39 59-AGGAATCCGAGCGGAGCGACC-39 147
Lgr5 59-GGCTCGGTGTGCTCCTGTCCT-39 59-TGCCTCAGGGAATGCAGGCC-39 484
b-actin 59-GGACTTCGAGCAAGAGATGG-39 59-AGCACTGTGTTGGCGTACAG-39 67
doi:10.1371/journal.pone.0098458.t003
Figure 1. Pattern of macrophage infiltration in colorectal cancer and healthy surrounding tissues. The immunoreactivity to CD68 (MF
marker, A–B), CD86 (M1-MF marker, C–D) and CD206 (M2-MF marker, E–F) was analyzed in colorectal cancer (B, D, F) and healthy surrounding mucosa
(A, C, E). (G) Quantitative analysis of positive cells for these molecules in a representative area of 0.22 mm2 (Scale bar = 0.2 mm). Bars represent mean
6SEM (n= 21). **P,0.01 and ***P,0.001 vs corresponding value in normal mucosa.
doi:10.1371/journal.pone.0098458.g001
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stage was defined according to the TNM staging system. The
study was approved by the Institutional Review Board of The
Hospital of Manises (Valencia). Written informed consent was
obtained from all patients.
Inmunohistochemistry
Serial sections (4 mm) of samples containing tumor and normal
mucosa from each patient were stained for gastrin, Wnt1, CD68 as
a macrophage marker, CD86 as a M1-macrophage marker or
CD206 as a M2-macrophage marker. Samples were subjected to
different methods of antigen retrieval depending on the epitope
(Table 2). Endogenous peroxidase activity was suppressed by
immersion in 0.3% hydrogen peroxide. Once blocked with 5%
horse serum, sections were incubated overnight (4uC) with the
corresponding primary antibody (Table 2). A horse anti-mouse/
rabbit biotinylated antibody (Vector Laboratories, CA, USA,
1:200) was used as a secondary antibody. The VECTASTAIN
elite ABC system Kit (Vector Laboratories, CA, USA), followed by
the DAB Enhanced Liquid substrate System for Immunohisto-
chemistry (Sigma-Aldrich, Missouri, USA) were used for develop-
ment. All tissues were counterstained with hematoxylin and the
specificity of the immunostaining was confirmed if analogous tissue
sections showed an absence of staining after using non-immune
immunoglobulin of the same isotype and at the same concentra-
tion as the primary antibody or after omitting the secondary
antibody.
A representative area (objective 40X, 6 fields, 0.22 mm2) from
tumoral tissue or adjacent normal glandular tissue was selected for
quantitative analysis of macrophage infiltration. Gastrin staining in
each sample was evaluated and a score for intensity from 1 to 4
was assigned. Only cancer epithelial cells reacted to gastrin
antibody and the intensity of the staining was very homogeneous
through the entire epithelial tumor compartment. All samples
were processed in parallel and an observer, unaware of the patient
number and different from the person who processed and
analyzed the macrophage immunostainings, assigned an score to
each patient based on the intensity of staining observed in three
pictures representative of different parts of the tumor.
Cell culture
Human peripheral blood mononuclear cells were isolated from
healthy donors by Ficoll density gradient centrifugation. Mono-
cytes were seeded in tissue culture plates and matured to
macrophages by culturing in X-Vivo 15 medium (BioWhittaker)
supplemented with 1% human serum and 20 ng/nl of recombi-
nant human M-CSF (Peprotech) at 37uC in 5% CO2 for up to 6
days. In order to obtain an M1 polarization, cells were incubated
with 1 mg/ml LPS (from Escherichia coli 0111:B4, Sigma-Aldrich)
plus 20 ng/ml human recombinant IFNc (Peprotech) for the last
24 hours. M2 polarization was obtained by treating cells with
20 ng/ml of human recombinant IL4 (Peprotech) for the last
48 hours of the culturing period. The maturation process as well
as the activation treatments were carried out in the presence or
Figure 2. Relationship between gastrin expression and the
pattern of macrophage infiltration in colorectal cancer sam-
ples. The number of total macrophages (CD68 + cells, B), M1-
macrophages (CD86+ cells, C), and M2-macrophages (CD206 cells, D),
in the tumor and normal surrounding tissue were analyzed in relation to
gastrin expression in tumoral tissue (A, score 1 to 4, scale bar
= 0.2 mm). A negative and significant correlation is observed between
the intensity of gastrin staining and the number of M2-macrophages in
normal mucosa and tumoral tissue (D).
doi:10.1371/journal.pone.0098458.g002
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absence of different concentrations of progastrin (10211–1027M,
Abgent).
Caco-2 cells (American Type Culture Collection, VA, USA)
were cultured in MEM medium (Sigma-Aldrich) supplemented
with 20% inactivated bovine foetal serum, 100 U/ml penicillin,
100 mg/ml streptomycin, 2 mM L-glutamine, 100 mM sodium
pyruvate and 1% of non-essential amino acids.
Caco-2 cells were co-cultured with monocyte-derived macro-
phages using Transwell inserts (Corning Incorporated, MA, USA)
with a 0.4 mm porous membrane [12]. Monocytes were seeded on
these inserts and differentiated to macrophages in the presence or
absence of different concentrations of progastrin. On day 6 after
seeding, the inserts were placed on top of Caco-2 cells (t = 0) and
were maintained in co-culture for 24 hours.
The presence of the surface molecules CD86 (M1) and CD206
(M2) in cultured macrophages was analyzed by fluorescence
microscopy (microscope IX81, Olympus, Hamburg, Germany).
Macrophages were incubated with hoescht to identify the nuclei
and with fluorescent labeled antibodies against these targets
(Table 2). Fluorescence was analyzed with the static cytometry
software ScanR (.5000 cells/well).The concentration of the
cytokines IL12 (Th1) and IL10 (Th2, antiinflammatory) in cell
supernatants was determined by ELISA (Diaclone).
The number of Caco-2 cells after co-culture was counted in a
Newbauer chamber. Apoptosis in these cells was studied by flow
cytometry as bivariate Annexin V/PI analysis (Apoptosis Detec-
tion Kit, Abcam).
Total RNA from macrophages or Caco-2 cells was isolated by
using the extraction kit (Illustra RNAspin Mini, GE HealthCare
Life Science) and cDNA was obtained with the Prime Script RT
reagent Kit (Takara Biotechnology). Real-time PCR was per-
formed with the Prime Script Reagent Kit Perfect Real Time
Figure 3. Influence of progastrin on the phenotype of human monocyte-derived macrophages. Human peripheral monocytes were
derived to macrophages in the presence or absence of progastrin and the phenotype of the resultant macrophages evaluated by analyzing the
following parameters: expression of CD86 (A, C, n = 3); expression of CD206 (B, D, n = 3); secretion of IL12 (F, n = 4); and secretion of IL10 (G, n = 4). Bars
represent mean 6SEM. *P,0.05 and **P,0.01 vs corresponding value in vehicle-treated cells.
doi:10.1371/journal.pone.0098458.g003
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(Takara Biotechnology) in a thermo cycler LightCycler (Roche
Diagnostics, Mannheim, Germany). Specific oligonucleotides were
designed according to sequences shown in Table 3. Relative gene
expression was expressed as previously described [15].
Statistical analysis
Data are expressed as mean 6s.e.m. and were compared by
analysis of variance (one way-ANOVA) with a Newman-Keuls
post-hoc correction for multiple comparisons or a t-test when
appropriate. A P value ,0.05 was considered to be statistically
significant. The clinical correlations in human samples were
analyzed using the Pearson’s correlation coefficient.
Results
M2 macrophage number is increased in the tumoral area
We first analyzed the amount and phenotype of macrophages in
the non-tumor and tumor areas of colorectal cancer patients.
Immunohistochemistry for CD68 (macrophage marker), CD86
(M1 macrophage marker) and CD206 (M2 macrophage marker)
was performed in biopsy samples from colorectal carcinoma
resections. Of note, the number of macrophages was similar in
tumor and normal surrounding tissue, but the number of M1 and
M2 macrophages was significantly different between the two areas
(Figure 1). Tumor stroma contained a lower number of CD86(+)
cells than lamina propria of the normal tissue. In contrast, a higher
number of CD206(+) cells was encountered in tumoral tissue
Figure 4. Influence of progastrin on human M1 and M2 macrophages. Human monocyte-derived macrophages were stimulated with LPS
plus IFNc to obtain a M1-phenotype or with IL4 to obtain M2-macrophages in the presence or absence of progastrin, and the resultant phenotype
evaluated by analyzing the following parameters: expression of CD86 (A, n = 3); expression of CD206 (B, n = 5); secretion of IL10 (C, D, n = 5); and
secretion of IL12 (E, F, n = 5). Bars represent mean 6SEM. *P,0.05 vs corresponding value in vehicle-treated cells; + P,0.05 and ++P,0.01 vs
corresponding value in control cells.
doi:10.1371/journal.pone.0098458.g004
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compared with normal surrounding tissue, suggesting that tumor
development favors the differentiation of monocytes to M2
macrophages.
Gastrin expression is increased in the tumor but
negatively correlates with the number of M2
macrophages
Searching for mediators that could modulate the phenotype of
macrophages into the tumor we studied the role of gastrin peptides
on the expression of different macrophage markers in the biopsy
samples. Since the gastrin antibody used in this study recognizes
both gastrin and gastrin precursors, like progastrin, we cannot
discriminate between different gastrin peptides, but we observed
extensive immunoreactivity in tumor epithelial cells of biopsies
analyzed. Staining in each sample was evaluated and a score for
intensity from 1 to 4 was assigned (Figure 2A). No correlation was
observed between gastrin levels in tumors and the number of total
(CD68+ cells) or M1 (CD86+ cells) macrophages either in the
tumor or in normal tissue (Figures 2B and 2C). Surprisingly, the
number of M2 macrophages in tumoral and normal tissue
correlated negatively with gastrin expression. This correlation
was more significant in the tumor, where the peptide is
synthesized. Taken together these data suggest that gastrin
peptides synthesized by tumor cells reduces the number of M2
macrophages, without affecting the total macrophage number.
Progastrin decreases the differentiation of macrophages
towards a M2 phenotype
We hypothesized that progastrin could be responsible for the
effects observed on macrophage phenotype, because colon cancer
cells lack the enzymes necessary for complete gastrin maturation
[7]. To investigate whether progastrin can modulate the differen-
tiation of macrophages to a M1- or M2-phenotype we treated
human peripheral monocytes obtained from healthy volunteers
with several concentrations of progastrin and left them to
differentiate. Static cytometry experiments carried out with
specific fluorescent antibodies showed that progastrin reduced
the expression of the M2-marker CD206 in monocyte-derived
macrophages even at the lowest concentration analyzed. In
contrast, no changes in the expression of the M1-marker CD86
were detected. In addition, we measured the concentration of IL-
12 and IL-10 in the supernatant of monocyte-derived macro-
phages after 6 days of differentiation in the presence of increasing
doses of progastrin. The gastrin precursor elicited a significant
reduction of IL-10 secretion but did not alter the IL-12 levels
(Figure 3). Our data indicate that progastrin inhibits the expression
of M2-markers during macrophage differentiation without affect-
ing the expression of M1-markers.
In order to study the effect of progastrin on IL4-mediated
differentiation of macrophages towards a M2-phenotype we
incubated fully differentiated monocyte-derived macrophages with
IL-4 and different doses of progastrin for two days. Basal
macrophages treated with IL-4 showed a significant increase in
CD206 expression, a non-significant increase in IL-12 secretion
and similar IL-10 production than controls. Progastrin signifi-
cantly reduced the induction of CD206 by IL-4 and increased IL-
12 secretion to levels significantly higher than those observed in
control cells, while secretion of IL-10 remained unchanged.
However, differentiation of macrophages towards a M1-pheno-
type was not affected by progastrin. Treatment with LPS plus
Figure 5. Influence of progastrin on macrophage-derived Wnt ligands. Immunoreactivity to Wnt1 in the stroma of colorectal cancer in
relation to the expression of gastrin in the same tissue (scale bar = 0.2 mm) (A); and effects of the presence of progastrin during differentiation of
human peripheral monocytes to macrophages on mRNA expression of three different Wnt ligands in these macrophages (B–D, n = 5) and mRNA
expression of Lgr5 in co-cultured Caco-2 cells (E, n = 7). Bars represent mean 6SEM. *P,0.05 and **P,0.01 vs corresponding value in vehicle-treated
cells.
doi:10.1371/journal.pone.0098458.g005
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IFNc increased the expression of CD86, and the secretion of both
IL12 and IL10 in macrophages, but progastrin did not modify any
of these parameters (Figure 4).
Progastrin down-regulates Wnt ligands in macrophages
and increases cell death in co-cultured Caco2 cells
Next we analyzed whether the modulation of macrophage
phenotype by progastrin could affect the surrounding tumor cells.
We have recently reported that M2-macrophages synthesize and
secrete Wnt ligands which can modulate co-cultured epithelial cell
behavior [16] and in the present study we observed immunore-
activity for Wnt1 in cells of the tumor stroma. Qualitative
assessment of the expression of this Wnt ligand indicates that the
amount of positive cells decreases as gastrin production in cancer
cells increases (Figure 5A). A causal relationship between both
factors is pointed out by our in vitro studies showing that
macrophages maturated in the presence of progastrin present a
significantly reduced mRNA expression of three different Wnt
ligands (Wnt1, Wnt3a, and Wnt5, Figures 5B–5D). Functional
relevance of the down-regulation of the three Wnt ligands in
macrophages is demonstrated by the fact that Caco2 cells co-
cultured with progastrin-treated macrophages expressed less Lgr5
mRNA than Caco2 cells co-cultured with control macrophages
(Figure 5E). These data indicate that the effects of progastrin on
macrophage-derived Wnt ligands modulate the Wnt signaling
pathway in surrounding tumor cells.
Furthermore, co-culture of Caco-2 with progastrin-treated
macrophages resulted in a significant reduction in the total
number of epithelial cells together with an increased rate of
apoptosis (Figure 6).
Discussion
This study shows that macrophages infiltrating colorectal
tumors have a different phenotypic profile than those that are
present in the normal tissue surrounding the cancerous lesion, with
a higher proportion of the anti-inflammatory M2-macrophages
and significantly lower numbers of classically activated M1-
macrophages. Interestingly, our results indicate that gastrin
expression in tumoral tissue exerts a negative influence on the
number of tumoral M2-macrophages.
The expression of gastrin in tumoral epithelial cells correlates
negatively with the number of tumoral M2-macrophages and our
in vitro results suggest a causal relationship between both factors.
Human macrophages obtained by culturing peripheral monocytes
in the presence of progastrin showed a reduced expression of
CD206. Moreover, this peptide significantly prevented the
expression of CD206 when mature macrophages were stimulated
with the Th2 cytokine IL4 to induce an M2-phenotype. In
contrast, progastrin did not affect the expression of the co-
stimulatory molecule CD86 either in resting conditions or in
macrophages stimulated with LPS plus IFNc to develop an M1-
phenotype. Progastrin also affects the pattern of cytokine secretion.
Macrophages maturated in the presence of this peptide released
lower amounts of the anti-inflammatory cytokine IL10 while
maintaining normal release of the Th1 inducer IL12. In IL4-
stimulated macrophages, the effects on cytokine secretion were
different but in the same direction. In this case, IL10 release was
unaffected while the peptide facilitated IL12 secretion. Thus, it is
expectable that those macrophages that are under the influence of
progastrin in the cancerous tissue present a blunted anti-
inflammatory, immunosuppressive profile.
This effect is in line with the previously described proinflam-
matory action of gastrin [11–13]. We observed that gastrin
contributes to the inflammation induced by Helicobacter pylori in
rats probably through CCK-2 receptor activation in macrophages
while the stimulation of this receptor activates human endothelial
cells to promote monocyte adhesion. CCK-2 receptors can bind all
gastrin peptides, although their affinity for mature gastrin is
significantly higher than that demonstrated for progastrin. The
actions of the latter may be alternatively transmitted by the
recently characterized non-conventional receptor annexin-II [9].
Both kinds of receptors are present in macrophages and both
pathways promote macrophage activation [14]. Thus, the present
results reinforce the notion that gastrin peptides tend to contribute
to inflammation although different mechanism may be involved in
each case.
The influence of macrophages on cancer progression is due to
their effect on the immune response against the tumor but also to a
direct local effect on the surrounding epithelial cancer cells.
Macrophages can be a source of Wnt ligands [17], the oncogenic
pathway activated in the majority of colorectal cancers and a
significant contributor to cancer cell stemness [18,19]. Secretion of
these factors is especially relevant in a subpopulation of TAMs that
seem to play a particular role in tumor invasiveness by promoting
angiogenesis and tumoral cell migration through Wnt-signaling
[20,21]. Wnt1 was detected in cells of the tumor stroma and its
Figure 6. Influence of progastrin-treated macrophages on
colorectal cancer cells. The effects of human monocyte-derived
macrophages obtained in the presence or absence of progastrin on the
number (A) and the rate of apoptosis (B) of Caco-2 cells were analyzed
in a co-culture system (24 h, n = 4). Bars represent mean 6SEM. *P,
0.05 vs corresponding value in vehicle-treated macrophages, +P,0.05
and ++P,0.01 vs cells incubated with an empty insert (w/o MF).
doi:10.1371/journal.pone.0098458.g006
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presence tended to decrease, as the level of gastrin in the tumor
increased. We have recently observed that secretion of Wnt
ligands is specifically increased in M2 macrophages, which
promote Wnt/b-catenin signaling pathway and the consequent
proliferative activity in co-cultured colon cancer cells [16]. Our
present results show that macrophages maturated in the presence
of progastrin express lower amounts of three different Wnt ligands
and provoke a significant reduction in the number of co-cultured
Caco-2 cells. This effect occurs with a concomitant decrease in the
expression in these colonic cells of Lgr5, a Wnt target gene [22]
that potentiates Wnt/b-catenin signaling [18]. Moreover, macro-
phages maturated in the presence of progastrin tend to increase
the apoptosis rate in Caco-2 cells, an effect that may also be
related with reduced Wnt signaling [23]. Thus, the phenotypical
changes induced by progastrin in macrophages modify their
influence on colon cancer epithelial cells resulting in a diminished
number of these cells probably by a combination of reduced
proliferation and increased apoptotic cell death. Additionally, the
reduced production of Wnt ligands induced by progastrin may also
contribute to the described phenotypical changes induced by this
peptide since an autocrine effect of Wnt5a in macrophages to
reduce the expression of IL12 in response to bacterial products has
been described [24].
From our results we can infer that gastrins, by inhibiting the
acquisition of an M2-phenotype in local macrophages, may
regulate cancer progression. It is clear that M2 macrophages
stimulate the growth of colon-cancer epithelial cells in vitro and
experimental studies demonstrate that M2-macrophages in the
tumor promote colon cancer in mice [25–27]. In human colorectal
cancers, the effect of M2-macrophages seems more complicated
and affected by several factors like their spatial distribution [4], the
relative amount of M1 macrophages [5] or the stage of the disease
[4]. Although their presence have been seen as a negative
prognostic factor by some authors [28], others suggest that M2
macrophages have a less hazardous effect in human colorectal
cancer than in other settings and point to the idea that some local
factor specifically present in this kind of tumors may be down-
regulating their tumor promoting action [4,5,29]. Keeping in
mind that M1 and M2 macrophages are not clonally different sets
of cells but the extremes of a wide spectrum of intermediate
phenotypes and that classification of a cell as an M2 macrophage
may be biased by the molecular marker selected in each case, we
launch the idea that those macrophages identified as M2 in these
studies may be less deleterious because of progastrin.
A direct proliferative function of progastrin on epithelial cells
has been clearly demonstrated in isolated cells and mice, and
experimental studies with transgenic animals suggest that overex-
pression of gastrins in the presence of DNA-damaging agents
enhances carcinogenesis. This evidence has prompted several
pharmacological strategies to neutralize the activity of gastrin
peptides, with successful results in murine models but, unfortu-
nately, few and indefinite results in patients [30]. Our findings
suggest that, at least in humans, progastrin can play a multifaceted
role in the progression of colorectal tumors, as its proliferative
activity on epithelial cells would be opposed by a potentially anti-
tumoral action exerted on macrophages. The relevance of this
effect on immune cells for the global activity of progastrin awaits
evaluation by future research.
Conclusions
Our study indicates that gastrin peptides synthesized by colon
cancer cells have macrophages as their targets and probably affect
the inflammatory infiltrate of the tumor, which in turn affects
cancer progression. The inhibition of M2-polarization induced by
progastrin would counteract their proliferative activity and,
although it is difficult to estimate the magnitude of this effect,
this observation should be taken into account when analyzing the
therapeutic value of gastrin immunoneutralization [31].
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ABSTRACT 
Background: The Notch signaling pathway plays an essential role in mucosal 
regeneration, which constitutes a key goal of Crohn´s disease treatment. Macrophages 
coordinate tissue repair and several phenotypes have been reported which differ in the 
expression of surface proteins, cytokines and HIF. We aim to analyze the role of HIF in 
the expression of Notch ligands in macrophages and the relevance of this pathway in 
mucosal regeneration. Methods: Human monocytes- and U937-derived- macrophages 
were polarized towards the M1 and M2 phenotype and the expression of HF-1α, HIF-2α, 
Jag1 and Dll4 was evaluated. The effects of macrophages on the expression of HES-1 
(the main target of Notch signaling) and IAP (enterocyte marker) in epithelial cells in co-
culture were also analyzed. Phenotype macrophage markers and Notch signaling were 
evaluated in the mucosa of CD patients. Results: M1 macrophages are associated with 
a HIF-1 dependent induction of Jag1 and Dll4 which increase HES1 protein levels and IAP 
activity in co-culture epithelial cells. In the mucosa of CD patients a high percentage of 
M1 macrophages express both HIF-1α and Jag1 while M2 macrophages mainly 
expressed HIF-2α and we detected a good correlation between the ratio of M1/M2 
macrophages and both HES1 and IAP protein levels.  Conclusion: M1, and not M2, 
macrophages are associated with a HIF-1 dependent induction of Notch ligands and 
activation of epithelial Notch signaling pathway. In the mucosa of chronic CD patients, 
the prevalence of M2 macrophages is associated with diminution of Notch signaling and 
impaired enterocyte differentiation. 
 
Keywords: macrophages, crohn´s disease, mucosal healing, Notch signaling.  
INTRODUCTION 
Crohn´s disease (CD) is a chronic relapsing inflammatory disorder of the gastrointestinal 
tract characterized by transmural inflammation, architectural distortion and thickening 
of all the layers of the bowel wall, which leads to intestinal fibrosis and stricture 
development 1. The aim of current clinical management is to prolong periods of 
remission and halt the destructive and progressive course of the disease. In recent years 
mucosal healing has been established as a key treatment goal in CD that predicts 
sustained clinical remission and resection-free survival of patients 2, 3. This process is 
highly dependent on the adequate reconstruction of the intestinal epithelium that 
depends on proliferation and differentiation of the progenitor cells located at the base 
of the crypts. The coordination of several signalling pathways including Wnt and Notch 
plays an essential role in epithelial regeneration 4-10.  
The Notch signalling pathway is mediated by Notch proteins that act as receptors for the 
transmembrane ligands, Jagged and Delta-like proteins. Upon binding to their ligands, 
Notch receptors are cleaved by y-secretase and the Notch intracellular domain 
translocates to the nucleus where it up-regulates the expression of specific target genes 
such as HES1. This gene, in turn, represses the expression of Math1, a master regulator 
of secretory cell lineage differentiation 6, 7. It was initially reported that deletion of the 
HES1 gene resulted in the generation of an excessive number of secretory cells 11. Later 
studies demonstrated that inactivation of Notch signalling results in conversion of 
proliferating progenitors into post-mitotic goblet cells 12, which led to the assumption 
that Notch signalling plays an essential role in regulating cell-fate decisions in intestinal 
homeostasis. However, there is still controversy regarding the regulation of Notch 
signalling in CD. An increase in Math1 mRNA expression has been reported in the 
damaged mucosa of CD patients 13 while increased cleavage of Notch-1, which is the 
upstream signal regulating HES1 expression, has also been stated 14.  
Macrophages constitute one of the central components of the inflamed mucosa where 
local hypoxia and inflammatory mediators modulate their gene expression through the 
activity of hypoxia inducible factors (HIFs) 15, 16. Several macrophage phenotypes have 
been characterized, and differ in the expression of surface proteins and the production 
of cytokines 17. The M1 or pro-inflammatory phenotype mediates the defence of the 
host from microorganisms and contributes to inflammatory injury. There is evidence in 
the literature of a role for the transcription factor HIF-1 in M1 polarization 18 and several 
studies report the up-regulation of Notch receptors and Notch signalling in classical 
macrophage differentiation 19-21. The M2 macrophage phenotype expresses high levels 
of anti-inflammatory cytokines and coordinates tissue repair 22, 23. It has recently been 
reported that inhibition of Notch signalling enhances M2 polarization 20. In the present 
study we aimed to analyse the role of HIF in the expression of Notch ligands in 
macrophages. In addition, taking into account the strategic position of macrophages in 
maintaining communication with epithelial cells we explored the relevance of 
macrophages in the regulation of  Notch signalling and regeneration of the mucosa of 
CD patients.  
 
MATERIAL AND METHODS 
Intestinal Mucosal Samples  
Colonic surgical resections were obtained from the damaged mucosa of CD patients and 
from the healthy mucosa of patients with colorectal cancer (as controls) (Table 1). The 
study was approved by the Institutional Review Board of The Hospital of Manises 
(Valencia). Written informed consent was obtained from all participating patients. 
Isolation of colonic crypts 
Human intestinal crypts were isolated from the mucosa of surgical resections obtained 
from control and CD patients, as described previously 24. 
Isolation of macrophages from human intestine 
Macrophages were isolated from the mucosa of surgical resections obtained from 
control and CD patients as described previously 24.  
Cell culture 
Caco-2 cells (American Type Culture Collection, VA) were cultured in MEM medium 
(Sigma-Aldrich) supplemented with 20% inactivated FBS with 100 Um/l penicillin, 100 
mg/ml streptomycin, 2 mM L-glutamine (Lonza), 100 mM sodium pyruvate (Lonza), and 
1% non-essential amino acids (Lonza). 
HT29 (American Type Culture Collection, VA, USA) were cultured in McCoy’s Medium 
Modified (Sigma-Aldrich) supplemented with 10% inactivated FBS, 100 U/ml penicillin, 
100 mg/ml streptomycin and 2 mM L-glutamine. 
Human monocytes (U937, European Collection of Cell Culture, Salisbury, UK) were 
cultured in RPMI medium with 10% inactivated FBS with 100 U/ml penicillin and 100 
mg/ml streptomycin. Monocytes were differentiated into macrophages by culturing 
them in the presence of PMA for 48 h 25. U937-derived macrophages were stimulated 
with LPS (0.1 µg/ml; E. coli 0111:B4) and IFN-γ (20 ng/ml) or with IL-4 (20 ng/ml) in order 
to polarize them towards M1 or M2 phenotypes, respectively as previously reported 26. 
Hypoxia (3% O2) was established by incubating macrophages in a CO2/O2 incubator 
(model INVIVO2 400, RUSKINN Technology Ltd, Pencoed, UK) with a blend of 5% CO2 
and the appropriate percentage of O2 and N2 up to a total of 100%. Normoxic controls 
were obtained by incubating the cells at 21% O2. 
Isolation of mononuclear cells 
Human peripheral blood mononuclear cells were isolated from both healthy donors and 
CD patients by Ficoll density gradient centrifugation at 400 g for 40 minutes. Monocyte-
derived macrophages (MDMs) were obtained from monocytes seeded in 12-well tissue 
culture plates and differentiated into macrophages through culture in X-Vivo 15 medium 
(Lonza) supplemented with 1% human serum, 100 U/ml penicillin, 100 mg/ml 
streptomycin and 20 ng/ml recombinant human M-CSF (Peprotech, London, UK) at 37ºC 
in 5% CO2 for 6 days.  
Co-culture  
U937-derived macrophages were seeded and differentiated as above. Afterwards the 
epithelial cells were placed in the same wells at a ratio 1:1 and were maintained in co-
culture for 24 hours.  
Alkaline phosphatase activity 
Following 24 hours of co-culture with macrophages, cells were washed with cold PBS 
and lysed in 150 ml of 0.5% Triton X-100, 10 mM Tris-HCl [pH=8] and 150 mM NaCl. Each 
sample was mixed with a p-nitrophenyl phosphate solution (Sigma-Aldrich). Thirty 
minutes later, absorbance at 405 nm was measured. Protein content was quantified 
using the Bradford Assay (Bio-Rad Laboratories, Madrid, Spain). Alkaline phosphatase 
activity was also determined in macrophages cultured alone. 
Immunohistochemistry, immunofluorescence and goblet cell count 
Immunohistochemistry for HES1, CD68, CD86, and CD206 was performed in 5 µm 
sections of paraffin-embedded tissues (Table 2). A horse anti-mouse/rabbit biotinylated 
antibody (Vector Laboratories, CA, USA, 1:200) was used as a secondary antibody as 
previously described 26.  An area of 0.3 mm2 was selected for quantitative analysis. 
Goblet cells were counted following standard PAS staining of the sections adjacent to 
those used for immunostaining. We counted the number of goblet cells (by counting the 
vacuoles) in at least three crypts per sample and results were normalized to the total 
number of epithelial cells (by counting the nuclei) in the same crypt. 
 
Static cytometry 
Macrophages isolated from the mucosa of surgical resections obtained from control and 
CD patients were fixed with 2% paraformaldehyde, permeabilized with 0.1% Triton-
X100, and double stained (Jag1/CD86, Jag1/CD206, HIF1α/CD86, HIF1α/CD206, 
HIF2α/CD86, HIF2α/CD206, CD86/CD68, CD206/CD68, ArginaseI/CD68, iNOs/CD68,) 
with specific monoclonal antibodies  (Table 2) as previously described 24. Fluorescent-
labeled (TR and FITC) goat anti-mouse or goat anti-rabbit (1:100, Santa Cruz 
Biotechnology) were used as the secondary antibodies, and Hoechst 33342 was added 
to stain the nuclei.  
U937 macrophages co-cultured with epithelial cells were incubated overnight at 4ºC 
with monoclonal antibodies against HES1 or Muc2 combined with an antibody against 
CD18 to identify and exclude macrophages from the cytometric analysis (Table 2). 
Fluorescent-labeled (TR and FITC) goat anti-mouse or goat anti-rabbit (1:100, Santa Cruz 
Biotechnology) were used as the secondary antibodies, and Hoechst 33342 was added 
to stain the nuclei.  In all cases the fluorescent signal (16 images per well) was quantified 
using the static cytometer software ScanR version 2.03.2 (Olympus, Barcelona, Spain). 
RNA interference and cellular transfection 
U937 cells were transfected with a vector-targeting human HIF-1a (miHIF-1a, described 
previously27 ) or a non-targeting control vector (mock), as described previously 27.  In 
addition we have now designed vectors-targeting human Jag1 (miJag1; 28.82 ± 15.70% 
of reduction vs. mock; based on the targeting sequence 5`-CCTAAGCATGGGTCTTGCAAA-
3’ (Gen-Bank Accession No NM_000214.2) and Dll4 (miDll4; 27.74 ± 13.39% of reduction 
vs. mock;   based on the targeting sequence 5` -TCCAACTGCCCTTCAATTTCA-3’ (Gen-Bank 
Accession No NM_019074.3). Lipofectamine-2000 (Invitrogen Life Technologies, 
Carlsbad, CA) was employed as a transfection reagent according to the manufacturer’s 
instructions. Twenty-four hours post-transfection, cells were incubated for 8 h in 
normoxic or hypoxic conditions, as described above. M1 macrophages were transfected 
with miHIF-1a, miJag1, miDll4 or a mock vector before M1 polarization. 
Protein extraction and Western blot analysis  
Equal amounts of protein from macrophages, HT29 cells, Caco-2 cells or colonic tissue 
28 were loaded onto SDS/PAGE gels and analyzed by Western blot as described 
previously (Table 2). Protein expression was quantified by means of densitometry using 
Image Gauge Version 4.0 software (Fujifilm). Data were normalized to β-actin. 
RNA extraction and qRT-PCR analysis 
Total RNA and cDNA from macrophages or colonic tissue were obtained as described 
previously 25. Real-time PCR was performed with the Prime Script Reagent Kit Perfect 
Real Time (Takara) in a thermo cycler LightCycler (Roche Diagnostics). Specific 
oligonucleotides were designed according to the sequences shown in Table 3.  
Chromatin Immunoprecipitation assay. 
ChIP assay was carried out in U937 derived macrophages, incubated under hypoxia or 
normoxia for 5 h, as previously described 25. Immunoprecipitation was performed with 
anti-HIF1α antibody (BD, Madrid, Spain), or control IgG antibody. After reverse 
crosslinking, DNA fragments were purified with a Montage PCR Kit (Millipore, Germany). 
PCR was performed using PCR Master (Roche Diagnostics GmbH, Mannheim, Germany) 
with the following primers: 5'-TGTCCACCCTTCAAAGGAAGTC-3' and 5'-
CAAATCCGAGTCTGCGGAGC-3', detecting the region -1646 to -1166 in Jag1 promoter or 
5'-CCCTGAGCATCCCGCTG-3' and 5'-CCGGCTCTAATATACTCCGCC-3', detecting the region 
-638 to -106 in Jag1 promoter as shown in Figure 1c. The PCR products were separated 
by electrophoresis in 2% agarose gel. 
Statistical Analysis 
Data were expressed as mean ± S.E.M. and compared by analysis of variance (one way-
ANOVA) with a Newman-Keuls post hoc correction for multiple comparisons or a t-test 
when appropriate. A P value<0.05 was considered to be statistically significant. Clinical 
correlations were analyzed in the human samples using Pearson’s correlation 
coefficient. 
RESULTS 
HIF-1 mediates the expression of Notch ligands in M1 macrophages 
Hypoxia induced in macrophages a time-dependent increase in HIF-1α stabilization 
which peaked at eight hours and then progressively decreased. In parallel, hypoxia 
induced a time-dependent increase in the mRNA expression of Jag1 and Dll4 compared 
with the expression detected in cells in normoxia (fig. 1a). To evaluate the role of HIF-1 
in gene expression, we used a miRNA approach to selectively knockdown this 
transcription factor in U937 derived macrophages. As shown in Figure 1b, the up-
regulation of the mRNA expression of both, Dll4 and Jag1 induced by hypoxia was 
significantly reduced in cells transfected with miHIF1α, showing that HIF-1 is involved in 
the induction of these ligands in hypoxia.  
Analysis of the Jag1 gene promoter identified potential HIF-1 binding sites (HRE 
sequence). To examine the binding of HIF-1α to the promoter region of Jag1, we 
performed ChIP assays using an affinity-purified antibody directed against HIF-1α and 
primers specific for two Jag1 promoter regions containing HIF-1 binding sites (fig. 1c). 
Our data revealed HIF-1α binding to the proximal promoter region of Jag1 gene in 
hypoxia through the HREs sequences located between positions -106 and -638 (Figure 
1c) from the start codon. 
Polarization of U937-macrophages towards an M1 phenotype 26 following treatment 
with LPS+IFN induced HIF-1α stabilization within the first 24 hours and failed to 
significantly induced HIF-2α stabilization at any time analyzed (fig 2a). In contrast, 
polarization towards an M2 phenotype 26 as a result of treatment with Il-4 induced HIF-
2α stabilization and no HIF-1α stabilization (fig. 2a). Analysis of the expression of HIF-1 
target genes reveal a significant increase (fold induction) in the mRNA expression of 
LDHA (2.2±0.4) and iNOS (6.0±1.7) by M1 macrophages compared with both, non-
polarized (1.0±0.2 and 0.9±0.1, respectively) and M2 macrophages (1.2±0.3 and 2.4±1.3, 
respectively). In addition the expression of a HIF-2 target gene, ArgI was increased in M2 
macrophages (2.7±0.7) compared with non-polarized (1.0±0.1) and M1 cells (0.8±0.1). 
The analysis of the expression of Notch ligands revealed a significant increase in the 
mRNA expression of Dll4 and the mRNA expression and protein levels of Jag1 in M1 
macrophages but not in M2 cells (fig. 2b). These effects were also observed in 
macrophages derived from primary monocytes obtained from both healthy donors and 
CD patients (fig. 2c). The up-regulation of the mRNA expression of both, Dll4 and Jag1, 
detected in U-937 macrophages polarized towards an M1 phenotype was significantly 
reduced in cells transfected with miHIF1α (fig. 2d), demonstrating that HIF-1 is involved 
in the induction of Notch ligands in M1 macrophages.  
 
A HIF-1 dependent induction of Notch ligands mediates the increase in HES1 
expression and IAP activity induced by M1 macrophages 
Next we analysed whether macrophages modulate the Notch signalling pathway and 
markers of differentiation in co-cultured epithelial cells. First, we determined the 
expression of HES1 and IAP (a marker of enterocyte differentiation) protein levels in two 
different epithelial cell lines, HT29 and Caco-2 cells, at sub-confluence and at different 
times after reaching cell confluence. Our data show a time-dependent increase in 
protein levels of both, HES1 and IAP as well as IAP enzymatic activity in both HT29 and 
Caco-2 cells by culturing post-confluence. (fig. suppl. 1).  
In the co-culture experiments, M1 macrophages increased protein levels of HES1 and 
IAP enzymatic activity without affecting Muc2 expression in either HT29 or Caco-2 cells 
(fig. 3a, b, c and d). The effects induced by M1 macrophages on epithelial protein levels 
of HES-1 were significantly reduced in macrophages treated with miHIF1, miDLL4 and 
miJag1, suggesting that the HIF-1 dependent induction of Notch ligands mediate the 
activation of Notch signalling in epithelial cells (fig. 3a, c). In contrast, M2 macrophages 
did not significantly modify HES1 protein levels but induced a significant reduction in IAP 
activity in both, HT29 and Caco-2 cells (fig. 3a, b, c and d). No IAP activity was detected 
in macrophages.  
 
M1 macrophages express HIF-1α and Notch ligands while M2 macrophages express 
HIF-2α in the mucosa of CD patients 
Next we performed a comparative study of control and CD patients to characterize the 
macrophage phenotype present in the mucosa of CD patients and the expression of HIF 
and Notch ligands in these cells.  
Immunohistochemical experiments revealed macrophages in an adjacent position to 
epithelial cells (fig. 4a) and a quantitative analysis showed that the number of CD68 
positive cells and CD206 positive cells was significantly higher in the mucosa of chronic 
CD patients than in that of control patients. In contrast, no significant differences were 
observed in the number of CD86+ cells (fig. 4b). Double immunofluorescence 
experiments in macrophages isolated from the mucosa revealed that the percentage of 
CD68 positive cells that expressed M1 markers, CD86 and iNOS, was similar in Crohn´s 
disease and control patients. In contrast, the percentage of CD68 positive cells that 
expressed M2 markers, CD206 and ArgI, was significantly higher in macrophages 
isolated from the mucosa of CD patients (fig. 4c).  
In addition we also detected a high percentage of CD86+ cells expressing HIF-1α in 
macrophages isolated from both control and CD patients while a very low percentage of 
CD206 + cells express HIF-1α (fig. 5b). In contrast a great percentage of CD206 + cells 
from the mucosa of both control and CD patients express HIF-2α while a low percentage 
of CD86 + cells expressed HIF-2α (fig. 5c).  Finally, the percentage of cells expressing the 
Notch ligand Jag1 in the population of CD86 positive cells was higher than that recorded 
in cells expressing CD206 (fig. 5a) and these values were similar between macrophages 
obtained from control and CD patients (fig. 5a).  
 
Macrophages modulate in a phenotype dependent manner Notch signalling and 
markers of differentiation in human intestine 
To determine whether macrophages in the mucosa modulate Notch signaling in 
epithelial cells we analysed this pathway specifically in crypts isolated from the mucosa 
of control and Crohn´s disease patients. Results reveal a low HES1 immunostaining and 
decreased mRNA and protein HES1 expression in the mucosa of CD patients compared 
with that of controls (fig. 6a). In addition, we also detected enhanced Math1 mRNA 
expression, increased Muc2 mRNA expression, a higher percentage of goblet cells per 
crypt and decreased IAP protein levels in the mucosa of chronic CD patients compared 
with control mucosa, suggesting a diminution of the Notch signalling pathway and 
impaired differentiation associated with CD. To study a possible regulatory link between 
M1 macrophages and Notch signaling, the relationship between HES1 protein levels 
detected by western blot and the proportion of CD86+/CD68+ macrophages was 
analyzed and a positive correlation coefficient (r 0.4631, p 0.045, fig. 5d) was obtained. 
A detailed analysis revealed a different distribution of points marked by the presence of 
CD, and when data were analyzed separately the correlation coefficient was closer for 
both, controls (r 0.89, p 0.001) and CD patients (r 0.79, p 0.001). This suggests that other 
factors were regulating HES1 in the mucosa (fig. 5d). Interestingly, a better correlation 
coefficient (r 0.804, p<0.001) was obtained between HES1 protein levels and the ratio 
between CD86+ (M1) and /CD206+ (M2) macrophages (fig. 6e). The M1/M2 ratio also 
exhibited a positive and significant correlation with IAP protein levels (r 0.66, p 0.002) 
(Figure 6e), which suggests that both M1 and M2 macrophages regulate Notch signaling 
in the mucosa.   
 
DISCUSSION 
The present study demonstrates that M1 macrophages, and not M2 macrophages are 
associated with a HIF-1 dependent induction of Jag1 and Dll4 which increase HES1 
protein levels and IAP activity in co-culture epithelial cells. In the mucosa of chronic CD 
patients, the ratio M1/M2 macrophages closely correlate with Notch signaling and 
markers of enterocyte differentiation suggesting that macrophages play a role in the 
diminished Notch signaling and impaired enterocyte differentiation observed. 
 
Our data show that HIF-1, a transcription factor induced by hypoxia and inflammatory 
conditions, mediates the expression of Dll4 and Jag1 in hypoxic macrophages. A 
previous study reported activation of Dll4 promoter by HIF-1 in endothelial cells 29., We 
demonstrate for the first time the activation of the Jag1 promoter by HIF-1 and provide 
further evidence that HIF-1 regulates the expression of Notch ligands. Emerging 
evidence suggests that the functional phenotype of macrophages is regulated by 
transcription factors that define alternative activation 18. We found HIF-1α stabilization 
in human macrophages polarized towards an M1 phenotype and HIF-2α stabilization in 
those that had been polarized towards an M2 phenotype. Of interest, our data associate 
for the first time M1, but not M2, macrophages with a HIF-1 dependent increase in the 
mRNA expression of Dll4 and Jag1, which suggest that this transcription factor mediates 
the selective Notch ligands expression that characterizes the macrophage phenotype. 
These effects have been also observed in macrophages derived from primary monocytes 
obtained from both healthy and CD patients properly polarized supporting the 
preferential expression of Notch ligands by the M1 phenotype. The pattern of Notch 
ligands expression is functionally relevant since M1, and not M2 macrophages increased 
the expression of the main target gene of the canonical Notch signaling, HES1, in 
epithelial cells in co-culture through an action mediated by the HIF-1 dependent 
induction of Jag1 and Dll4.  This was observed in two epithelial cell lines capable of 
expressing differentiation features characteristic of mature intestinal cells, such as 
enterocytes or mucus cells 30, 31. In line with this, the increase in HES1 induced by M1 
macrophages was parallel with an increase in IAP activity, a well-known marker of 
enterocyte differentiation 32 and with no changes in Muc2 expression. Considering that 
our results show that spontaneous differentiation of these cells is associated with a 
time-dependent increase in both IAP activity and HES1 protein levels, our results 
strongly suggest that M1 macrophages promote enterocyte differentiation in epithelial 
cells. Previous studies have shown that Jag1 up-regulates AP in stem cells 33 which lead 
us to propose that M1 macrophages activate the Notch signaling pathway and 
enterocyte differentiation in epithelial cells through the expression of Dll4 and Jag1.  
The pathophysiological relevance of these observations has been analyzed in the 
mucosa of CD patients in which we found an increased number of macrophages 
compared with that of control patients. The expression of both M1 and M2 markers was 
detected but, in a similar manner to that previously reported in the mucosa of ulcerative 
colitis patients 26, the number of M2 macrophages was higher than the number of M1 
macrophages. Of interest, a high percentage of M1 macrophages were positive for HIF-
1α and Jag1 reinforcing the observations reported in vitro and suggesting that the 
expression of Notch ligands by M1 macrophages in human intestine is also associated 
with HIF-1. Of particular interest, macrophages were frequently detected in an adjacent 
position to epithelial cells and we observed a positive and significant correlation 
between CD86+ cells and HES1 protein levels in crypts isolated from the mucosa which 
strongly supports that M1 macrophages activate Notch signaling pathways in epithelial 
cells. A detailed analysis of this correlation reveals differences in the distribution of data 
marked by the presence or absence of CD; a higher number of macrophages with lower 
protein levels of epithelial HES1 were detected in the mucosa of CD patients compared 
with control patients. These observations led us to suggest that, in addition to M1 
macrophages, HES1 expression was modulated by other factors present in the inflamed 
mucosa. Considering our data showing that M2 macrophages prevail in the mucosa of 
CD patients and that most of them express HIF-2α, which has been related to Notch 
signaling inhibition 34, results suggest that M2 macrophages may also be modulating the 
Notch pathway. Reinforcing this observation, we have previously demonstrated that M2 
macrophages activate Wnt signaling in epithelial cells 26, and this pathway has been 
widely associated with inhibition of Notch signaling 35-37. In this line our data show a very 
good correlation between HES-1 protein levels and the ratio of M1/M2 macrophages, 
and propose that M2 macrophages act, in an opposite manner to M1 cells modulating 
Notch signaling. 
The Notch pathway governs the intestinal binary cell fate decision between the 
secretory versus absorptive cell lineages 38. Our results reveal a diminished HES1 
expression in crypts isolated from the mucosa of CD patients in parallel with an 
enhanced expression of Math1, a transcription factor that is repressed by HES-1, 
strongly suggesting that the Notch signaling pathway was impaired 13. It has been 
reported that the up-regulation of Math 1 directs epithelial cell fate toward secretory 
lineage cells, including goblet cells 7, 39. Our data demonstrate an increased mRNA 
expression of Muc2, a marker of goblet cells and a higher number of goblet cells per 
crypt, in parallel with a decreased IAP protein levels in the mucosa of CD patients 
compared with controls, suggesting that enterocyte differentiation is specifically 
impaired. Previous studies have reported diminished IAP mRNA and protein expression 
40, 41 in the intestinal mucosa of adults and children with CD. We extend these 
observations and show that these diminished IAP protein levels correlate with 
diminished HES1 protein levels which lead us to propose that enterocyte differentiation 
is impaired in CD as a consequence of an undermined Notch signaling pathway. This 
hypothesis is backed by the fact that macrophages, which were closely correlated with 
HES1 protein levels, were also correlated with the expression of the enterocyte marker 
IAP. 
As a whole our results provide evidence of a HIF-1 dependent induction of Notch ligands 
associated with M1 macrophages. In contrast to M2 macrophages, M1 cells activate the 
Notch signaling pathway in epithelial cells. The prevalence of M2 over M1 macrophages 
in the mucosa of chronic CD patients may mediate the diminished enterocyte 
differentiation and impaired mucosal regeneration observed in these patients. A better 
understanding of the reciprocal regulation of macrophage phenotype and mucosal 
repair following intestinal damage will help to establish new approaches to CD therapy. 
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FIGURES 
Figure 1. HIF-1 mediates the hypoxic up-regulation of Dll4 and Jag1 in macrophages.  a) 
Graphs show time-course analysis of the effects of hypoxia on HIF-1α protein levels and 
the mRNA expression of Jag1 and Dll4 in U937 macrophages. In all cases, points in the 
graphs represent mean± SEM (n>3). *P<0.05 vs. time 0h or vs. macrophages in normoxia 
at the same time point. b) Graphs show the mRNA expression of Dll4 and Jag1 and 
protein levels of HIF-1α in mock-transfected U937 cells and cells treated with miHIF-1α 
under normoxic or hypoxic conditions (8 h). In all cases, bars in the graphs represent 
mean± SEM (n>3). *P<0.05. vs. the same group in normoxia and #P<0.05. vs. mock-
transfected cells in hypoxia. c) Representative chromatin immunoprecipitation (ChIP) 
experiment performed in samples from U937-derived macrophages in normoxia or 
hypoxia. Chromatin was immunoprecipitated with anti-HIF-1α antibody, or a non-
related antibody anti-IgG as a control. An aliquot of the input chromatin is also shown. 
Primers specific to the promoter region for Jag1 gene were used to amplify the DNA 
isolated from the ChIP assay.  
 Figure 2. HIF-1 mediates the expression of Notch ligands associated with M1 
macrophages. U937-derived macrophages (n=6) were either treated with LPS and IFN-γ 
and polarized towards M1 macrophages or treated with IL-4 and polarized towards M2 
macrophages; some cells were treated with the vehicle (non-polarized macrophages). 
a) Representative Western blots and graph showing HIF-1α or HIF-2 α protein levels at 
different time points. Points in the graphs represent mean± SEM (n>3), *P<0.05 vs. time 
0h. b) Graphs show the relative mRNA expression levels of Dll4 and Jag1 in macrophages 
and protein levels of Jag1 in M1 macrophages at different time points. Bars represent 
mean±SEM. *P<0.05 vs. the respective value in non-polarized macrophages and M2 
macrophages. c). Graphs show the relative mRNA expression levels of Dll4 and Jag1 in 
macrophages derived from primary monocytes (healthy donors, n=6; CD patients, n=6). 
Bars represent mean±SEM. *P<0.05 vs. the respective value in non-polarized 
macrophages and M2 macrophages. d) Representative Western blots and graphs 
showing protein levels of HIF-1α and mRNA expression of Dll4 and Jag1 in U937 derived 
macrophages transfected with mock or miHIF-1α and polarized towards M1. Bars 
represent mean±SEM. *P<0.05 vs.mock-M1 macrophages.  
 
 
 
 
 
 
 
 
 
Figure 3. M1 macrophages activate HES1 expression and markers of differentiation in 
epithelial cells. HT29 cells (a) or Caco-2 cells (b) at  pre-confluence were co-cultured (24 
h) with M1 or M2 macrophages (stained with CD18, FITC). In some cases macrophages 
were transfected with mock, miHIF1α, miDll4 or miJag1 vectors previous M1 
polarization. Levels of HES1 staining (TR) or Muc2 staining (TR) in epithelial cells were 
determined by static cytometry (n=6). Graphs show a significant increase in the 
expression of epithelial HES1 induced by M1 but not M2 macrophages compared with 
that detected in epithelial cells cultured alone. M1- miHIF1α, M1- miDll4, M1- miJag1 
macrophages reduced significantly HES1 expression in either HT29 or Caco-2 cells. M1 
or M2 macrophages failed to significantly modify the expression of Muc2 in either HT29 
or Caco-2 cells. IAP enzymatic activity in epithelial cells was significantly increased by 
M1 macrophages and significantly reduced by M2 macrophages. In ars represent mean± 
SEM. *P<0.05 and **P<0.01 vs. epithelial cells and #P<0.05 and ###P<0.001 vs. epithelial 
cells co-cultured with M1-mock macrophages.  
  
 
 
Figure 4. Characterization of the macrophage phenotype in the mucosa of CD patients 
a) Representative images showing CD68 immunostaining in lamina propria and in close 
proximity to epithelial cells in the mucosa of control and CD patients. b) Graph shows 
quantitative analysis of CD68, CD86 and CD206 positive cells in a total area of 0.3 mm2. 
Bars represent mean±SEM. **P<0.01 vs. control mucosa. c) Graphs show the percentage 
of CD86+ /CD68+ cells, CD206+ /CD68+ cells, iNOS+ /CD68+ cells and ArginaseI+ /CD68+ 
cells in isolated macrophages obtained from the mucosa (Static cytometry). Bars 
represent mean±SEM. *P <0.01 vs. macrophages from control mucosa. 
 
 
 
 
  
Figure 5. CD86+ macrophages from human mucosa express HIF1α and Jag1. A 
quantitative analysis (Static cytometry) was performed in macrophages isolated from 
the mucosa and graph shows the percentage of CD86 or CD206 positive cells that 
expressed Jag1, HIF-1α or HIF-2α. Bars represent mean±SEM. *P <0.05 vs. CD206 
positive cells expressing the respective marker in the same group of patients.  
 
 Figure 6. The M1/M2 ratio correlates with HES1 and IAP protein levels in human 
intestinal mucosa. a) Representative Western blots showing HES1 and IAP protein levels 
in the mucosa of CD and control patients and photographs showing HES1 
immunostaining. Graphs show quantification of HES1 and IAP protein levels and the 
mRNA expression of HES1, Math1 and Muc2 in intestinal crypts isolated from the 
mucosa of control and CD patients. b) A quantitative analysis showing the percentage of 
goblet cell vs. nuclei per crypt in the mucosa (three crypts were analyzed per sample).  
In all cases bars in graphs represent mean± SEM. Significant difference from control 
mucosa is shown by *P<0.05. c) A positive and significant correlation was observed 
between HES1 and IAP protein levels in the mucosa of CD and control patients. d) A 
positive and significant correlation was observed between CD86/CD68 positive cells and 
HES1 protein levels in the mucosa of CD and control patients. e) A closer correlation was 
established between the CD86/CD206 ratio and HES1 protein levels as well as the 
CD86/CD206 ratio and IAP protein levels. 
  
Supplementary Figure 1. Caco-2 cells and HT29 cells differentiate towards enterocytes 
by culturing post-confluence. HT29 or Caco-2 cells were cultured post-confluence (PC) 
and a time-dependent increase in protein levels of IAP and HES1 was detected in the 
course of 11 day-period while no significant changes in Muc2 mRNA expression were 
observed. Bars represent mean±SEM. *P<0.05 vs. sub-confluence (SC). 
  
Table 1. Patient characteristics 
Crohn’s disease patients  
Number of patients 16 
Age  
17-40 years 6 
>40 years 10 
Gender  
Male 9 
Female 7 
Concomitant medication  
Azathioprine 3 
Anti-TNF 16 
Mesalazine 2 
 
Control patients  
Number of patients 11 
Age  
17-40 years 0 
>40 years 11 
Gender  
Male 7 
Female 4 
 
 
Table 2. Specific antibodies used for immunohistochemistry, immunofluorescence 
studies and Western blot analysis. 
 
Antibody Immunofluorescence Immunohistochemistry Western 
blot 
 Antibody dilution Antigen Retrieval Antibody 
dilution 
IAP (Santa Cruz 
Biotechnology) 
  1:1000 
HES1 (Santa Cruz 
Biotechnology) 
1:100 sodium citrate buffer 
pH=6°C 20 min 
1:200 
1:500 
Jag1 (Santa Cruz 
Biotechnology) 
1:100 sodium citrate buffer 
pH=9°C 20 min 
1:200 
 
CD18 (BD, Barcelona 
Spain) 
1:100   
CD68 (Biolegend, 
Madrid, Spain) 
1:100 α-chymotrypsin 37°C 20 
min 
1:100 
 
CD86 (Epitomics, 
Burlingame, CA, 
USA) 
1:100 α-chymotrypsin 37°C 20 
min 
1:200 
 
CD206 (Novus 
Biologicals, 
Cambridge, UK) 
1:100 sodium citrate buffer 
pH=9°C 20 min 
1:200 
 
ArginaseI (Santa 
Cruz Biotechnology) 
1:100   
iNOs (Santa Cruz 
Biotechnology) 
1:100   
HIF-1α (Novus 
Biologicals) 
1:100  1:500 
HIF-2α (Santa Cruz 
Biotechnology) 
1:100   
Muc2 (Santa Cruz 
Biotechnology) 
1:100   
b-actin (Sigma-
Aldrich) 
  1:10000 
 
Table 3. Primer sequences of specific PCR products for each gene analyzed. 
Human 
Gene 
Sense Antisense Length 
(bp) 
Jag1 5´-gaacacgggcgttgcccact-3´  5´-gtggacgcatcccgggtgtg-3´ 304 
Dll4 5’-gtgcagcgtacaccggcact-3’  5’- tctgttcgcgacgccgcttt-3’ 223 
HES1 5’-aaaattcctcgtccccggtg-3’  5’-tttgt tatccgttcg-3’ 64 
Muc2 5’-gctggccgccggctattacc-3’  5’-accccggccgtcatccatca-3’ 79 
Math1 5’-ccgcccagtatttgctacat-3’  5’-cattcacctgtttgctggaa-3’ 234 
b-actin 5´-ggacttcgagcaagagatgg-3´ 5´-agcactgtgttggcgtacag-3´ 67 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
ARTICLE 4: 
 
 
“Induction of CD36 and 
thrombospondin-1 in 
macrophages by hypoxia-
inducible factor 1 and its 
relevance in the 
inflammatory process” 
 
 
Ortiz-Masià D, Díez I, Calatayud S, Hernández C, 
Cosín-Roger J, Hinojosa J, Esplugues JV, 
Barrachina MD. 
 
 
PLoS One. 2012;7(10):e48535. doi: 10.1371/ 
journal.pone.0048535. Epub 2012 Oct 31 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Induction of CD36 and Thrombospondin-1 in
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Abstract
Inflammation is part of a complex biological response of vascular tissue to pathogens or damaged cells. First inflammatory
cells attempt to remove the injurious stimuli and this is followed by a healing process mediated principally by phagocytosis
of senescent cells. Hypoxia and p38-MAPK are associated with inflammation, and hypoxia inducible factor 1 (HIF-1) has been
detected in inflamed tissues. We aimed to analyse the role of p38-MAPK and HIF-1 in the transcriptional regulation of CD36,
a class B scavenger receptor, and its ligand thrombospondin (TSP-1) in macrophages and to evaluate the involvement of
this pathway in phagocytosis of apoptotic neutrophils. We have also assessed HIF-1a, p38-MAPK and CD36 immunostaining
in the mucosa of patients with inflammatory bowel disease. Results show that hypoxia increases neutrophil phagocytosis by
macrophages and induces the expression of CD36 and TSP-1. Addition of a p38-MAPK inhibitor significantly reduced the
increase in CD36 and TSP-1 expression provoked by hypoxia and decreased HIF-1a stabilization in macrophages. Transient
transfection of macrophages with a miHIF-1a-targeting vector blocked the increase in mRNA expression of CD36 and TSP-1
during hypoxia and reduced phagocytosis, thus highlighting a role for the transcriptional activity of HIF-1. CD36 and TSP-1
were necessary for the phagocytosis of neutrophils induced by hypoxic macrophages, since functional blockade of these
proteins undermined this process. Immunohistochemical studies revealed CD36, HIF-1a and p38-MAPK expression in the
mucosa of patients with inflammatory bowel disease. A positive and significant correlation between HIF-1a and CD36
expression and CD36 and p38-MAPK expression was observed in cells of the lamina propria of the damaged mucosa. Our
results demonstrate a HIF-1-dependent up-regulation of CD36 and TSP-1 that mediates the increased phagocytosis of
neutrophils by macrophages during hypoxia. Moreover, they suggest that CD36 expression in the damaged mucosa of
patients with inflammatory bowel disease depends on p38-MAPK and HIF-1 activity.
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Introduction
Inflammation is part of the complex biological response of
vascular tissues to harmful stimuli such as pathogens or damaged
cells, by which the injurious stimuli should be removed and the
healing process initiated. Hypoxia and p38 group mitogen-
activated protein kinase (p38-MAPK) have been associated with
inflammatory diseases [1–3]. Hypoxia inducible factor-1 (HIF-1) is
the main regulator of the transcriptional response to hypoxia and
its activity is modulated by the p38-MAPK signaling pathway
[4,5]. Stabilized HIF-1a is observed in several inflamed tissues
and, in the case of clinical colitis it has been detected in epithelial
and inflammatory cells [6–8]. In epithelial cells HIF-1 induces the
expression of genes involved in mucosal defence and repair, such
as mucin 3 and trefoil factors [9,10], and has been identified as
a critical factor for barrier protection. The role it plays in
inflammatory cells seems to be more complex, with specific
functions being reported according to the type of cell. HIF-1
increases the expression of ß2 integrin, which promotes neutrophil
binding to the endothelium [11,12], and activation of HIF has
been reported during macrophage differentiation [13]. At the
inflammatory focus, HIF-1 prevents the apoptosis of neutrophils
and mediated bacterial phagocytosis by macrophages [12,14–16].
Considered as a whole, these observations demonstrate a protective
effect of HIF-1 in epithelial cells and point to a key role in the
activation of the innate immune response against pathogens and
injury. However, the involvement of HIF-1 and its transcriptional
activity in the clearance of cellular debris and apoptotic cells
mediated by macrophages [17], a crucial process in the resolution
of inflammation, is yet to be clarified.
CD36 is a heavily glycosylated transmembrane protein belong-
ing to an evolutionarily conserved family of scavenger receptors.
This multifunctional receptor is expressed on the surface of
different cells, including macrophages, and is known to be involved
in scavenger recognition of apoptotic cells [18,19], exogenous
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e48535
pathogens and their inflammatory compounds [20]. The in-
teraction between CD36 and apoptotic cells seems to be mediated
specifically by thrombospondin-1 (TSP-1), an extracellular matrix
glycoprotein that bridges apoptotic cells, CD36 and the vitronectin
receptor, thus creating a phagocytically active ternary complex
[21]. CD36 expression is transcriptionally controlled by the
nuclear receptor PPARc [22]. However, a recent study has
demonstrated that inflammatory macrophages, in which activation
of PPARc is down-regulated, are endowed with an alternative
mechanism of CD36 expression [23]. Given that HIF-1 has been
related to CD36 expression in vascular and smooth muscle cells
[24] but that little is known about the regulation of CD36 and
TSP-1 in hypoxic macrophages, we set out to analyse the role of
HIF-1 and its transcriptional activity in phagocytosis of neutro-
phils. Our results show a HIF-1 dependent induction of CD36 and
TSP-1 in macrophages which regulates hypoxia-induced phago-
cytosis of apoptotic neutrophils. They also suggest that CD36
regulation by HIF-1is implicated in the damaged mucosa of
patients with inflammatory bowel disease.
Materials and Methods
Ethics Statements
All protocols were approved by the Ethics Committee of the
Faculty of Medicine, University of Valencia. The experiments
performed with human samples were approved by the Institutional
Review Board of Manises’ Hospital (Valencia). Written informed
consent was obtained from all patients.
Cell Culture and Treatment
Human monocytes (U937 and THP1, European Collection of
Cell Culture Salisbury, UK) were cultured in RPMI medium
(Sigma Chemical CO, St. Louis, MO) with 10% inactivated
bovine fetal serum (FBS, Lonza, Basel, Switzerland), 1.1 mg/ml
sodium pyruvate, 100 U/ml penicillin and 100 mg/ml streptomy-
cin. In both cases monocytes were differentiated into macrophages
by culturing them in the presence of phorbol 12-myristate 13-
acetate (PMA, Sigma Chemical, St. Louis, MO [25]) for 48 h.
Some cells were pre-treated with a p38-MAPK inhibitor
(10 mM SB 202190, 24 h; Sigma Chemical, St. Louis, MO). In
other experiments the following functional antibodies were
employed: polyclonal antibody against CD36 (0.2 mg/ml, 3 h,
Santa Cruz Biotechnology, CA, USA); monoclonal antibody
against TSP-1 (0.2 mg/ml, 3 h; Santa Cruz Biotechnology),
horseradish peroxidase-conjugated goat anti-mouse IgG (0.2 mg/
ml; 3 h; Pierce, Rockford, IL USA); or goat anti-rabbit IgG
(0.2 mg/ml; 3 h, Pierce).
Human peripheral blood mononuclear cells (PBMC) were
isolated from healthy donors by Ficoll density gradient centrifu-
gation. Monocytes were plated in 12-well tissue culture plates and
matured to macrophages by culturing in X-Vivo 15 medium
(BioWhittaker) supplemented with 1% human serum and 20 ng/
nl recombinant human M-CSF (Peprotech, France) at 37uC in 5%
CO2 for 6 days.
Hypoxia (3% O2) was established by incubating the cells for 5 h
in a CO2/O2 incubator (model INVIVO2 400, RUSKINN
Technology Ltd, Pencoed, UK) with a blend of 5% CO2 and the
desired percentage of O2 and N2 up to a total of 100%. Normoxic
controls were obtained by incubating the cells at 21% O2.
RNA interference. U937 cells were transfected with a vector-
targeting human HIF-1a (miHIF-1a) or a non-targeting control
vector (mock), as described previously [26]. Lipofectamine-2000
(Invitrogen Life Technologies, Barcelona, Spain) was employed as
a transfection reagent and used according to the manufacturer’s
instructions. Twenty-four hours after transfection the cells were
incubated for 5 h in normoxic or hypoxic conditions, as described
above.
Neutrophil isolation, apoptosis and staining. Human
peripheral blood polymorphonuclear (PMN) cells were isolated
from whole blood of healthy volunteers using sodium citrate as
an anticoagulant [27]. Samples were incubated with dextran
(3%) for 45 min. PMN cells in the supernatant were separated
by gradient density centrifugation (250 g, 25 min) with Ficoll-
PaqueTM Plus. Following red blood cell lysis, neutrophils were
washed (HBSS without Ca2+ or Mg2+) and re-suspended in
complete RPMI medium. To induce spontaneous apoptosis,
neutrophils were cultured at 37uC for 24 h (56106 cells/ml in
cultured medium without serum in a humidified atmosphere
containing 5% CO2). Purity of isolation and apoptosis of
neutrophils were assessed by Wright’s Giemsa staining. Neutro-
phil preparations with more than 90% apoptotic cells were
labeled with 5-(and-6)-carboxy fluoresceindiacetatesuccinimidyl
ester (CFSE) (Invitrogen Life Technologies, Barcelona, Spain)
following the manufacturer’s instructions. Labelled cells were
used as targets in the phagocytosis assay.
Phagocytosis assay. Following a 4 h-period of normoxic or
hypoxic conditions, macrophages were co-cultured with CFSE-
labeled apoptotic neutrophils at a phagocyte-to-target ratio of
1:10. One hour later, cells were washed thoroughly with PBS.
U937 cells were stained with Hoechst 33342 (Sigma-Aldrich,
Steinheim, Germany) in order to visualize the nuclei and with
a fluorescent mitochondrion-selective probe (MitoTrackerH Red
580, Invitrogen Life Technologies, Barcelona, Spain) in order to
define the cytoplasm area, and were then fixed with para-
formaldehyde 4% for 10 min. Samples were analyzed with
a fluorescent microscope (IX81, Olympus, Hamburg, Germany)
and the CFSE fluorescent signal was quantified using the static
cytometer software ‘Scan’ version 2.03.2 (Olympus, Hamburg,
Germany). This system automatically counts the total number of
cell nuclei per field and the number of phagocytic cells (green
fluorescence on red fluorescence). All treatments were performed
in duplicate in 12-well plates, and 20 images per well (around 2000
cells) were recorded. Results are expressed as intensity of
fluorescence in arbitrary units.
Protein extraction and western blot analysis of HIF-1a,
CD36 and TSP-1 expression. U937cells (2.5?106 cells) were
suspended and incubated on ice for 15 min with 50 ml of lysis
buffer (10 mM HEPES, pH 7.5, 2 mM MgCl2, 1 mM EDTA,
1 mM EGTA, 10 mM NaCl, 1 mM DTT, 10 mM NaF,
0.1 mM Na3VO4, 0.2% NP40, 1 mM Pefabloc SC (AEBSF)
(Roche Diagnostics GmbH, Mannheim, Germany), supplemen-
ted with Protease Inhibitor Cocktail (Roche Diagnostics GmbH,
Mannheim, Germany). Lysates were centrifuged for 10 min at
4uC (16000 g). Supernatants were considered cytosolic extracts.
Pellets were sonicated for 10 min in 50 ml nuclear extraction
buffer (25 mM HEPES, pH7.5, 500 mM NaCl, 1 mM DTT,
10 mM NaF, 10% Glycerol, 0,2% NP40, 5 mM MgCl2, 1 mM
Pefabloc SC (Roche Diagnostics GmbH, Mannheim, Germany)
supplemented with Protease Inhibitor Cocktail (Roche Diag-
nostics GmbH, Mannheim, Germany). Nuclear lysates were
centrifuged for 10 min at 4uC (16000 g). Supernatants were
considered nuclear extracts. Total protein concentration in
lysates was quantified using the Pierce BCA protein assay kit
(Pierce, Rockford, IL USA). Equal amounts of protein were
loaded onto SDS/PAGE gels and analyzed by Western blot, as
described previously [10]. TSP-1 gels were run in non-reducing
conditions. Membranes were blocked with 5% non-fat dry milk
in TBS-T (20 mM Tris/HCl pH 7.2, 150 mM NaCl and 0.1%
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Tween 20) and incubated overnight with a monoclonal antibody
against human HIF-1a (dilution 1:250; BD Biosciences, San
Jose, CA), human TSP-1 (dilution 1:300; Thermo Scientific,
Runcorn, Cheshire WA7 1PR, UK), human CD36 (1:250;
Abcam, Cambridge, UK) or Actin (dilution 1:10000; Sigma-
Aldrich, MO, USA). Protein bands were detected by LAS-3000
(Fujifilm) during incubation with horseradish peroxidase-conju-
gated goat anti-mouse IgG (dilution 1:2500; Pierce, Rockford,
IL USA) or goat anti-rabbit IgG (1:5000; Pierce, Rockford, IL
USA) following treatment with supersignal west picochemilumi-
nescent substrate (Pierce, Rockford, IL USA). Protein expression
was quantified by means of densitometry using Image Gauge
Version 4.0 software (Fujifilm Global, Barcelona, Spain). Data
were normalized to actin and results are expressed as fold
induction vs control group.
RNA Extraction and PCR Analysis
Total RNA was isolated from U937cells using the RNeasy Mini
kit (Qiagen, Valencia, CA, USA). cDNA was synthesised and real-
time PCR was performed as described previously [26]. Specific
oligonucleotides for HIF-1a (59-GAAAGCGCA AGTCCT-
CAAAG-39 and 59-TGGGTAGGAGATGGAGATGC-39),
TSP-1 (59-AGAGAACAGAGCCCCAC AGA-39 and 59-
CCCAAAATATCCTGGGAGGT-39), and CD36 (59-CAGTTG-
GAGACCTGCTTATCC-39 and 59-GCGTCC TGGGTTA-
CATTTTC-39) were designed according to reported sequences.
Actin (59-GGAC TTCGAGCAAGAGATGG-39 and 59-
CTGTACGCCAACACAGTGCT-3`) expression was used as an
internal control. The threshold cycle (CT) was determined and
relative gene expression was expressed as follows: change in
expression (fold) = 22D(DCT
) where DCT=CT (target) - CT
(housekeeping), and D(DCT) =DCT (treated) - DCT (control).
Static Cytometry
PBMC and U937-derived macrophages were exposed to
hypoxia for 5 h. After treatment, cells were fixed with 2%
paraformaldehyde, permeabilized with 0.1% Triton-X100, and
then stained with polyclonal antibody against CD36 (1:200, Santa
Cruz Biotechnology, Santa Cruz, CA). FITC or TexRed labeled
goat anti-rabbit IgG (H + L) (1:200, Abcam, Cambridge, UK)
were used as the secondary antibody, and 1 mM Hoechst 33342
(Sigma-Aldrich, Steinheim, Germany) was added to stain nuclei.
Fluorescence (18 images per well) was visualized using the
fluorescence microscope and the fluorescent signal was quantified
using the static cytometer software ‘Scan’ version 2.03.2.
Chromatin Immunoprecipitation
U937 cells were differentiated to macrophages. Following the
hypoxia/normoxia treatment for 5 h, cells were washed twice with
PBS and cross-linked with 1% formaldehyde at room temperature
for 10 min. Cells then were rinsed with ice-cold PBS twice and
collected into 100 mM Tris-HCl (pH 9.4), 10 mM DTT and
incubated for 15 min at 30uC and centrifuged for 5 min at 2000 g.
Cells were washed sequentially with 1 ml of ice-cold PBS, buffer I
(0.25% Triton X-100, 10 mM EDTA, 0.5 mM EGTA, 10 mM
HEPES, pH 6.5), and buffer II (200 mM NaCl, 1 mM EDTA,
0.5 mM EGTA, 10 mM HEPES, pH 6.5). Cells were then
resuspended in 0.3 ml of lysis buffer (1% SDS, 10 mM EDTA,
50 mM Tris-HCl, pH 8.1, 16 protease inhibitor cocktail (Roche
Diagnostics GmbH, Mannheim, Germany) and sonicated three
times for 10 s each at the maximum setting (Branson, Digital
Sonifier) followed by centrifugation for 10 min. Supernatants were
collected and diluted in buffer (1% Triton X-100, 2 mM EDTA,
150 mM NaCl, 20 mM Tris-HCl, pH 8) followed by immuno-
clearing with 2 mg sheared salmon sperm DNA, 20ml pre-immune
serum and protein A-sepharose (45 ml of 50% slurry in 10 mM
Tris-HCl, pH 8, 1 mM EDTA) for 2 h at 4uC. Immunoprecip-
itation was performed overnight at 4uC with anti-HIF1a antibody
(Novus Biologicals, CO, USA), or with control IgG antibody
(Pierce). After immunoprecipitation, 45 ml protein A-Sepharose
and 2 mg of salmon sperm DNA were added and the incubation
continued for 1 h. Precipitates were washed sequentially for
10 min each in TSE I (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris-HCl, pH 8, 150 mM NaCl), TSE II (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8,
500 mM NaCl), and buffer III (250 mMLiCl, 1% NP-40, 1%
deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8). Precipi-
tates were then washed three times with TE buffer and extracted
three times with 1% SDS, 100 mM NaHCO3. Eluates were
pooled and heated at 65uC for at least 6 h to reverse the
formaldehyde cross-linking. DNA fragments were purified with
a Montage PCR Kit (Millipore, Germany). PCR was performed
using PCR Master (Roche Diagnostics GmbH, Mannheim,
Germany) with the following primers: 59-AGATCTTTCGT-
TAAACCCCTGGTCCG-39 and 59-CTCGAGT-
CATGTCCTTTCTCACGTCCA-39, detecting the region 233
to2493 in TSP-1 promoter (35 cycles). The PCR products were
separated by electrophoresis in 2% agarose gel.
Electrophoretic Mobility Shift Assay
Nuclear extracts from miHIF1a or mock-transfected and non-
transfected U937 cells were obtained as described above.
Synthetic oligonucleotides (biotin-labelled) were synthesized
(TIB MOLBIOL GmbH Berlin, Germany) and used as probes
in electrophoretic mobility shift assays (EMSAs). Analysis
revealed what appeared to be a hypoxic response element
(HRE) motif (-62 TCA CAA TCT GGA CGT GAG AAA
GGA CAT-35) in the TSP-1 promoter. A mutated probe-
binding site (TSP-1 mt: TCA CAA TCT GGA AAA AAG
AAA GGA CAT) or excess unlabelled probes (XS) were used as
controls. Nuclear extracts (10mg) were incubated for 5 min with
or without an excess unlabelled probe in DNA binding buffer
(Pierce) supplemented with 5 mM MgCl2, 50 ng/ml poly-d[I-C]
(Pierce), 0.05% NP40 (Pierce) and 2.5% glycerol at room
temperature. The labelled probe (25 fmol) was then added to
the reaction mixture and incubated for 30 min at room
temperature in a final volume of 20 ml. DNA-protein was
resolved in a 6% non-denaturing polyacrylamide gel, as
described previously. DNA-protein complexes were transblotted
to BiodyneH B nylon membrane (Pierce, Rockford, IL USA),
probed with streptavidin-horseradish peroxidase conjugate
(Pierce, Rockford, IL USA) and developed by enhanced
chemiluminescence.
Immunohistochemical Studies
Patients clinically diagnosed with typical Crohn’s disease and
ulcerative colitis underwent a colonoscopy or sigmoidoscopy
during which biopsy specimens were taken, from damaged and
non-damaged mucosa (Table 1). HIF-1a, p38-MAPK and
CD36 immunostaining was performed in representative 5 mm
sections of paraffin-embedded tissues. Antigen retrieval was
carried out with a-chymotrypsin for HIF-1a antibody (37uC,
20 min) or sodium citrate buffer pH=9 for CD36 and p38-
MAPK antibody (100uC, 20 min). In all cases, endogenous
peroxidase activity was suppressed by immersion in 0.3%
hydrogen peroxide (15 min). Following blocking with 5% horse
serum, sections were incubated overnight (4uC) with a macro-
phage marker antibody (Vector Laboratories, Peterborough,
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UK) or a mouse monoclonal antibody against HIF-1a (Novus
Biologicals, CO, USA, 1:60), CD36 (1:100) or p38-MAPK
phosphorylated at Tyr182 (Novus Biologicals, CO, USA, 1:200).
A horse anti-mouse/rabbit biotinylated antibody (Vector Lab-
oratories, Peterborough, UKr, 1:200) was employed as a sec-
ondary antibody. The VECTASTAIN elite ABC system Kit
(Vector Laboratories, Peterborough, UK) was used to develop.
All tissues were counterstained with hematoxylin and the
specificity of the immunostaining was confirmed by the absence
of staining in analogous tissue sections when the primary or
secondary antibodies were omitted. An area of 0.135 mm2 was
analyzed for quantitative analysis.
Statistical Analysis
Data are expressed as mean 6 s.e.m. and were compared by
analysis of variance (one way-ANOVA) with a Newman-Keuls
post hoc correction for multiple comparisons or a t-test when
appropriate. A P value,0.05 was considered to be statistically
significant. The correlation between CD36 and HIF-1 or CD36
and p38-MAPK was analyzed using the Spearman’s correlation
coefficient.
Results
Hypoxia Increases the Phagocytosis of Apoptotic
Neutrophils by Macrophages
Phagocytosis of CFSE-labelled apoptotic neutrophils was
analyzed by static cytometry. As shown in Fig. 1, hypoxia
enhanced the phagocytic activity (analyzed as intensity fluores-
cence in the assay) of both U937 and THP1 macrophages
compared with normoxia. Western blotting revealed that in-
cubation of U937 and THP1 macrophages in hypoxic conditions
(3% O2) induced HIF-1a stabilization.
Hypoxia Induces the Expression of CD36 and TSP-1 and
HIF-1a Stabilization through a p38-MAPK-dependent
Mechanism
CD36 protein expression was detected in control U937cells
(Fig. 2). Hypoxia induced a slight but significant increase in CD36
protein expression compared with normoxia as analyzed by
western blot. This increase was confirmed by fluorescence static
cytometry in both U937 cells and primary macrophages obtained
from buffy coat (Figure S1). In a similar manner, TSP-1 protein
expression was detected in control U937cells and hypoxia induced
a significant increase in its expression compared with normoxia
(Fig. 2).
The role of the p38-MAPK pathway in the effects of hypoxia on
CD36 and TSP-1 expression and HIF-1a stabilization was studied
by applying SB 202190, a p38-MAPK inhibitor. As shown in
Fig. 2, treatment of cells with SB 202190 significantly decreased
the protein expression of CD36 and TSP-1 induced by hypoxia,
while it did not significantly modify levels of either protein in
normoxia. This drug significantly undermined the stabilization of
HIF-1a induced by hypoxia (Fig. 2).
HIF-1 Mediates Phagocytosis and the Induction of CD36
and TSP-1 Induced by Hypoxia
Expression of HIF-1a in U937 macrophages was knocked down
with miRNA as previously described [26]. HIF-1a protein levels in
hypoxia were significantly lower in cells expressing miHIF-1a than
in mock cells (Fig. 3A). CD36 and TSP-1 mRNA expression was
detected in control U937cells in normoxia and it was increased by
hypoxia (Fig. 3A). The hypoxia-induced increase in the expression
of CD36 and TSP-1 proteins and mRNA was abolished in cells
treated with miHIF-1a, thus confirming the involvement of HIF-1
in the up-regulation of these genes during hypoxia. Phagocytosis of
CFSE-labelled apoptotic neutrophils was analyzed in miHIF-1a
and mock macrophages. As shown in Fig. 3B, hypoxia enhanced
the phagocytic activity of mock macrophages compared with
normoxia, but it failed to do so in miHIF-1a cells.
HIF-1 Binds to the Promoter Region of TSP-1
Analysis of the TSP-1 gene promoter identified some HIF-1
binding sites (HRE sequence) between positions 2493 and 233
relative to the transcription starting site. To examine the potential
role of HIF-1a on the expression of TSP-1, ChIP assays were
performed with an affinity-purified antibody directed against HIF-
1a (Fig. 4A). DNA was extracted from the input, bound (anti-
HIF1a), and unrelated (anti-IgG) antibody fractions; equal
amounts from each fraction were amplified using primers specific
for the TSP-1 promoter region. The binding was determined by
the relative intensity of ethidium bromide fluorescence compared
with the input control. Our data show HIF-1a binding to the TSP-
1 gene in hypoxia. Afterwards we employed EMSA to examine the
binding of HIF-1 to the HRE consensus between positions 262
and 235 relative to the transcription starting site, in the TSP-1
promoter. Hypoxia increased the binding of HIF-1 to its consensus
sequence in the TSP-1 promoter in both non-transfected and
control mock-transfected cells (Fig. 4B). The specificity of the assay
was confirmed by the fact that binding was diminished when cells
were transfected with miHIF1a (lane 6), when a mutated promoter
was used (lane 5) or with an excess of unlabelled probe (XS, lane
4). Collectively, these results indicate that hypoxia elicits nuclear
accumulation of HIF-1a, which binds to the consensus HRE
located within the TSP-1 promoter.
Table 1. Patient clinical information.
Ulcerative colitis Crohn’s disease
Number of patients 10 4
Age
17–40 years 3 1
.40 years 7 3
Gender
Male 3 3
Female 7 1
Location
Colonic 10 2
Ileum – 2
Extent of UC
Pancolitis 3
Left-sided colitis 6
Proctitis 1
Concomitant medication
Corticosteroids 5 2
5 ASA 9 –
AZA 1 3
Anti TNF 1 1
doi:10.1371/journal.pone.0048535.t001
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CD36 and TSP-1 Mediate Phagocytosis Induced by
Hypoxia
Specific functional antibodies were employed to block the
activity of CD36 and TSP-1 in U937 and THP1 cells and thus
evaluate the role of these molecules in phagocytosis. While
hypoxia induced a significant increase in phagocytosis in IgG
control cells, it failed to do so in cells treated with a monoclonal
antibody against CD36. This antibody did not significantly modify
phagocytosis in normoxia (Fig. 5). In a similar manner, a TSP-1
antibody significantly reduced the increase in phagocytosis in-
duced by hypoxia (Fig. 5). In neither case did functional blockade
of TSP-1 significantly modify phagocytosis in normoxic condi-
tions.
CD36 Expression Correlates with HIF-1 and p38-MAPK
Expression in the Damaged Mucosa of Patients with IBD
In order to analyze the relevance of CD36 expression by HIF-1
in inflammation, we performed immunohistochemical studies of
the damaged and non-damaged mucosa of patients with in-
flammatory bowel disease. As can be seen in Fig. 6A, cells of the
lamina propria of the non-damaged mucosa, morphologically
identified as macrophages, exhibited CD36 expression. The
number of CD36-positive cells was significantly lower in the
damaged mucosa than in non-damaged mucosa (Fig. 6B). The
analysis of HIF-1a stabilization revealed a very low expression of
this transcription factor in the lamina propria of non-damaged
mucosa and an increased expression in the damaged mucosa
(Fig. 6A, B). Evaluation of p38-MAPK immunostaining showed
that this enzyme was widely expressed in non-damaged mucosa
and the signal was increased in damaged mucosa (Fig. 6A, B).
A detailed analysis of the immunostaining in the damaged
mucosa of patients with IBD showed a positive and significant
correlation between HIF-1a and CD36-positive cells (R Spear-
man= 0.7170, P= 0.0087**, n = 12). In contrast, no significant
correlation was observed between CD36 and HIF-1a immunos-
taining in non-damaged mucosa (R Spearman=20.0513,
P= 0.95, n= 5) (Fig. 6C). Interestingly, a significant correlation
was also observed in the damaged mucosa between p38-MAPK
and CD36 (R Spearman= 0.6525, P= 0.0215*, n= 12) while no
significant correlation was observed in the non-damaged mucosa
(R Spearman= 0.5204, P= 0.2311, n = 7) (Fig. 6C).
Discussion
The findings of the present study demonstrate that HIF-1
transcriptional regulation plays an important role in hypoxia-
induced phagocytosis of apoptotic neutrophils mediated by
macrophages.
Phagocytosis by macrophages is critical for the uptake and
degradation of infectious agents and senescent cells, a process
implicated in development, tissue remodeling, the immune
response and inflammation [28]. The present results show that
exposure of human macrophages to hypoxia leads to an increase
Figure 1. Hypoxia increases phagocytosis of apoptotic neutrophils by human macrophages. Representative images show phagocytosis
of apoptotic neutrophils by U937 or THP1 cells in normoxia and hypoxia. In all cases blue staining identifies the nuclei, red staining defines the
cytoplasm of the cells, and green staining indicates neutrophils. This system automatically counts the total number of cell nuclei per field and the
number of cells exhibiting green fluorescence on red fluorescence (phagocytic cells). Inserts show magnification of the image. Results are expressed
as intensity of fluorescence in arbitrary units. Bars in the graphs represent mean6 SEM (n.3). Groups were compared using t-test analysis. Significant
difference from the respective group in normoxic conditions is shown by *P,0.05. Western blot showing HIF-1a stabilization induced by hypoxia in
U937 or THP1 cells.
doi:10.1371/journal.pone.0048535.g001
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in the rate of phagocytosis of apoptotic neutrophils. Previous
studies have shown an increase in bacterial phagocytosis by
murine macrophages in hypoxia [15,16,29] and we have observed
a similar process in E coli phagocytosis by human macrophages
(data not shown). Considered together, the evidence points to the
existence of a general mechanism that is activated in macrophages
by hypoxia and which leads to an increase in phagocytic activity
irrespective of the particle that is to be recognized and in-
ternalized. By highlighting the induction of neutrophil phagocy-
tosis by low oxygen levels, our data extend the pathophysiological
relevance of hypoxia from the initial stages of the inflammatory
process to the resolution of inflammation.
CD36 in macrophages acts as a class B scavenger receptor
known to recognize, bind with and internalize apoptotic
neutrophils [19,20]. CD36 regulation by hypoxia has been studied
and contradictory results have been reported [13,30]. The present
study, by using different experimental approaches, demonstrates
a slight but significant increase in CD36 expression induced by
hypoxia. In addition we also show an increased up-regulation of
TSP-1 expression by hypoxia in macrophages. It has been report
that CD36 binds to TSP-1 as a pattern recognition receptor, thus
constituting a phagocytically active ternary complex which
mediates the phagocytosis of neutrophils [21]. Hypoxia has been
implicated in the activation of p38-MAPK [31,32], and our
present data reveal a role for this pathway in the hypoxia-induced
expression of CD36 and TSP-1, since pharmacological blockade
of the activity of these enzymes by SB 202190 significantly
decreased their levels. The p38-MAPK signalling pathway is
known to modulate the activity of HIF-1 [4,5] and HIF-1 has been
related to CD36 expression in endothelial vascular and smooth
muscle cells [24]. Interestingly, the present study shows that
inhibition of p38-MAPK significantly undermines the HIF-1a
stabilization induced by hypoxia in macrophages, which suggests
a role for HIF-1 in said expression. In line with this, our results
demonstrate that the transcriptional activity of HIF-1 is involved
in the effects of hypoxia on both CD36 and TSP-1 expression,
since down-regulation of this transcription factor by transient
transfection significantly decreased the mRNA and protein
expression of both molecules. As far as we know, this is the first
report of hypoxia-induced HIF-1-dependent generation of TSP-1
in macrophages. In addition, our results take current evidence one
step further by confirming the binding of HIF-1 to an HRE
sequence in the promoter region of the TSP-1 gene, which
suggests that this gene is a direct target of HIF-1. In light of
a previous study reporting CD36 as a target gene of HIF-1 [24],
the present findings indicate that, in hypoxic macrophages, HIF-1
synchronizes the transcriptional up-regulation of these two genes,
both of which are crucial to the process of phagocytosis.
A previous study by our group showed a correlation between
the expression of HIF-1 in macrophages and the clearance of
infiltrated neutrophils in the mesentery of aspirin-treated rats [33]
which lead us to suggest the involvement of this transcription
factor in phagocytosis of neutrophils. The present study by the
selective diminution of HIF-1a in cultured macrophages demon-
strates a role for HIF-1 in phagocytosis of apoptotic neutrophils. In
addition we have evaluated the relevance of CD36 and TSP-1 up-
regulation by hypoxia in the phagocytic activity of macrophages
using function-specific antibodies. Results show that CD36 is
required for the induction of macrophage-mediated phagocytosis
of apoptotic neutrophils during hypoxia. In a similar manner,
immunological blockade of TSP-1 abolished the increase in
phagocytosis of apoptotic neutrophils induced by hypoxia. This is
in accordance with a putative role for TSP-1 as a bridge between
CD36 and membrane phospholipids of apoptotic cells [21]. Since
Figure 2. Hypoxia induces TSP-1 and CD36 expression and HIF-
1a stabilization through activation of p38-MAPK. U937 cells were
maintained under normoxia or hypoxia in the presence or absence of
SB 202190 (a p38-MAPK inhibitor, 10 mM, 24 h) and levels of proteins
were determined by Western blot. Graphs show quantification of HIF-
1a, TSP-1 and CD36 by densitometry. In hypoxia, cells treated with SB
202190 exhibited significantly lower protein expression of HIF-1a, TSP-1
and CD36 than cells treated with vehicle. In all cases bars represent
mean6 SEM (n.3). Comparisons between groups were performed
using ANOVA followed by a Newman Keuls test. *P,0.05 and
***P,0.001 with respect to all groups in the same graph and
###P,0.001 vs. bars in normoxia.
doi:10.1371/journal.pone.0048535.g002
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Figure 3. HIF-1 mediates phagocytosis and the increased expression of TSP-1 and CD36 induced by hypoxia. A) Western blot showing
HIF-1a stabilization, CD36 and TSP-1 in U937 cells transfected with miHIF-1a and mock-transfected cells (controls). Graphs show quantification of the
HIF-1a, TSP-1 and CD36 proteins by densitometry and mRNA expression of CD36 and TSP-1 by RT-PCR in mock-transfected cells and cells treated with
miHIF-1a. B) Graph shows phagocytosis of apoptotic neutrophils in miHIF-1a or mock-transfected cells. Bars in the graphs represent mean6 SEM
(n.3). Comparisons between groups were performed using ANOVA followed by a Newman Keuls test. *P,0.05 or **P,0.01 with respect to all bars in
the same graph.
doi:10.1371/journal.pone.0048535.g003
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CD36 and TSP-1 need each other to recognize and phagocyte
apoptotic neutrophils, our results reveal that HIF-1 functions by
promoting an effector response by which apoptotic cells are
removed from hypoxic microenvironments. Regulation of these
two genes by HIF-1 could be part of a wider response in which
a subset of genes helps to resolve inflammation.
Finally, we have analyzed the pathophysiological relevance of
CD36 regulation by HIF-1 and p38-MAPK in the intestinal
mucosa of patients with inflammatory bowel disease. Our results
show low HIF-1a stabilization and high CD36 expression in the
non-damaged mucosa which leads us to suggest that transcription
factors other than HIF-1 are involved in the expression of this
scavenger receptor at the healthy mucosa. In this line constitutive
CD36 expression has been shown to be regulated by several
nuclear receptors, including PPARc [22]. Interestingly gene
expression of PPAR-c is down-regulated in the damaged mucosa
of patients with ulcerative colitis [34] which is in accordance with
results in the present study showing a decrease in CD36 expression
in damaged mucosa compared with non-damaged. In contrast to
that observed in the non-damaged mucosa, a detailed analysis of
the damaged mucosa revealed a positive and significant correla-
tion between CD36 and HIF-1a immunostaining. Considering
that HIF-1 is significantly increased in the damaged mucosa our
results propose that at sites of inflammation where the mechanisms
that modulate the constitutive expression of CD36 are down-
regulated, the expression of this scavenger receptor may depend
Figure 4. Recruitment of HIF-1 to the promoter of TSP-1 gene. A) Results show a representative chromatin immunoprecipitation (ChIP)
experiment performed in samples from U937-derived macrophages in normoxia or hypoxia. Chromatin was immunoprecipitated with anti-HIF-1a
antibody, or a non-related antibody anti-IgG as a control. An aliquot of the input chromatin is also shown. Primers specific to the promoter region for
TSP-1 gene were used to amplify the DNA isolated from the ChIP assay. B) HIF-1a expression in nuclear lysates derived from non-transfected cells and
frommiHIF1a or mock-transfected U937cells exposed to normoxia or hypoxia. Interactions between HIF-1a and HRE of the TSP-1 promoter gene were
examined by EMSA using synthetic oligonucleotides and nuclear lysates derived from transfected or non-transfected cells exposed to normoxia or
hypoxia. Specificity was determined with excess unlabelled probed (XS) or mutated probe (n = 3).
doi:10.1371/journal.pone.0048535.g004
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on HIF-1 activity. It is important to note that both down-
regulation of PPAR-c [35] and HIF-1a stabilization have been
related to hypoxia. Taking into account that low oxygen levels are
associated with inflamed tissue results lead us to suggest hypoxia as
an important regulator of CD36 expression at sites of in-
flammation. Reinforcing this observation, both hypoxia and IBD
have been related to p38-MAPK activity [4,5,36–38] and the
present study shows high expression of p38-MAPK in the
damaged mucosa of IBD patients. Positive immunostaining has
been observed in epithelial cells and different cells of the lamina
propria, including macrophages. Despite the high expression, the
quantitative analysis of p38-MAPK immunostaining in cells of the
lamina propria morphologically identified as macrophages shows
a positive and significant correlation with CD36 expression. Taken
together results suggest that CD36 expression at the damaged
mucosa of IBD patients may depend on both p38MAPK and HIF-
1 activity. It is important to note that in some samples we found
a higher number of p38-MAPK positive cells than CD36 positive
cells which suggests that some of the p38-MAPK positive cells are
not expressing CD36. Considering that these cells have been
identified as macrophages it seems likely that in the damaged
mucosa of IBD patients, macrophages with a different pattern of
expression may be present [39]. Further experiments are necessary
to address this question.
Figure 5. Role of CD36 and TSP-1 in phagocytosis mediated by macrophages. Graphs show the effects of CD36 and TSP-1 functional
antibodies or control IgG on phagocytosis of apoptotic neutrophils mediated by U937 cells or THP1 cells. In both cases, blockade of CD36 or TSP-1
significantly reduced hypoxia-induced phagocytosis. Data show the intensity of fluorescence in arbitrary units (quantified by static cytometry). Bars
represent mean6 SEM (n.3). Groups were compared using ANOVA followed by a Newman Keuls test. *P,0.05 shows significant difference with
respect to all groups in the same graph.
doi:10.1371/journal.pone.0048535.g005
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In summary, our findings reveal a mechanism by which the
transcriptional activity of HIF-1 coordinates induction of CD36
and TSP-1 expression in macrophages, a mechanism that
mediates the enhanced phagocytosis of apoptotic neutrophils in
hypoxia. In addition to its known pro-inflammatory action, HIF-1
may also constitute an important regulator in the resolution of
inflammation.
Supporting Information
Figure S1 Hypoxia increases CD36 expression in PBMC
and U937-derived macrophages. Graphs show the effect of
hypoxia on the expression of CD36 in PBMC and U937-derived
macrophages. Results are expressed as intensity of fluorescence in
arbitrary units. Bars in the graphs represent mean6 SEM (n = 3).
Groups were compared using t-test analysis. Significant difference
from the respective group in normoxic conditions is shown by
*P,0.05.
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Hypoxic macrophages impair autophagy in
epithelial cells through Wnt1: relevance in IBD
D Ortiz-Masia´1, J Cosı´n-Roger1, S Calatayud1, C Herna´ndez2, R Alo´s3, J Hinojosa3, N Apostolova4,
A Alvarez1 and MD Barrachina1
A defective induction of epithelial autophagy may have a role in the pathogenesis of inflammatory bowel diseases. This
process is regulatedmainly byextracellular factors suchasnutrients andgrowth factors and is highly inducedbydiverse
situations of stress. We hypothesized that epithelial autophagy is regulated by the immune response that in turn is
modulatedby local hypoxia and inflammatory signals present in the inflamedmucosa.Our results reveal thatHIF-1a and
Wnt1 were co-localized with CD68 in cells of the mucosa of IBD patients. We have observed increased protein levels
of b-catenin, phosphorylated mTOR, and p62 and decreased expression of LC3II in colonic epithelial crypts from
damaged mucosa in which b-catenin positively correlated with phosphorylated mTOR and negatively correlated with
autophagic protein markers. In cultured macrophages, HIF-1 mediated the increase in Wnt1 expression induced by
hypoxia, which enhanced protein levels of b-catenin, activated mTOR, and decreased autophagy in epithelial cells in
co-culture. Our results demonstrate a HIF-1-dependent induction of Wnt1 in hypoxic macrophages that undermines
autophagy in epithelial cells and suggest a role for Wnt signaling and mTOR pathways in the impaired epithelial
autophagy observed in the mucosa of IBD patients.
Inflammatory bowel disease (IBD) is a chronic disorder of the
gastrointestinal tract characterized by impairment of the
intestinal epithelium function as a regulator of the host
immune response to microbiota.1,2 In colonic epithelial cells,
autophagy has a homeostatic role by engulfing intracellular
organelles and endogenous pathogens via double-membrane
vesicles that fuse with lysosomes, leading to the degradation of
their contents.3–5 This process is mediated by intracellular
microbial sensing via NOD2.6,7 In recent years polymorphisms
in gene loci containing autophagy-related proteins such as
ATG16L1, IRGM, and NOD2 have been associated with an
increased risk of IBD, which implicates a defective induction of
autophagy in the pathogenesis of IBD.3,6,8–10 Autophagy is
regulated mainly by extracellular factors such as nutrients,
hormones, and growth factors and is induced by situations of
stress including starvation, hypoxia, and endoplasmic reticu-
lum stress.11,12 We hypothesized that immunological mechan-
isms modulate autophagy in the mucosa of IBD patients.
Macrophages constitute one of the central components of the
inflamed mucosa, where local hypoxia and inflammatory
mediators modulate their gene expression through the activity
of hypoxia-inducible factors (HIFs).13,14 These infiltrated macro-
phages could be the source of signaling molecules such as soluble
growth factors or Wnt glycoproteins,15,16 which by acting on
epithelial cells may have an important role in the maintenance
of intestinal homeostasis and tissue regeneration.17–19
The Wnt glycoprotein family comprises several ligands that
mediate close-range signaling.20,21 Two branches of Wnt
signaling have been described: canonical and non-canonical
pathways. Binding of canonical Wnt ligands to frizzled receptors
results in the inhibition of glycogen synthase kinase 3 (GSK3),
which is associated with the accumulation of b-catenin in the
cytoplasm and translocation to the nucleus to activate gene
expression.22 Interestingly, stimulation of frizzled receptors has
recently been related to activation of mTOR, a central negative
regulator of autophagy.12,23–26 Although most evidence sug-
gests that the canonical Wnt signaling pathway is involved,
some studies have shown that Wnt1 activates mTOR through
an action that is mediated by both canonical and non-
canonical-independent pathways.27
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The aim of the present study was to analyze the expression of
autophagic protein markers in epithelial cells from the mucosa
of IBD patients. Considering the hypoxic microenvironment of
inflamed mucosa and the strategic position of macrophages in
maintaining communication with epithelial cells, we set out to
determine whether HIFs modulate the expression of Wnt1 in
macrophages and to explore the role of this ligand on epithelial
autophagy and the relevance of this pathway in IBD.
RESULTS
An impaired autophagy is observed in epithelial cells of the
damaged mucosa of IBD patients
Analysis of the expression of autophagic protein markers in the
mucosa of IBD patients revealed an impaired autophagy in the
damaged mucosa compared with the non-damaged (Figure 1b).
Western blot studies showed lower levels of LC3II and increased
levels of p62 and phosphorylated mTOR (p-mTOR) in damaged
vs. non-damagedmucosa. These differences were also observed
in the mucosa of DSS-treated mice compared with the mucosa
of control animals (Figure 1a), suggesting that activation of
mTOR and impaired autophagy are associated with human and
murine-injured colon.
The epithelial expression of autophagic protein markers was
analyzed in isolated crypts from the mucosa of IBD patients
(Figure 1c). Western blot protein analysis revealed increased
levels of p62 and phosphorylatedmTOR and decreased levels of
LC3II in isolated crypts of damaged mucosa vs. non-damaged
mucosa of the same patients (Figure 1c). The evaluation of the
Figure 1 Autophagic protein markers are reduced in damaged colonic mucosa. Representative western blots and graphs showing p-mTOR, p62, and
LC3expression in panela themucosaof vehicle- orDSS-treatedmice (n¼10), (b) themucosaof IBDpatients (n¼14), and (c) the colonic crypts from IBD
patients (n¼ 14); representative photographs showing isolated intestinal crypts of human mucosa, magnification  20 and  40. (d) Representative
images showing p62 immunostaining in the damagedand non-damagedmucosa of IBDpatients (scale bar 100 mm).Graph shows a quantitative analysis
(n¼ 14) of the number of p62-positive cells in a total area of 0.135mm2. Bars in the graphs represent mean±s.e.m. Significant difference from the
respective non-damaged mucosa is shown by *Po0.05.
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expression of these proteins in crypts obtained from themucosa
of patients with Crohn’s disease (CD) and ulcerative colitis
(UC) revealed non-significant differences (Supplementary
Figure S1a online).
Moreover, immunostaining for p62 showed accumulation of
this protein in epithelial cells of the damagedmucosa (Figure 1d).
In this way, by highlighting differences in the expression of
autophagic protein markers between damaged and non-
damaged areas, our results suggest that epithelial autophagy
is modulated by mechanisms associated with damage.
HIF-1a stabilization and Wnt1 expression are upregulated
in the damaged mucosa of IBD patients
We and others have previously reportedHIF-1a stabilization in
the mucosa of IBD patients.28,29 In the present study, we
perform a comparative study between damaged and non-
damaged mucosa of the same patients. Quantitative analysis
revealed that protein levels of HIF-1a were higher in the
damaged mucosa of human and murine IBD samples than in
the respective non-damaged mucosa (Figure 2a). In contrast,
protein levels of HIF-2a did not differ significantly between
injured and non-injured areas (Figure 2a). A similar pattern of
the expression of these transcription factors was observed in
the mucosa of patients with UC and CD (Supplementary
Figure S1a). Immunohistochemical experiments revealed
the presence of HIF-1a and HIF-2a in epithelial cells
and cells of the lamina propria. Quantitative analysis
showed a higher number of HIF-1a-positive cells in cells
of the lamina propria of damaged mucosa vs. non-damaged
mucosa, whereas the number of HIF-2-positive cells was
similar in the injured and non-injured tissue (Supplementary
Figure S1b).
Wnt ligands have been reported to regulate multiple aspects
of intestinal pathophysiology. Our results show increased
protein levels of Wnt1 in the damaged mucosa of both DSS-
treated mice and IBD patients with respect to those observed in
the respective non-damagedmucosa (Figure 2a). Furthermore,
a significant increase in the mRNA expression of Wnt1 was
observed in the damaged vs. non-damaged human mucosa
(Figure 2b). Our results demonstrate that both HIF-1a and
Wnt1 are upregulated in the injured mucosa of IBD patients.
HIF-1a stabilization and Wnt1 expression are detected in
macrophages of the mucosa of IBD patients
Immunofluorescence experiments revealed that CD68-positive
cells were co-localized with HIF-1a and Wnt1 in the mucosa
Figure 2 HIF-1a protein levels andWnt1 expression are increased in damaged colonic mucosa. (a) Representative western blots and graphs showing
HIF-1a, HIF-2a, andWnt1 protein levels in themucosa of vehicle- or DSS-treatedmice (n¼10) and IBD patients (n¼ 14). (b) Graph showsWnt1mRNA
expression in the damaged and non-damagedmucosa of IBD patients (n¼ 14). In all cases, bars in the graphs represent mean±s.e.m., and significant
difference from the respective non-damaged mucosa is shown by *Po0.05, **Po0.01 and ***Po0.001.
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(Figure 3a and b), which shows that these proteins are
expressed in gut macrophages. To confirm this, we isolated
macrophages from the mucosa and evaluated the expression of
Wnt1. Our results demonstrate that the percentage of
macrophages that were positive for Wnt1 was significantly
higher in macrophages from damaged mucosa than in non-
damaged mucosa as well as the mRNA expression of Wnt1
(Figure 3c and d).
HIF-1 mediates the hypoxic upregulation of Wnt1 in
macrophages
Next, we set out to determine whether HIFs in cultured
macrophages modulated the expression of Wnt1. First, we
observed HIF-1a and HIF-2a stabilization in macrophages
under hypoxia (Figure 4a). Interestingly, hypoxia increased the
protein (Figure 4a) andmRNAexpression (Figure 4b) ofWnt1
with respect to normoxic cells. This was a consistent pattern, as
it was observed in U937- and THP-1 macrophages as well
as in monocyte-derived macrophages (MDMs) (Figure 4b,
Supplementary Figure S2a). The role of HIF-1 and HIF-2 in
Wnt1 expression was determined using an miRNA approach
to selectively knockdown these transcription factors in
U937-derived macrophages (Supplementary Figure S2b).
As shown in Figure 4c, hypoxic upregulation of Wnt1
mRNA expression was significantly reduced in cells trans-
fected with miHIF1a, but not in those transfected with
miHIF2a, suggesting that HIF-1, and not HIF-2, is involved
in the induction of this ligand by hypoxia. In line with this
observation, the increase in the amount of Wnt1 protein
induced by hypoxia was significantly diminished in miHIF1a
cells (Figure 4d). No significant changes in the expression of
Wnt1 were observed in normoxic macrophages treated with
miHIF1a ormiHIF2a compared withmock-treated cells, which
suggests that neither HIF-1 nor HIF-2 mediates the expression
of this ligand in macrophages under normoxia (Figure 4c,
Supplementary Figure S2b). A role forHIF-1 in the expression
of Wnt1 in hypoxia was also observed in THP-1 macrophages
(Supplementary Figure S2c).
Hypoxic macrophages-derived Wnt1 activates Wnt
signaling pathways in epithelial cells
Macrophages in the mucosa are strategically located to interact
with epithelial cells. The role of Wnt1 from hypoxic macro-
phages in the activation of theWnt signaling pathway in colonic
epithelial cells was analyzed in a co-culture setup in which cells
were treated with miWnt1 (Supplementary Figure S2d).
A significant increase in protein levels of total and nuclear
b-catenin and the mRNA expression of Lgr5, a target gene of
Wnt, was detected in Caco-2 cells co-cultured with hypoxic
macrophages vs. normoxic macrophages (Figure 5a). The
increase induced by hypoxic macrophages was prevented when
these cells underwent transient transfection with miHIF1a or
miWnt1 (Figure 5a). Our results suggest that Wnt1 released
from hypoxic macrophages has a role in the activation of the
canonical Wnt signaling pathway in epithelial cells. This
was confirmed when Wnt1 was administered exogenously to
epithelial cells. As shown in Figure 5b, Wnt1 significantly
increased b-catenin stabilization in Caco-2 cells with respect to
the vehicle.
Hypoxic macrophages-derived Wnt 1 activates mTOR and
reduces autophagy in epithelial cells
The role of hypoxic macrophages in the expression of the
autophagic proteinmarkers p62 and LC3II and in the activation
ofmTOR in epithelial cells was evaluated in the aforementioned
co-culture system. As can be seen in Figure 5c, the amount of
LC3II was lower in Caco-2 cells that had been co-cultured with
hypoxic macrophages than in those co-cultured with normoxic
macrophages, while the amount of p62 and phosphorylated
mTOR was higher. These results demonstrate that hypoxic
macrophages activate mTOR and reduce autophagy in
epithelial cells.
Interestingly, the amount of LC3II, p62, and phosphorylated
mTOR in epithelial cells co-cultured with hypoxic macro-
phages treated with miHIF-1 or miWnt1 (Figure 5c) did not
Figure 3 HIF-1a stabilization and Wnt1 expression in macrophages of
the mucosa of IBD patients. (a) Representative images of three
experiments showing CD68 immunostaining in the damaged and non-
damaged mucosa of IBD patients (Fluorescence microscopy). (b) CD68
co-localizes with HIF-1a and Wnt1 in the lamina propria of the mucosa
(Confocal microscopy). (c, d) Macrophages were isolated from damaged
and non-damaged mucosa of IBD patients (n¼3), and graphs show the
percentage of these cells that were positive for Wnt1 (c) and the Wnt1
mRNA expression in these cells (d). Bars in the graphs represent mean
±s.e.m., and significant difference from the respective non-damaged
mucosa is shown by *Po0.05.
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differ significantly from those observed in normoxic
macrophages, showing that the absence of HIF-1 or Wnt1
in hypoxic macrophages prevented the inhibition of epithelial
autophagy induced by these cells. Under these co-culture
conditions, the exogenous administration of Wnt1 reproduced
the effects induced by hypoxicmacrophages, which was evident
in the lower amount of LC3II, the enhanced expression of p62,
and the activation of mTOR (Figure 5c). Finally, the role of
Wnt1 in epithelial autophagy was further confirmed when
Wnt1 was administered exogenously to epithelial cells, which
led to activation of mTOR, p62 accumulation, and reduced
protein levels of LC3II (Figure 5b).
Wnt signaling correlates with impaired autophagy in
epithelial cells from the damaged mucosa of IBD patients
A comparative western blot analysis revealed increased
b-catenin protein levels in crypts of damaged vs. non-damaged
mucosa (Figure 6a), which provided evidence of the activation
of the Wnt signaling pathway in the epithelial cells of injured
mucosa. Immunohistochemical experiments revealed the
presence of nuclear b-catenin immunostaining mainly located
in epithelial cells of the damaged mucosa (Figure 6b). Inter-
estingly, a detailed analysis of crypts isolated from damaged
mucosa revealed a positive and significant correlation between
b-catenin protein levels and phosphorylated mTOR (Figure 6c).
In addition, protein levels of b-catenin positively correlated
with those of p62 and negatively correlated with protein
expression of LC3II in crypts of damaged mucosa (Figure 6c).
These results point to a role for the Wnt signaling pathway in
the impaired epithelial autophagy detected in the damaged
mucosa of IBD patients.
DISCUSSION
The present study demonstrates impaired autophagy in a
murine model of colitis and in the intestinal mucosa of IBD
patients. In both cases, differences in the expression of two
Figure 4 HIF-1 mediates the hypoxic upregulation of Wnt1 in macrophages. (a) Western blots showing HIF-1a and HIF-2a stabilization and Wnt1
expression induced by hypoxia in U937macrophages. Graph shows a time-course analysis of protein expression in these cells. (b) Graph shows a time-
course analysis of the effects of hypoxia onWnt1 mRNA expression in U937 macrophages. In all cases, points in the graphs represent mean±s.e.m.
(n43). *Po0.05. vs. time 0 h (a) and vs. macrophages in normoxia at the same time point (b). (c) Graph shows the mRNA expression ofWnt1 in mock-
transfected U937 cells and cells treated withmiHIF-1a ormiHIF-2a under normoxic or hypoxic conditions. (d) Graph shows Wnt1 protein expression in
macrophages in normoxia or hypoxia inmock-transfectedU937 cells and cells treatedwithmiHIF-1a. In all cases, bars in graphs representmean±s.e.m.
(n43). *Po0.05. vs. the same group in normoxia and #Po0.05. vs. mock-transfected cells in hypoxia.
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autophagic protein markers, LC3II and p62, were observed
between the damaged and non-damagedmucosa. Furthermore,
the activation of mTOR, a central negative regulator of
autophagy, was detected in the damaged area, which led us
to suspect that colonic inflammation and injury may be
associated with impaired autophagy. At the intestinal level,
autophagy proteins are required for a variety of cellular
functions, including antigen presentation by dendritic cells,
cytokine secretion by macrophages, and antimicrobial peptide
secretion by paneth cells.3 The impaired autophagy detected in
isolated crypts of damaged human mucosa indicates that
inflammation and injury specifically affect epithelial autophagy
in IBD.
Hypoxia and inflammatory cytokines are present in the
mucosa of IBD patients14,29 and may modulate the activity of
HIFs. Our results show that levels ofHIF-1a, but not ofHIF-2a,
are higher in damaged vs. the non-damaged mucosa of both
IBD patients and DSS-treated mice. The upregulation of HIF-1
in damaged mucosa is in line with previous studies relating
HIF-2 with mild hypoxia and HIF-1 with intense hypoxia,30 a
condition that is likely associated with mucosal inflammation
and injury.14,29 Previous studies have highlighted the presence
of HIF-1a in epithelial cells of the mucosa of IBD patients,29
where it promotes epithelial barrier function.31 Our results
demonstrate that HIF-1, in addition to epithelial cells, is also
present in macrophages that infiltrate the mucosa of these
patients, and we have analyzed whether epithelial function is
modulated by the transcriptional activity mediated by HIF-1 in
these cells.
Wnt glycoproteins are small signaling molecules that have a
crucial role in the regulation of epithelial proliferation and
differentiation.14,20,21 Our immunohistochemical experiments
reveal that macrophages in the lamina propria express Wnt1,
and the studies we have performed in macrophages isolated
from mucosa indicate that the proportion of cells expressing
this ligand is higher in damaged mucosa than in normal tissue.
This suggests that the enhanced expression ofWnt1 observed in
damaged mucosa is due to infiltrated macrophages, which is
Figure 5 Wnt1 frommacrophages increases the canonicalWnt pathway and decreases autophagy in epithelial cells. (a) Caco-2 cells were co-cultured
for 24 h with mock, miHIF-1a or miWnt1 transfected U937-derived macrophages under normoxic or hypoxic conditions (16 h). Western blots showing
protein expression of b-catenin in Caco-2 cells from total, cytosolic and nuclear extracts. Graphs showquantification of b-catenin protein by densitometry
and Lgr5mRNA expression in Caco-2 cells. (b) Caco-2 cells were treated with Wnt1 (20 ngmlÿ1) or vehicle for 24 h. Western blots and graphs showing
protein expression of p-mTOR, b-catenin, p62, and LC3 (n¼ 3). (c) Caco-2 cells were co-cultured as described in panel a and in some caseswere treated
withWnt1 (20 ngmlÿ 1). Representative western blots and graphs showing protein expression of p-mTOR, p62, and LC3 (n¼3). In all cases, bars in the
graphs represent mean±s.e.m. *Po0.05. vs. mock-transfected U937 cells in normoxia, #Po0.05. vs. mock-transfected U937 cells in hypoxia and
&Po0.05 and &&Po0.01 vs. the respective Wnt1-treated cells.
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consistent with the low levels of Wnt1 mRNA expression
reported in the colonic epithelial cells of IBD patients.16,32
Immunofluorescence analysis revealed the co-localization of
HIF-1 and Wnt1 in macrophages of the mucosa and the
presence of HRE sequences in the promotor region of the
Wnt1 gene led us to determine whether HIFs were
involved in the expression of this ligand. We observed that
hypoxia, which induced HIF-1a and HIF-2a stabilization,
enhanced the expression ofWnt1 inmacrophages derived from
two different cell lines and human monocyte-derived macro-
phages in a time-dependent manner. Interestingly, specific
silencing studies revealed that HIF-1, but not HIF-2, mediated
Wnt1 induction, which points to Wnt1 being a target gene
of HIF-1.
The results obtained in our co-culture system suggest that the
increased synthesis of Wnt1 induced by HIF-1a in hypoxic
macrophages acts in a paracrine way to modulate the epithelial
compartment, since we detected the activation ofWnt signaling
pathways in co-cultured epithelial cells. This is consistent with
previous reports showing that epithelial cells respond to rather
than produce Wnt ligands.32 Of interest, we observed the
activation of Wnt signaling in epithelial cells, which is
associated with a decreased expression of autophagic protein
markers. This effect was prevented after knocking down Wnt1
in macrophages and was reproduced by the exogenous
administration of Wnt1. As a whole, these results suggest
that Wnt1 mediates the impaired epithelial autophagy induced
by hypoxic macrophages, which is in accordance with the role
of this ligand in the epithelial activation of mTOR.Wnt ligands
have been shown to activate the mTOR pathway through
b-catenin-dependent23,26 and canonical- and non-canonical-
independent pathways.27 Although we have not analyzed the
precise molecular pathway involved, our results showing that
hypoxic macrophages increase the protein levels of nuclear
b-catenin in parallel to those of phosphorylated mTOR suggest
that Wnt1 activates mTOR through the inhibition of GSK3.
These results together with previously published evidence of
autophagy negatively modulating Wnt signaling33 suggest a
regulatory feed-back mechanism between Wnt signaling and
autophagy.
Figure 6 Increased Wnt signaling correlated with decreased autophagy in epithelial cells of damaged mucosa. (a) Representative western blots and
graph show b-catenin protein levels in crypts of the mucosa of IBD patients. Bars in the graph represent mean±s.e.m. (n¼14); *Po0.05. vs. non-
damaged mucosa. (b) Representative microphotographs of 14 patients showing b-catenin immunostaining in the mucosa of IBD patients. Arrows show
nuclear staining. (c) A positive and significant correlationwasobservedbetweenprotein levels ofb-catenin and the expressionof p62or p-mTOR in crypts
of damagedhumanmucosa,whereasanegative and significant correlationwasdetected between protein levels ofb-catenin andLC3II in the samecrypts
(n¼ 14).
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Finally, we set out to analyze whether Wnt signaling
modulates autophagy in epithelial cells of the mucosa of
IBD patients. Activation of the canonical Wnt pathway has
previously been reported as a response to injury.34,35 Our
results endorse this by showing that canonical Wnt signaling is
activated specifically in colonic epithelial crypts from damaged
mucosa of IBD patients, as demonstrated by the increased
protein levels of b-catenin. Interestingly, levels of b-catenin in
these crypts correlated negatively with LC3II and positively
with p62, suggesting that the activation of Wnt signaling is
involved in impaired epithelial autophagy. In addition, our
results show a positive and significant correlation between b-
catenin and the activation of mTOR in the same crypts. The
crucial role had by mTOR pathways in the negative regulation
of autophagy12 and our in vitro results showing a role forWnt1
in the activation of mTOR strongly suggest that Wnt signaling
impairs autophagy in epithelial cells of the damaged mucosa of
IBD patients through activation of mTOR pathways.
In summary, our results demonstrate a HIF-1-dependent
induction of Wnt1 in hypoxic macrophages that impairs
autophagy in epithelial cells. In the damaged mucosa of IBD
patients, macrophage-derived Wnt1 may be involved in the
epithelial activation of Wnt signaling and mTOR pathways,
which mediate the impaired epithelial autophagy. A better
understanding of the pathophysiological role had by autophagy
in colonic epithelial cells will help to clarify the relevance of the
HIF-1-dependent induction of Wnt1 in macrophages on
epithelial function.
METHODS
DSS-induced colitis in mice. Male 6- to 8-week-old C57BL/6 mice
received vehicle (n¼ 10) or Dextran Sulfate Sodium (n¼ 10) (DSS,
40 kDa, Sigma-Aldrich, St Louis, MO) via their drinking water in a 3%
(w/v) solution (7 days). Body weight and clinical signs of disease
were recorded from day 1. On day 7, mice were killed, and colon
tissue samples were collected for further analysis. All the animals were
housed under appropriate conditions and treated according to
institutional guidelines.
Intestinal mucosal samples. Colonic surgical resections from both
damaged and non-damaged mucosa were obtained from IBD patients
(Table 1). The study was approved by the Institutional Review Board
of The Hospital of Manises (Valencia). Written informed consent was
obtained from all patients.
Isolation of colonic crypts. Human intestinal crypts were isolated
from both damaged and non-damaged mucosa of surgical resections
obtained from IBD patients (n¼ 14). The intestinal epithelial cell
isolation procedure was performed using a non-enzymatic dissocia-
tion technique based on short-term EDTA treatment, as described
previously.36 The resulting crypt suspension was analyzed by light
microscopy (Figure 1c).
Isolation ofmacrophages fromhuman intestine. Macrophages were
isolated from both damaged and non-damaged mucosa of surgical
resections obtained from IBD patients (n¼ 3) by a previously
described technique37 with modifications. The mucosa was trans-
ported in cold (4 1C) 0.9%NaCl and washed with Hanks’ balanced salt
solution without calcium and magnesium (cmHBSS). Epithelial cells
were removed by shaking themucosa (5–10mmstrips ofmucosa)with
1mM DTT and 5mM EDTA for 20min at 4 1C, followed by washing
with cmHBSS. This was repeated twice, and, after the last step, washing
was performed with Hanks’ balanced salt solution with calcium and
magnesium (HBSS). The mucosa was then cut into 2mm pieces and
digested with collagenase (from Clostridium histolyticum; Lonza,
Basel, Switzerland) at a concentration of 100mg per 100ml in culture
medium (10% inactivated bovine fetal serum (FBS, Lonza, Basel,
Switzerland)) in RPMI (Sigma-Aldrich) by shaking for 3 h at 37 1C.
After digestion, the cells were filtered through a 100 m nylon mesh and
washed thoroughly withHBSS. Cells were cultured for 24 h with RPMI
medium with 10% inactivated FBS with 100Umlÿ 1 penicillin
(Lonza), and 100 mgmlÿ 1 streptomycin (Lonza) in the presence of
phorbol-12-myristate-13-acetate (PMA, Sigma-Aldrich). Adhered
cells were washed thoroughly with HBSS and stained with a specific
monoclonal antibody CD68 (1:100, Biolegend, Madrid, Spain); Tex-
Red-labeled anti-mouse was used as the secondary antibody. Hoechst
33342 (Sigma-Aldrich) was used for nuclear staining. The fluorescent
signal (18 images per well) was quantified using the static cytometer
software (Olympus, Barcelona, Spain) ‘Scan’ version 2.03.2, and results
showed that 82±2% of the cells were macrophages.
Cell culture. Caco-2 cells (American Type Culture Collection, VA)
were cultured in MEM medium (Sigma-Aldrich) supplemented with
20% inactivated FBS with 100Umlÿ 1 penicillin 100mgmlÿ 1
streptomycin, 2mM L-glutamine (Lonza), 100mM sodium pyruvate
(Lonza), and 1% of non-essential amino acids (Lonza).
Human monocytes (U937 and THP-1, European Collection of Cell
Culture, Salisbury, UK) were cultured in RPMI medium with 10%
inactivated FBS with 100Umlÿ 1 penicillin and 100mgmlÿ 1 strep-
tomycin. Monocytes (U937 or THP-1) were differentiated into
macrophages by culturing them in the presence of PMA for 48 h.28
Hypoxia (3% O2) was established by incubating macrophages in a
CO2/O2 incubator (model INVIVO2 400, RUSKINN Technology Ltd,
Pencoed, UK) with a blend of 5% CO2 and the appropriate percentage
ofO2 andN2up to a total of 100%.Normoxic controls were obtained by
incubating the cells at 21% O2.
Isolation of mononuclear cells. Human peripheral blood mono-
nuclear cells were isolated from healthy donors by Ficoll density
gradient centrifugation at 400 g for 40min. Monocyte-derived
macrophages were obtained from monocytes seeded in 12-well tissue
culture plates and differentiated into macrophages through culture in
X-Vivo 15 medium (Lonza) supplemented with 1% human serum,
100Umlÿ 1 de penicillin, 100 mgmlÿ 1 streptomycin, and 20 ngmlÿ 1
recombinant human M-CSF (Peprotech, London, UK) at 37 1C in 5%
CO2 for 6 days.
Co-culture with Caco-2 cells. Caco-2 cells were co-cultured with
U937 macrophages using Transwell inserts (Corning Incorporated,
Table 1 Patient characteristics
Ulcerative colitis Crohn’s disease
Number of patients 5 9
Age
17–40 years 3 1
440 years 2 8
Gender
Male 4 4
Female 1 5
Concomitant medication
Azathioprine 3
Anti-TNF 4 9
Mesalazine 2
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MA) with a 0.4-mm porous membrane.38 U937-derived macrophages
were seeded on the inserts and differentiated, after which they were
incubated in hypoxia for 16 h. Subsequently, the inserts were placed on
top of Caco-2 cells andmaintained in co-culture for 24 h. SomeCaco-2
cells were treated with Wnt1 (20 ngmlÿ 1, 24 h, Sigma-Aldrich).
Immunohistochemical studies. Immunostaininig for HIF-1a,
HIF-2a, p62, and b-catenin was performed with 5 mm sections of
paraffin-embedded tissues (Table 2). A horse anti-mouse/rabbit
biotinylated antibody (Vector Laboratories, CA, 1:200) was used as a
secondary antibody. The VECTASTAIN elite ABC system Kit (Vector
Laboratories) was employed for signal development. All tissues were
counterstained with hematoxylin, and the specificity of the immuno-
staining was confirmed by the absence of signal when primary or
secondary antibodies were omitted. An area of 0.135mm2was selected
for quantitative analysis.
For immunofluorescence studies, colonicmucosa from IBDpatients
was frozen in liquid nitrogen, and sections of 4–8 mmwere cut with the
cryo-microtome. The slides were blocked with PBS/ 0.5% BSA for
20min and incubatedwith diluted primary antibodies (CD68,Wnt1 or
HIF-1 (Table 2), dilution 1:100) in PBS/ 0.5% BSA for 30min at 37 1C
in a humidified atmosphere. After washing with PBS, fluorescent
double-labeling was performed with the secondary antibodies, goat
anti-rabbit immunoglobulin G (IgG)-fluorescein isothiocyanate
(FITC, HIF-1 and Wnt1) and goat anti-mouse IgG-Tex-Red (1:200,
Abcam, Cambridge, UK, CD68); 1mM Hoechst 33342 was added to
stain nuclei (30min at 37 1C). The specificity of the immunostaining
was confirmed by the absence of fluorescencewhen primary antibodies
were omitted. Samples were analyzed with a Olympus FLUOVIEW
FV1000 confocal or a Olympus IX81 fluorescent microscopes
(Olympus, Hamburg, Germany).
Static cytometry. Isolatedmacrophages from both damaged and non-
damaged mucosa of surgical resections obtained from IBD patients
were fixed with 2% paraformaldehyde, permeabilized with 0.1%
Triton-X100, and then stained with antibodies against CD68 and
Wnt1 (dilution 1:100). Tex-Red-labeled goat anti-mouse or FITC goat
anti-rabbit, respectively, were used as the secondary antibodies
(dilution 1:200), and Hoechst 33342 was added to stain nuclei. The
fluorescent signal (18 images per well) was quantified using the static
cytometer.
RNA interference and cellular transfection. U937 or THP-1 cells
were transfected with a vector-targeting human HIF-1a (miHIF-1a,
targeting sequence: 50-AGCTATTTGCGTGTGAGGAAA-30, GenBank
Accession No. NM_001530), HIF-2a (miHIF-2a, targeting sequence:
50-CTCCAACAAGCTGAAGCTGAA-03, GenBank Accession No.
NM_001430), Wnt1 (miWnt1, targeting sequence: 50-TGACTTGT
TAAACAGACTGCGAA-30, GenBank Accession No. NM_005430)
or a non-targeting control vector (mock), as described previously.38
Lipofectamine-2000 (Invitrogen Life Technologies, Carlsbad, CA) was
employed as a transfection reagent according to the manufacturer’s
instructions. Twenty-four hours post transfection, the cells were
incubated for 16 h in normoxic or hypoxic conditions, as described
above.
Protein extraction and western blot analysis. Equal amounts of
protein from macrophages or Caco-2 cells (nuclear, cytosolic or total
extracts),39,28 or from colonic tissues40 were loaded onto SDS/PAGE gels
and analyzed by western blot. Membranes were incubated overnight at
4 1C with different primary antibodies (Table 2). Subsequently,
membranes were incubated with a peroxidase-conjugated anti-mouse
IgG (Thermo Scientific, Rockford, IL, 1:5,000) or anti-rabbit IgG
(Thermo Scientific, 1:10,000). Following treatment with supersignal
west pico chemiluminescent substrate (Thermo Scientific), protein
bands were detected by a LAS-3000 (Fujifilm, Barcelona, Spain).
Protein expression was quantified by means of densitometry using the
Image Gauge Version 4.0 software (Fujifilm). Data were normalized to
b-actin.
RNA extraction and qPCR analysis. Total RNA from colonic tissue
was isolated using the Tripure Isolation reagent (Roche Diagnostics,
Barcelona, Spain), and total RNA from macrophages (isolated
macrophages, THP1- or U937-derived macrophages or from MDMs
cells) was obtained by using an extraction kit (Illustra RNA spin mini
isolation kit, GE Health Care Life Science, Spain). In all cases, cDNA
was obtained with the Prime Script RT reagent Kit (Takara, Otsu,
Japan). The protocol was followed as described previously.28Real-time
PCR was performed with the Prime Script Reagent Kit Perfect Real
Time (Takara) in a thermo cycler LightCycler (Roche Diagnostics).
Specific oligonucleotides for human Wnt1 (50-cgcccacccgagtacctcca-
30, 50-ttcatgccgccccaggcaag-30) or Lgr5 (5’-tgctccgacctggggctctc-3’,
5’- tcggaggctaagcaactgctgga-3’) were designed according to the
reported sequences, and human b-actin (50-ggacttcgagcaagagatgg-30,
50-agcactgtgttggcgtacag-30) expression was used as a housekeeping
gene. The threshold cycle (CT) was determined, and relative gene
expression was expressed as follows: change in expression
(fold)¼ 2ÿD(DCT) where DCT¼CT (target)ÿCT (housekeeping),
and D(DCT)¼DCT (treated)ÿDCT (control).
Statistical analysis. Data were expressed as mean±s.e.m. and were
compared by analysis of variance (oneway-ANOVA)with aNewman-
Keuls post hoc correction for multiple comparisons or a t-test when
appropriate. A P–value o0.05 was considered to be statistically
significant. Clinical correlations were analyzed in the human samples
using Pearson’s correlation coefficient.
Table 2 Specific antibodies used for immunohistochemical and western blot analysis
Immunohistochemistry Western blot
Antibody Antigen retrieval Antibody dilution
P62 (Santa Cruz Biotechnology, Heidelberg, Germany) Sodium citrate buffer pH¼ 9, 97 1C 20min. 1:100 1:1,000
HIF 1a (Santa Cruz Biotechnology) Sodium citrate buffer pH¼ 9, 97 1C 20min. 1:100 1:250
HIF 2a (Sigma-Aldrich) Sodium citrate buffer pH¼ 9, 97 1C 20min. 1:200 1:250
Wnt1 (Santa Cruz Biotechnology) 1:1,000
b-Catenin (Sigma-Aldrich) Sodium citrate buffer pH¼ 6, 97 1C 20min. 1:200 1:1,000
LC3 (Novus Biologicals, CO) 1:1,000
p-mTOR (Ser 2448) (Santa Cruz Biotechnology) 1:1,000
b-Actin (Sigma-Aldrich) 1:10,000
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The activation of Wnt signaling by a STAT6-
dependent macrophage phenotype promotes
mucosal repair in murine IBD
J Cosı´n-Roger1, D Ortiz-Masia´2, S Calatayud1, C Herna´ndez3, JV Esplugues1,3 and MD Barrachina1
The complete repair of the mucosa constitutes a key goal in inflammatory bowel disease (IBD) treatment. The Wnt
signaling pathwaymediatesmucosal repair andM2macrophages that coordinate efficient healing have been related to
Wnt ligand expression. Signal transducer and activator of transcription 6 (STAT6) mediates M2 polarization in vitro and
we hypothesize that a STAT6-dependent macrophage phenotype mediates mucosal repair in acute murine colitis by
activating theWnt signaling pathway.Our results reveal an impairedmucosal expression ofM2macrophage-associated
genes and delayed wound healing in STAT6 (ÿ /ÿ ) mice treated with 2,4,6-trinitrobenzenesulfonic acid (TNBSQ1 ). These
mice also exhibited decreasedmucosal expression ofWnt2b,Wnt7b, andWnt10a, diminished protein levels of nuclear
b-catenin that is mainly located in crypts adjacent to damage, and reduced mRNA expression of two Wnt/b-catenin
target molecules Lgr5 and c-Myc when compared with wild-type (WT) mice. Murine peritoneal macrophages treated
with interleukin-4 (IL-4) and polarized toward an M2a phenotype overexpressed Wnt2b, Wnt7b, and Wnt10a in a
STAT6-dependentmanner. Administrationof aWntagonist aswell as transferof properlypolarizedM2amacrophages to
STAT6 (ÿ /ÿ ) mice activated the Wnt signaling pathway in the damaged mucosa and accelerated wound healing. Our
results demonstrate that a STAT6-dependent macrophage phenotype promotes mucosal repair in TNBS-treated mice
through activation of the Wnt signaling pathway.
INTRODUCTION
Inflammatory bowel disease (IBD) is a disorder of the
gastrointestinal tract characterized by chronic inflammation
at the submucosal level and disruption of epithelial barrier
function. The complete repair of the epithelial layer is a key goal
of current IBD treatment, as it has been related to long-term
remission of this pathology.1–4 Regeneration of the mucosa
depends on a well-coordinated regulation between prolifera-
tion and differentiation into epithelial cell lineages of the
progenitor cells, a process that is controlled principally by the
Wnt signaling pathway.5–7 This pathway includes a group of
ligands that act as intercellular signalingmolecules that regulate
cellular fate in normal gut epithelium and in response to
epithelial injury. Upon binding to their receptors, canonical
Wnt ligands induce inactivation of glycogen synthase kinase-
3b and accumulation and nuclear translocation of b-catenin
where it engages DNA-bound T-cell factor transcription
factors Q2.8–11
Macrophages constitute an essential element of inflamed
tissues, where they contribute to inflammatory injury and
coordinate tissue repair. This variety of roles is possible because
macrophages can adopt different functional phenotypes that
differ in the expression of surface proteins and the production
of cytokines.12–14 Two of the best characterized in vitro
phenotypes are a proinflammatory M1 phenotype that
mediates the defense of the host from microorganisms and
the M2a phenotype that expresses high levels of antiinflam-
matory cytokines and scavenger molecules. M2a macrophages
are frequently termed ‘‘wound healing macrophages’’ as they
express factors that are important for tissue repair.15–17 Several
studies have reported that activated macrophages express Wnt
ligands,18–20 and we have recently demonstrated in cultured
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macrophages that M2a, but not M1, macrophages overexpress
the canonical Wnt ligands Wnt1 and Wnt3a.21
In contrast to that reported in vitro, infiltratingmacrophages
do not conform to defined M1 or M2 phenotypes during tissue
repair and adopt a continuum spectrum of functional
phenotypes depending on the microenvironment. Previous
studies that have analyzed the expression of M1 or M2markers
over time have reported the phenotypic transition of macro-
phages during skin and skeletalmuscle repair,15,16,22 but there is
limited information available regarding the switch during
intestinal repair. The transcription factor signal transducer and
activator of transcription 6 (STAT6) plays an essential role in
M2a polarization induced by treatment with interleukin (IL)-4
or IL-13 in vitro.23–25 As would be expected, this pathway also
promotes M2 macrophage polarization in vivo,26–28 although
an IL-4/STAT6-independent M2 polarization has also been
reported.17,29,30 In this study we aim to analyze the role of
STAT6 in regulating the macrophage phenotype in the mucosa
of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-treated mice and
the relevance of this pathway in intestinal repair. Our results
demonstrate that STAT6 mediates the expression of M2
markers as well asWnt2b,Wnt7b, andWnt10a in themucosa of
TNBS-treated mice and show that a STAT6-dependent
macrophage phenotype promotes mucosal repair through
the activation of the Wnt signaling pathway.
RESULTS
STAT6 deficiency delays wound healing in a murine model
of acute colitis
The role of STAT6 in the severity of colitis induced by TNBS
was analyzed in wild-type (WT) and STAT6ÿ /ÿ mice. The
STAT6 (ÿ /ÿ ) mice had a normal birth rate and similar
weight gain and intestinal histology to WT mice. Treatment of
WTmice with TNBS induced a loss of body weight, an increase
in the histological damage score, and a diminution in colon
length that peaked 2 days after treatment. Subsequently, mice
began to recover and, 6 days after treatment, reached similar
values to those of control animals in all these parameters.
Changes in body weight, histological damage score, and colon
length in STAT6 (ÿ /ÿ ) mice were similar 2 days after TNBS
treatment. However, the recovery of these mice was delayed, as
significant differences were observed with respect to WT mice
in body weight gain, histological damage, and colon length 4
and 6 days after injury (Figure 1a–c). These results show that
STAT6 deficiency significantly delays the functional recovery
of mice and colonic wound healing in acute colitis.
The expression of M2macrophage-associated genes in the
colonic mucosa of TNBS-treated mice is STAT6 dependent
Real-time PCR of the colonic mucosa of vehicle-treated mice
demonstrated that mRNA levels of M1macrophage-associated
genes (iNOS, Cd11c, CD86 and Ccr7) and proinflammatory
cytokines (TNFa, IL-1b, and IL-6) did not significantly differ
between STAT6 (ÿ /ÿ ) and WT animals. Similar mRNA
expression of M2 macrophage-associated genes (CD206, ArgI,
Fizz1, and Ym1) and antiinflammatory cytokines (IL-10 and
IL-13) was also observed between STAT6 (ÿ /ÿ ) and WT
animals, except for IL-4 that was significantly decreased in
knockout animals compared with WT mice (Supplementary
Figure S1 online).
In WT mice, treatment with TNBS increased the mucosal
mRNAexpression of proinflammatory cytokines (TNFa, IL-1b,
and IL6) and M1 markers (iNOS, Cd11c, CD86, and Ccr7),
although the magnitude and temporal pattern of expression
slightly differed between genes (Figure 2a,b). Expression of
TNFa, IL-1b, iNOS, and Cd11c peaked 2 days after TNBS
treatment, whereas IL6, CD86, and Ccr7 peaked 4 days after
injury. Nonsignificant differences were detected between WT
and STAT6 (ÿ /ÿ ) animals, except for the expression of iNOS,
TNFa, and IL6 that dropped in WT mice whereas it remained
high in STAT6 (ÿ /ÿ ) mice. The analysis of M2 markers and
antiinflammatory cytokines in WT animals showed an early
increase in themRNA expression ofYm1 andArgI, whereas the
expression ofCD206 peaked 4 days after injury andFizz1, IL-10,
IL-4, and IL-13 did at day 6. Of interest, TNBS failed to induce
the expression ofCD206, Fizz1, IL-10, IL-4, and IL-13 in STAT6
(ÿ /ÿ ) mice and induced a lower expression of ArgI and Ym1
in STAT6 (ÿ /ÿ ) than in WT mice (Figure 2a,b).
Immunohistochemical studies revealed the presence of
Ccr7- and CD206-positive cells in the lamina propria of the
murine intestinal mucosa. A quantitative analysis indicated
that the number of Ccr7-positive cells was higher in themucosa
of TNBS- than vehicle-treated animals at 2 days after injury.
This number remained high at day 4 but fell at day 6, with a
similar number of positive cells being detected in treated and
control animals. Similar results were observed in STAT6
(ÿ /ÿ ) mice 2 and 4 days after injury. However, the number of
Ccr7-positive cells at 6 days after TNBSwas significantly higher
in STAT6 (ÿ /ÿ ) than in WT mice (Figure 2c).
The number of CD206-positive cells in the mucosa of WT
mice was similar in vehicle- and TNBS-treated mice at 2 days
after injury, but a significant increase was observed at day 4 that
was maintained until 6 days after treatment. In contrast, the
number of CD206-positive cells in the mucosa of STAT6
(ÿ /ÿ ) mice was not significantly increased by TNBS at any of
the time points analyzed (Figure 2c). As a whole, our results
demonstrate that STAT6 mediates the expression of M2, and
not M1, macrophage-associated genes in the damaged mucosa
of TNBS-treated mice.
STAT6 deficiency prevents the increase in the Wnt
signaling pathway detected in the mucosa of TNBS-treated
mice
The canonical Wnt/b-catenin signaling pathway plays an
essential role in mucosal regeneration following intestinal
injury. The study of mRNA expression of canonical Wnt
ligands in the mucosa of Balb/c mice revealed the presence of
Wnt2b, Wnt6, Wnt7b, Wnt10a, and Wnt10b, whereas Wnt1
andWnt3a were not detected (Figure 3a). All these genes were
also detected in cells of the lamina propria, whereas only
Wnt2b, Wnt6, and Wnt10b were expressed in intestinal
epithelial cells from the mucosa. The analysis of the basal
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expression of these genes in themucosa revealed nonsignificant
differences between WT and STAT6 (ÿ /ÿ ) mice. At 4 days
after TNBS administration toWTmice, we found an increased
expression ofWnt2b,Wnt7b, andWnt10a in both the mucosa
and cells of the lamina propria and an increased expression of
Wnt2b in epithelial cells. The expression ofWnt6 andWnt10b
was not significantly altered by TNBS treatment in any cell type
analyzed (Figure 3a). In STAT6 (ÿ /ÿ ) mice, treatment with
TNBS failed to significantly induce Wnt2b, Wnt7b, and
Wnt10a mRNA expression in both the mucosa and cells of
the lamina propria, whereas it significantly increased Wnt2b
expression in epithelial cells, as happened in WT mice.
(Figure 3a).
The analysis of the mRNA and protein expression of DKK1,
as well as the mRNA expression of sFRP1, the two negative
regulators of Wnt, revealed a significant increase in the
mucosa of TNBS-treated mice compared with that of vehicle-
treated mice. Nonsignificant differences in the expression of
Figure 1 Signal transducer and activator of transcription 6 (STAT6) deficiency delays wound healing in acute colitis induced by 2,4,6-
trinitrobenzenesulfonic acid (TNBS).Wild-type (WT) andSTAT6 (ÿ /ÿ )micewere treatedwith intrarectal administration of TNBS (3.5mg per 20 gmice)
or vehicle (Vh) and were killed 2, 4, and 6 days after treatment. Graphs show (a) body weight as a percentage of starting weight, measured daily after
TNBS administration; and (b) colon length after killing. (c) Histological score analyzed according to the Wallace score parameters and representative
photographs of the mucosa after TNBS administration (original magnification  10). Points or bars in the graphs represent mean±s.e.m. of at least 12
animals per experimental group. Significant differences in relation to the respective vehicle-treated group are shown by *Po0.05, **Po0.01, and
***Po0.001 and from the TNBS-WT mice by #Po0.05, ##Po0.01, and ###Po0.001.
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these negative regulators were detected between WT and
STAT6 (ÿ /ÿ ) mice (Figure 3b,c).
Immunohistochemical studies revealed the presence of
b-catenin in epithelial cells of the mucosa of TNBS-treated
animals. Nuclear expression of this protein was mainly
observed in crypts adjacent to damage (Figure 4a).
Western blot quantification of the amount of nuclear
b-catenin revealed higher protein levels in the mucosa of
TNBS-treated mice than in that of vehicle animals 4 days after
injury (Figure 4b). Furthermore, TNBS also induce the mRNA
expression of two target genes, c-Myc and Lgr5, in WT mice
(Figure 4c). The increase in nuclear b-catenin induced by
TNBS was not observed in themucosa of STAT6 (ÿ /ÿ ) mice,
in which a significant reduction in themRNA expression of two
target genes, c-Myc and Lgr5, was also detected with respect to
WT mice (Figure 4c). These results show the activation of the
Figure 3 Signal transducer and activator of transcription 6 (STAT6) regulates the expression of Wnt ligands in cells of lamina propria. Wild-type (WT)
and STAT6 (ÿ /ÿ ) mice were treated with 2,4,6-trinitrobenzenesulfonic acid (TNBS) and were killed 4 days after treatment. (a) Representative
photograph showing the presence of canonical Wnt ligands in themucosa, lamina propria cells, or epithelial cells from Balb/c mice (n¼ 3). Graphs show
quantification ofWnt2b,Wnt6,Wnt7b,Wnt10a, andWnt10bmRNA in the intestinal mucosa, lamina propria cells, and epithelial cells (n¼ 5). (b) Graphs
show mRNA expression levels of DKK-1 and SFRP1 in the mucosa 4 days after treatment with TNBS. (c) Graph show protein expression of DKK-1 in
mucosa 4 days after treatment with TNBS (n¼ 5). Photograph of a representative western blot. In all cases, bars representmean±s.e.m. and significant
differences from the respective vehicle (Vh)-treated group are shownby *Po0.05, **Po0.01, and ***Po0.001 and from theTNBS-WTmiceby #Po0.05,
##Po0.01, and ###Po0.001.
Figure 2 Signal transducer and activator of transcription 6 (STAT6) regulates the expression of M2macrophage-associated genes in themucosa of
2,4,6-trinitrobenzenesulfonic acid (TNBS)-treated mice. Wild-type (WT) and STAT6 (ÿ /ÿ ) mice were treated with TNBS or vehicle (Vh) and were
killed 2, 4, and 6 days (2d, 4d, and 6d) after treatment. (a) Graphs show relative mRNA expression levels of proinflammatory and antiinflammatory
cytokines in the mucosa vs. the housekeeping gene b-actin and represented as fold induction vs. vehicle WT group (horizontal dot line) (n¼6).
(b) Graphs show relative mRNA expression levels of M1 markers (CD86,Ccr7,Cd11c, and iNOS) and M2markers (CD206, Ym1, Fizz1, and ArgI) in
the mucosa vs. the housekeeping gene b-actin and represented as fold induction vs. vehicle WT group (horizontal dot line) (n¼ 6).
(c) Immunohistochemistry for Ccr7- and CD206-positive cells was performed in the mucosa 4 days after TNBS treatment and graphs show the
quantification of these cells in a total area of 0.3mm2 (n¼ 6). (d) Representative photographs of Ccr7 andCD206 immunostaining inWTmice (original
magnification 40). In all cases, bars represent mean±s.e.m. Significant differences from the respective vehicle-treated group are shown by
*Po0.05, **Po0.01, and ***Po0.001 and from the TNBS-WT mice by #Po0.05, ##Po0.01, and ###Po0.001.
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Wnt signaling in the damaged mucosa of TNBS-treated WT
mice and reveal that this pathway is impaired in the damaged
mucosa of STAT6 (ÿ /ÿ ) animals.
Interestingly, analysis of nuclear b-catenin protein levels
and the number of CD206-positive cells in the mucosa
ofWTand STAT6 (ÿ /ÿ )mice treatedwithTNBShighlighted
a positive and significant correlation between these two
parameters (Figure 4d), leading us to suggest that M2
macrophages modulate the Wnt signaling pathway in
damaged mucosa.
STAT6 mediates Wnt ligands expression in M2a
macrophages
Peritoneal murine macrophages were obtained from WT
and STAT6 (ÿ /ÿ ) mice and polarized into M1 or M2a
macrophages in vitro by administration of lipopoly-
saccharideþ interferon-g or IL-4, respectively. An increase
in the mRNA expression of M1 markers (iNOS and CD86) and
proinflammatory cytokines (TNFa, IL-1b, and IL-6) was
observed in macrophages from both WT and STAT6
(ÿ /ÿ ) mice treated with lipopolysaccharideþ interferon-g.
Administration of IL-4 enhanced the mRNA expression of
CD206, ArgI, and IL-10 in macrophages from WT mice, but it
was not observed in macrophages obtained from STAT6
(ÿ /ÿ ) mice, reinforcing previous evidence that STAT6 is
required for in vitro M2a polarization induced by IL-4
(Figure 5a,b).
The study of mRNA expression of canonical Wnt ligands in
peritoneal macrophages from WT mice revealed the presence
of Wnt2b, Wnt7b, Wnt10a, and Wnt10b (Figure 5c).
Figure 4 Signal transducer and activator of transcription 6 (STAT6) deficiency prevents the increase in themucosal Wnt signaling pathway induced by
2,4,6-trinitrobenzenesulfonic acid (TNBS). Wild-type (WT) and STAT6 (ÿ /ÿ ) mice were treated with TNBS and were killed 4 days after treatment. (a)
Representative photographs showing b-catenin immunostaining in paraffin-embedded colons (original magnifications  10,  20, and  40); n¼4). (b)
A representativewestern blot of nuclearb-catenin andnucleolin.Graphshows thequantificationof nuclearb-catenin normalizedwith nucleolin (n¼ 4). (c)
Graphs show themRNA expression of twoWnt/b-catenin target genes, Lgr5 and c-Myc (n¼ 4). In all cases, bars representmean±s.e.m. and significant
differences from the respective vehicle (Vh)-treated group are shown by *Po0.05 and **Po0.01 and from the TNBS-WT mice by #Po0.05, ##Po0.01,
and ###Po0.001. (d) Graph shows a positive and significant correlation between the number of CD206-positive cells and nuclear b-catenin protein levels
normalized with nucleolin in the mucosa of TNBS-treated mice.
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Polarization of these cells toward an M2a and not M1
phenotype was associated with increased mRNA expression
of Wnt2b, Wnt7b, and Wnt10a, whereas Wnt10b was not
significantly modified. The expression of these genes in
nonpolarized macrophages was not significantly different
between WT and STAT6 (ÿ /ÿ ) mice. However, no
induction of these genes was observed in STAT6 (ÿ /ÿ )
macrophages treated with IL-4, showing that STAT6 mediates
the expression ofWnt ligands associatedwithM2amacrophage
polarization (Figure 5c).
Macrophages obtained from WT mice and polarized
toward an M2a phenotype increased the nuclear b-catenin
expression in epithelial cells in coculture compared with
nonpolarized macrophages (Figure 5d). In contrast,
macrophages obtained from STAT6 (ÿ /ÿ ) mice did not
significantly modify nuclear b-catenin protein levels in
epithelial cells (Figure 5d). As a whole, the result
demonstrates that STAT6 mediates the expression of
canonical Wnt ligands in M2a macrophages that activate
Wnt signaling in intestinal epithelial cells.
Transfer of M2a macrophages activates Wnt signaling
pathway and accelerates wound healing in the mucosa of
STAT6 (ÿ /ÿ ) TNBS-treated mice
We next aimed to analyze whether the administration of M2a
macrophages may modulate mucosal Wnt signaling and
wound healing in STAT6 (ÿ /ÿ ) mice. First, in order to
study the importance of this pathway in mucosal healing, we
administered a Wnt agonist to TNBS-treated STAT6 (ÿ /ÿ )
mice and the results showed an accelerated recovery of body
weight (Figure 6a), an enhancement of the colon length
(Figure 6b), and a reduction in the histological damage score at
4 days after TNBS (Figure 6c). All these changes paralleled with
a significant increase in nuclear b-catenin protein levels in the
colonic mucosa (Figure 6d) and suggest that activation of
mucosal Wnt signaling is associated with acceleration of
wound healing.
Finally, macrophages obtained from WT and STAT6
(ÿ /ÿ ) mice and treated with IL-4 were administered
intraperitoneally to STAT6 (ÿ /ÿ ) mice at 2 days after
TNBS treatment. Immunolocalization studies revealed the
Figure 5 M2a macrophages overexpressed Wnt ligands through signal transducer and activator of transcription 6 (STAT6). Murine peritoneal
macrophages were obtained and polarized into M1 and M2a macrophages with lipopolysaccharideþ interferon-g (LPSþ IFN-g) or interleukin-4 (IL-4)
respectively. (a)Graphs showmRNAexpression of iNOS,CD86,CD206, andArgI inmacrophages (n¼ 4). (b)Graphs showmRNAexpression ofTNF-a,
IL-1b, IL-6, and IL-10 in macrophages (n¼ 4). (c) Representative photograph showing the presence of canonical Wnt ligands in peritoneal macrophages
obtained frommice (n¼ 3). Graphs show the quantification ofWnt2b,Wnt7b, andWnt10amRNAexpression inmacrophages (n¼ 4). In all cases, results
were normalized with b-actin and are represented as fold induction vs. nonpolarizedmacrophages. Significant differences from respective nonpolarized
macrophagesare shownby *Po0.05, **Po0.01, and ***Po0.001 and fromM2amacrophagesobtained fromWTmiceby #Po0.05and ###Po0.001. (d)
Caco-2 cells were cocultured 24 h with peritoneal macrophages from WT and STAT6 (ÿ /ÿ ) mice polarized toward M2a macrophages and protein
expression of nuclear b-catenin in Caco-2 cells was analyzed. Results were normalized with nucleolin. A representative western blot is shown. Bars in
graphs representmean±s.e.m. Significant differences fromCaco-2 cells coculturedwith nonpolarizedmacrophages fromWTare shownby ***Po0.001
and from M2-macrophages from WT by ###Po0.001.
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presence of these cells in the colon, with no differences in the
accumulation of either cell type. As shown in Figure 7a, the rate
of recovery in body weight ofmice receivingmacrophages from
WT animals was higher than in those receiving macrophages
from STAT6 (ÿ /ÿ ) mice. Analysis of the mucosa at day 4
revealed an increased colon length (Figure 7b), lower
histological damage score (Figure 7b,c), and decreased
mRNA expression of iNOS, TNFa, and IL-1b (Figure 7d)
in mice receiving macrophages fromWT animals than in those
receiving macrophages from STAT6(ÿ /ÿ ) mice. A
quantitative analysis showed that the exogenous
administration of macrophages obtained from WT mice
significantly increased nuclear protein levels of b-catenin
compared with administration of macrophages from STAT6
(ÿ /ÿ ) animals (Figure 7e). In line with this, the mucosal
mRNA expression of Lgr5 and c-Myc was higher in the mucosa
of mice treated with macrophages fromWTmice than in those
receiving macrophages from STAT6 (ÿ /ÿ ) mice (Figure 7f).
As a whole, these results suggest that the administration ofM2a
macrophages, which signal through STAT6, accelerates the
mucosal repair in TNBS-treated STAT6 (ÿ /ÿ ) mice by the
activation of the Wnt signaling pathway.
DISCUSSION
This study demonstrates that a STAT6-dependentmacrophage
phenotype mediates mucosal repair in TNBS-treated mice
through the activation of the Wnt signaling pathway.
The experimental model of colitis induced by a single
administration of TNBS to Balb/c mice was characterized by
loss of body weight, distortion of mucosal architecture, and
dense infiltration of macrophages, similar characteristics to
those observed in human Crohn’s disease.31 These changes
peaked 2 days after injury and were followed by efficient tissue
repair and functional recovery. Our data demonstrate that the
absence of STAT6 delays regeneration of the mucosa and the
subsequent recovery of mice. These observations are in line
with previous studies showing exacerbation of chronic32 or
acute colitis33 in STAT6 (ÿ /ÿ ) mice, but contrast with those
reported by Rosen et al.,34 who observed amelioration of
oxazolone-induced colitis. This is an expected exception
because in this particular model, but not in the TNBS model,
colitis depends on IL-13 secretion and the consequent STAT6
activation,35–37 a pathway that has been described as a possible
pathogenic mechanism of human colitis, but irrelevant in
Crohn’s disease.38,39
Macrophages are essential to efficient healing as they
promote clearance of debris, cell proliferation, angiogenesis,
collagen deposition, and matrix remodeling.40–42 The diversity
of the roles played by macrophages is because of their ability to
assume a continuum spectrum of functional phenotypes.12,15,22
Our results reveal increased expression of both M1 and M2
markers and proinflammatory and antiinflammatory cytokines
in the damaged mucosa of WT mice treated with TNBS. The
early expression observed in iNOS and Cd11c, as well as that of
two hallmark indicators of M2 activation (ArgI and Ym1),
suggests that macrophages in the inflammatory phase of
intestinal repair adopt a combination of M1 and M2
phenotypes similar to that reported in other tissues.15,16,43
At 4 days after TNBS, there was a reduction in the expression of
iNOS, Cd11c, and Ym1 in parallel with a peak in the expression
ofCD86,Ccr7,CD206, andArgI, and an increased expression of
antiinflammatory cytokines, suggesting a different phenotypic
profile than that observed in the inflammatory phase. At 6 days
after TNBS, when a functional and histological recovery was
observed in WT mice, low levels in M1- and sustained levels in
M2-macrophage-associated genes were recorded, pointing to
the fact that macrophages had been properly activated to repair
the mucosa. This assumption is supported by the different time
course of macrophage activation subject to STAT6 deficiency.
A higher expression of proinflammatory cytokines together
with a lower expression of both M2 markers and antiin-
flammatory cytokines coexisted with a delayed wound healing
in STAT6 (ÿ /ÿ ) mice. Interestingly, this defect was counter-
acted by exogenous administration of effectively polarizedM2a
macrophages obtained fromWTmice but not by macrophages
obtained from STAT6 (ÿ /ÿ ) mice in whichM2a polarization
had failed. The beneficial effects of administration of M2a
macrophages to STAT6 (ÿ /ÿ ) mice were also evident in the
functional recovery of mice and the diminished mucosal
Figure 6 Treatment with a Wnt agonist accelerates wound healing
in 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in
STAT6 (ÿ /ÿ ) mice. STAT6 (ÿ /ÿ ) mice treated with TNBS received
daily an intraperitoneal injection of a Wnt agonist (5mg kgÿ1) until day 4.
STAT6, signal transducer and activator of transcription 6. (a)Graph shows
bodyweight asapercentageof startingweight,measureddaily after TNBS
administration. (b, c) Graphs show colon length after killing and
histological score analyzed according to the Wallace score parameters.
Representative photographs of the mucosa after TNBS administration
(original magnification  10). (d) Graph shows quantification of nuclear
b-catenin vs. nucleolin and results are represented as fold induction.
A representative western blot showing nuclear b-catenin. In all cases,
points or bars in graphs represent mean±s.e.m. Significant differences in
relation to vehicle (Vh)-treated group are shown by *Po0.05 and
**Po0.01.
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expression of proinflammatorymarkers. As awhole, our results
indicate that a STAT6-dependent macrophage phenotype
mediates mucosal repair in TNBS-treated mice.
During tissue repair, the proliferation of numerous cell types
is a requirement of normal healing. In the gastrointestinal tract,
the Wnt signaling pathway mediates regeneration of the
mucosa by activating proliferation of the progenitor cells
located at the base of the crypts.10,11,44
Our results reveal in the mucosa of TNBS-treated mice an
accumulation of nuclear b-catenin, the central player in the
canonical Wnt pathway, and increased transcriptional
expression of twoWnt target genes, Lgr5 and c-Myc, indicating
that upregulation of the canonical Wnt pathway is an
injury-associated response.19 Of interest, nuclear b-catenin
was mainly located in crypts adjacent to injury, strongly
supporting that activation of Wnt signaling in epithelial cells
takes place to renew the damaged area Q3.11,14 This is strongly
reinforced by results showing activation of Wnt signaling and
acceleration of mucosal healing with the administration of a
Wnt agonist to STAT6 (ÿ /ÿ ) mice that had exhibited a
delayed wound healing associated with a diminished activation
of this pathway.
Regulation of theWnt signaling pathway is complex andmay
occur at multiple levels, including the ligand/receptor,
Figure 7 Transfer of M2a macrophages accelerate wound healing in STAT6 (ÿ /ÿ ) 2,4,6-trinitrobenzenesulfonic acid (TNBS) mice through the
activation of theWnt signaling pathway. STAT6, signal transducer and activator of transcription 6. Peritonealmacrophages fromwild-type (WT) and from
STAT6 (ÿ /ÿ ) mice were polarized toward M2a macrophages with interleukin-4 (IL-4) and injected intraperitoneally (i.p.; 2 106macrophages) 2 days
after TNBSadministration.Micewere killed 2 days aftermacrophage injection. (a)Graph shows bodyweight as a percentage of startingweightmeasured
daily after TNBSadministration (n¼5). (b)Graphs showcolon length andhistological score 2 days aftermacrophage injection (n¼ 5). (c) Representative
photographsof themucosa of TNBS-treatedmice that receivedmacrophages (originalmagnification  10). (d)Graphs showmRNAexpression of iNOS,
TNFa, and IL-1b in themucosaofmice receivingmacrophages.Resultswere normalizedwithb-actin andare representedas fold induction vs. expression
in the group of mice treated with macrophages obtained from STAT6 (ÿ /ÿ ) mice. (e) Graph shows the densitometry quantification of nuclear b-catenin
normalized with nucleolin (n¼5) and a representative western blot is also shown. (f) Graphs show the expression of c-Myc and Lgr5 normalized with b-
actin and represented as fold induction vs. expression in mice receiving macrophages obtained from STAT6 (ÿ /ÿ ) mice (n¼ 5). In all cases, bars in
graphs represent mean±s.e.m. and significant differences from the group of mice treated with macrophages obtained from STAT6 (ÿ /ÿ ) mice are
shown by *Po0.05, **Po0.01, and ***Po0.001.
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translocation of b-catenin, and transcriptional activation.9Our
results showed an increase in the expression of canonical Wnt
ligands in the mucosa of TNBS-treated mice. We also detected
an enhanced expression of negative regulators ofWnt that have
been reported to be expressed during intestinal inflammation.45
Of interest, data revealed that the expression of Wnt ligands,
but not that of the Wnt inhibitors, is mediated by STAT6,
pointing to upregulation of Wnt ligands expression in the
activation of mucosal Wnt signaling. In response to injury,
these ligands were upregulated in both cells of the lamina
propria and epithelial cells. However, this regulation was
dependent on STAT6 in only cells of the lamina propria,
suggesting that differences detected in mucosal levels of b-
catenin betweenWT and STAT6 knockout mice are because of
the expression ofWnt ligands in cells other than epithelial cells Q4.
Macrophages have been related with the expression of Wnt
ligands,21 and it has been reported that activated macrophages
promote Wnt signaling in epithelial cells in the kidney and
Table 1 Primary antibodies used for both immunohistochemical studies and western blot analysisQ20
Antibody Immunohistochemistry Western blot
Antigen retrieval Antibody dilution Antibody dilution
CCR7 Sodium citrate buffer, pH¼6, 97 1C, 20min 1:200
CD206 Sodium citrate buffer, pH¼6, 97 1C, 20min 1:200
b-Catenin (Sigma-Aldrich) Sodium citrate buffer, pH¼6, 97 1C, 20min 1:200 1:2,500
Nucleolin (Sigma-Aldrich) 1:5,000
DKK1 (Sigma-Aldrich) 1:1,000
b-Actin (Sigma-Aldrich) 1:10,000
Table 2 Primer sequences of specific PCR products for each gene analyzedQ21
Mouse gene Sense (50–30) Antisense (50–30) Length (bp)
TNFa CCCTCACACTCAGATCATCTTCT GCTACGACGTGGGCTACAG 61
IL-1b GAAATGCCACCTTTTGACAGTG CTGGATGCTCTCATCAGGACA 117
IL-6 GAGTCCTTCAGAGAGATACAGAAAC TGGTCTTGGTCCTTAGCCAC 150
IL-10 GGACAACATACTGCTAACCGAC CCTGGGGCATCACTTCTACC 110
IL-4 GTACCAGGAGCCATATCCACG CGTTGCTGTGAGGACGTTTG 128
IL-13 GCCAAGATCTGTGTCTCTCCC ACTCCATACCATGCTGCCG 106
iNOS CGCTTGGGTCTTGTTCACTC GGTCATCTTGTATTGTTGGGCTG 222
Cd11c TCTTCTGCTGTTGGGGTTTG CAGTTGCCTGTGTGATAGCC 204
ArgI GTGGGGAAAGCCAATGAAGAG TCAGGAGAAAGGACACAGGTTG 232
Ym1 AGAAGCAATCCTGAAGACACC GCATTCCAGCAAAGGCATAG 205
Fizz1 CGTGGAGAATAAGGTCAAGGAAC CAACGAGTAAGCACAGGCAG 212
CD86 GCACGGACTTGAACAACCAG CCTTTGTAAATGGGCACGGC 194
CD206 TGTGGAGCAGATGGAAGGTC TGTCGTAGTCAGTGGTGGTTC 201
Ccr7 CTCTCCACCGCCTTTCCTG ACCTTTCCCCTACCTTTTTATTCCC 126
c-Myc CCTTTGGGCGTTGGAAACC GTCGCAGATGAAATAGGGCTG 115
Lgr5 TTCCACAGCAACAACATCAGG CGAGGCACCATTCAAAGTCAG 159
Wnt1 ACATAGCCTCCTCCACGAAC TGATTGCGAAGATGAACGCTG 276
Wnt2b AGCACCAGTTCCGTCACCAC AGCCACCCCAGTCAAAGTCC 240
Wnt3a TGGCTCCTCTCGGATACCTC ACAGAGAATGGGCTGAGTGC 125
Wnt6 CTGGGGGTTCGAGAATGTCAG GGAACAGGCTTGAGTGACCG 165
Wnt7b CGTGTTTCTCTGCTTTGGCG AGTTCTTGCCCGAAGACGG 258
Wnt10a GACCTGAGTAGGAGCTGTGTG GATGTCGTTGGGTGCTGAC 256
Wnt10b AACCCGACAGTTTCCCCAC TGAACAAAGCCAAGAACAGGAG 203
DKK1 GACCACAGCCATTTTCCTCG AGCCTTTCCGTTTGTGCTTG 268
SFRP1 AGGGGTCTGCTCATTTTGGG TGAAATCCTCACAGGTCCGC 292
b-Actin GCCAACCGTGAAAAGATGACC GAGGCATACAGGGACAGCAC 95
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stomach, as well as in cocultured intestinal epithelial
cells.19,21,46,47 The present study extends these observations
and show that both the expression of Wnt ligands by M2a
macrophages and the activation of epithelial Wnt signaling by
cocultured M2a macrophages are STAT6 dependent. These
results help to explain the deficiency in Wnt signaling detected
in the mucosa of STAT6 (ÿ /ÿ ) mice and point to M2
macrophages as important modulators of Wnt signaling in
damaged mucosa. Strong evidence of the role played by M2a
macrophages in activating theWnt pathway comes from results
showing that the injection of M2a macrophages to STAT6
(ÿ /ÿ ) mice increased the amount of nuclear b-catenin and
mRNA expression of two Wnt/b-catenin target genes and
accelerated wound repair in the mucosa of TNBS-treated mice.
This acute response, which seems to be required for wound
healing, needs to be balanced to avoid a mucosal dysfunction
because of the persistence of Wnt signaling associated with
accumulation ofM2macrophages, as seen in chronic ulcerative
colitis patients.21
In summary, our study demonstrates that a
STAT6-dependent macrophage phenotype promotes mucosal
repair in TNBS-treated mice through activation of the Wnt
signaling pathway. A better understanding of the reciprocal
regulation of macrophage phenotype and mucosal repair
following intestinal damagewould help to establish new cellular
approaches to IBD therapy.
METHODS
Mice. WT Balb/cj and STAT6ÿ /ÿ knockout (C.129S2-Stat6tm1Gru/J)
mice were purchased from The Jackson Laboratory and kept under
specific pathogen-free conditions during experiments that were
performed when mice were 7–8 weeks oldQ5 . All protocols were
approved by the institutional animal care and use committees of the
University of Valencia (Valencia, Spain).Q6
Induction and evaluation of colitis. TNBS colitis was induced by
intrarectal administration of 100ml of TNBS (3.5mg per 20 g mice)
dissolved in 40% ethanol. Mice were anesthetized and a 16G catheter
was then carefully inserted through the anus into the colon. The
catheter was introduced 3 cm from the anus and mice were hung
upside down for 1min. Vehicle-treated mice received 100 ml of 0.9%
NaCl dissolved in 40% ethanol. Mice were weighed daily and were
killed by cervical dislocation on days 2, 4, and 6 after TNBS
administration. Colon length was measured and colon tissue was
frozen in liquid nitrogen for protein and RNA extraction and fixed in
4% paraformaldehyde acid and embedded in paraffin for immuno-
histochemistry experiments. Some mice were treated daily with aWnt
agonist (5mg kgÿ 1, CID 11210285 hydrochloride, Sigma-Aldrich) or
its vehicle (dimethyl sulfoxide 5%) intraperitoneallyQ7 . Histological
analysis was performed on a scale of 0 to 10, taking into account the
parameters of the Ameho Criteria48 that are degree of inflammatory
infiltrate, the presence of erosion, ulceration or necrosis, and the depth
and surface extension of lesions.
Isolation of peritoneal macrophages and in vitro polarization. Mice
were killed and 10ml of cold phosphate-buffered saline was injected
into the peritoneal cavity. The fluid was then withdrawn and cen-
trifuged for 5min at 350 g at 4 1C. The pellet was resuspended in 1ml of
RPMI-1640 (HiClone) supplemented with 2% penicillin–
streptomycin and 10% bovine fetal serum These cells were seeded
in Petri dishes for 4 h at 37 1C. Nonadherent cells were subsequently
removed by washing with phosphate-buffered saline and adherent
macrophages were polarized toward M1 macrophages with lipopo-
lysaccharide (0.1 mgmlÿ 1; Escherichia coli 0111:B4) and interferon-g
(20 ngmlÿ 1) for 24 h or toward M2a macrophages with IL-4
(20 ngmlÿ 1) for 72 h.49 Macrophages were characterized by reverse
transcription–PCR for iNOS, CD86, ArgI, and CD206.
Transfer of M2a macrophages. M2a macrophages derived from
peritoneal macrophages were labeled with Vybrant Cell-Labeling
Solutions (Molecular Probes) according to the manufacturer’s
instructions Q8
Q9
. In brief, cells were removed by incubation with TrypLE
Express (Invitrogen) and EDTA (1mM) in Dulbecco’s phosphate-
buffered saline at 37 1C for 30min. They were then resuspended at a
density of 1.0 106 cells and incubated for 20min with Vybrant Cell-
Labeling Solution. Cells were washed with warm medium twice and
2.0 106 macrophages were injected intraperitoneally with a 19G
needle 2 days after TNBS administration. Mice were killed 2 days after
macrophage injection.
Epithelial and lamina propria cell isolation. Mice were killed 4 days
after TNBS administration and fresh colons were removed andwashed
with Hanks’ balanced salt solution without Caþ 2 or Mgþ 2. Colons
were cut and incubated with 3mM EDTA and 2mM dithiothreitol
(1 h, 4 1C). Supernatant was collected and epithelial cells were obtained
after centrifugation (5min, 1,500 r.p.m.).47 Intestinal pieces were cut
and incubated with Collagenase IV (1mgmlÿ 1, Life Technologies)
andDNAse (0.3mgmlÿ 1, GEHealthcare) for 30min at 37 1C Q10.Mucosa
was dissociated with gentle MACS dissociator (Miltenyi Biotec) and
filtered with 70 mm Q11
Q12
. Lamina propria cells were collected after cen-
trifugation (10min, 1,500 r.p.m).
Cell culture and coculture. Caco-2 cells (American Type Culture
Collection, VA) were cultured in minimum essential medium (Sigma-
Aldrich) supplemented with 20% inactivated bovine fetal serum,
100Umlÿ 1 penicillin, 100mgmlÿ 1 streptomycin, 2mM L-glutamine,
100mM sodium pyruvate, and 1% of non-essential amino acids Q13. These
cells were cocultured with peritoneal macrophages from WT and
STAT6 (ÿ /ÿ ) mice using Transwell inserts (Corning, MA) with a
0.4 mm porous membrane Q14.21 Peritoneal macrophages were seeded on
the inserts and polarized toward theM2 phenotype as described above.
After polarization, the inserts were placed on top of a monolayer of
Caco-2 cells and were cocultured for 24 h.
Protein extraction and western blot. Intestinal frozen tissues were
homogenized and nuclear and cytoplasm protein was extracted as
previously described.21 Nuclear protein from Caco-2 cells was
obtained by sonication of nuclear pellets followed by centrifugation.
Equal amounts of protein were loaded onto sodium dodecyl sulfate–
polyacrylamide gel electrophoresis gels. After electrophoresis,
membranes were blocked with 5% non-fat dry milk in TBS-T (20mM
Tris/HCl pH 7.2, 150mM NaCl, and 0.1% Tween-20) and incubated
overnight with different primary antibodies (Table 1). Later,
membranes were incubated with a peroxidase-conjugated anti-
mouse IgG (1:2,500; Thermo Scientific, Rockford, IL) or anti-
rabbit IgG (1:5,000; Thermo Scientific) followed by treatment with
supersignal west pico chemiluminescent substrate (Thermo
Scientific). Protein bands were detected by a LAS-3000 (Fujifilm,
Barcelona, Spain) and protein expression was quantified by means of
densitometry using Image Gauge Version 4.0 software (Fujifilm). Data
were normalized to b-actin for total and cytoplasm proteins or
nucleolin for nuclear proteins.
Immunohistochemistry. Intestinal tissues were fixed in 10% par-
aformaldehyde and immunohistochemical studies were performed in
representative 5 mm sections of paraffin-embedded tissues. After
dehydration of the tissues, endogenous peroxidase activity was
suppressed by immersion in 0.3% hydrogen peroxide (15min), after
which antigen retrieval was performed. Following blocking with 5%
rabbit or goat serum for 30min, sections were incubated overnight
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(4 1C) with different primary antibodies (Table 1). Tissues were
incubated with anti-mouse IgG (1:200; Thermo Scientific) or anti-
rabbit IgG (1:200; Thermo Scientific) and 3,30-diaminobenzidine was
employed for signal development. All tissues were counterstained with
hematoxylin and the specificity of the immunostaining was confirmed
by the absence of staining in analogous tissue sections when the
primary or secondary antibodies were omitted. Quantification of
CCR7þ cells and CD206þ cells was performed in a total area of
0.3mm2.
RNA extraction and real-time PCR analysisQ15 . RNA extraction was
performed using Tripure Isolation reagent (RocheQ16 ). In short, tissues
were homogenized by Ultraturrax in 750 ml Trizol, and epithelial cells,
cells from the lamina propria, or peritoneal macrophages were
suspended in 750ml TrizolQ17 . Afterward, 200 ml chloroformwas added to
the separation phaseQ18 . RNA precipitation was performed by adding
500 ml isopropanol, and RNA pellets were washed twice with 70%
ethanol. RNA was quantified with Nanodrop and 1 mg of RNA was
used to obtain complementary DNAwith the Prime Script RT reagent
Kit (Takara Biotechnology, Dalian, ChinaQ19 ). Real-time PCR was
performed with the Prime Script Reagent Kit Perfect Real Time
(Takara Biotechnology) in a thermo cycler Light Cycler (Roche
Diagnostics, Mannheim, Germany). Specific oligonucleotides were
designed according to the sequences shown in Table 2. Relative gene
expression was expressed as follows: change in expression
(fold)¼ 2ÿD(DCT) where DCT¼CT (target)ÿCT (housekeeping),
and D(DCT)¼DCT (treated)ÿDCT (control). b-Actin was used as
the housekeeping gene. PCR products ofWnt ligandswere loaded onto
an agarose gel and bands were detected by a LAS-3000 (Fujifilm).
Statistical analysis. Data were expressed as mean±s.e.m. and
compared by analysis of variance (one-way analysis of variance) with
Newman–Keuls post hoc correction for multiple comparisons or
unpaired Student’s t-test where appropriate. A P value ofo0.05 was
considered to be statistically significant. Correlations were analyzed
using Spearman’s correlation coefficient.
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at http://www.nature.com/mi
ACKNOWLEDGMENTS
This work was supported by Ministerio de Economı´a y Competitividad
(SAF2013-43441-P), CIBERehd, and Generalitat Valenciana [PROME-
TEOII/2014/035]. J.C.-R. is supported by FPU fellowships from Ministerio
de Educacio´n, Cultura y Deporte. C.H. acknowledges support from the
‘Ramon y Cajal’ programme of Spain. We thank Brian Normanly for his
English language editing.
DISCLOSURE
The authors declared no conflict of interest.
& 2015 Society for Mucosal Immunology
REFERENCES
1. Neurath, M.F. & Travis, S.P. Mucosal healing in inflammatory bowel
diseases: a systematic review. Gut 61, 1619–1635 (2012).
2. Maloy, K.J. & Powrie, F. Intestinal homeostasis and its breakdown in
inflammatory bowel disease. Nature 474, 298–306 (2011).
3. Henderson, P., van Limbergen, J.E., Schwarze, J. &Wilson, D.C. Function
of the intestinal epithelium and its dysregulation in inflammatory bowel
disease. Inflamm. Bowel Dis. 17, 382–395 (2011).
4. Bernstein, C.N. Treatment of IBD: where we are and where we are going.
Am. J. Gastroenterol. 110, 114–126 (2015).
5. Pinto, D., Gregorieff, A., Begthel, H. & Clevers, H. Canonical Wnt signals
are essential for homeostasis of the intestinal epithelium. Genes Dev. 17,
1709–1713 (2003).
6. van de Wetering, M. et al. The beta-catenin/TCF-4 complex imposes a
crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241–250
(2002).
7. van der Flier, L.G. & Clevers, H. Stem cells, self-renewal, and differentia
tion in the intestinal epithelium. Annu. Rev. Physiol. 71,
241–260 (2009).
8. Yeung, T.M., Chia, L.A., Kosinski, C.M. & Kuo, C.J. Regulation of self-
renewal and differentiation by the intestinal stem cell niche. Cell. Mol. Life
Sci. 68, 2513–2523 (2011).
9. Clevers, H. & Nusse, R. Wnt/beta-catenin signaling and disease. Cell 149,
1192–1205 (2012).
10. Clevers, H. The intestinal crypt, a prototype stem cell compartment. Cell
154, 274–284 (2013).
11. Clevers, H., Loh, K.M. &Nusse, R. Stem cell signaling. An integral program
for tissue renewal and regeneration: Wnt signaling and stem cell control.
Science 346, 1248012 (2014).
12. Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo
veritas. J. Clin. Invest. 122, 787–795 (2012).
13. Murray, P.J. & Wynn, T.A. Protective and pathogenic functions of
macrophage subsets. Nat. Rev. Immunol. 11, 723–737 (2011).
14. Pull, S.L., Doherty, J.M., Mills, J.C., Gordon, J.I. & Stappenbeck, T.S.
Activated macrophages are an adaptive element of the colonic epithelial
progenitor niche necessary for regenerative responses to injury.Proc. Natl.
Acad. Sci. USA 102, 99–104 (2005).
15. Novak, M.L. & Koh, T.J. Macrophage phenotypes during tissue repair.
J. Leukoc. Biol. 93, 875–881 (2013).
16. Gensel, J.C. & Zhang, B. Macrophage activation and its role in repair and
pathology after spinal cord injury. Brain Res. 2015).
17. Daley, J.M., Brancato, S.K., Thomay, A.A., Reichner, J.S. &Albina, J.E. The
phenotype of murine wound macrophages. J. Leukoc. Biol. 87, 59–67
(2010).
18. Boulter, L. et al. Macrophage-derived Wnt opposes Notch signaling to
specify hepatic progenitor cell fate in chronic liver disease. Nat. Med. 18,
572–579 (2012).
19. Lin, S.L. et al. Macrophage Wnt7b is critical for kidney repair and
regeneration. Proc. Natl. Acad. Sci. USA 107, 4194–4199 (2010).
20. Smith, K. et al. Up-regulation of macrophage wnt gene expression in
adenoma-carcinoma progression of human colorectal cancer.
Br. J. Cancer 81, 496–502 (1999).
21. Cosin-Roger, J. et al. M2 macrophages activate WNT signaling
pathway in epithelial cells: relevance in ulcerative colitis. PLoS One 8,
e78128 (2013).
22. Novak, M.L. & Koh, T.J. Phenotypic transitions of macrophages
orchestrate tissue repair. Am. J. Pathol. 183, 1352–1363 (2013).
23. Mikita, T., Campbell, D., Wu, P., Williamson, K. & Schindler, U.
Requirements for interleukin-4-induced gene expression and functional
characterization of Stat6. Mol. Cell. Biol. 16, 5811–5820 (1996).
24. Egan, B.S., Abdolrasulnia, R. & Shepherd, V.L. IL-4 modulates transcrip-
tional control of themannose receptor inmouseFSDCdendritic cells.Arch.
Biochem. Biophys. 428, 119–130 (2004).
25. Welch, J.S. et al. TH2 cytokines and allergic challenge induce Ym1
expression in macrophages by a STAT6-dependent mechanism. J. Biol.
Chem. 277, 42821–42829 (2002).
26. Weng, M. et al. Alternatively activated macrophages in intestinal helminth
infection: effects on concurrent bacterial colitis. J. Immunol. 179, 4721–
4731 (2007).
27. Odegaard, J.I. et al. Macrophage-specific PPARgamma controls alter-
native activation and improves insulin resistance. Nature 447, 1116–1120
(2007).
28. D’Alessio, S. et al. VEGF-C-dependent stimulation of lymphatic function
ameliorates experimental inflammatory bowel disease. J. Clin. Invest. 124,
3863–3878 (2014).
29. He, L. & Marneros, A.G. Macrophages are essential for the early wound
healing response and the formation of a fibrovascular scar. Am. J. Pathol.
182, 2407–2417 (2013).
30. Maier, E., Duschl, A. & Horejs-Hoeck, J. STAT6-dependent and -
independent mechanisms in Th2 polarization. Eur. J. Immunol. 42,
2827–2833 (2012).
31. Wirtz, S. & Neurath, M.F. Mouse models of inflammatory bowel disease.
Adv. Drug Deliv. Rev. 59, 1073–1083 (2007).
ARTICLES
12 www.nature.com/mi
32. Fichtner-Feigl, S. et al. IL-13 orchestrates resolution of chronic intestinal
inflammation via phosphorylation of glycogen synthase kinase-3beta.
J. Immunol. 192, 3969–3980 (2014).
33. Elrod, J.W. et al. DSS-induced colitis is exacerbated in STAT-6 knockout
mice. Inflamm. Bowel Dis. 11, 883–889 (2005).
34. Rosen,M.J.et al.STAT6deficiency ameliorates severity of oxazolone colitis
by decreasing expression of claudin-2 and Th2-inducing cytokines.
J. Immunol. 190, 1849–1858 (2013).
35. Heller, F., Fuss, I.J., Nieuwenhuis, E.E., Blumberg, R.S. & Strober, W.
Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is
mediated by IL-13-producing NK-T cells. Immunity 17, 629–638 (2002).
36. Boirivant, M., Fuss, I.J., Chu, A. & Strober, W. Oxazolone colitis: a murine
model of T helper cell type 2 colitis treatablewith antibodies to interleukin 4.
J. Exp. Med. 188, 1929–1939 (1998).
37. Hoving, J.C. et al. B cells that produce immunoglobulin E mediate colitis in
BALB/c mice. Gastroenterology 142, 96–108 (2012).
38. Geremia, A., Biancheri, P., Allan, P., Corazza, G.R. & Di, S.A. Innate and
adaptive immunity in inflammatory bowel disease. Autoimmun. Rev. 13,
3–10 (2014).
39. Monteleone, G., Caruso, R. & Pallone, F. Targets for new immunomodula-
tion strategies in inflammatory bowel disease. Autoimmun. Rev. 13, 11–14
(2014).
40. Wynn, T.A., Chawla, A. & Pollard, J.W. Macrophage biology in develop-
ment, homeostasis and disease. Nature 496, 445–455 (2013).
41. Mahida, Y.R. The key role of macrophages in the immunopathogenesis
of inflammatory bowel disease. Inflamm. Bowel Dis. 6, 21–33 (2000).
42. Mowat, A.M. &Bain, C.C.Mucosal macrophages in intestinal homeostasis
and inflammation. J. Innate Immun. 3, 550–564 (2011).
43. Atochina, O., Da’dara, A.A., Walker, M. & Harn, D.A. The immunomo-
dulatory glycan LNFPIII initiates alternative activation of murine macro-
phages in vivo. Immunology 125, 111–121 (2008).
44. Miyoshi, H., Ajima, R., Luo, C.T., Yamaguchi, T.P. & Stappenbeck, T.S.
Wnt5a potentiates TGF-beta signaling to promote colonic crypt regen-
eration after tissue injury. Science 338, 108–113 (2012).
45. Nava, P. et al. Interferon-gamma regulates intestinal epithelial homeostasis
through converging beta-catenin signaling pathways. Immunity 32,
392–402 (2010).
46. Oguma, K. et al. Activated macrophages promote Wnt signaling through
tumour necrosis factor-alpha in gastric tumour cells. EMBO J. 27,
1671–1681 (2008).
47. Ortiz-Masia, D. et al. Hypoxic macrophages impair autophagy in epithelial
cells throughWnt1: relevance in IBD.Mucosal Immunol. 7, 929–938 (2013).
48. Ameho, C.K. et al. Prophylactic effect of dietary glutamine supplementa-
tion on interleukin 8 and tumour necrosis factor alpha production in
trinitrobenzene sulphonic acid induced colitis. Gut 41, 487–493 (1997).
49. Hunter, M.M. et al. In vitro-derived alternatively activated macrophages
reduce colonic inflammation in mice. Gastroenterology 138, 1395–1405
(2010).
ARTICLES
MucosalImmunology 13
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
III.- DISCUSSION 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
131 
 
In last years, mucosal healing has emerged as a key target for IBD treatment. In 
the present study we analysed the role of macrophages in intestinal mucosal 
regeneration. Results demonstrate the coexistence of several macrophage phenotypes in 
the mucosa of IBD patients, which differ in the expression of Wnt and Notch ligands. 
As a consequence, those macrophages differentially modulate Wnt and Notch signaling 
pathways in intestinal epithelial cells, which is crucial for mucosal repair due to the 
influence of these pathways in essential processes such as differentiation or autophagy. 
 
 IBD is characterized by an abnormal mucosal architecture with a variable degree 
of crypt shortening, reduced crypt density, variable crypt diameter and crypt branching. 
We have included in this study both damaged and non-damaged mucosa obtained from 
patients at the moment of diagnosis (newly diagnosed patients) and from chronic IBD 
patients. In both cases, the architecture of the non-damaged mucosa was preserved. In 
contrast, damaged mucosa exhibited significant changes in the structure of the tissue, 
with dilated and branching crypts and a considerable distance between crypts that were 
similar between newly diagnosed and chronic patients. 
 
In addition to mucosal damage, an exacerbated infiltration is detected in the 
injured mucosa of IBD patients which is predominantly composed of lymphocytes, 
plasma cells and macrophages (Jevon G.P. et al., 2010). In order to analyse the 
macrophage phenotype present in the mucosa of these patients we performed double 
immunostaining in both paraffin embedded tissues and intestinal isolated macrophages. 
Data revealed a significant increase of CD68 positive cells in damaged mucosa 
compared with non-damaged mucosa in both newly diagnosed and chronic patients. A 
more detailed analysis of the macrophage phenotype showed that the prevalence of 
CD86 or iNOS positive cells (M1 macrophages) was not significantly different between 
damaged and non-damaged in both newly diagnosed and chronic patients. In contrast, 
the prevalence of CD206 or ArgI positive cells (M2 macrophages) significantly 
increased in damaged mucosa of chronic patients but such increase was not observed in 
newly diagnosed patients. All of these results are not in line with previous studies 
showing that the number of M2 macrophages decrease in damaged mucosa (Hunter 
M.M. et al., 2010; Vos A.C. et al., 2012). However, in those studies they compared the 
mucosa of the same patients in different moments of the disease (remission and relapse) 
or before and after pharmacological treatment while we have compared the non-
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damaged and damaged mucosa of the same patient at the same time. Taking together, 
results demonstrate that M2 macrophages prevail in the injured area and suggest that 
these macrophages accumulate with chronicity.  
 
Wnt and Notch signaling pathways play an essential role in the physiological 
turnover of the crypts as well as in mucosal regeneration after damage (Nakamura T. et 
al., 2007). In the inflamed mucosa, macrophages are located close to intestinal crypts 
and maintain communication with epithelial cells (Lin S.L. et al., 2010; Oguma K. et al., 
2008; Boulter L. et al., 2012). The induction of canonical Wnt ligands by macrophages 
has recently been reported in kidney repair (Lin S.L. et al., 2010). We analysed here 
whether macrophages differentially expressed those ligands depending on their 
phenotype. Our results demonstrated for the first time a selective induction of canonical 
Wnt ligands associated with M2 macrophages. In fact, U937 monocytic cell line as well 
as primary bone marrow derived macrophages from both healthy and IBD patients 
showed a higher expression of canonical Wnt ligands (Wnt1 and Wnt3a) when 
macrophages were polarized towards the M2 phenotype than in non-polarized or M1 
macrophages. Little is known about the transcription factors involved in the expression 
of Wnt ligands, but in line with our results, it has been described that IL-4, the stimulus 
used here for M2 polarization, activate SOX2 (Asonuma S. et al., 2009), a 
transcriptional factor that has been related with the induction of Wnt1 (Chen S. et al., 
2012).  
 
In parallel to Wnt ligands we evaluated the expression of Notch ligands in 
different macrophage phenotypes. It had been previously reported that activation of 
Notch signaling pathway by Dll4 shifted macrophage polarization towards the M1 
phenotype (Fukuda D. and Aikawa M., 2013). However, there was no evidence of the 
expression of these ligands in polarized macrophages. Results in U937 cell line and 
bone marrow derived macrophages from healthy and IBD patients revealed that M1 
macrophages express higher levels of Notch ligands (Jag1 and Dll4) than non-polarized 
and M2 macrophages. Taking all together results suggest that there is a selective and 
specific induction of Wnt and Notch ligands depending on the macrophage phenotype. 
 
 We evaluated next whether the expression of these ligands was functional and 
macrophages activated the Wnt and Notch signaling pathways in intestinal epithelial 
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cells. In order to achieve this goal, we established an in vitro system in which 
macrophages were co-cultured in inserts over a monolayer of intestinal epithelial cells 
for 24 hours. According to what we expected, M2 macrophages, and not non-polarized 
or M1 macrophages, activated Wnt signaling pathway in intestinal epithelial cells since 
they induced an increased expression of both, nuclear β-catenin, the central component 
of the canonical Wnt pathway, and two well-known target genes of β-catenin, c-Myc 
and Lgr5. Interestingly, the amount of β-catenin bound to Tcf-4, the main transcription 
factor involved in the expression of Wnt genes, was also increased only by M2 
macrophages, which strongly reinforced the activation of this pathway by these cells. 
These results are in line with previous studies reporting that activated macrophages 
promote Wnt signaling pathway in epithelial cells of the kidney and stomach (Lin S.L. 
et al., 2010; Oguma K. et al., 2008). Our results extend these observations to intestinal 
epithelial cells and demonstrated by silencing experiments that among Wnt ligands, 
specifically Wnt1 mediates the activation of the Wnt signaling pathway in intestinal 
epithelial cells.  
 
Unlike Wnt signaling, Notch pathway requires direct contact between adjacent 
cells (Koch U. et al., 2013). Therefore, we seeded the macrophages and intestinal 
epithelial cells in the same well in order to allow them to establish cell-cell interactions. 
Results revealed that M1 macrophages and not non-polarized and M2 macrophages 
significantly increased Hes1 protein levels, the central component of Notch pathway, in 
intestinal epithelial cells. Furthermore, silencing experiments of Notch ligands revealed 
that both, Jag1 and Dll4, mediate the activation of this pathway which points to a 
functional role of Notch ligands from M1 macrophages to epithelial signaling.  
 
Once we reported a selective induction of Wnt and Notch ligands in each 
macrophage phenotype and a selective activation of those pathways in intestinal 
epithelial cells, we aimed to study the relevance of these observations in the mucosa of 
IBD patients. Firstly, the isolation of intestinal macrophages from the mucosa of CD 
patients revealed that the proportion of Jag1+/CD86+ macrophages was significantly 
higher than the proportion of Jag1+/CD206+ macrophages. Furthermore, double 
immunohistochemistry experiments revealed that CD206+ macrophages express Wnt1 
ligand in intestinal mucosa of IBD patients, which suggests that the selective expression 
of ligands associated with the macrophage phenotype is also observed in vivo. 
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The analysis of the mucosal Wnt signaling in both human and murine colitis 
revealed an activation of this pathway in colitis since levels of nuclear β-catenin, and 
the expression of two well-known target genes of β-catenin, c-Myc and Lgr5, were 
significantly higher in damaged than in non-damaged mucosa. Furthermore, 
immunohistochemical experiments of β-catenin performed in human and murine 
samples revealed that crypts that are closer to the ulcer expressed more nuclear β-
catenin than those crypts that are far away the injury, which led us to suggest that this 
pathway is essential for the regeneration of the ulcer and is activated specifically in 
areas close to injury.  
 
In contrast to that observed with Wnt signaling, the Notch signaling pathway 
was diminished in damaged mucosa of IBD patients since mRNA and protein levels of 
Hes1 were significantly reduced in damaged compared with non-damaged mucosa and 
this was associated with an increased expression of Hath1, a transcription factor which 
is repressed by Hes1. These results seem to be contradictory with a study reported by 
Zehng X. et al. 2011 showing a suppression of Hath1 in UC. However, they compared 
UC patients with healthy volunteers while we detected a diminished Notch pathway in 
damaged compared with non-damaged mucosa from the same patient. Our results are in 
line with previous studies in which a significant increase in Hath1 expression was 
reported in IBD patients (Gersemann M. et al., 2009) and a lower expression of Notch-1 
was detected in epithelial cells from IBD patients compared with those from healthy 
controls (Werner L. et al., 2012). 
 
Trying to understand the role of macrophages in the modulation of Wnt and 
Notch signaling pathways, we correlated the number of CD206 positive macrophages 
and the intensity of the β-catenin immunostaining in damaged mucosa and results 
revealed a positive and significant correlation. Although other sources of Wnt ligands 
cannot be ruled out, the activation of Wnt signaling present in damaged mucosa could 
be due to the accumulation of M2 macrophages during chronicity. In a similar manner 
we hypothesized that M1 macrophages could modulate Notch pathway in the gut. Our 
results revealed a correlation between M1 macrophages and Hes1 protein levels but the 
fact that we detected a diminished Notch pathway in damaged mucosa led us to think 
that, in addition to M1 cells this pathway was being modulated by another mechanisms. 
Taking into account that Wnt signaling had been reported to inhibit Notch signaling in 
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liver (Huang M. et al., 2014) we performed a correlation between the ratio of 
CD86+/CD206+ and Hes1 and results revealed a better positive correlation coefficient. 
As a whole, these observations suggest that M2 macrophages activate Wnt signaling 
while M1 macrophages activate Notch signaling. Furthermore, the imbalance between 
M1 and M2 macrophages detected in the damaged mucosa of chronic IBD patients is 
associated with the final inhibition of Notch signaling observed. 
 
Both Wnt and Notch signaling pathways determine the fate of differentiation of 
intestinal epithelial cells towards an absorptive or secretory lineage (Milano J. et al., 
2004). It has been reported that the Wnt-c-Myc pathway acts as an intracellular 
molecular switch between proliferation and differentiation (Nakamura T. et al., 2007). 
Hence, we studied next the relevance of each macrophage phenotype in the 
differentiation of intestinal epithelial cells. Our in vitro results revealed that M2 
macrophages significantly decreased alkaline phosphatase activity in Caco-2 cells, 
which suggest that the spontaneous differentiation of these cells towards an absorptive 
lineage (Fleet J.C. et al., 2003; Mariadason J.M. et al., 2001) was impaired. This effect 
was mediated by canonical Wnt signaling pathway, since treatment of cells with 
XAV939, a destabilizing of epithelial β-catenin, reversed the diminished alkaline 
phosphatase activity. This observation was strongly reinforced by experiments showing 
that the exogenous administration of Wnt1 significantly reduced the alkaline 
phosphatase activity in both, Caco-2 and HT29 cells. Therefore, we concluded that M2 
macrophages induced an impairment of the enterocyte differentiation due to the 
activation of Wnt signaling pathway. 
 
In contrast to M2 cells, M1 macrophages induced an increase in the alkaline 
phosphatase activity with no changes in expression of Muc2, a marker of secretory cells, 
in both HT29 and Caco-2 cells. Therefore, we could suggest that M1 macrophages 
activate Notch pathway promoting enterocyte differentiation in intestinal epithelial cells. 
The fact that Jag1 has been reported to regulate alkaline phosphatase in stem cells 
(Osathanon T. et al., 2013) led us to suggest that M1 macrophages activate Notch 
pathway and promote enterocyte differentiation through the expression of Jag1 and Dll4.  
 
The analysis of markers of differentiation in damaged mucosa of IBD patients 
showed a significant decrease in protein levels and activity of intestinal alkaline 
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phosphatase, compared with levels detected in non-damaged mucosa of both UC and 
CD patients. Furthermore, a significant increase in the expression of Muc2 and in the 
number of Goblet cells was also reported pointing to an impaired differentiation of 
intestinal epithelial cells selectively towards an absorptive lineage. It is known that 
differentiation towards secretory cells needs high Wnt and low Notch, while 
differentiation towards absorptive cells needs high Wnt and high Notch (Milano J. et al., 
2004). Indeed, Wnt signaling pathway has been associated with diminished 
differentiation and transgenic mice over expressing a Wnt inhibitor had a reduced 
proliferation in crypts region and a higher alkaline phosphatase activity, a marker of 
absorptive cells (Sussman N.L. et al., 1989; Pinto D. et al., 2003). Therefore, we 
suggest that the impaired differentiation towards absorptive cells present in IBD patients 
is mediated by the activation of Wnt and the inhibition of Notch detected in damaged 
mucosa of these patients. Of interest our experiments revealed a positive and significant 
correlation between M1/M2 macrophages and IAP protein levels, thus suggesting that 
the impaired differentiation towards an absorptive lineage detected in IBD patients may 
be due to the imbalance between M1 and M2 macrophages observed with chronicity. 
 
Intestinal inflammation detected in IBD is associated with hypoxia in the 
mucosal surface and the stabilization of hypoxia-dependent transcription factors. In the 
present thesis, we have demonstrated the presence of both HIF-1α and HIF-2α, in the 
damaged mucosa of DSS-treated mice and IBD patients. The transcription factors HIF1 
and HIF2 are constituted by two subunits, α and β. In normoxia, HIF-1α and HIF-2α are 
continuously degraded by the activity of cytosolic prolylhydroxylases but under 
hypoxic conditions they are stabilized in the cytoplasm and translocated into the nucleus 
(Bartels K. et al., 2013). Once in the nucleus, they activate the expression of several 
target genes with hypoxia-responsive elements (HREs) in their promoters (Nauta T.D. 
et al., 2014). The presence of HRE sequences in the promoter region of Wnt1 gene led 
us to analyze whether HIFs were involved in the expression of this ligand. Then we 
cultured macrophages under hypoxia and observed HIF-1α and HIF-2α stabilization, 
and enhanced expression of Wnt1 in both human cell lines, U937 and THP1. 
Interestingly, we knocked-down HIF-1α and HIF-2α and results showed that HIF1, and 
not HIF2, mediated the Wnt1 induction under hypoxia conditions, which point to Wnt1 
as a target gene of HIF1. 
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On the other hand, the presence of HRE sequences in the promoters of Dll4 and 
Jag1, joined with a previous study that demonstrated the activation of Dll4 promoter by 
HIF1 in endothelial cells (Díez H. et al., 2007), led us to hypothesize that HIF1 is also 
responsible of the expression of Notch ligands. We also observed that hypoxic 
macrophages increased the expression of Dll4 and Jag1, in a HIF1-dependent manner 
which strongly points to these genes as targets of HIF1. Furthermore, our results by 
using a ChIP assay strongly reinforced that HIF1 directly regulated the transcription of 
Jag1. As a whole results showed that HIF1 mediates the expression of Wnt and Notch 
ligands associated with hypoxic macrophages. 
 
A selective expression of HIF1 in murine M1 macrophages and HIF2 in M2 
macrophages has been reported (Takeda N. et al., 2010). In the present study we found 
that HIF-1α is selectively stabilized in M1 macrophages, while HIF-2α was detected in 
M2 macrophages from both U937 cell line and intestinal isolated macrophages from 
healthy volunteers and CD patients, suggesting that the stabilization of these 
transcription factors is dependent on the macrophage phenotype. In accordance with 
these observations, our silencing experiments revealed that HIF1 mediated the 
transcription of Notch ligands in M1 macrophages. However we did not find induction 
of Wnt ligands in M1 cells, despite the HIF1 dependent induction of Wnt1 detected in 
hypoxic macrophages. It seems likely that the experimental model used to polarize 
towards M1 macrophages (LPS+IFN-γ), in parallel to stabilize HIF-1α, is activating 
some co-repressors of HIF1 activity which may avoid the activation of the expression of 
Wnt ligands by HIF1 (Qing H.E. et al., 2011).  
 
Wnt ligands had been shown to activate the mTOR pathway (Jin T. et al., 2008; 
Valvezan A.J. et al., 2012, Castilho R.M. et al., 2009), which is the main negative 
regulator of autophagy. Our data showed that hypoxic macrophages activated Wnt 
signaling pathway in intestinal epithelial cells increasing the levels of nuclear -catenin 
and the expression of c-Myc and Lgr5 and diminished autophagy. Interestingly, when 
we silenced both HIF1 and Wnt1, the effects in autophagy were partially reverted 
indicating that hypoxic macrophages impair autophagy in intestinal epithelial cells 
through the secretion of Wnt ligands. These observations were strongly reinforced by 
the exogenous administration of Wnt1, which caused an enhancement of p-mTOR and 
p62 and a reduction of LC3II, pointing to an impaired autophagy associated with the 
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activation of Wnt signaling. Taking into account that we had demonstrated the 
activation of this pathway in both murine and human colitis we proceed to analyze the 
expression of autophagy markers in the intestinal mucosa of DSS-treated mice and IBD 
patients. Results demonstrated in both cases that autophagy was impaired. Furthermore, 
we also showed that p-mTOR was increased in damaged mucosa which suggests an 
impairment of the autophagy p-mTOR dependent in IBD. Due to the fact that autophagy 
plays an essential role in intestinal epithelial cells (Tsuboi K. et al., 2015; Fritz T. et al., 
2011), we isolated colonic crypts of IBD patients and we demonstrated that autophagy 
was also impaired specifically in intestinal epithelial cells. Furthermore, results showed 
a positive and significant correlation between β-catenin and p-mTOR and p62 and a 
significant and negative correlation between β-catenin and LC3II, strongly pointing to 
an impaired autophagy due to the activation of Wnt pathway.  
 
Although we have not analyzed the role of the macrophage phenotype in the 
regulation of epithelial autophagy, the high expression of Wnt ligands associated with 
the M2 phenotype joined to the accumulation of these cells in chronic IBD, strongly 
suggest that the impaired autophagy observed in damaged mucosa could be due to the 
accumulation of M2 macrophages. Considering that an impaired autophagy reduces the 
defensive mechanisms of the intestinal mucosa against injury, our results suggest that 
M2 macrophages in chronic IBD patients may be delaying mucosal regeneration. These 
results are in line with the impaired differentiation previously attributed to M2 
macrophages in the present study. However they are in contradiction with the known 
role attributed to M2 macrophages on wound healing. Considering that three different 
subtypes of M2 macrophages have been reported which are differentially expressed 
depending on the phase of inflammation (Arango-Duque G.and Descoteaux A., 2014; 
Gensel J.C. and Zhang B., 2015; Novak M.L. and Koh T.J., 2013; Daley J.M. et al., 
2010) and the fact that our study has been centered in chronic patients we proceed to 
analyze the role of M2 macrophages in an acute model of experimental colitis  
 
Several studies had previously reported that STAT6 is an essential transcription 
factor for in vitro polarization towards M2 phenotype (Huber S. et al., 2010; Sajic T. et 
al., 2013; Juhas U. et al., 2015), which led us to evaluate the role of STAT6 in M2 
polarization and wound healing in a murine model of colitis using STAT6-/- mice. The 
administration of TNBS to WT and STAT6-/- mice revealed a protective role of STAT6 
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in mucosal wound healing and in the functional recovery of mice. These observations 
were in line with previous studies that reported an exacerbation of chronic (Fichtner-
Feigl S. et al., 2014) and acute colitis (Elrod J.W. et al., 2005) in STAT6-/- mice. 
However, our results differ from a study that demonstrated an amelioration of 
oxazolone-induced colitis in STAT6-/- mice (Rosen M.J. et al., 2013). This could be 
explained by the fact that in this particular model, and not in TNBS, colitis depends on 
IL-13 secretion and the consequent STAT6 activation (Heller F. et al., 2002; Boirivant 
M. et al., 1998; Hoving J.C. et al., 2012), a pathway that has been described as a 
possible pathogenic mechanism of human colitis, but not relevant in Crohn’s Disease 
(Geremia A. et al., 2014, Monteleone G. et al., 2014). 
 
In addition to wound healing we analyzed the pattern of expression of both M1 
and M2 markers to determine the role that STAT6 plays in macrophage polarization in 
vivo. Our results in WT mice demonstrated an increase of both M1 and M2 markers and 
pro-inflammatory and anti-inflammatory cytokines in damaged mucosa treated with 
TNBS. In the inflammatory phase, the early expression of M1 markers, such as iNOS 
and CD11c, as well as two hallmarks of M2 macrophages, such ArgI and Ym1, revealed 
a mix of both phenotypes in the beginning of the inflammation, in the same way to that 
reported in another tissues (Novak M.L. et al., 2013; Gensel J.C. et al., 2015; Atochina 
O. et al., 2008). Four days after TNBS administration, there was a reduction of some 
M1 markers in parallel with an increase of some M2 markers, which led us to suggest 
that in this phase there is a different phenotypic profile. When a functional and 
histological recovery was observed in WT, six days after TNBS treatment, there were 
lower levels of M1 markers and higher levels of M2 markers, suggesting that M2 
macrophages may have repaired the mucosa. This observation is strongly reinforced in 
STAT6-/- mice, in which a delayed wound healing paralleled with a higher expression of 
pro-inflammatory cytokines and M1 markers and lower expression of anti-inflammatory 
cytokines and M2 markers. Furthermore, immunohistochemistry for CCR7 and CD206 
revealed that the number of CCR7 positive cells was significantly increased in colitis in 
WT and STAT6-/- mice while the number of CD206 positive cells was only increased in 
WT animals. Taking together these results suggest that STAT6 plays an important role 
in M2 polarization associated to murine colitis.  
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The specific analysis of the Wnt signaling pathway in murine mucosa revealed 
an activation of this pathway after TNBS administration, since we observed an 
accumulation of nuclear β-catenin, and increased expression of two β-catenin target 
genes, Lgr5 and c-Myc. In a similar manner to that observed in human IBD, nuclear β-
catenin was mainly located in crypts adjacent to injury, which strongly supported that 
the activation of Wnt signaling pathway in epithelial cells takes place to renew the 
damage area (Clevers H. et al., 2014; Pull S.L. et al., 2005). The fact that this pathway 
was not increased in STAT6-/- mice treated with TNBS in parallel with the delayed 
regeneration observed in these animals point to the relevance of this pathway in 
mucosal repair. This observation was strongly reinforced with experiments performed 
with exogenous administration of a Wnt agonist, which activated mucosal Wnt 
signaling pathway and accelerated the regeneration of the mucosa in STAT6-/- mice 
treated with TNBS.  
 
Taking into account the low number of M2 macrophages and the diminished 
Wnt signaling detected in STAT6-/- mice we analyzed the role of STAT6 in the 
expression of Wnt ligands associated with M2 macrophages and the relevance of these 
ligands in mucosal regeneration. Results revealed higher levels of canonical Wnt 
ligands (Wnt2b, Wnt7b and Wnt10a) in M2 macrophages obtained from WT than in 
those from STAT6-/- mice which suggest that this transcription factor mediates the 
expression of canonical Wnt ligands associated with this phenotype.  
 
The beneficial effects of M2a macrophages in wound healing was strongly 
reinforced by experiments in which we administered intraperitoneally M2a 
macrophages from both WT and STAT6-/- into STAT6-/- TNBS treated mice and results 
revealed that mice receiving M2a macrophages from WT recovered faster their weight, 
had an improvement of the histological score and a diminished expression of pro-
inflammatory cytokines than those receiving M2a macrophages from STAT6-/- mice. 
Accordingly with what we expected, administration of M2a macrophages activated 
mucosal Wnt signaling pathway in STAT6-/- mice. These experiments are in line with 
previous studies showing that activated macrophages can promote Wnt signaling 
pathway in epithelial cells in the kidney and stomach (Lin S.L. et al., 2010; Oguma K. 
et al., 2008).  
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As a whole, these results point to a beneficial effect of M2a macrophages in 
intestinal healing in an acute murine model of colitis, through the activation of mucosal 
Wnt signaling. These results seem to be in contradiction with the role previously 
attributed to M2 macrophages through the activation of Wnt signaling in the mucosa of 
chronic patients. We consider that acute colitis is an inflammatory process characterized 
by a transient increase of M2 macrophages in order to repair the mucosa through the 
activation of Wnt signaling in cells located at the base of the crypts. In contrast, human 
IBD is a chronic disorder of the gastrointestinal tract in which the accumulation of M2 
macrophages impairs mucosal healing through the over-stimulation of epithelial Wnt 
signaling. These observations would be in line with the exacerbated amount of M2 
macrophages that we and others (Chanmee T. et al., 2014; Mantovani A. et al., 2002) 
have observed in colon cancer, a clinical complication of chronic colitis. 
 
As a conclusion, the present study demonstrates that macrophages modulate in a 
phenotype-dependent manner epithelial Wnt and Notch signaling pathways which in 
turn regulates essential processes for mucosal regeneration. We found in the damaged 
mucosa of chronic IBD patients accumulation of M2 macrophages, activation of Wnt 
signaling and diminished Notch signaling, associated with impaired autophagy and 
differentiation. The fact that we also demonstrated an essential role of M2a 
macrophages on mucosal repair in acute colitis, forces us to better characterize the 
similarities and differences between M2 macrophages present in the mucosa of chronic 
IBD patients and M2 macrophages transiently increased in the mucosal repair in an 
acute model of colitis. 
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1.- An increased expression of both M1 and M2 markers is detected in damaged mucosa 
of newly diagnosed and chronic IBD patients which suggest the coexistence of different 
macrophage phenotypes. In contrast to M1 macophages, M2 macrophages accumulate 
with chronicity. 
 
2.- The expression of ligands that mediate mucosal regeneration and the stabilization of 
Hypoxia Inducible Factors (HIFs) are selectively modulated by the macrophage 
phenotype. M1 macrophages are associated with HIF-1α stabilization, express Notch 
ligands and activate Notch signaling in epithelial cells which promote enterocyte 
differentiation. M2 macrophages stabilize HIF-2α, express Wnt ligands and induce Wnt 
signaling pathway in intestinal epithelial cells which impairs differentiation towards an 
absorptive lineage. 
 
3.- The prevalence of M2 macrophages detected in the mucosa of chronic IBD patients 
is associated with an activation of Wnt signaling, a diminution of Notch pathway and an 
impaired autophagy and enterocyte differentiation. 
 
4.- A STAT6-dependent M2 macrophage mediates wound healing in an acute model of  
murine colitis through the activation of Wnt signaling in cells located at the base of the 
crypts. 
 
5.- M2 macrophages seem to play a dual role in IBD. In acute colitis the transient 
increase in M2 macrophages mediate mucosal repair through the specific activation of 
Wnt signaling in epithelial cells located at the base of the crypts. The accumulation of 
M2 macrophages in chronic colitis is associated with impaired differentiation probably 
due to the persistent activation of epithelial Wnt signaling. A better characterization of 
the functional role played by M2 macrophages will help to understand these 
observations.  
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Abstract: 
Background: A novel family of proton sensing G-protein coupled receptors (GPCRs) including 
ovarian cancer G-protein coupled receptor 1 (OGR1, GPR68) was identified to play an 
important role in pH homeostasis of the human body. Hypoxia, which stabilizes the 
transcription factor hypoxia-inducible factor-1α (HIF-1α), is known to change tissue pH due 
to anaerobic glucose metabolism. We investigated how hypoxia regulates the function of the 
GPCR pH-sensing receptor OGR1 in the intestinal mucosa.  
Methods: OGR1 mRNA expression in murine tumors, human colonic tissue and myleoid cells 
was determined by real-time PCR. The influence of hypoxia on OGR1 expression was studied 
in the human monocytic cell line Mono Mac 6 (MM6) and in primary human intestinal 
macrophages. Changes in OGR1 expression in MM6 cells under hypoxia were determined on 
activation by TNF, with or without NF-κB inhibitors. 
Results: OGR1 expression was significantly higher in tumor tissue compared to normal 
murine colon tissue. Hypoxia positively regulated the expression of OGR1 in MM6 cells, 
primary human intestinal macrophages and in colonic tissue from inflammatory bowel 
disease patients compared to healthy subjects. In MM6 cells, hypoxia enhanced TNF induced 
OGR1 expression was reversed by NF-κB inhibition. In addition to the effect of TNF and 
hypoxia, OGR1 mRNA expression was elevated at low pH, suggesting positive feed-forward 
regulation of OGR1 activity in acidic conditions. 
Conclusion: OGR1 expression is induced in cells of human myleoid lineage by TNF, hypoxia 
and acidic pH. Hypoxia, known to cross-talk with the NF-κB pathway, enhances the TNF- 
mediated induction of OGR1 expression. The induction of OGR1 expression by TNF and 
hypoxia, and subsequently of its pH-sensing activity, may play a role in IBD pathogenesis. 
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Introduction 
Cells in diseased tissues, such as malignant tumors, atherosclerotic plaques, arthritic joints 
and chronically inflamed tissue, experience prolonged periods of hypoxia. A family of 
hypoxia-inducible factors (HIFs) transcription factors are predominately responsible for 
mediating cellular adaptation to low oxygen availability.1,2 HIF-1 has been implicated in a 
number of inflammatory diseases including rheumatoid arthritis, allergic asthma, psoriasis 
and inflammatory bowel disease (IBD).3 
Hypoxia and inflammation are interconnected and linked on many levels and may induce 
and influence each other in various ways.4 Inflammation may be hypoxia-driven or hypoxia 
may be induced by inflammation (inflammatory hypoxia).4 Hypoxia not only maintains or 
aggravates inflammation via stabilization of HIF, but it also influences the local tissue pH in 
the mucosa.5 Subsequently, an acidic environment is not only the result of an inflammation 
but also affects the degree and outcome of inflammation.6-8 Inflammation has been 
attributed to an increase in local proton concentration and lactate production9 and linked to 
subsequent proinflammatory cytokine production, such as tumor necrosis factor (TNF), 
interleukin-6 (IL-6), interferon-gamma (IFN-γ) and interleukin -1-beta (IL-1β).  
Hypoxia is also a consequence of cancer formation. Larger colorectal cancers with 
insufficient angiogenesis are characterized by a lack of oxygen supply. However, even in the 
case of sufficient oxygen supply, as first described by Otto Warburg in 192410, cancer cells 
may metabolize glucose to lactate by a pathway (known as Warburg effect).  Lactate induces 
the expression of HIF-1 and causes acidification of the surrounding tissue.11,12 (Hsu, 2008 
#336)REF? 
Hypoxia inflicts a broad spectrum of effects on the cellular, organ and systemic levels. In the 
intestine, hypoxic conditions affect different processes including absorption, metabolism 
and inflammation. During mucosal inflammation edema, vasculitis and vasoconstriction 
separate epithelial and other cells from blood supply and thus access to oxygen. Karhausen 
and coworkers showed that even at basal condition some extent of hypoxia is detectable in 
the superficial epithelial layers of a murine colon.13 After induction of colitis in a mouse 
model aggravated hypoxia occurred which even reached submucosal regions.13 
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HIF is an oxygen sensing transcription factor that regulates the expression of various genes 
enhancing oxygen delivery or promote survival under hypoxic conditions. As heterodimeric 
transcription factor HIF1-α undergoes oxygen-dependent hydroxylation, leading to binding 
of the von-Hippel-Lindau (VHL) tumor suppressor protein and subsequent ubiquitin-
mediated proteosomal degradation. No hydroxylation occurs under hypoxic conditions, 
followed by an accumulation of HIF-1α and binding to HIF-1β forming the active HIF-1 
complex. The active HIF-1 dimer binds to hypoxia response elements in the DNA, thereby 
leading to the expression of its target genes.14 
A family of G-protein-coupled receptors (GPCRs), which include OGR1, GPR4 and TDAG8, 
sense extracellular protons through histidine residues located on the extracellular region of 
the receptor.15,16 Signaling pathways induced by proton activation of these GPCRs include 
phospholipase C activation, inositol trisphosphate formation and subsequent Ca2+ 
release15,17,18 or cyclic adenosine monophosphate (cAMP) production.19,20  
In a previous study we reported that IBD patients expressed higher levels of OGR1 in the 
mucosa than healthy control subjects.17 We also observed that OGR1 expression is induced 
in cells of human macrophage lineage and primary human monocytes by TNF, whereby this 
effect is reversed by inhibition of the key regulator of chronic mucosal inflammation, nuclear 
transcription factor kappa B (NF-kB).  These studies indicated a role for OGR1 in the 
development of mucosal inflammation, indicating that acidic extracellular pH can have a 
signaling function and impact the physiology of intestinal epithelial cells. 17,18 
Hypoxia induces a decrease in tissue pH which is sensed by OGR1, thereby influencing 
inflammation, however information on its signaling remains limited. Therefore, we 
investigated the role of OGR1 during hypoxia associated with inflammation. We studied the 
expression and function of OGR1 in a human monocyte model, in primary intestinal 
macrophages and in IBD patients subjected to hypoxia. We show that OGR1 expression is 
enhanced by hypoxia. In a human cell model hypoxia enhanced TNF induced OGR1 
expression was reversed by NF-κB inhibition. 
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Methods and Material 
 
Chemicals  
All chemicals and cytokines were obtained from Sigma-Aldrich (St. Louis, MA, USA), unless 
otherwise stated. TNF (#654205) was purchased from Calbiochem (Merck Darmstadt, 
Germany). 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) (#100102-41), 
BAY-11-7082 (#100010266), CAY10512 (#10009536), Curcumin (#81025.1), SC-514 
(Cayman#10010267), SP600125 (Cayman #100010466) were purchased from Cayman (Ann 
Arbor, Michigan, USA).  
Human subjects and exposure to hypobaric hypoxia. 
Human colon biopsies were taken from patients with CD or UC, or from healthy volunteers 
(HV). HV (n = 10), CD patients (n = 11), and 9 UC patients (n = 9) were subjected to hypoxic 
conditions in a hypobaric chamber resembling an altitude of 4,000 m above sea level for 3 h. 
Distal colon biopsies were collected the day before entering the hypobaric chamber (T1), 
immediately after hypoxia (T2), and one week after the first biopsy (T3) at the Division of 
Gastroenterology and Hepatology of the University Hospital Zurich. Total RNA was isolated, 
reverse transcribed, and hypoxia-induced changes in gene expression were analyzed using 
qRT-PCR. This study was approved by the Ethics Committee of the Canton of Zurich (KEK-ZH 
Nr. 2013-0284) and all participants signed an informed consent. 
Isolation of human intestinal macrophages 
Healthy intestinal resections from carcinoma patients were obtained by surgery. Resections 
were washed with HANKS solution and epithelial cell isolation was performed adding DTT 
(10mM) for 30 minutes and EDTA (1mM) for 10 minutes at 37ºC with agitation. Tissue 
digestion was do a mix of DNAse (0.3mg/ml, Roche), hyaluronidase (2mg/ml, Sigma-Aldrich) 
and Colagenase (1mg/ml, Sigma-Aldrich), 60 minutes at 37°C.  Solution was filtered with a 70 
mm filter and cells were centrifuged with Ficoll at 2000 rpm for 20 minutes. Cells from the 
interphase were labelled with CD33 MicroBeads (MiltenyiBiotec) and CD33 positive cells 
were collected after the magnetic separation using AutoMacsPro (MiltenyiBiotec). The purity 
of the cells was checked with flow cytometry and the purity obtained was higher than 95%. 
Intestinal macrophages were seeded in 12-well plates to perform the hypoxia experiments. 
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Cell Culture and Hypoxia Treatment 
The monocytic cell line MonoMac 6 (MM6, obtained from DMSZ) was cultured in RPMI 
(Sigma-Aldrich, Munich, Germany) supplemented with 10% FCS, 1% nonessential amino 
acids, and 1% oxalacetic acid–pyruvate–insulin medium supplement (Sigma-Aldrich), and 
maintained according to the American Type Culture Collection (ATCC). Preliminary 
expression studies were carried out in serum-free RPMI medium (1-41F24-I, Amimed), 
supplemented with 2 mM Glutamax (35050-038, Gibco), 20 mM HEPES, at unadjusted, 
normal cell culture medium pH (≈ pH 7.2 – 7.3). 
THP-1 cells were maintained in RPMI medium (Invitrogen) supplemented with 10 % fetal calf 
serum (FCS, VWR; Dietlikon, Switzerland). HT-29 were obtained from the German Collection 
of Cells and Microorganisms (DSMZ) and cultured under conditions as recommended by the 
DSMZ.  
Cells were exposed to hypoxia (0.2% or 2% O2, 5% CO2) in a hypoxia workstation incubator 
(In vivo 400, Ruskin Technology, Leeds, UK); the addition of cytokines or inhibitors was 
performed in the hypoxic chamber. Cells which were maintained in normoxia (21% O2) for 
the same time- period of treatment were used as controls. 
pH experiments  
The pH shift experiments were carried out in serum-free RPMI medium with 2 mM Glutamax 
and 20 mM HEPES. The pH of all solutions was adjusted using a calibrated pH meter 
(Metrohm, Herisau, Switzerland), the appropriate quantities of NaOH or HCl were added and 
the media were allowed to equilibrate in the 5% CO2 incubator for at least 36h. All data 
presented in this paper are referenced to pH measured at room temperature. To obtain pH 
at 37°C, 0.15 pH units should be subtracted for HEPES buffers in the range of pH 6.8–7.8 
according to our calibration experiments.  
Animal models 
All animal experiments were performed according to Swiss animal welfare laws and were 
approved by the Veterinary Office of the Canton Zürich, Switzerland. Transketolase-like 1 
(TKTL1) deficient mice were generated as described.21  Animal Genotyping was confirmed by 
PCR of tail or colon genomic DNA. DNA extraction was performed according to standard 
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NaOH methods. The PCR reactions used for TKTL1 genotyping were performed with the 
following oligonucleotides: 5=-ATGGCTCATGTTTCTGCTGC-3= (intron 3) and 5=-
CTTGCCTTGCTTCTGTAAGG-3= (intron 7) as previously described.21  
RNA extraction and real-time quantitative PCR.  
Colon and tumor samples. Tissue used for RNA analysis were transferred immediately into 
RNAlater solution (Qiagen, Valencia, CA) and stored at −80°C. Tissue biopsies were disrupted 
in RLT buffer (Qiagen) using a 26G needle. Total RNA was isolated using the RNeasy Mini Kit 
in the automated QIAcube following the manufacturer’s recommendations (Qiagen, 
Hombrechtikon, Switzerland). For removal of residual DNA, DNase treatment, 15 min at 
room temperature, was integrated into the QIAcube program according to the 
manufacturer’s instructions. For cDNA synthesis, the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Foster City, CA), was used, following the 
manufacturer’s instructions. Determination of mRNA expression was performed by real-time 
quantitative PCR (qRT-PCR) on a 7900HT real-time PCR system (Applied Biosystems, Foster 
City, USA), under the following cycling conditions: 20 sec at 95 °C, then 45 cycles of 95 °C for 
3 sec and 60 °C for 30 sec with the TaqMan Fast Universal Mastermix. Samples were 
analyzed as triplicates. Relative mRNA expression was determined the by the comparative 
∆∆Ct method22, which calculates the quantity of the target sequences relative to the 
endogenous control and a reference sample. TAQMAN Gene Expression Assays, (all from 
Applied Biosystems, Foster City, USA), used in this study are listed in Supplementary Table 1.  
Data Analysis and Statistics  
Data are presented as mean ± SEM for a series of n experiments. Statistical analysis of 
mouse data was performed using a paired t test, and probabilities (p, two tailed) of p < 0.05 
were considered statistically significant. For statistical analysis of groups, one-way analysis of 
variance (ANOVA) was performed followed by the Tukey Post Hoc test. Differences were 
considered significant at a p value of < 0.05 (*), highly significant at a p value of < 0.01 (**) 
and very highly significant at a p value of < 0.001 (***). 
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Results  
OGR1 expression in murine tumor tissue is increased compared to normal tissue 
We examined OGR1 mRNA expression levels in a murine colorectal cancer model. OGR1 
expression was significantly higher; (2.2-fold, p < 0.05), in tumor tissue compared to normal 
colon tissue. Groups: normal, n = 7 wild type (WT), Tumor group: n = 4 WT + 3 transketolase-
like 1 (Tktl1 -/-) mice. (Figure 1).  
IBD patients under hypoxia exhibit an enhanced OGR1 mRNA expression when compared 
to healthy controls 
In order to study the effects of hypoxia on the expression of the pH-sensing receptors OGR1 
and TDAG8 in the colon of human subjects, HV (n = 10), CD patients (n = 11), and UC patients 
(n = 9) were subjected to hypoxic conditions in a hypobaric chamber resembling an altitude 
of 4,000 m above sea level for 3 h. Although not significant, the mRNA expression of OGR1 
shows a clear trend to an increase one week after hypoxia in CD and UC patients when 
compared to HV (Figure 2A). Conversely, mRNA levels of TDAG8 in CD, but not HV were 
significantly reduced at T2 and T3 after hypoxia  when compared to T1, and a similar trend 
was showed in UC patients (Figure 2B). 
Hypoxia induces OGR1 expression in cultured human IECs and monocytes 
Following our results pointing to a positive regulation of OGR1 expression in IBD patients 
under hypoxia, we sought to confirm this effect in innate immune cells playing a major role 
in gut homeostasis. For this purpose, we subjected cultured human IEC line HT-29 and 
monocytic THP-1 cells to hypoxia (0.2% O2) for 24 h. Hypoxia significantly induced OGR-1 
mRNA expression in HT-29 (Figure XA) and THP-1 (Figure XB) cells. 
We next investigated the effects of hypoxia on the expression of the pH-sensing receptors in 
the human cell line MM6, a cell model commonly used to demonstrate the action of 
peripheral blood monocytes.23,24 Expression levels of pH-sensing receptors OGR1, GPR4 and 
TDAG8, in MM6 cells exposed to quite severe hypoxia (0.2% O2) or modest hypoxia (2% O2) 
for 18 h was examined by qRT-PCR. OGR1 mRNA expression increased (2 and 1.7 –fold, P < 
0.05, p < 0.01) at 0.2% and 2% O2, respectively (Figure 2A). Conversely TDAG8 expression 
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decreased (0.7 and 0.6 –fold, p < 0.001, p < 0.001) at 0.2% and 2% O2, respectively (Figure 
2B). Hypoxia did not significantly affect GPR4 gene expression in MM6 cells (data not 
shown), however as it is only very weakly expressed with Ct values ≈ 38, the expression 
values are not reliable. 
To determine the induction time required to induce OGR1 expression in MM6 cells under 
hypoxia (0.2% O2), we selected five different time points (0 – 24 h); no change was detected 
at 8 h, but at time points 16 and 24 h expression increased 1.6 and 2.3 -fold respectively (p < 
0.001, p < 0.001) (Figure 2C). 
Influence of pH on OGR1 expression in MM6 cells subjected to hypoxia 
To assess the influence of pH in MM6 cells under hypoxia, we compared expression levels of 
cells at pH 7.7, 7.3 and 6.8 under normoxic and hypoxic conditions. OGR1 expression levels 
of MM6 cells exposed to 0.2% O2 for 20 h, increased 2.1, 2.9 and 6.6 -fold (p< 0.05, 0.001, 
0.001) respectively, relative to the corresponding pH at normoxia (Figure 3A). OGR1 
expression of cells at acidic pH increases more than 2 -fold compared to pH 7.7 or pH 7.3. 
Conversely MM6 cells exposed to hypoxia at pH 7.7, 7.3 and 6.8 resulted in decreased 
TDAG8 expression levels (0.33, 0.38, 0.74 -fold, P<0.01, 0.01, ns) respectively.  
 
We also measured expression levels of known HIF target genes; vascular endothelial growth 
factor A (VEGFA)25,26, proto-oncogene c-Fos (c-Fos)27 and proinflammatory cytokines, IL-626, 
IL-826, as positive controls. VEGFA was markedly induced, 14.8, 12.8, 22 -fold (P<0.001, P< 
0.001, P< 0.001) at pH 7.7, 7.3 and 6.8 respectively, under hypoxic conditions. Exposure of 
MM6 cells to acidic pH resulted in ≈ 40% increased VEGFA expression levels in comparison to 
levels measured at pH 7.7 and 7.3. Expression levels of c-Fos increased 1.3, 2.3, 2.6 -fold, (ns, 
P<0.001, P< 0.001), similarly IL-6 increased 3.8, 6.8, 7.1 -fold, (ns, P<0.01, P<0.01) and IL-8 
increased 2.9, 2.7, 3.4 -fold, (P< 0.001, P< 0.001, P< 0.001) at pH 7.7, 7.3 and 6.8 under 
hypoxic conditions, respectively. Induction of IL-8 expression by hypoxia was not influenced 
by pH. 
In addition, expression levels of TNF were also analyzed; with no significant changes at pH 
7.7 or 7.3 (1.3, 0.94 -fold increase) under hypoxic conditions, however at acidic pH, TNF 
decreased 0.6 -fold, P<0.01. 
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An increase in the exposure time to hypoxia (0.2% O2) until 24 h further enhanced the 
expression of OGR1 at acidic pH. Thus, hypoxia induced 10.9 –fold increase (P< 0.001) in the 
expression of OGR1 at pH 6.8 compared to normoxia, and -----, ---- fold (p>0.0--, p>0.0--) 
compared to hypoxia at pH 7.7 and 7.3, respectively (N=5, Figure 4B). 
Although no significant, a tendency towards a reduced expression of TDAG8 was observed 
under hypoxic conditions at all pHs tested, which is in agreement with the results obtained 
at 20 h hypoxia. 
 
Effect of hypoxia and pH in the expression of pH receptors and proinflammatory cytokines 
in human intestinal macrophages 
To confirm the effect of hypoxia and acidic pH on the expression of pH receptors and 
proinflammatory cytokines in primary macrophages, we isolated intestinal macrophages 
from healthy intestinal tissue from colon carcinoma patients.  Independently of pH, OGR1 
expression was significantly increased under hypoxia conditions whereas TDAG8 expression 
was significantly reduced although acidic conditions induced an increased in the expression 
of OGR1 (Fig X. A – B).  We have also measured the expression of pro-inflammatory 
cytokines and our results show that hypoxia significantly increased the expression of IL-1β, 
IL-6, IL-8 and TNF (Fig. X. C – E). However, this increase is significantly higher in acidic 
conditions in in all cases (Fig. X. C – E). In this condition, we have seen that OGR1 is increased 
whereas TDAG8 is reduced suggesting that the increased expression observed in acidic 
conditions may be regulated by the differential expression of the pH receptors under 
hypoxia conditions. Finally, we have also measured the expression of Ephx2 and Tpsb2 which 
were significantly more expressed in pH 6.8 under hypoxic conditions. No differences were 
detected in the expression of Sparc. 
 
Hypoxia enhanced TNF-induced OGR1 expression is reversed by NF-κB inhibitors 
In a previous study we observed that treatment of MM6 cells with TNF led to significant up-
regulation of OGR1 with evidence indicating that NF-κB plays a key role in this process.17 This 
prompted us to examine the additional influence of hypoxia on TNF treated MM6 cells in the 
presence or absence of NF-κB inhibitors. Our previous time course studies at normoxic 
conditions showed that maximum OGR1 induction by TNF treatment occurred between 6 to 
8 h.17 Therefore in the current study, in order to examine the influence of hypoxia on TNF -
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induced OGR1 expression we chose a longer time point (18  ̶ 24 h), and included the shorter 
time point (6 h) for an additional reference. We observed that OGR1 expression levels of 
MM6 cells treated with TNF (25 ng/ml), exposed to 0.2% O2 for 6 h and 24 h, increased 1.5 
and 17.8 -fold (p< 0.0001, 0.001) respectively, compared to the corresponding treatment at 
normoxic conditions (Figure XX A.1 - 2). Under hypoxic conditions, (0.2% oxygen), a synergy 
with TNF in the induction of OGR1 expression was observed; however this increase in 
expression may also be due to acidic pH, after 24 h due to cell metabolism and growth. 
Cells treated with TNF in the presence of the NF-κB inhibitor SC-514 (25 μM),known to 
inhibit the kinase activity of IκB kinase28 for 6 h, showed decreased OGR1 expression at 
normoxia (3.9 fold or 68% decrease, p<0.001) and hypoxia (5.74 fold or 80% decrease, 
p<0.001), relative to the corresponding controls. The degree of inhibition between normoxic 
and hypoxic conditions showed no significant difference. However, on longer exposure to 
hypoxia (24 h) we observed a 9.5 fold or 42% decrease (p<0.001) in OGR1 expression. The 
effectiveness of inhibition showed a significant difference (p<0.001) compared to that at 
normoxic conditions (3.26 fold or 78% decrease, p<0.001) (Figure 4 A.2). At hypoxic 
conditions the inhibitory effect of SC-514 was less effective and OGR1 expression decreased 
only 42% (10 -fold decrease P<0.001) compared to TNF treatment without SC-514 (Figure 4 
A.2). Control/non-treated cells exposed to hypoxia for 6 and 24 h increased 1.13 and 9.8 -
fold (ns, P<0.001) respectively (Figure 4 A.1 - 2). 
 
In addition to SC-514, we also tested AICAR (5-Aminoimidazole-4-carboxyamide) 
ribonucleoside which blocks the expression of pro-inflammatory cytokines (TNF, IL-1β and IL-
6), iNOS, COX-2, and MnSOD (Mangano-Superoxide Dismutase) genes in glial cells and 
macrophages by inhibiting NFκB and C/EBP pathways.29 The ability of AICAR to inhibit NF-κB 
signaling is due to a reduction in NF-κB DNA-binding activity but may also be partly due to 
activation of AMP (5' adenosine MnSOD (Mangano-Superoxide Dismutase) genes in glial cells 
and macrophages by inhibiting NFκB and C/EBP pathways monophosphate) - activated 
protein kinases.30 Non-treated or controls cells exposed to hypoxic conditions induced a 1.83 
fold increase (P<0.05) in OGR1 expression compared to cells at normoxic conditions. OGR1 
expression of cells under hypoxia for 18 h, treated with TNF (50 ng/ml), showed a 1.3 fold 
increase (P<0.001) compared to similarly treated cells at normoxia; no enhancement or 
synergism occurred. TNF treated cells in the presence of 0.05 mM AICAR showed a 41% 
decrease (1.2 fold decrease P<0.001) compared to cells in the absence of Aicar. The same 
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treatment under hypoxic conditions resulted in a comparable decrease (35% or 1.5 fold 
decrease, P<0.001). In the presence of SC-514 together with TNF, OGR1 expression 
decreased 59% decrease (1.7 fold decrease, P<0.001) compared to the relevant control 
without SC-514. However, under hypoxic conditions the degree of inhibition decreased 
significantly (40% decrease equivalent to a 1.6 fold decrease, P<0.001). 
 
Discussion 
Tissue hypoxia stimulates multiple responses, including glycolysis and the extrusion of lactic 
acid and protons, thereby decreasing extracellular pH.31-33 One of the mechanisms 
responsible for the high rate of glycolysis is HIF-1a, the main hypoxic switch,34 which 
upregulates the expression of the glucose transporters GLUT1 and GLUT3,35 and the 
activation of the glycolytic enzymes lactate dehydrogenase (LDH),36 pyruvate dehydrogenase 
kinase-1 (PDK-1)37 and PDK-3.38 The tumor environment is characterized by hypoxia and low 
pH, particularly at the core. In the present manuscript we demonstrate that the mRNA 
expression of the pH sensor OGR1 is increased 2-fold in murine tumor tissue. Although small, 
the induction of OGR1 in tumor tissue is in good agreement with the known interaction 
between tumor hypoxia and acidosis39 and several putative DNA binding sites for HIF-1 
within the proximal regions of the OGR1 promoter variants have been identified.17 In 
accordance with the severe hypoxic environment and increased acidosis observed in the 
intestinal mucosa in IBD,40,41 we also show that OGR1 expression is upregulated ≈2-fold in CD 
and UC patients, however, one week following hypoxia we observe a 4- and 6-fold increase 
in OGR1 expression in CD and UC patients respectively when compared to HV. This result 
identifies OGR1 as an important regulatory factor contributing to the onset of mucosal 
inflammation and a marker for IBD. In agreement with this, previous studies have 
demonstrated a critical role for ORG1 in pro-inflammatory cytokine expression and tissue 
remodeling following extracellular acidification.42,43 We also show that OGR1 expression 
increases in human monocytic cell lines, intestinal epithelial cells and macrophages 
subjected to hypoxia, thereby suggesting a pivotal role of OGR1 in hypoxia-induced 
responses.  
We show that hypoxia enhances TNF-mediated induction of OGR1 expression. We reported 
in a previous study that TNF treatment induced OGR1 expression in MM6 cells, primary 
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human and murine monocytes; and that this process was reversed by the NF-κB inhibitors 
MG132, AICAR, BAY-11-7082, CAY10512, and SC-514 in MM6 cells.17 In the current study we 
report that hypoxia enhances TNF-mediated induction of OGR1 expression, and that this 
effect was reversed by NF-κB inhibition under hypoxic conditions. The two central 
transcription factors, HIF and NF-κB, involved in the regulation of decreased oxygen 
availability are known to demonstrate an intimate interdependence at several mechanistic 
levels.44 Two alternative predicted promoter variants ≈ 9 kpb apart, exist for the OGR1 gene 
in chromosome 14. In a previous study we showed that an in silico analysis using 
MatInspector software and visual inspection reveals several putative DNA-binding sites for 
NF-κB and HIF-1α within the proximal regions of the OGR1 promoter variants.17  
 
CONCLUSION: We previously reported that OGR1 expression is induced in cells of human 
macrophage lineage and primary human monocytes by TNF and that NF-κB inhibition 
reverses the induction of OGR1 mRNA expression by TNF. Here we report that hypoxia, 
known to cross-talk with the NF-κB pathway, enhances the TNF-mediated induction of OGR1 
expression and is reversed by NF-κB inhibition. The stimulation of OGR1 expression by TNF 
and hypoxia, and subsequently pH-sensing activity, may play a role in IBD pathogenesis.  
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Figure 1. OGR1 expression increases in murine tumors  
OGR1 expression levels were significantly higher (P=0.0220) in murine colonic tumors 
compared to the normal colonic mucosa. Groups: normal, n = 7 wild type (WT), Tumor 
group: n = 4 WT + 3 transketolase-like 1 (Tktl1 -/-) mice.  
 
Figure 2. Hypoxia induces a tendency to increase OGR1 mRNA expression and significantly 
decreases TDAG8 expression in the colon of IBD patients. 
A − B. HV (n = 10), CD patients (n = 11) and 9 UC patients (n = 9) were subjected to hypoxic 
conditions in an hypobaric chamber resembling an altitude of 4,000 m for 3 h. Distal colon 
biopsies were taken the day before entering the hypobaric chamber (T1), immediately after 
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hypoxia (T2), and one week after the first biopsy (T3). Total RNA was isolated, reverse 
transcribed, and hypoxia-induced changes in gene expression were analyzed using qRT-PCR. 
Although not significant, OGR1 mRNA expression following hypoxia shows an increasing 
tendency at T3 in CD and UC patients when compared to HV (A). Conversely, mRNA levels of 
TDAC8 were significantly reduced at T1 and T3 in CD patients subjected to hypoxia (B). 
Expression changes were calculated relative to samples taken at T1 after normalizing with 
human β-actin endogenous control. Results represent means ± SEM. Statistical analysis was 
performed using One Way-ANOVA followed by Tukey’s test (* p < 0.05, *** p < 0.001). 
 
Figure 3. Hypoxia induces the expression of OGR1 in cultured human IECs and monocytes. 
A − B. HT-29 and THP-1 cells were incubated under hypoxic conditions (0.2% O2) for 24 h. 
Total RNA was isolated, reverse transcribed, and hypoxia-induced changes in gene 
expression were analyzed using qRT-PCR. Hypoxia significantly induced the expression of 
OGR1. Results represent means ± SEM of two independent experiments. Statistical analysis 
was performed using Student t test (n = 5; **p < 0.01). 
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Figure 4. Expression of pH sensing receptors OGR1 and TDAG8 changes under hypoxic 
conditions. 
MonoMac 6 cells were exposed to quite severe hypoxia (0.2% O2) or modest hypoxia (2% O2) 
for 18 h. A. OGR1 expression increases (2, 1.7 -fold at 0.2%, 2% O2 respectively) B. 
Conversely, TDAG8 expression decreases (0.7, 0.6 -fold at 0.2% and 2% O2 respectively). C. 
OGR1 expression remained unchanging from 0 to 8 h, but increases 1.6 and 2.3 -fold after 16 
and 24 h respectively. Asterisks denote significant differences from the respective control 
(*P < 0.05, **P < 0.01, ***P <0 .001). 
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Figure 5. Expression of pH sensing receptors OGR1 and TDAG8 under hypoxic conditions is 
further influenced by pH in Mono Mac6 (MM6) cells 
MonoMac 6 cells were exposed to hypoxia (0.2% O2) for 20 h at various pH levels; pH 7.7, pH 
7.3, pH 6.8. Under hypoxic conditions: A. OGR1 expression increased at acidic pH compared 
to expression at pH 7.7 or pH 7.3. B. TDAG8 expression decreased 50% at pH 7.7 and pH 7.3. 
At pH 6.3 a decrease of 25% (ns) was observed. In addition, expression levels of genes 
known to be induced under hypoxic conditions were measured: C. Vascular endothelial 
growth factor A (VEGFA) was induced at all pH conditions tested, but OGR1 expression was 
35-40%  higher at low pH compared to pH 7.7 and 7.3. D. Proto-oncogene c-Fos (c-Fos) was 
induced ≈ 2 -fold at pH 7.3 and 6.8. E. Interleukin (IL) IL-6significantly increased at pH 7.3 and 
6.8, but not at pH 7.7. F. IL-8. Induction of IL-8, ≈ 2 to 3 -fold was not influenced by pH.  
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Figure 6. Expression of pH sensing receptors OGR1 and TDAG8 under hypoxic conditions is 
further influenced by pH in human intestinal macrophages.  
Intestinal macrophages from healthy mucosa of carcinoma patients were isolated and 
cultured with different PHs (7.7, 7.3 and 6.8) under normoxia or hypoxia (0.2% O2) during 24 
hours. RNA isolation was performed and the expression of several genes was measured by 
qPCR. A. OGR1 expression was significantly higher in hypoxia with acidic pH. B. TDAG8 
expression was reduced in hypoxia in all pHs tested. C. The expression of proinflammatory 
cytokines (IL-1β, TNF-α, IL-6 and IL-8) was significantly higher in hypoxia with 6.8 pH. D. No 
differences in the expression of Sparc. E. The expression of HIF1-α was only significantly 
increased with pH 6.8 under normoxia. F. Tpsb2 and Ephx2 expression was significantly 
increased in hypoxia with pH 6.8. In all cases results are expressed as fold induction using β-
actin as housekeeping gene. Results are expressed as Mean±SEM. *P<0.05, **P<0.01 and 
**P<0.001 using ONE-way ANOVA after Tukey`s test.  
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Figure 7. Hypoxia enhances TNF induction of OGR1 expression and is reversed by NF-κB 
inhibitors  
Effect of hypoxia on TNF treatment: A.1 After 6 h OGR1 expression was enhanced. A.2 
Exposure to hypoxia, (24 h, 0.2% O2) a synergy with TNF in the induction of OGR1 expression 
was observed. The inhibitory effect of NF-κB inhibitor SC-514 (25 μM), was less effective at 
hypoxic conditions, 24 h (78% and 42 % inhibition at normoxia or hypoxia respectively). 
OGR1 expression at normoxia (3.9 fold or 68% decrease) and hypoxia (5.74 fold or 80% 
decrease.  
de Vallière et al.   Hypoxia and OGR1  
 
References 
1. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Current opinion in cell 
biology. 2001;13(2):167-171. 
2. Semenza GL. Oxygen sensing, homeostasis, and disease. The New England journal of 
medicine. 2011;365(6):537-547. 
3. Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease 
pathophysiology. Annual review of pathology. 2014;9:47-71. 
4. Eltzschig HK, Bratton DL, Colgan SP. Targeting hypoxia signalling for the treatment of 
ischaemic and inflammatory diseases. Nature reviews. Drug discovery. 
2014;13(11):852-869. 
5. Palazon A, Goldrath AW, Nizet V, Johnson RS. HIF Transcription Factors, 
Inflammation, and Immunity. Immunity. 2014;41(4):518-528. 
6. Hanly EJ, Aurora AA, Shih SP, et al. Peritoneal acidosis mediates immunoprotection in 
laparoscopic surgery. Surgery. 2007;142(3):357-364. 
7. Mogi C, Tobo M, Tomura H, et al. Involvement of Proton-Sensing TDAG8 in 
Extracellular Acidification-Induced Inhibition of Proinflammatory Cytokine Production 
in Peritoneal Macrophages. J Immunol. 2009;182(5):3243-3251. 
8. Brokelman WJ, Lensvelt M, Borel Rinkes IH, Klinkenbijl JH, Reijnen MM. Peritoneal 
changes due to laparoscopic surgery. Surgical endoscopy. 2011;25(1):1-9. 
9. Lardner A. The effects of extracellular pH on immune function. Journal of leukocyte 
biology. 2001;69(4):522-530. 
10. Warburg O, Posener K, Negelein E. Ueber den Stoffwechsel der Tumoren. 
Biochemische Zeitschrift. 1924;152:319-344. 
11. Dellian M, Helmlinger G, Yuan F, Jain RK. Fluorescence ratio imaging of interstitial pH 
in solid tumours: effect of glucose on spatial and temporal gradients. Br J Cancer. 
1996;74(8):1206-1215. 
12. Martin GR, Jain RK. Noninvasive measurement of interstitial pH profiles in normal 
and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer research. 
1994;54(21):5670-5674. 
13. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH. Epithelial 
hypoxia-inducible factor-1 is protective in murine experimental colitis. The Journal of 
clinical investigation. 2004;114(8):1098-1106. 
14. Stubbs M, Griffiths JR. The altered metabolism of tumors: HIF-1 and its role in the 
Warburg effect. Advances in enzyme regulation. 2010;50(1):44-55. 
15. Ludwig MG, Vanek M, Guerini D, et al. Proton-sensing G-protein-coupled receptors. 
Nature. 2003;425(6953):93-98. 
16. Seuwen K, Ludwig MG, Wolf RM. Receptors for protons or lipid messengers or both? 
J Recept Signal Transduct Res. 2006;26(5-6):599-610. 
17. de Valliere C, Wang Y, Eloranta JJ, et al. G Protein-coupled pH-sensing Receptor OGR1 
Is a Regulator of Intestinal Inflammation. Inflammatory bowel diseases. 
2015;21(6):1269-1281. 
18. de Valliere C, Vidal S, Clay I, et al. The pH-Sensing Receptor OGR1 Improves Barrier 
Function of Epithelial Cells and Inhibits Migration in an Acidic Environment. American 
journal of physiology. Gastrointestinal and liver physiology. 2015:ajpgi 00408 02014. 
de Vallière et al.   Hypoxia and OGR1  
 
19. Mogi C, Tomura H, Tobo M, et al. Sphingosylphosphorylcholine antagonizes proton-
sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol 
phosphate production and cAMP accumulation. J Pharmacol Sci. 2005;99(2):160-167. 
20. Tomura H, Wang JQ, Komachi M, et al. Prostaglandin I(2) production and cAMP 
accumulation in response to acidic extracellular pH through OGR1 in human aortic 
smooth muscle cells. The Journal of biological chemistry. 2005;280(41):34458-34464. 
21. Bentz S, Pesch T, Wolfram L, et al. Lack of transketolase-like (TKTL) 1 aggravates 
murine experimental colitis. American journal of physiology. Gastrointestinal and 
liver physiology. 2011;300(4):G598-607. 
22. Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time 
Quantitative PCR and the 2−ΔΔCT Method. Methods. 2001;25(4):402-408. 
23. Wright EL, Quenelle DC, Suling WJ, Barrow WW. Use of Mono Mac 6 human 
monocytic cell line and J774 murine macrophage cell line in parallel 
antimycobacterial drug studies. Antimicrobial agents and chemotherapy. 
1996;40(9):2206-2208. 
24. Ziegler-Heitbrock HW, Thiel E, Futterer A, Herzog V, Wirtz A, Riethmuller G. 
Establishment of a human cell line (Mono Mac 6) with characteristics of mature 
monocytes. International journal of cancer. Journal international du cancer. 
1988;41(3):456-461. 
25. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor 
gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16(9):4604-4613. 
26. Fang HY, Hughes R, Murdoch C, et al. Hypoxia-inducible factors 1 and 2 are important 
transcriptional effectors in primary macrophages experiencing hypoxia. Blood. 
2009;114(4):844-859. 
27. Muller JM, Krauss B, Kaltschmidt C, Baeuerle PA, Rupec RA. Hypoxia induces c-fos 
transcription via a mitogen-activated protein kinase-dependent pathway. The Journal 
of biological chemistry. 1997;272(37):23435-23439. 
28. Kishore N, Sommers C, Mathialagan S, et al. A selective IKK-2 inhibitor blocks NF-
kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial 
fibroblasts. The Journal of biological chemistry. 2003;278(35):32861-32871. 
29. Ayasolla KR, Singh AK, Singh I. 5-aminoimidazole-4-carboxamide-1-beta-4-
ribofuranoside (AICAR) attenuates the expression of LPS- and Abeta peptide-induced 
inflammatory mediators in astroglia. Journal of neuroinflammation. 2005;2:21. 
30. Katerelos M, Mudge SJ, Stapleton D, et al. 5-aminoimidazole-4-carboxamide 
ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-
kappaB. Immunology and cell biology. 2010;88(7):754-760. 
31. Calorini L, Peppicelli S, Bianchini F. Extracellular acidity as favouring factor of tumor 
progression and metastatic dissemination. Exp Oncol. 2012;34(2):79-84. 
32. Hashim AI, Zhang X, Wojtkowiak JW, Martinez GV, Gillies RJ. Imaging pH and 
metastasis. NMR Biomed. 2011;24(6):582-591. 
33. Cairns R, Papandreou I, Denko N. Overcoming physiologic barriers to cancer 
treatment by molecularly targeting the tumor microenvironment. Molecular cancer 
research : MCR. 2006;4(2):61-70. 
34. Weljie AM, Jirik FR. Hypoxia-induced metabolic shifts in cancer cells: moving beyond 
the Warburg effect. The international journal of biochemistry & cell biology. 
2011;43(7):981-989. 
35. Hong SS, Lee H, Kim KW. HIF-1alpha: a valid therapeutic target for tumor therapy. 
Cancer Res Treat. 2004;36(6):343-353. 
de Vallière et al.   Hypoxia and OGR1  
 
36. Semenza GL. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. 
Semin Cancer Biol. 2009;19(1):12-16. 
37. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to 
hypoxia by actively downregulating mitochondrial oxygen consumption. Cell 
metabolism. 2006;3(3):187-197. 
38. Lu CW, Lin SC, Chen KF, Lai YY, Tsai SJ. Induction of pyruvate dehydrogenase kinase-3 
by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. The 
Journal of biological chemistry. 2008;283(42):28106-28114. 
39. Mekhail K, Gunaratnam L, Bonicalzi ME, Lee S. HIF activation by pH-dependent 
nucleolar sequestration of VHL. Nat Cell Biol. 2004;6(7):642-647. 
40. Giatromanolaki A, Sivridis E, Maltezos E, et al. Hypoxia inducible factor 1alpha and 
2alpha overexpression in inflammatory bowel disease. Journal of clinical pathology. 
2003;56(3):209-213. 
41. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nature reviews. 
Molecular cell biology. 2004;5(5):343-354. 
42. Matsuzaki S, Ishizuka T, Yamada H, et al. Extracellular acidification induces connective 
tissue growth factor production through proton-sensing receptor OGR1 in human 
airway smooth muscle cells. Biochemical and biophysical research communications. 
2011;413(4):499-503. 
43. Ichimonji I, Tomura H, Mogi C, et al. Extracellular acidification stimulates IL-6 
production and Ca(2+) mobilization through proton-sensing OGR1 receptors in 
human airway smooth muscle cells. American journal of physiology. Lung cellular and 
molecular physiology. 2010;299(4):L567-577. 
44. Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-
kappaB in hypoxic inflammation. The Journal of physiology. 2008;586(Pt 17):4055-
4059. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
ARTICLE 8: 
 
 
“Anti-inflammatory 
function of High-Density 
Lipoproteins via autophagy 
of IκB kinase” 
 
Ragam Gerster, Jyrki J. Eloranta, Martin Hausmann, 
Pedro A. Ruiz, Jesús Cosín-Roger, Anne Terhalle, 
Urs Ziegler, Gerd A. Kullak-Ublick, Arnold von 
Eckardstein and Gerhard Rogler 
 
 
 
 
Cellular and Molecular Gastroenterology and 
Hepatology. doi.org/10.1016/j.jcmgh.2014.12.006 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORIGINAL RESEARCH
Anti-inﬂammatory Function of High-Density Lipoproteins via
Autophagy of IkB Kinase
Ragam Gerster,1,2,3 Jyrki J. Eloranta,2 Martin Hausmann,1 Pedro A. Ruiz,1
Jesus Cosin-Roger,1,4 Anne Terhalle,1 Urs Ziegler,5 Gerd A. Kullak-Ublick,2,3
Arnold von Eckardstein,3,6 and Gerhard Rogler1,3
1Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland; 2Department of Clinical
Pharmacology and Toxicology, University Hospital Zurich, Schlieren, Switzerland; 3Zurich Center of Integrative Human
Physiology, University of Zurich, Zurich, Switzerland; 4Departamento de Farmacología and CIBERehd, Facultad de Medicina,
Universidad de Valencia, Valencia, Spain; 5Centre for Microscopy and Image Analysis, University Hospital Zurich, Zurich,
Switzerland; 6Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland
SUMMARY
High-density lipoprotein and its major protein constituent
apolipoprotein A-I suppress intestinal inﬂammation in vitro
and in vivo via activation of the autophagic pathway.
BACKGROUND & AIMS: Plasma levels of high-density lipo-
protein (HDL) cholesterol are frequently found decreased in
patients with inﬂammatory bowel disease (IBD). Therefore, and
because HDL exerts anti-inﬂammatory activities, we investi-
gated whether HDL and its major protein component apolipo-
protein A-I (apoA-I) modulate mucosal inﬂammatory responses
in vitro and in vivo.
METHODS: The human intestinal epithelial cell line T84 was
used as the in vitro model for measuring the effects of HDL on
the expression and secretion of tumor necrosis factor (TNF),
interleukin-8 (IL-8), and intracellular adhesion molecule
(ICAM). Nuclear factor-kB (NF-kB)-responsive promoter activ-
ity was studied by dual luciferase reporter assays. Mucosal
damage from colitis induced by dextran sodium sulphate (DSS)
and 2,4,6-trinitrobenzenesulfonic acid (TNBS) was scored by
colonoscopy and histology in apoA-I transgenic (Tg) and apoA-I
knockout (KO) and wild-type (WT) mice. Myeloperoxidase
(MPO) activity and TNF and ICAM expression were determined
in intestinal tissue samples. Autophagy was studied by Western
blot analysis, immunoﬂuorescence, and electron microscopy.
RESULTS: HDL and apoA-I down-regulated TNF-induced mRNA
expression of TNF, IL-8, and ICAM, as well as TNF-induced NF-
kB-responsive promoter activity. DSS/TNBS-treated apoA-I KO
mice displayed increased mucosal damage upon both colonos-
copy and histology, increased intestinal MPO activity and
mRNA expression of TNF and ICAM as compared with WT and
apoA-I Tg mice. In contrast, apoA-I Tg mice showed less severe
symptoms monitored by colonoscopy and MPO activity in both
the DSS and TNBS colitis models. In addition, HDL induced
autophagy, leading to recruitment of phosphorylated IkB kinase
to the autophagosome compartment, thereby preventing NF-kB
activation and induction of cytokine expression.
CONCLUSIONS: Taken together, the in vitro and in vivo ﬁnd-
ings suggest that HDL and apoA-I suppress intestinal inﬂam-
mation via autophagy and are potential therapeutic targets for
the treatment of IBD. (Cell Mol Gastroenterol Hepatol 2015;
1:171–187; http://dx.doi.org/10.1016/j.jcmgh.2014.12.006)
Keywords: Apolipoprotein A-I; Autophagy; Inﬂammatory Bowel
Disease; NF-kB.
H igh-density lipoproteins (HDL) are particlescomposed of proteins and lipids synthesized by the
liver and the intestine. In addition to mediating reverse
transport of cholesterol from macrophages to the liver,1–4
HDL performs many anti-inﬂammatory activities.5–7
Whereas the reverse cholesterol transport-function of HDL
has become the classic explanation for the inverse associa-
tion between HDL cholesterol levels and cardiovascular risk,
both the mechanisms and the consequences of its anti-
inﬂammatory properties are less well understood. In an
in vivo model of intestinal inﬂammation, colonoscopy and
histology showed increased mucosal damage and inﬂam-
mation in apolipoprotein A-I (apoA-I) knockout (KO) mice,
which lack HDL. In contrast, transgenic (Tg) mice over-
expressing human apoA-I, which has very high plasma levels
of HDL, were protected from intestinal inﬂammation. In
cultivated enterocytes, both HDL and its major protein
component apoA-I down-regulated the expression of
proinﬂammatory cytokines in vitro via a nuclear factor-kB
Abbreviations used in this paper: ApoA-I, apolipoprotein A-I; CD,
Crohn’s disease; DAPI, 40,6-diamidino-2-phenylindole; DSS, dextran
sodium sulphate; EMSA, electrophoretic mobility shift assay; HDL,
high-density lipoprotein; IBD, inﬂammatory bowel disease; ICAM,
intracellular adhesion molecule; IL, interleukin; KO, knockout; LC3II,
light chain 3 II; 3-MA, 3-methyl adenine; MEICS, murine endoscopic
index of colitis severity; MPO, myeloperoxidase; mTOR, the mamma-
lian target of rapamycin; NF-kB, nuclear factor kB; PBS, phosphate-
buffered saline; PFA, paraformaldehyde; PI-3, phosphatidylinositol-3;
p-IKK, phosphorylated IkB kinase; RT-PCR, real-time polymerase
chain reaction; siRNA, small interfering RNA; Tg, transgenic; TNBS,
2,4,6-trinitrobenzenesulfonic acid; TNF, tumor necrosis factor; WT,
wild type.
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(NF-kB)-dependent pathway. In addition, HDL stimulated
the expression of light chain 3 II (LC3II), an autophagosomal
membrane-bound protein, through the inhibition of mTOR,
the mammalian target of rapamycin, and induced auto-
phagy. HDL-induced autophagy led to the recruitment of
phosphorylated IkB kinase (p-IKK, which mediates NF-kB
activation) to the autophagosome compartment, thereby
preventing further NF-kB activation and induction of cyto-
kine expression. Inhibition of autophagy reversed the sup-
pressive effect of HDL on inﬂammation. Thus, HDL and its
major protein component apolipoprotein A-I (apoA-I) act in
an anti-inﬂammatory manner via induction of autophagy
and subsequent recruitment of p-IKK to the autophagosome
compartment. The clinical exploitation of HDL could be
signiﬁcant for the treatment of inﬂammatory diseases such
as inﬂammatory bowel disease (IBD).
HDL encompasses a heterogeneous class of plasma
lipoproteins, which contain apoA-I as the main protein, and
phospholipids and cholesterol as the main lipids. HDL par-
ticles as well as apoA-I exert various anti-inﬂammatory,
antioxidative, and cytoprotective effects in vitro and
in vivo, which are thought to confer protection against
chronic inﬂammatory disorders.8,9 A low plasma concen-
tration of HDL cholesterol is a risk factor for cardiovascular
disease, diabetes mellitus, and certain cancers.10–15
The intestine and liver are the major organs responsible
for HDL synthesis. Dysfunction of either of these organs as a
result of inﬂammation is associated with a decrease in
plasma levels of HDL cholesterol and apoA-I.16,17 For
example, HDL cholesterol levels are signiﬁcantly decreased
in patients with active IBD.18,19 Traditionally, it was thought
that low levels of HDL cholesterol in IBD patients are a
consequence of the disorder; however, due to the well-
known anti-inﬂammatory effects of HDL, we hypothesized
that HDL and apoA-I might in fact modulate intestinal
inﬂammation in such patients. Having established the anti-
inﬂammatory effects of HDL and apoA-I in the intestine,
we further hypothesized that autophagy plays a role in
this process as earlier studies had shown an uptake of
HDL into intracellular compartments now identiﬁed as
autophagosomes.20
Materials and Methods
Cell Cultures
Human colon-derived epithelial cell line T84 cells were
cultured in Dulbecco’s modiﬁed Eagle’s medium 12 (Invi-
trogen, Basel, Switzerland) in a humidiﬁed atmosphere
containing 5% CO2 at 37
 C. The medium was supplemented
with 10% fetal bovine serum (Bruschwig, Basel,
Switzerland) and penicillin/streptomycin (100 mg/mL/100
mg/mL) (Invitrogen).
Isolation of High-Density Lipoprotein and
Apolipoprotein A-I from Plasma
Human HDL (1.063<d<1.21 kg/L) was isolated from the
plasma of normolipidemic blood donors by sequential ul-
tracentrifugation.21 Purity was conﬁrmed using sodium
dodecyl sulfate polyacrylamide gel electrophoresis and by
the presence of apoA-I and the absence of low-density
lipoprotein, apolipoprotein B, and albumin. ApoA-I was
puriﬁed from delipidated HDL by fast protein liquid
chromatography.22
RNA Isolation, Reverse Transcription, and
Real-Time Polymerase Chain Reaction
The T84 cells were incubated with HDL 50–200 mg/mL
for 18 hours and then with tumor necrosis factor (TNF) 25
ng/mL for 3 hours. Total RNA was isolated using TRIzol
reagent (Invitrogen). We reverse transcribed 1–2 mg RNA
with a High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Rotkreuz, Switzerland) before real-
time polymerase chain reaction (RT-PCR) analysis
(7900HT; Applied Biosystems) using various TaqMan as-
says: Hs00174128_m1 (human TNF), Mm00443258_m1
(murine TNF), Hs00174103_m1 (human interleukin-8 [IL-
8]), Hs00164932_m1 (human intracellular adhesion mole-
cule [ICAM]), Mm00516023_m1 (murine ICAM),
Hs00222677_m1 (human b-actin), 4352341E_mACTB (mu-
rine b-actin), Hs00797944_s1 (LC3), Hs00250530_m1
(ATG16L1), and endogenous controls for human and ani-
mals (Applied Biosystems). Constitutively expressed b-actin
was measured as an internal standard for normalization.
Relative mRNA levels were calculated using the comparative
threshold cycle method. For each experiment, all tests were
performed in triplicate. The mRNA levels obtained in control
conditions were set to 1, and the results are shown relative
to those.
Luciferase Reporter Assays
Cells were cotransfected with the luciferase reporter
constructs of NF-kB (400 ng) and the expression plasmids
pTAL-luc (200 ng) at a ratio of 3 mg FuGENE HD per 1 mg
DNA. The pcDNA33.1(þ) vector was added to normalize the
amount of DNA transfected, where necessary. We cotrans-
fected 100 ng of the Renilla luciferase (pRL-CMV) reporter
plasmid (Promega, Dübendorf, Switzerland) to assess
transfection efﬁciency. Cells were harvested 36 hours after
transfection, and luciferase activity was determined using
the Dual Luciferase Assay System (Promega) and a Lumi-
noskan Ascent Microplate Luminometer (Thermo Fisher
Scientiﬁc, Wohlen, Switzerland). Reporter activities ob-
tained from the empty pGL3basic corresponding to each test
condition and for the test construct containing the test
promoter in the control conditions were set to 1, and fold
activities were shown relative to this. All experiments were
performed in triplicate and repeated at least three times.
Electrophoretic Mobility Shift Assays
Oligonucleotides with 5-GATC overhangs were used for
annealing NF-kB consensus (top strand, 5-GATCAGTT
GAGGGGACTTTCCCAGGC-3; bottom strand, 5-GATCGCCTGG
GAAAGTCCCCTCAACT) for radioactive labeling by ﬁll-in
reactions as described by Saborowski et al.23 Protein
(5 mg) from nuclear extracts prepared by using the NE-PER
extraction kit (Pierce, Lausanne, Switzerland) were mixed
with 50,000 cpm (1.0 ng) of the radioactive probe, and
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protein-DNA complexes were allowed to form for 30 mi-
nutes at 30 C. In supershift experiments, 1 mg of the anti-
NF-kB p65 antibody (C-20; Santa Cruz Biotechnology, Santa
Cruz, CA) was added to the extracts before binding reactions
and incubated at 4 C for 1 hour before the addition of
radioprobes. The electrophoretic mobility shift assay
(EMSA) gels were run at 200V in 0.5X Tris-borate-ethylene-
diamine-tetraacetic acid (EDTA) and processed as described
for autoradiography.23
Animals
Female wild-type (WT) (C57BL/6J) mice, apoA-I
knockout (KO) (B6.129P2-ApoA-Itm1Unc/J [–/–]) mice,
and apoA-I Tg (C57BL/6-Tg [ApoA-I]1Rub/J) mice (all 7–8
weeks old) were used. The animals, which were purchased
from the Jackson Laboratory (Bar Harbor, ME), were
housed in a speciﬁed pathogen-free facility in individually
ventilated cages. For the dextran sodium sulphate (DSS)
model, colitis was induced with drinking water containing
2.5% of DSS (MP Biomedicals, Illkirch, France).24 The an-
imals were divided into six groups: three DSS groups and
three DSS-free water control groups (with six mice in each
group). Animals were fed food and water with or without
DSS ad libitum; 24 hours before animals were sacriﬁced,
DSS groups were fed with water without DSS.
For the 2,4,6-trinitrobenzenesulfonic acid (TNBS) model,
colitis was induced with TNBS (Fluka/Sigma-Aldrich
Chemie Gmbh, Munich, Germany) with ﬁve mice in each
group. Brieﬂy, on day 1, mice were shaved between the
shoulders, and 150 mL of TNBS presensitization solution
(ﬁnal concentration 1% in ethanol/acetone/olive oil) was
applied to the abdominal skin. On day 8, 100 mL of TNBS
solution (ﬁnal concentration 2.5% in 50% ethanol) was
slowly administered into the colon 4 cm proximal to the
anus with a 3.5F catheter to a 1 ml syringe. The catheter was
gently removed from the colon, and the mouse was kept
with the head down in a vertical position for 60 seconds.
Mice were sacriﬁced on day 18.25 All the animal experi-
ments were approved by the veterinary authorities of Zur-
ich, Switzerland, and were performed according to Swiss
animal welfare laws.
Determination of Colonoscopy and Total
Histologic Score
Macroscopic mucosal damage was assessed by colonos-
copy scoring using the murine endoscopic index of colitis
severity (MEICS), monitored by a miniendoscope. Animals
were anesthetized intraperitoneally with a mixture of ke-
tamine, 90–120 mg/kg body weight (Vétoquinol, Bern,
Switzerland), and xylazine, 8 mg/kg body weight (Bayer,
Lyssach, Switzerland), and were examined as described
previously elsewhere.26–28 The endoscope was introduced
with a lubricant (2% lidocaine) through the anus in the
sedated mouse, the colon was gently inﬂated with air, and
photographs were taken. Recording was performed with the
Karl Storz Tele Pack Pal 20043020 (Karl Storz Endoskope,
Tuttlingen, Germany).
The MEICS was scored based on mucosal bleeding,
abundant ﬁbrin, altered vascular pattern, nontransparent
mucosa (granularity), and stool composition as described by
Becker et al.26 Colonoscopy was performed on day 8 before
sacriﬁcing the mice. From the distal third of the colon, 1 cm
of colonic tissue was removed, washed with saline buffer,
and ﬁxed in 4% formalin overnight. Sections of the parafﬁn-
embedded tissue were used for histologic analysis, as
described previously elsewhere, based on loss of crypts, loss
of goblet cells, inﬁltration of lymphocytes, and thickening of
submucosa/mucosa.25,26 The histologic examination was
performed by two independent, blinded investigators.
Isolation and Culture of Human Colonic Lamina
Propria Fibroblasts
Primary human colonic lamina propria ﬁbroblast cul-
tures were derived from surgical specimens of patients with
active Crohn’s disease and were cultured as described
previously elsewhere.29 Fibroblasts were cultured in Dul-
becco’s modiﬁed Eagle’s medium containing 10% fetal calf
serum, penicillin 100 IU/mL, streptomycin 100 mg/mL,
ciproﬂoxacin 8 mg/mL, gentamicin 50 mg/mL, and ampho-
tericin B 1 mg/mL. Genomic DNA was isolated from cultured
ﬁbroblasts and genotyped for the ATG16L1 variant using
predesigned genotyping assays (Applied Biosystems, Foster
City, CA) and TaqMan technology. Written informed consent
was obtained before specimen collection, and the studies
were approved by the local ethics committee.
Gold Labeling of High-Density Lipoprotein
Colloidal gold was prepared as described previously
elsewhere30 using a particle size of 8 nm. For the conjuga-
tion of HDL to colloidal gold, 10 mL of a monodisperse gold
solution was added to a 16-mL lipoprotein solution con-
taining 50 mg of lipoprotein per milliliter in a phosphate
buffer at pH 5.5. Excess lipoprotein was removed by
centrifugation at 9000 g for 20 minutes against glycerine
and then dialyzed in Tris-borate-ethylene-diamine-
tetraacetic acid (EDTA) buffer to remove the glycerine.
To follow the uptake of HDL into the intestinal cell line,
colon carcinoma HT29 cells were incubated with gold-
labeled HDL for 18 hours. The cells were washed in
phosphate-buffered saline (PBS) and ﬁxed with 2.5%
glutaraldehyde þ 0.8% formaldehyde in NaCL 50 mM and
phosphate buffer 0.1 M for 2 hours at room temperature,
postﬁxed in 1% OsO4 (phosphate buffer 50 mM) at 4
 C for 1
hour, and block stained with 1% uranyl acetate in water for
1 hour. Thereafter, the tissue was dehydrated in ethanol
(70%–100%, 30 minutes) and propylene oxide (two times
20 minutes), polymerized, and embedded in Epon Araldite.
Electron microscopy was performed on a Philips CM100
transmission electron microscope (Philips, Eindhoven, the
Netherlands).
Transfection of Cells with Small Interfering RNAs
Cells were seeded at a density of 400,000 cells/well
onto 24-well plates and transfected with LC3 siGenome
SMARTpool (Dharmacon, Lafayette, CO) or siCONTROL
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nontargeting small interfering RNA (siRNA) #2 (Dharma-
con) at a ﬁnal concentration of 50 nM using the TransIT-
TKO reagent (Mirus Bio LLC, Madison, WI). The
transfections were repeated after 24 hours, and the cells
were harvested in 1 mL TRIzol (Invitrogen) 24 hours after
the second transfection.
Western Blotting
Cells were grown on six-well plates for 24 hours, fol-
lowed by incubation with HDL for 18 hours before treat-
ment with 25 ng/mL TNF for 3 hours where indicated. Cells
were harvested into radioimmune precipitation assay buffer
with protease inhibitors. The cell debris was removed by
centrifugation, and the supernatants were denatured at
94 C. We subjected 20 mg of protein to electrophoresis,
which was then blotted onto a nitrocellulose membrane.
Immunodetection was performed using anti-phospho-IKKa,
anti-phospho mTOR, anti-mTOR (all from Cell Signaling
Technology, Beverly, MA), anti-LC3 (Sigma-Aldrich, St. Louis,
MO), and anti-actin (Millipore, Billerica, MA) where indi-
cated. The bands were visualized using the electro-
chemiluminescence system, and densitometry of bands was
measured using ImageJ (http://imagej.nih.gov/ij/).
Confocal Microscopy
After treatment of cells with HDL for 18 hours and TNF
for 3 hours, the cells were washed with PBS and ﬁxed with
4% paraformaldehyde (PFA) for 15 minutes. For LC3
staining, ﬁxed cells were washed with PBS, permeabilized
in 100% methanol at –20 C for 10 minutes, washed with
PBS, and blocked with 3% bovine serum albumin for 1
hour at room temperature. Cells were subsequently
incubated with LC3/p-IKK antibody (1:200 dilution; Cell
Signaling Technology) overnight at 4 C. After 3 PBS-
Tween washes, cells were incubated with Alexa 488 con-
jugated secondary rabbit antibody (Invitrogen) for 1 hour
at room temperature and then washed three times in Tris-
buffered saline with Tween before mounting with antifade
medium (Dako, Glostrup, Denmark). Cells were analyzed
by confocal microscopy in a Leica SP5 laser scanning
confocal microscope (Leica Microsystems, Wetzlar, Ger-
many) using a Zeiss AxioCam HRm CCD camera, and Zeiss
EC Plan-Neoﬂuar 10!/0.3 and Zeiss LD Plan-Neoﬂuar
20!/0.4 objectives (Carl Zeiss Microscopy GmbH, Jena,
Germany). After sequential excitation, green and blue
ﬂuorescent images of the same sample were acquired and
processed using Leica confocal software (LAS-AF Lite;
Leica Microsystems).
Results
Anti-inﬂammatory Effect of High-Density
Lipoprotein and Apolipoprotein A-I In Vivo
Intestinal Inﬂammation Is Ameliorated in Apolipo-
protein A-I Transgenic Mice with Dextran Sodium
Sulphate Colitis. Upon application of DSS to the drinking
water of WT, apoA-I KO, and human apoA-I Tg mice, ani-
mals experienced mucosal damage of the intestine and
colon but of different severity. The apoA-I Tg mice, which
have strongly elevated plasma levels of HDL cholesterol,
displayed an intact epithelial surface with still-formed
stools compared with the WT mice. In contrast, a severe
disruption of the epithelium was observed in the apoA-I
KO mice (Figure 1A), which are HDL deﬁcient. A histo-
logic analysis of distal colon tissue samples showed that,
upon DSS treatment, the apoA-I KO mice had severe bar-
rier breakdown with extensive inﬁltration reaching the
lamina muscularis mucosae, and the total histologic
score was signiﬁcantly increased for apoA-I KO mice
(Figure 1B).
Weight loss was monitored during the 7-day course of
acute colitis. Upon treatment with DSS and in comparison
with the DSS-free-water control animals, the body weight
decreased signiﬁcantly in the WT mice and apoA-I KO mice
but not in the apoA-I Tg mice (Figure 1C). Tissue homoge-
nates of DSS-treated apoA-I Tg mice showed signiﬁcantly
lower myeloperoxidase (MPO) activity than the DSS-treated
apoA-I KO mice and WT mice (Figure 1D). Finally, DSS
supplementation led to a signiﬁcant increase in mRNA
expression of TNF and ICAM in the whole colon tissue in all
animals, but the expression of TNF and ICAM in apoA-I KO
mice was 18 and 34 times higher, respectively, than in the
WT mice, and 10 and 168 times higher, respectively, than in
the apoA-I Tg mice (Figure 1E).
Intestinal Inﬂammation Is Ameliorated in Apo-
lipoprotein A-I Transgenic Mice with 2,4,6-
Trinitrobenzenesulfonic Acid Colitis. Upon
administration of TNBS to the WT, apoA-I KO, and human
apoA-I Tg mice, the animals experienced mucosal damage
of the intestine and colon but of different severity. Upon
TNBS-induced colitis, weight loss in the apoA-I KO mice
was signiﬁcantly higher as compared with the apoA-I Tg
mice during the last 2 days before the animals were
sacriﬁced (Figure 2A). The macroscopic mucosal damage
was assessed by colonoscopy and MEICS. On day 2 after
TNBS administration into the colon mucosa, the apoA-I Tg
mice displayed a smooth and transparent mucosa with a
normal vascular pattern compared with the opaque mucosa
with altered vascular pattern in the apoA-I KO mice. On day
9 after TNBS administration, the colon of the apoA-I Tg
mice appeared to be less transparent. In the apoA-I KO
mice, the colon appeared with a thickened, more granular
mucosa and a clearly altered vascular pattern. The apoA-I
KO animals were given a signiﬁcantly higher MEICS score
compared with the apoA-I Tg mice (Figure 2B). Also on a
microscopic level for the apoA-I KO mice, a more severe
colitis was found compared with the apoA-I Tg mice. The
total histologic score for the apoA-I KO mice with induced
TNBS colitis was increased compared with the apoA-I Tg
mice (Figure 2C).
Anti-inﬂammatory Effect of High-Density
Lipoprotein and Apolipoprotein A-I in Vitro
A series of in vitro experiments in the colonic epithelial
cell line T84 were performed to further elucidate the
mechanism of the effects found in vivo. These experiments
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Figure 1. Intestinal inﬂammation is ameliorated in apolipoprotein A-I transgenic (apoA-I Tg) mice upon colitis induced
with dextran sodium sulphate (DSS). (A) Miniendoscopy showed severe disruption of the epithelium in apoA-I knockout (KO)
mice receiving DSS. Macroscopic mucosal damage was assessed by colonoscopy scoring (murine endoscopic index of colitis
severity). Each bar represents the mean ± standard error of the mean (SEM); n ¼ 6; *P < .05, ***P < .001. (B) H&E staining of
sections from apoA-I KO mice receiving DSS displayed severe barrier breakdown with extensive inﬁltration reaching the lamina
muscularis mucosae. The total histologic score, calculated as the sum of the epithelium and inﬁltrate score, was plotted. Each
bar represents themean±SEM; n¼ 6; *P< .05, **P< .01. (C) Weight losswasmonitored during the 7-day course of acute colitis.
Upon treatment with DSS and in comparisonwith the DSS-free-water control animals, the bodyweight decreased signiﬁcantly in
wild-type (WT) and apoA-I KOmice (P< .001) but not in apoA-I Tgmice. (D) Tissue homogenates of DSS-treated apoA-I Tgmice
showed signiﬁcantly lower myeloperoxidase (MPO) activity than the DSS-treated apoA-I KO and WTmice ***P < .001. (E) Upon
DSS-induced colitis, apoA-I KO mice receiving DSS displayed a signiﬁcant increase in mRNA expression of tumor necrosis
factor (TNF) and intracellular adhesion molecule (ICAM), whereas apoA-I Tg mice displayed lower expression levels of TNF and
ICAM compared with WT and apoA-I KO mice. The mRNA expression was calculated relative to WT mice receiving DSS-free
water. Each bar represents the mean ± SEM; n ¼ 6; ***P < .001).
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demonstrated that HDL and apoA-I down-regulated the
expression of proinﬂammatory cytokines via a NF-kB-
dependent pathway. The mRNA expression of TNF, IL-8,
and ICAM was quantiﬁed in T84 cells in the presence or
absence of HDL. The T84 cells were incubated with 200 mg
HDL for 18 hours and then stimulated with 25 ng/mL TNF
for 3 hours. TNF signiﬁcantly induced the mRNA expres-
sion of TNF, IL-8, and ICAM by factors of 178, 127, and 830,
respectively, whereas HDL pretreatment signiﬁcantly
suppressed this expression by 59%, 31%, and 50%,
respectively (Figure 3A). The suppressive effect of HDL on
TNF-induced mRNA expression of TNF was concentration
dependent, ranging from 20% in the presence of 50 mg/mL
HDL to 60% in the presence of 200 mg/mL HDL
(Figure 3B).
Lipid-free apoA-I mimicked these anti-inﬂammatory
effects of HDL, pointing to an important role of apoA-I in
this process. Incubation of T84 cells with 100 mg/mL apoA-I
for 18 hours before the addition of 25 mg/mL TNF for 3
hours led to a decrease in TNF-induced mRNA expression of
TNF, IL-8, and ICAM by 73%, 54%, and 51%, respectively
(Figure 3C); the suppressive effect of apoA-I on the
TNF-induced mRNA expression of TNF was concentration
dependent (Figure 3D).
The down-regulation of proinﬂammatory cytokines by
HDL and apoA-I occurred via a NF-kB-dependent pathway.
Immunoblotting showed that when cells were pretreated
with HDL for 18 hours and then stimulated for 3 hours with
25 ng/mL TNF, the phosphorylation of the IkB kinase
complex (p-IKK), a process that precedes the translocation
of NF-kB to the nucleus, was slightly decreased by HDL.
Pretreatment of the cells with TNF increased p-IKK by 46%;
however, this effect was reduced by 70% in the presence of
HDL (Figure 3E).
Next, tests were performed to determine whether HDL
suppresses TNF-induced NF-kB responsive promoter activ-
ity. The T84 cells were transiently transfected with lucif-
erase constructs expressing an NF-kB responsive element.
Figure 1. (continued).
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After 24 hours, the cells were incubated with 100 mg/mL
HDL for 18 hours and then 25 ng/mL TNF for 6 hours. HDL
signiﬁcantly inhibited NF-kB luciferase activity (by 26%).
Treatment with TNF alone almost tripled luciferase activity,
but preconditioning with HDL or lipid-free apoA-I signiﬁ-
cantly suppressed this effect (both by 50%; Figure 3F).
Nuclear extracts from T84 cells were subjected to EMSA.
This showed that pretreatment of the T84 cells with HDL
or apoA-I decreased TNF-induced binding of NF-kB to a
32P-labeled consensus NF-kB binding DNA sequence
(Figure 3G).
High-Density Lipoprotein Induces Autophagy
and Is Taken Up into Autophagosomes
Autophagy increases cell survival during periods of
stress via catabolism of subcellular proteins, organelles, and
Figure 2. Intestinal in-
ﬂammation is amelio-
rated in apolipoprotein
A-I transgenic (apoA-I Tg)
mice with colitis induced
by 2,4,6-trinitrobenzene-
sulfonic acid (TNBS). (A)
Percentage body weight
loss showed an increase in
body weight in apoA-I
Tg mice compared with
apoA-I knockout (KO) mice
at days 9 and 10 after
TNBS administration into
the colon (± standard error
of the mean [SEM], n ¼ 5
each, *P < .05). (B) Mini-
endoscopy showed a
clearly altered vascular
pattern in apoA-I Tg mice
receiving TNBS compared
with both apoA-I KO and
wild-type (WT) mice.
Macroscopic mucosal da-
mage was assessed by
colonoscopy scoring (mu-
rine endoscopic index of
colitis severity) (± standard
deviation [SD], n ¼ 5 each,
*P < .05). (C) H&E staining
of sections from apoA-I
KO mice receiving TNBS
displayed barrier break-
down with inﬁltration. The
total histologic score, cal-
culated as the sum of the
epithelium and inﬁltrate
score, was plotted. Each
bar represents the mean ±
SD; n ¼ 5.
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Figure 3. Anti-inﬂammatory effect of high-density lipoprotein (HDL) and apolipoprotein A-I (apoA-I) in vitro. (A) HDL
suppressed tumor necrosis factor (TNF)-induced mRNA expression of TNF, interleukin-8 (IL-8), and intracellular adhesion
molecule (ICAM). The mRNA expression of TNF, IL-8, and ICAM was quantiﬁed by reverse-transcriptase real-time polymerase
chain reaction (RT-PCR) and normalized to actin. Results represent mean ± standard deviation (SD), n ¼ 3, ***P < .001. (B)
HDL suppressed TNF-induced mRNA expression of TNF in a concentration-dependent manner. The mRNA expression
of TNF was quantiﬁed by RT-PCR and normalized to actin. Each bar represents the mean ± standard deviation (SD), n ¼ 3,
***P < .001. (C) ApoA-I (similar to HDL) suppressed mRNA expression of TNF, IL-8, and ICAM. The mRNA expression of TNF,
IL-8, and ICAM was quantiﬁed by RT-PCR and normalized to actin. The results represent the mean ± SD, n ¼ 3, ***P < .001. (D)
ApoA-I suppressed TNF-induced mRNA expression of TNF in a concentration-dependent manner. The mRNA expression of
TNF was quantiﬁed by RT-PCR and normalized to actin. Each bar represents the mean ± SD, n ¼ 3, ***P < .001. (E) HDL
decreased the phosphorylation of IkB kinase (p-IKK). The p-IKK arbitrary units represent the ratio of p-IKK to actin normalized
to the untreated controls. (F) HDL and apoA-I suppressed TNF-induced NF-kB-responsive promoter activity. *P < .05, ***P <
.001. (G) HDL and apoA-I decreased the TNF-induced NF-kB DNA binding activity. The top arrow indicates the binding re-
action of TNF to the NF-kB consensus, and the bottom arrow shows the supershift observed upon incubation of nuclear
extracts with the anti-p65 antibody.
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cytoplasmic components that generate free fatty acids,
amino acids, and nucleotides.31–33 Autophagy is critically
involved in regulating innate immune responses by
providing a defence against intracellular microbial patho-
gens and mediating antigen presentation via MHC class-II
molecules.34,35 Dysfunctional autophagy is associated with
defective bacterial handling, prolonged intracellular survival
of pathogens, and uncontrolled inﬂammation. Autophago-
somes are characterized by double membrane vesicles, the
formation of which is mediated by autophagy proteins
such as ATG12-ATG5-ATG16 and a microtubule associated
protein light chain 3 (LC3). Increase in autophagy can
be characterized by conversion of LC3-I to the
phosphatidylethanolamine-conjugated form of LC3II that
accumulates on autophagic vesicles.36,37 Levels of auto-
phagy proteins, such as ATG16L1 or IRGM, are signiﬁcantly
decreased in the intestine of Crohn’s disease (CD) pa-
tients.38 To date, three autophagy genes have been
Figure 3. (continued).
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conﬁrmed as CD susceptibility genes, namely, ATG16L1,
IRGM, and Leucine-rich repeat kinase 2 (LRRK2).
An uptake of HDL into vesicles that retrospectively
appear to be autophagosomes has already been reported in
1992.20 We therefore investigated whether the HDL/apoA-I
mediated anti-inﬂammatory effect could be associated with
autophagy. Incubation of T84 cells with HDL stimulated
autophagy, as demonstrated by a signiﬁcant increase in
punctate staining for LC3. The T84 cells were treated with
0 or 100 mg/mL HDL for 18 hours, then ﬁxed with 4% PFA,
and stained for LC3 (green) or cell nuclei (40,6-diamidino-2-
phenylindole [DAPI, blue]). An increase in punctate
staining—representing LC3 protein accumulation (ie, auto-
phagosome formation)—was observed in the cells incu-
bated with HDL (Figure 4A). Incubation of the T84 cells with
HDL also led to increased conjugation of the cytosolic pro-
tein LC3I to the autophagosomal membrane-bound LC3II
during autophagy. This was demonstrated by an increase in
the LC3II:LC3I ratio after the incubation of T84 cells with
increasing concentrations of HDL for 18 hours, conﬁrmed by
Western blot analysis and immunoﬂuorescence analysis of
whole cell protein extracts with anti-LC3 antibodies. The
increase was concentration dependent, and LC3 II expres-
sion was maximum at 18 hours (Figure 4B).
The HDL-induced increase in LC3II was found to be
mediated via inhibition of mTOR, a negative regulator
of autophagy. T84 cells were treated with 50 mg HDL
for 18 hours, and whole cell protein extracts were
analyzed by Western blotting. Phosphorylation of mTOR
decreased upon treatment with HDL by more than 50%
(Figure 4C).
Electron microscopy revealed that HDL is taken up into
autophagosomes. The T84 cells were incubated with 8 nm
gold-labeled HDL for 18 hours and then ﬁxed and embedded
in Epon Araldite. Gold-labeled HDL was visible within ves-
icles resembling autophagosomes (the vesicles had typical
characteristics of engulfed cytoplasmic materials and or-
ganelles and were found in close proximity to organelles
Figure 4. High-density
lipoprotein (HDL) induces
autophagy and is taken
up into autophagosomes.
(A) HDL increased auto-
phagy, demonstrated by an
increase in punctate stain-
ing for light chain 3 (LC3).
The cells were stained for
visualization of LC3 (green)
or cell nuclei (DAPI [blue]).
Scale bars: 25 mm. Repre-
sentative data from one of
four experiments is shown.
(B) HDL induced an in-
crease in conjugation of
LC3II during autophagy.
LC3 arbitrary units repre-
sent the ratio of LC3 to
actin normalized to the un-
treated controls. (C) HDL
decreased phosphorylation
of mammalian target of
rapamycin (p-mTOR), a
negative regulator of auto-
phagy. (D) HDL was taken
up into autophagosomes.
Electron microscopy shows
autophagic uptake of gold-
labeled HDL (arrows). (E)
HDL was found to coloc-
alize with LC3, conﬁrming a
possible autophagic uptake
of HDL into cells, Scale
bars: 25 mm.
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that may represent lysosomes) (Figure 4D). Upon confocal
immunoﬂuorescence microscopy, HDL was found colo-
calized with LC3. The T84 cells were transduced with len-
tiviral constructs harboring GFP-LC3 and, after 24 hours,
were incubated with ﬂuorescently labeled HDL (Atto_655
HDL) for 18 hours. The cells were then ﬁxed with 4% PFA,
and the nuclei was stained with DAPI. Colocalization of HDL
with LC3 was clearly demonstrated, supporting our
conclusion of HDL uptake into autophagosomes of T84 cells
(Figure 4E).
Autophagy is necessary for an HDL-mediated anti-
inﬂammatory effect, which involves recruitment of p-IKK to
Figure 4. (continued).
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the autophagosome. The anti-inﬂammatory effect mediated
by HDL was shown to be dependent on tubulin. The T84
cells were incubated with 5 mM colchicine (which binds
tubulin and blocks its polymerization) followed by HDL 100
mg/mL for 18 hours and TNF 25 ng/mL for 3 hours. The
addition of colchicine statistically signiﬁcantly reversed by
19% (P < .05) the anti-inﬂammatory effect mediated by
HDL on mRNA expression of TNF (Figure 5A).
The anti-inﬂammatory effect of HDL was also reversed
after the inhibition of autophagy. The T84 cells were
pretreated with the autophagy-speciﬁc class III
phosphatidylinositol-3 (PI-3) kinase inhibitor 3-methyl
adenine (3-MA) at a concentration of 10 nM or the PI-3 ki-
nase inhibitor wortmannin at a concentration of 25 nM for 6
hours. Twenty-four hours after being transfected with lucif-
erase constructs expressing NF-kB-responsive elements, the
cells were incubated with 100 mg/mL HDL for 18 hours and
then25ng/mLTNF for 6hours. The ability ofHDL to suppress
TNF-induced NF-kB-responsive promoter activity, as
analyzed by the use of a dual luciferase reporter assay, was
decreased in the presence of 3-MA (by 26%) andwortmannin
(33%) (Figure 5B).
Figure 5. Autophagy is necessary for a high-density lipoprotein (HDL)-mediated anti-inﬂammatory effect, which in-
volves the recruitment of phosphorylated IkB kinase (p-IKK) to the autophagosome. (A) The anti-inﬂammatory effect
mediated by HDL on mRNA expression of TNF was tubulin dependent, as shown by incubation of T84 cells with colchicine (a
tubulin blocker). The mRNA expression of TNF was quantiﬁed relative to actin. Each bar represents the mean ± standard
deviation (SD), n ¼ 3. (B) Inhibition of autophagy using the phosphatidylinositol-3 (PI-3) kinase inhibitor wortmannin and the
autophagy-speciﬁc class III PI-3 kinase inhibitor 3-methyl adenine (3-MA) reversed the anti-inﬂammatory effect of HDL (as
demonstrated by suppression of TNF-induced NF-kB-responsive promoter activity). Each bar represents the mean ± SD, n ¼
3. (C) Inhibition of autophagy (with wortmannin and 3-MA) reversed the anti-inﬂammatory effect of HDL (as demonstrated by
suppression of TNF-induced mRNA expression of TNF). The mRNA expression of TNF was quantiﬁed relative to actin. Each
bar represents the mean ± SD, n ¼ 3. (D) The anti-inﬂammatory effect of HDL was decreased in the presence of the auto-
phagosome fusion inhibitor baﬁlomycin A1. The mRNA expression of TNF was quantiﬁed relative to actin. Each bar represents
the mean ± SD, n ¼ 3. (E) The siRNA knockdown of the autophagy gene LC3 decreased the anti-inﬂammatory effect of HDL.
The mRNA expression of LC3 and TNF was quantiﬁed relative to actin. Each bar represents the mean ± SD, n ¼ 3. (F) In
ﬁbroblasts harboring the ATG16L1 mutation, the anti-inﬂammatory effect mediated by HDL was reduced. The mRNA
expression of TNF was quantiﬁed relative to actin. Each bar represents the mean ± SD, n ¼ 3. (G) HDL colocalizes with p-IKK
and LC3 in T84 cells. Scale bars: 25 mm.
182 Gerster et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 2
Figure 5. (continued).
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In a similar experiment, after incubation for 6 hours with
3-MA and wortmannin, the cells were incubated with
100 mg/mL HDL for 18 hours followed by 25 ng/mL TNF for
3 hours. The ability of HDL to suppress the TNF-induced
mRNA expression of TNF was signiﬁcantly reduced in the
presence of wortmannin and 3-MA (Figure 5C).
Further testing showed that the anti-inﬂammatory effect
of HDL is decreased in the presence of the autophagosome
fusion inhibitor baﬁlomycin A1. The T84 cells were pre-
treated with baﬁlomycin A1 100 nM (to inhibit autophagy)
before the addition of HDL for 18 hours and subsequently
25 ng/mL TNF for 3 hours. Pretreatment with baﬁlomycin
signiﬁcantly decreased the ability of HDL to suppress TNF-
induced mRNA expression of TNF by 31% (Figure 5D).
In addition, siRNA knock down of the autophagy gene LC3
decreased the anti-inﬂammatory effect of HDL. The T84 cells
were transfected with 50 nM control siRNA or LC3 siRNA; 48
hours after transfection, the cells were incubated with 100
mg/mL HDL or 50 mg/mL apoA-I for 18 hours, before the
incubation with 25 ng/mL TNF for 3 hours. A 33% decrease
in LC3 expression was demonstrated (Figure 5E).
Genetic variants in autophagy genes ATG16L1 and
IRGM1 have been shown to increase the susceptibility to
CD.39–41 Cells expressing the variant ATG16L1 protein were
shown to have a defect in autophagy.35,42–45 To investigate
whether our ﬁnding is of relevance in humans, we isolated
mucosal ﬁbroblasts from CD patients with the ATG16L1
variant as well as WT patients. The anti-inﬂammatory effect
mediated by HDL was signiﬁcantly reduced in ﬁbroblasts
harboring the ATG16L1 mutation, which compromises
autophagocytic activity. Human mucosa-derived ﬁbroblasts
were preconditioned with or without HDL for 18 hours,
before the incubation with 25 ng/mL TNF for 3 hours. TNF
stimulated mRNA expression of TNF more pronouncedly in
ﬁbroblasts with ATG16L1 mutations. The ability of HDL to
suppress TNF-induced mRNA expression of TNF was
signiﬁcantly reduced by 44% and 12% in ﬁbroblasts
with homozygous and heterozygous ATG16L1 mutations
as compared with control ﬁbroblasts (Figure 5F). These
results suggest that dysfunctional autophagy limits the
anti-inﬂammatory functionality of HDL in human cells car-
rying the IBD-associated ATG16L1 variant.
To further investigate the role of HDL in the NF-kB
pathway, whole cell protein from T84 cells was extracted
and treated with HDL for 18 hours in the presence or
absence of 25 ng/mL TNF. Immunoblotting showed that
TNF increased p-IKK levels by 46%, but this effect was
reduced by 70% in the presence of HDL (Figure 3E). To
elucidate the relationship between HDL-induced autophagy
and decreased NF-kB activation, a colocalization experiment
was performed. The T84 cells were transfected with lenti-
viral constructs of GFP-LC3; Twenty-four hours after
transfection, the cells were incubated with ﬂuorescently
labeled HDL (Atto_655 HDL) for 18 hours. The cells were
ﬁxed with 4% PFA and stained for p-IKK using Alexaﬂuor
594 and for nuclei by using DAPI. Colocalization of LC3 with
HDL and p-IKK was observed (Figure 5G), indicating that
HDL might speciﬁcally recruit p-IKK to autophagosomes for
degradation, resulting in a decreased inﬂammatory
response via the prevention of further NF-kB activation and
induction of cytokine expression.
These studies demonstrate that HDL and its major pro-
tein component apoA-I act in an anti-inﬂammatory manner
via induction of autophagy and subsequent recruitment of
p-IKK into autophagosomes. Traditionally, the many cyto-
protective and anti-inﬂammatory functions of HDL have
been related to the ability of HDL to regulate cellular
cholesterol homeostasis by mediating cholesterol efﬂux5,6,11
or to elicit signal transduction by the interaction with cell
surface receptors such as scavenger receptor class B type I
(SR-BI), sphingosine-1-phosphate receptors, or ectopic
b-ATPase.7,11 Our data suggest a third mechanism: endo-
cytosis into intracellular organelles for neutralization of
proinﬂammatory molecules. Endocytosis was previously
identiﬁed as crucial for the antibiotic activity of HDL toward
Trypanosoma brucei46 but appears to be also relevant for
the blockage of NF-kB signaling in epithelial cells. From the
clinical perspective, our ﬁndings provide additional ratio-
nales to target or mimic8 HDL for the treatment of inﬂam-
matory diseases such as IBD.
Conclusions
IBD patients of both genders display dyslipidemia with
signiﬁcantly lower HDL cholesterol. Because HDL is a
negative acute phase reactant and because the intestine is
the second most important site of HDL production, low HDL
cholesterol has traditionally been interpreted to be the
consequence of IBD. Because HDL exerts many anti-
inﬂammatory activities on many cells including endothelial
cells, pancreatic b-cells, and leukocytes, we hypothesized
that HDL may also modulate intestinal inﬂammation.11,47–50
We found evidence for anti-inﬂammatory effects of HDL and
apoA-I in the intestine, both in vitro and in vivo.
The proinﬂammatory cytokine TNF alters the integrity of
epithelial and endothelial cell barriers and is a key mediator
of mucosal inﬂammation in both CD and ulcerative colitis. An
increased concentration of TNF has been found in the blood,
mucosa, and feces of CD patients.51 In several animal models
of IBD, genetic ablation or anti-TNF treatment result in
amelioration of mucosal inﬂammation. Furthermore, inﬂix-
imab, a monoclonal antibody against TNF has been effective
in clinical management of IBD.51,52–54We therefore used TNF
as a proinﬂammatory stimulator for our in vitro experiments.
Preincubation of colon carcinoma T84 cells with HDL or
apoA-I for 18 hours signiﬁcantly suppressed TNF triggered
mRNA expression of IL-8, ICAM, and TNF by inhibiting NF-kB
promoter activity as measured by relative luciferase activity
and NF-kB DNA binding activity by EMSA. These ﬁndings are
very similar to those previously made in experiments with
endothelial cells and vascular smooth muscle cells where
HDL was also found to reduce cytokine production and
adhesion molecule expression via inhibition of NF-kB.55–58
Importantly, the anti-inﬂammatory properties of HDL
and apoA-I could be reproduced in an animal model of
colitis. Upon DSS or TNBS treatment, the apoA-I KO
phenotype exhibited a more severe intestinal inﬂammation
compared with the WT mice, as indicated by increased
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mucosal damage upon both colonoscopy and histology,
shorter colon length, increased intestinal MPO activity, and
mRNA expression of TNF and ICAM. Conversely, apoA-I Tg
mice, which have elevated levels of HDL, were partially
protected from DSS/TNBS-induced mucosal damage, as
indicated by the less severe symptoms upon colonoscopy
and less severe increase in MPO activity. The functional
importance of the attenuated intestinal inﬂammation
in apoA-I Tg mice is highlighted by the fact that WT and
apoA-I KO mice but not apoA-I Tg mice lost body weight
with DSS/TNBS treatment. These observations are in very
good agreement with previous ﬁndings of Cuzzocrea et al,57
who showed that administration of reconstituted HDL
reduces intestinal inﬂammation in animals with splanchnic
artery occlusion shock or colitis induced by dinitrobenzene
sulfonic acid.
HDL and apoA-I have been increasingly recognized as a
part of innate immune system for their ability to bind and
neutralize the toxic effects of lipopolysaccharide, a bacterial
product that can activate Toll-like receptors and thereby
stimulate the secretion of cytokines.59 This function may be
of special importance in the control of barrier integrity, such
as in the vascular endothelium and the intestinal epithelium.
Increased LC3-II is an indicator of preautophagosome
formation. In our experiments, we observed increased pro-
cessing of LC3 in the presence of HDL. This correlated with a
decrease in phosphorylation of mTOR, a negative regulator of
autophagy. Chemical inhibition of the autophagic pathway
using wortmannin and 3-MA decreased the ability of HDL to
decrease TNF-induced NF-kB responsive promoter activity
as well as expression of TNFmRNA expression. Interestingly,
pretreatment of T84 cells with baﬁlomycin A1, which in-
hibits the late stages of autophagosome fusion to lysosomes,
also inhibited the suppressive effect mediated by HDL on
TNF-induced mRNA expression of TNF. The intracellular
transport of HDL seems to be tubulin mediated, as demon-
strated by the reverse effect of HDL when T84 cells were
incubated with colchicine, a tubulin blocker.
Whereas siRNA knockdown of LC3 signiﬁcantly
decreased the ability of HDL to suppress inﬂammation, siRNA
knock down of the HDL receptors SRB1 and ABCA1 did not
have any effect (data shown in Supplementary Figure 1). This
observation correlates well with our studies in human ﬁ-
broblasts harboring the ATG16L1 mutation. Further, we
observed the uptake of gold-labeled HDL in autophagosomes,
which clearly depicted engulfed organelles such as mito-
chondria and which were found in close proximity to lipid
droplets. The autophagic uptake of HDLwas conﬁrmed by the
colocalization of ﬂuorescently labeled HDL with LC3 in colon
carcinoma cells. In addition, we could colocalize p-IKK with
LC3 and HDL, indicating that HDL might speciﬁcally recruit
p-IKK to be degraded in autophagosomes.
These results give an initial indication that autophagy
might regulate inﬂammatory pathways in intestinal cells
and HDL might modulate inﬂammation via autophagy. In
fact, apoL1, a minor component of HDL, has been shown to
induce autophagy and modulate host immunity.60–63
Although Muller et al65 have provided evidence that HDL
may, in contrast, inhibit autophagy and endoplasmic
reticulum stress induced by oxidized LDL in human micro-
vascular endothelial cells, this effect cannot be generalized,
taking into account the different cell model used and the fact
that an increase in autophagy, especially selective auto-
phagy, can have a positive effect in reducing cellular stress
by the removal of speciﬁc stress factors enabling cell sur-
vival64 but also can result in apoptosis and cellular death.65
Despite the complex crosstalk between autophagy,
apoptosis, and endoplasmic reticulum stress, increasing
evidence points to the association of dysfunctional auto-
phagy with the pathogenesis of IBD. Genetic variation and
dysfunction in the autophagy genes IRGM and ATG16L1
have been implicated in improper bacterial handling and
abnormalities in Paneth cells.39 Scharl et al38 have published
an interesting study showing that PTPN2 maintains intes-
tinal barrier functions and limits the effects of proin-
ﬂammatory cytokines by up-regulating autophagy. This
study also shows that expression of autophagy proteins
ATG16L1, IRGM, LC3, and ATG5-ATG12 are signiﬁcantly
decreased in the inﬂamed mucosa of CD patients. Future
studies will be needed to determine whether the differences
found in our preclinical models reﬂect the situation in
macrophage and dendritic cell populations from patients
with different ATG16L1 polymorphisms. The innate immune
cells of patients with ATG16L1 polymorphisms will have to
be studied for their response to HDL to take our ﬁndings
into potential clinical application.
In summary, we report that HDL can decrease inﬂam-
mation by suppressing TNF-induced NF-kB responses
through the induction of autophagy. Chemical inhibition of
autophagy as well as knockdown of autophagy genes
decreased the ability of HDL to suppress inﬂammation in
colon carcinoma cells. Immunoﬂuorescence experiments
also showed that HDL recruits p-IKK, a key component of
the NF-kB pathway, to autophagosomes where they might
be degraded, thereby decreasing NF-kB activation. Present
day therapy of IBD consists of salicylates, corticosteroids,
and immunosuppressants, most of which cause severe side
effects. The clinical exploitation of HDL could be signiﬁcant
for the treatment of inﬂammatory diseases such as IBD.
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Supplementary
Figure 1. The siRNA me-
diated knock down of the
HDL receptors SRB1 and
ABCA1 as well as ABCG1
did not have a signiﬁcant
effect on HDL mediated
suppression of TNF
mRNA induction by TNF
stimulation. The mRNA
expression of TNF, SRB1,
ABCA1, and ABCG1 was
quantiﬁed relative to actin.
Each bar represents the
mean ± SD, n ¼ 3.
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Abstract 
BACKGROUND: Fibrosis as a common problem in patients with Crohn’s disease is a result 
of an imbalance towards excessive tissue repair. At present there is no specific treatment 
option. Pirfenidone is approved for the treatment of idiopathic pulmonary fibrosis with both 
anti-fibrotic and anti-inflammatory effects.We subsequently investigated the impact of 
pirfenidonetreatment upon development of fibrosis in a new mouse model of intestinal 
fibrosis.  
METHODS: Small bowel resections from donor-mice were transplanted subcutaneously into 
the neck of recipients. Animals received eitherpirfenidone(100 mg/kg, tds, orally) orvehicle.  
RESULTS:Following administration of pirfenidone a significantly decreased collagen layer 
thickness was revealedas compared to vehicle (9.7 ± 1.0 vs. 13.5 ± 1.5 µm, respectively, ** 
p< 0.001). TGF-βand MMP-9 were significantly decreased after treatment withpirfenidoneas 
confirmed by real time PCR(0.42 ± 0.13 vs. 1.00 ± 0.21 and 0.46 ± 0.24 vs. 1.00 ± 0.62 
mRNA expression level relative to GAPDH, respectively, * p< 0.05). Significantly decreased 
TGF-β following administration ofpirfenidone was confirmed by Western.  
CONCLUSION:In our mouse model intestinal fibrosis can be reliably induced and is 
developed within 7 days. Pirfenidone partially prevented development of fibrosis making it a 
potential treatment option against Crohn’s disease associated fibrosis. 
 
 
Key Words 
Fibrogenesis, fibrosis, intestinal, pirfenidone, treatment, transplantation, graft, mouse model, 
TGF-β, MMP-9  
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Introduction 
Severe and persistent mucosal tissue damage is a main feature of inflammatory bowel disease 
(IBD). Tissue injury triggers an important inflammatory response which in turn leads to the 
initiation of a reparatory process(1-3). Rapid and adequate healing is essential to reduce the 
exposure of the underlying tissue to luminal antigens and potential pathogens and to restore a 
tight barrier. Furthermore, adequate wound healing physiologically is the result of an 
exquisite balance between multiple pro- and anti-fibrotic stimuli on ECM -producing cells(4-
7). The primary cellular mediator of fibrosis is the myofibroblast, which can be generated 
from several sources(8). Excessive tissue repair promotes fibrosis and impairs gastrointestinal 
function and is a common clinical problem in patients with Crohn’s disease (CD). 
Fibrosis is increasingly being recognised as an important cause of morbidity and mortality in 
many chronic inflammatory diseases.The pathogenesis of fibrosis in CD patients, however, is 
still poorly understood.Intestinal fibrosis leads to stricture formation in 30–50% of patients 
with CD(9, 10), and requires surgery in approximately 80% of strictured patients(9). 
 
Administration of potent anti-inflammatory agents effectively treats inflammatory flares, but 
may not alter the course of intestinal fibrosis and fail to prevent the formation of strictures(11, 
12). Despite earlier initiation of immunosuppressants or biologicals during the course of CD, 
the percentage of patients requiring intestinal surgery due to the occurrence of stricturing 
complications has only decreased slightly(13). Recently it was demonstrated that treating 
inflammationmay not be sufficient to prevent the progression of fibrosis.Further there is 
evidence that intestinal fibrogenesis after being once initiated is - at least to some extent - a 
self-perpetuatingprocess(14). Therefore, many experts point to the unmet clinical need of a 
medical treatment to prevent or inhibit fibrogenesis/fibrosis.  
 
The clinical investigation of intestinal fibrosis is confined to the limited amount of biological 
material available from patients.Establishing an animal model that reflects the development of 
intestinal fibrosis in humans is therefore regarded to be a prerequisite for the development of 
drugs targeted at intestinal fibrosis. To develop such an animal model we adopted a rat airway 
transplant model of bronchiolitis obliterans (15). Recently we described a new model of 
intestinal fibrosis by performing a heterotopic transplantation of small bowel resections in 
rats. The loss of intestinal epithelium morphology, exaggerated collagen deposition, 
expression of pro-fibrotic mediators and progressive luminal wall thickening culminating in a 
veritable fibrotic occlusion of the intestinal lumen faithfully reflect the histologic and 
molecular features of human intestinal fibrosis. The simplicity and efficiency of this model 
may greatly aid the study of the pathogenesis of intestinal fibrosis and the development of 
suitable therapeutics to prevent and treat intestinal fibrosis (16). However, to allow the study 
of mechanistic aspects of intestinal fibrosis in knock out animals and to allow drug treatment 
experiments with lower amounts of substance the model had to be transferred into mice. 
 
In this current study we describe the successful establishment of a mouse model of intestinal 
fibrosis in which we investigated pirfenidone as a possible candidate for an anti-fibrotic 
treatment in intestinal fibrosis.  
Pirfenidone (Esbriet
®, 
Roche) is an orally bioavailable small molecule developed by 
InterMune Inc. It exhibits well documented anti-fibrotic and anti-inflammatory properties in a 
variety of animal and in vitro models in different organs, including fibrosis of the lung(17), 
kidneys(18), heart(19), liver (20) and skin(21). The exact molecular mechanism of action so 
far is unknown(22). Prifenidone influencessignificantly the production of various cytokines 
and growth factors, with the most commonly reported effect being a reduction of transforming 
growth factor-β(TGF-β) (19, 20, 23). Others reported decreased IL-1β, IL-6 and MCP-1 
protein after treatment with pirfenidone shown in supernatants of lung homogenates in the 
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bleomycin-induced murine model of pulmonary fibrosis(23). Decreasedtranscript levels of the 
matrix metalloproteinase (MMP) 2and tissue inhibitor of metalloproteinase (TIMP)-1 after 
treatment with pirfenidone were shown in a dimethylnitrosamine-induced rat model of liver 
fibrosis(20). Decreased transcript levels of collagen I and III after treatment with 
pirfenidonewere shown in primary cultures of human myometrial and leiomyoma smooth 
muscle cells(24). 
A meta-analysis of progression-free survival time in three phase III clinical trials of 
pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) reported a significant overall 
treatment benefit(25). It was approved in Japan as Pirespa
®
 in 2008. It was approved in China 
and in Europe for the treatment of IPF in 2011 and in October 2014 in the United States by 
the FDA. 
In the present study we describe our rapid and reliable animal model of intestinal fibrosisand 
show that pirfenidone also prevents intestinal fibrosis indicating its potential as treatment 
option for stricturing CD. 
 
Materials and Methods 
 
Animals 
Female B6-Tg(UBC-GFP)30Scha/J donor mice (GFP-Tg) weighing 20g were bred locally. 
C57BL/6J-Crl1 mice (C57BL/6) were obtained from Charles River. BALB/c mice (BALB/c) 
were obtained from Jackson Laboratories. The animals received standard laboratory mouse 
food and water ad libitum. They were housed under specific pathogen-free conditions in 
individually ventilated cages. The experimental protocol was approved by the local Animal 
Care Committee of the University of Zurich (registration number ZH183/2014). 
 
Heterotopic intestinal transplant model 
The heterotopic mouse intestinal transplant model is an adaption of the heterotopic 
transplantation model of intestinal fibrosis in rats which has been previously described in 
detail (16). In short, donor small bowel resections were extracted and transplanted 
subcutaneously into the neck of recipient animals. Transplantations were carried out between 
mice of the same gender. All procedures were performed using a sterile non-touch technique. 
Donor mice were euthanized by neck dislocation. After an initial anterior midline incision the 
abdomen was opened completely to avoid contamination of the inner organs with hair. The 
small bowel was then exposed and carefully unfolded by cutting mesentery where necessary. 
From the small bowel proximal to the caecum a segment of 6cm was excised. The resection 
was thenflushed with 5 ml of 0.9% NaCl to remove stool and divided into six equal 10mm 
parts. Resections were kept moist with 0.9% NaCl solution while the recipient animals were 
prepared for transplantation (supplemental figure 1A).Recipient animals were anesthetized 
with isofluran and ocular lubricant was applied (Vitamine A BlacheAugensalbe 5g #109778). 
A small area of the back was shaved to avoid contamination with hair. Two subcutaneous 
pouches were prepared through a small incision perpendicular to the body axis on either side 
of the neck (supplemental figure 1B). A small bowel resection was implanted into each of the 
subcutaneous pockets (supplemental figure 1C) and the skin was closed using vicryl 5-0 
stiches or a 3M Precise Vista Skin Stapler (supplemental figure 1D). A single dose of 
Cefazolin (Kefzol
®
, 1g diluted in 2.5ml aqua dest) was applied i.p. as infection prophylaxis. 
The time interval between graft resection and subsequent implantation was less than 15 
minutes. No anesthesia-related recipient death, post-transplantation recipient death or 
evidence of infection was observed in any of the animals. 
Recipient mice were euthanized by neck dislocation.Intestinal grafts were explanted up to 21 
days after transplantation. Numerous blood vessels stretched towards the transplanted tissue 
(supplemental figure 1H) where they formed a dense network (supplemental figure 1I). At 
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explantation, each graft was divided into three equal segments. One segment was fixed in 4% 
formalin and prepared for histopathological assessment. The other segments weresnap frozen 
in liquid nitrogen and stored at -80° C until RNA extraction or lysis in MPER buffer. 
 
Pirfenidone preparation and application 
Esbriet
®
 tablets (276 mg, InterMune Inc., now part of the F. Hoffmann-La Roche AG) were 
dissolved in 14 ml sterile water to a pirfenidone concentration of 20 mg/mL. Pirfenidone was 
orally administered to recipient mice by oral gavage using a gastric tube. Pirfenidone (100 µL 
= 100 mg/kg) was administered three times a day orally (7:00–10:00, 13:00–16:00, 19:00–
22:00) for six days following transplantation. Sterile water was used as vehicle control. For in 
vitro experiments, Pirfenidone was dissolved in methanol. 
 
Stent insertion 
A cobalt chromium coronary stent coated with epoxy resin (Invatec Skylor, Roncadelle, Italy) 
measuring 10mm in length and 2mm in diameter was used. After isolating a section of 
intestine from a C57BL/6 donor mouse a stent was inserted into the open lumen of the 
resection before then being implanted in the subcutaneous neck pouch of a B6 recipient 
mouse. The graft was explanted at day 7 and embedded in epoxy resin for histological 
analysis. 
 
Paragon and Giemsa staining 
The specimens were prepared with a sequential water substitution process, then placed in 
xylene for 72 h and infiltrated by placing them in methyl methacrylate (MMA) for 72 h 
(Fluka 64200) followed by three days in 100 ml MMA + 2 g di-benzoylperoxid (Fluka 38581) 
at 4 Cº. Samples were embedded by placing them in 100 ml MMA + 3 g di-benzoylperoxid + 
10 ml plastoid N or dibutyl phthalate (Merck 800 19.25) and allowing polymerization to 
occur at 37 Cº in an incubator. After embedding, the specimens were sectioned by a diamond 
band saw (Exakt 300P) glued to a support and sectioned again, so that a 200 µm thick sample 
from the middle was attached to the support. The thickness of this sample was further reduced 
to 40-60 µm by a grinding machine (Exakt 420 CS). To visualize tissues, the samples were 
Paragon and Gimsa stained. Digital images were taken and processed with an image program 
(Adobes Photoshop CS3).  
 
Immunohistochemistry (IHC) 
TGF-1 was stained with a rabbit polyclonal antibody from Santa Cruz Biotechnology Inc. 
(#sc-146, dilution 1:200, immunstainer Leica Bond III Stainer, pretreatment: Bond 
EpitopRetrival Buffer 2 for 20 min., detections kit: Bond Polymer Refine Detections Kit, all 
reagents from Bond Leica). The sections were examined with the Imager Z2 microscope 
(Zeiss) and the software AxioVision (Zeiss). Sirius Red stained slides were analyzed in bright 
field using a polarisation filter. Under polarized light Sirius Red-stained collagen assumes a 
palette of colors ranging from green to red as a sign for fibrotic process maturation. Collagen 
layer thickness was determined by an investigator blinded to experiment. Thickness was 
calculated from at least eight places in representative areas at 10-fold magnification. 
 
TaqMan
®
 gene expression assays 
α-SMA Mm00725412_s1, BCL-XL Mm00437783_m1, MMP-9 Mm00442991_m1, MMP-2 
Mm00439498_m1, TIMP-1 Mm00441818_m1, TGF-β1 Mm01178820_m1, lysyl oxidase-
like 2 (LOXL-2) Mm00804740_m1, collagen type I alpha 1 (Col1a1) Mm00801666_g1, 
collagen type III alpha 1 (Col3a1) Mm01254476_m1 and GAPDH 4352339E. The relative 
cDNA concentration for the gene of interest was calculated using the ddCt-method. 
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Cell Viability Assay 
Primary murine colonic fibroblasts were isolated as described earlier (26). 5000 colonic 
fibroblasts per well were grown in triplicate cultures in 96-well plates. The final volume of 
culture medium in each well was 100 µL. Cells were starved 24h before stimulation. Cells 
were stimulated with 2 ng/mL TGF-β and 0, 0.1, 0.5 and 1mg/ml pirfenidone for 24 hours. 
The colorimetric assay (WST-8-based; DojindoMolecular Technologies) for quantification of 
cell viability was performed according the manufacturer’s protocol. Briefly, 10 µl CCK-8 
solution was added to detect viable cells. The absorption was measured four hours after 
addition of the CCK-8-labeling at 450 nm using a microplate reader. 
 
Wounding Assay 
Colonic fibroblasts were seeded in culture inserts (#80209, width of cell-free gap 500 µm ± 
50 µm, ibidi). Confluent monolayers of cells were starved 24h before the wounding assay. 
The culture inserts were removed and cells were stimulated with 2 ng/mL TGF-β and 1mg/ml 
pirfenidone. Wound closure was documented at t = 0, 24 and 48 hours with the Axiovert 
microscope (Zeiss) at 5-fold magnification and the Powershot camera (Canon).  
 
Western blot 
Equal amounts of protein were loaded onto SDS/PAGE gels. Western blots were performed 
using monoclonal rabbit anti-mouse TGF-β (#3711S, Bioconcept, 1:1000), polyclonal rabbit 
anti-mouse β-actin (#4970, 13E5, Cell Signaling, 1:2000) and the horseradish peroxidase-
conjugated secondary antibody goat anti-rabbit (#sc-2004, Santa Cruz, 1:2000), respectively. 
Focal adhesion kinase (FAK) protein detection was carried out with specific antibodies 
toFAK (#3285, Cell Signaling, 1:1000) andphosphorylated tyrosine 397 of FAK (#3283, Cell 
Signaling, 1:1000), and incubation with peroxidase-conjugated secondaryantibody goat anti-
rabbit (#sc-2004, Santa Cruz, 1:2000).Luminescence of Western blots was quantified 
densitometrically with Image J. 
 
Statistical analysis 
Statistical analysis for collagen layer thickness was performed usingKruskal-Wallis one way 
analysis of variance on ranks, all pairwise multiple comparison procedures (Tukey test). 
Statistical analysis for qPCR was performed usingKruskal-Wallis One Way Analysis of 
Variance on Ranks, All Pairwise Multiple Comparison Procedures (Holm-Sidak method) or 
unpair t-test when was appropriated. Differences were considered significant at a p-value of < 
0.05 (*) and highly significant at a p-value of < 0.01 (**) and p-value of < 0.001 (***). 
 
Ethical considerations 
The experimental protocol was approved by the local Animal Care Committee of the 
University of Zurich (registration number ZH183/2014). 
 
Results 
 
Establishment of a fast and reliable heterotopic transplantation model of intestinal 
fibrosis 
To determine the relevance of the genetic background of donor and recipient in our 
heterotopic transplantation model of intestinal fibrosis BALB/c mice were used as donors for 
allogeneic transplantation, while C57BL/6 were used as donors for isogeneic transplantation 
into C57BL/6 recipients.Eight isogeneic transplants (C57BL/6 into C57BL/6 mice) and 16 
allogeneic transplants (BALB/c into C57BL/6 mice) were performed.Grafts were explanted 
up to 21 days after transplantation.Macroscopically a reduction in the graft length appeared. 
Histologically evaluable tissue was recovered from all but 4 animals.  
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In EvG stained histological cross sectionsfreshly isolated small intestinewas characterized by 
an open lumen and distinctive epithelial crypts(Figure 1A and C).At day 21 after 
transplantation the lumen of intestinal grafts was obstructed by granulation tissue and fibrotic 
material (Figure 1B and E).Intestinal grafts already had lost their typical crypt structure at day 
two after transplantation.At day 5 after transplantation the loss of crypt structures was 
complete and a partial occlusion of the lumen was observed(Figure 1D). At day 14 luminal 
occlusion was complete.Epithelial structure was lost in heterotopic intestinal of both iso- and 
allografts. 
Collagen production and deposition in the intestinal transplants was determined by EvG 
staining in transmission light. The collagen layer thickness in harvested grafts was 
significantly increased after 7 and 21 days in a time dependent manner (* p < 0.05, Figure 
1F). To confirm the time dependent increase in collagen and to differentiate between long and 
short chain collagen we performed Sirius Red staining(supplemental figure2).Freshly isolated 
intestinal samples showed mostly long-chainedcollagen (red stain)adjacent to the submucosa 
(supplemental figure 2B). The presence of short-chained collagen (yellow stain) increased 
continuously with time in the submucosa and in the luminal occlusion after transplantation 
(supplemental figure 2D–N).The loss of epithelial structure and luminal occlusion was 
observed irrespective of the genotype of donor and recipient mice. 
As in the transplant model of bronchial fibrosis the lumen of the transplanted 
bronchus/trachea does not collapse to the cartilage present we investigated whether an open 
gut lumen would influence fibrosis in our intestinal transplant model. Subsequently a 
coronary stent was inserted into a graft before transplantation in an attempt to preserve the gut 
lumen. C57BL/6 mice were used as both donor and recipient. After explantation at day 7, we 
observed a shortened graft and a pronounced infiltration of cells into the lumen, causing an 
almost complete occlusion (supplemental figure 3).Thus the fibrotic model is effective 
irrespective of a preserved or collapsed lumen of the transplant. 
 
Mediators of fibrosis in the heterotopic transplant model of intestinal fibrosis 
To further substantiate that the observed changes represent fibrotic changes expression of 
TGF- was analyzed. Both BALB/c and C57BL/6 were used as donors for allogeneic and 
isogeneic transplantation. C57BL/6were used as recipients.TGF- was detected by IHC along 
the crypt villus axis in mouse intestinal epithelial cells in freshly isolated intestinal samples 
(figure 2A, C and D). No TGF- was detected in the lamina propria. Intense staining for TGF 
was found in the luminal occlusion in allografts from day 5 to day 21(2E and F).Intense 
staining for TGF was also found in heterotopic intestinal isografts (not shown). 
 
Host cells infiltrate the intestinal graft 
The presence of endogenous GFP inGFP-Tgrecipient miceallowed for a genotype-specific 
staining to be performed. We could thus determine the origin of the lumen-obstructing cells. 
We performed isogeneic transplantation using C57BL/6 mice as donors and GFP-Tg mice as 
recipient. As expected, the freshly isolated intestinal resections from C57BL/6 mice are 
negative for GFP staining (Figure 3A).An increase in infiltration of stained GFP cells ensued 
in a time-dependent manner. Initially, red-stained cells were visible exclusively in the 
submucosa and seemed to accumulate along the collagen layer (Figure 3B). Subsequent time-
points showed progressive infiltration along the crypts and into the lumen (Figure 3C-F). The 
collagen layer was free of red-stained cells. 
 
Typical fibrosis mediators are decreased in vitro in colonic fibroblasts after treatment 
with pirfenidone treatment  
We next investigated whether pirfenidone as an agent approved for the therapy and prevention 
of progress in IPF would be effective in vitro in colonic fibroblasts.2 ng/ml TGF-
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βsignificantly increased both MMP-9 and COL1A1 mRNA expression (*p < 0.05 and **p < 
0.01 respectively, n = 2, supplemental figure 4) andwas used for further stimulations. To 
determine effects of pirfenidone and TGF-β on the viability of colonic fibroblasts we used a 
CCK-8 colorimetric assay for the quantification of cell viability (supplemental figure 5). 
Colonic fibroblasts showed an increase in cell viability following administration of 
pirfenidone in a dose-dependent manner (n = 5 each column). Cell viability was also 
significantlyincreased upon TGF-β stimulation (162% ± 8%, n = 5) as compared to vehicle 
(set to 100%, n = 5, ***p < 0.001, supplemental figure 5) but did not further increase after 
treatment withadditional pirfenidone. 
In the absence of TGF-β stimulation,COL1A1 mRNA expression was significantly decreased 
in colonic fibroblasts following administration of 1µg/ml pirfenidone (n = 5 each column, 
***
p 
< 0.001, Figure 4A) and α-SMA mRNA expression was significantly decreased in a dose-
dependent manner (
*
p < 0.05, 
**
p < 0.01), whereas no changes in TGF-β expression were 
detected after treatment with pirfenidone. Following additional TGF-β stimulation a 
significantly decreasedTGF-β, COL1A1, MMP-9 and α-SMA mRNA expression was 
detected following administration of pirfenidone in a dose-dependentmanner compared to 
vehicle (n = 5 each column, 
##
p < 0.01, 
###
p < 0.001, Figure 4A).In contrast pro-survival BCL-
XL mRNA expression was significantly increasedfollowing administration of 1µg/ml 
pirfenidoneindependent ofTGF-β stimulation (n = 5 each column, ***p < 0.001, Figure 4A).  
Tyrosine phosphorylation of p125 FAK is a central regulator of cell migration. Western 
blotting revealed unchanged expression of total FAKafter treatment with pirfenidone (Figure 
4B, representative for four experiments).A quantification of FAK phosphorylation was also 
performed and revealedsignificantly increasedpFAKfollowing administration of pirfenidone 
in a dose-dependent manner independent ofTGF-β stimulation (n = 4 each column, ***p < 
0.001, Figure 4B).Accordingly, gain of migratory potential of colonic fibroblasts could be 
confirmed in a wounding assay. In line with this, the wounding assay revealed an advanced 
wound closure after 24 and 48h after treatment with pirfenidone independent ofTGF-β 
stimulation (supplemental figure 6, representative for two experiments).  
 
Development of intestinal fibrosis is partially prevented in grafts following 
administration of pirfenidone 
We next investigated whether pirfenidone would also be effective in our model of intestinal 
fibrosis. We performed isogeneic transplantation usingGFP-Tg mice as donors and 
C57BL/6mice as recipient. Body weight remained unchanged after treatment with pirfenidone 
(n = 7 mice) compared to vehicle (n = 8 mice, supplemental figure 4). Interestingly, a trend to 
lower body weight was seenfollowing administration of pirfenidone which may reflect 
dizzinesstriggered by pirfenidone as reported by others.We determined collagen production 
and deposition in the intestinal transplants by EvG staining in transmission light and under 
polarizing light (Figure 5). The collagen layer thickness in harvested grafts from mice after 
treatment with pirfenidone was significantly decreased in comparison to the collagen layer 
thickness in grafts from vehicle treated mice (** p < 0.001 for data obtained by transmission 
light and * p < 0.05 for data obtained by polarized light microscopy, n = 12 – 14 grafts as 
indicated).  
 
TGF-1 is expression significantly decreased in grafts following administration of 
pirfenidone 
In the grafts a significantly decreasedTGF-βmRNA expression afterpirfenidone treatment 
compared to vehicle (0.42 ± 0.13, n = 13 vs. 1.00 ± 0.21, n = 15 respectively, *p< 0.05, 
Figure 6A) was detected by qPCR.A quantification of TGF- expression by Western blotting 
of graft lysates was also performed and revealed a significant decrease in grafts from mice 
following administration of pirfenidone compared to grafts from mice upon vehicle (*p< 0.05, 
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n = 3 for each column, Figure 6B). A pronounced TGF-β staining upon vehicle as compared 
to pirfenidone six days after transplantation was detected (Figure 6C). A significantly 
decreased number of TGF- positive cellsafter treatment with pirfenidone as compared to 
vehicle (*p< 0.05, Figure 6D and E)confirmed the qPCR and Western blot data.TGF-was 
therefore shown to be decreased in the heterotopic intestinal grafts following administration 
of pirfenidone. 
 
pFAK is significantly increased in grafts after treatment with pirfenidone 
Western blotting revealed increased phosphorylation of FAK following administration of 
pirfenidone (Figure 7A, n = 4 each group). A quantification of FAK phosphorylation was also 
performed and revealedsignificantly increasedpFAKafter treatment with pirfenidone(
**
p < 
0.01). Western blotting also revealed unchanged expression of total FAK following 
administration of pirfenidone. In line within vitro experiments,α-SMA mRNA expression was 
significantly decreased (n = 9 each column, 
*
p < 0.05, Figure 7B)and pro-survival BCL-XL 
mRNA expression was significantly increasedafter treatment with pirfenidone(n = 9 each 
column, 
*
p < 0.05, Figure 7B).  
 
Matrix degrading MMPs and pro-inflammatory cytokines are decreased following 
administration ofpirfenidone 
We determined the expression of tissue remodeling proteases MMP-2, -9, -13 and the tissue 
inhibitor of metalloproteinase TIMP-1 in intestinal transplants by real-time PCR. Grafts from 
mice treated with pirfenidone showed a significant decrease in MMP-9 mRNA 
expressioncompared to vehicle (0.46 ± 0.24 vs. 1.00 ± 0.62 mRNA expression level relative 
to GAPDH, *p< 0.05, Figure 8A). Similar, MMP-2, -13 and TIMP-1 mRNA expression was 
decreased after treatment with pirfenidone compared to vehicle (0.59 ± 0.50 vs. 1.00 ± 0.68, 
0.60 ± 0.72 vs. 1.00 ± 1.01 and 0.42 ± 0.43 vs. 1.00 ± 0.92 mRNA expression level relative to 
GAPDH, respectively, not significant, Figure 8A). Transplants from mice treated with 
pirfenidone also showed a decrease in mRNA of pro-inflammatory cytokines IL-1β, IL-6 and 
MCP-1 as compared to vehicle (0.42 ± 0.43 vs. 1.00 ± 0.92, 0.52 ± 0.38 vs. 1.00 ± 0.89 and 
0.53 ± 0.44 vs. 1.00 ± 0.88 mRNA expression level relative to GAPDH, respectively, not 
significant, Figure 8B).LOXL-2 is a copper-dependent matrix amine oxidase and a member of 
the lysyl oxidase enzyme family. The function of this oxidase is the stabilization of collagen 
fibrils and fibers in the extracellular matrix. Grafts from mice treated with pirfenidone showed 
a decrease in mRNA of LOXL-2 as well as the major component of type I collagen COL1A1 
and COL3A1, frequently found in association with type I collagen compared to vehicle (0.54 
± 0.431 vs. 1.00 ± 0.67, 0.71 ± 0.65 vs. 1.00 ± 0.87 and 0.57 ± 0.59 vs. 1.00 ± 0.96 mRNA 
expression level relative to GAPDH, respectively, not significant, Figure 8C). 
 
Discussion 
 
Here we describe a new murine model of intestinal fibrosis. Heterotopic transplantation of 
small bowel resections in mice was followed by a rapid and constant fibrosis of the intestinal 
wall. The method is based on a recently described rat model of fibrosis as a substantial 
advance in understanding the formation of intestinal fibrosis(16). Small bowel resections of 
donor mice were implanted into subcutaneous pouches of recipients. Grafts showed complete 
fibrosis in a time-dependent manner characterized by an increased deposition of collagen. 
EvG and Sirius Red staining confirmed significantly increased collagen layer thickness in 
transplants and revealed a diffuse network of fibrils in the obliterated lumen. In addition, IHC 
revealed a time-dependent increase of TGF-β.  
Fibrosis is traditionally viewed as the end point of a long-term process consisting of a chronic 
responseof the digestive tract. Accordingly, intestinal fibrosis is viewed as a slow, 
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unidirectional process, in which inflammation encourages local fibroblast to multiply and 
deposit extracellular matrix as part of a wound healing process(27). Although not necessarily 
incorrect, based on our results this view should be extended to the observation that fibrosis 
could also be rapidly initiated and increased. Recent studies also suggest fibrogenesis as a 
very early process associated with inflammation(28).Results from our own studies support 
this hypothesis as rapid increase of collagen layer thickness, fast development of occlusion 
and rapid increase of TGF-β in grafts can be determined shortly after transplantation. 
The anti-fibrotic effect of pirfenidone was successfully tested both in vitro and in our new 
model of intestinal fibrosis. In in vitro experiments we determined a significant decrease in 
TGF-β, COL1A1,MMP-9 and α-SMA mRNA expression following administration of 
pirfenidone in a dose-dependent mannercompared to vehicle. This shows that hallmarks of 
progressive development of fibrosis are decreased after treatment with pirfenidone in 
intestinal fibroblasts. 
Studies concerning fibroblasts of other tissues revealed that pFAK is a central regulator of cell 
migration in health and disease (29-32). FAK is a nonreceptor protein tyrosine kinase 
involved in integrin-mediated control of cell behavior. The amount of FAK protein 
phosphorylation is increased during cell migration (33). The autophosphorylation of FAK at 
the tyrosine residue 397 is a marker for the activation of FAK. Phosphorylation creates an 
SH2 binding site for different signaling and adapter proteins (32, 34). Migration of colonic 
fibroblasts is stimulated by growth factors like TGF-β, PDGF-AB, IGF-I, EGF. Colonic 
fibroblasts also stimulate their own migration through an autocrine mechanism (26). 
Migratory potential of colonic fibroblasts from IBD patients is reduced compared with normal 
colonic fibroblasts, which is correlated with diminished FAK phosphorylation (35). In 
contrast to TGF-β,FAK protein phosphorylation and BCL-XLmRNA expression is 
increasedfollowing administration of pirfenidone in our studies. This suggests an increased 
migratory potential and viability of cells and is confirmative with results from the 
performedwounding assay that revealed an advanced wound closure after treatment with 
pirfenidone. In our murine model of intestinal fibrosis we determined a significantly deceased 
collagen layer thickness in harvested grafts from mice following administration oforal 
pirfenidonein comparison to vehicle treated mice. Further, TGF-β expression on mRNA and 
protein level was significantly reduced by pirfenidone. Confirmative to the in vitro 
experiments FAK protein phosphorylation and BCL-XL mRNA expression was increased after 
treatment with pirfenidone suggesting an increased migratory potential and viability of cells 
in the graft. Grafts from mice treated with pirfenidone showed a significant decrease in α-
SMA and MMP-9 mRNA expressioncompared to vehicle. MMP-2, -13, TIMP-1, IL-1β, IL-6, 
MCP-1 and LOXL-2 mRNA expression also was reduced. 
Pirfenidone is known to exhibit antifibrotic and anti-inflammatory effects in a variety of 
organs by modulating various genes known to be involved in wound healing and fibrosis, 
including TGF-β, MMP-2 and MMP-9 (20, 23, 24, 36, 37). Graham et al. showed that TGF-β 
promotes collagen deposition by smooth muscle cells isolated from CD tissue, a process that 
may play a significant role in stricture formation and fibrosis in CD patients (38). In addition 
TGF- β is known to inhibit intestinal epithelial cell proliferation, a process that may inhibit re-
epithelialisation after surface injury (39-41). The gelatinases (MMP-2 and -9) degrade 
denatured collagen of all types(42). MMP-2 and MMP-9 are up-regulated in IBD patients in 
active flares(43-46). MMP-2 is expressed in almost all tissues and is markedly increased in 
IBD tissues(47). MMP-9 activity and protein expression is up-regulated during DSS-colitis, in 
normal colonic mucosa the expression is absent(48). MMP-9
-/-
 mice have significantly less 
severe DSS-induced colitis with reduced inflammation and mucosal injury(49).  
Thus pirfenidone may be a new treatment option to prevent fibrogenesis and development of 
strictures in IBD patients. In patients with idiopathic pulmonary fibrosis after 72 weeks 
following daily pirfenidone administration following adverse effects could be detected with 
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an increased incidence: nausea, rash, dyspepsia, dizziness, vomiting, photosensitivity 
reaction, anorexia, arthralgia, insomnia, abdominal distention, decreased appetite, stomach 
discomfort, weight reduction, abdominal pain, asthenia, pharyngolaryngeal pain, pruritus and 
hot flush (17).  
The described heterotopic transplantation in mice will serve as a new model to develop 
treatments targeted at intestinal fibrosis and provide the opportunity of using genetically 
altered animals. Important aspects of human intestinal fibrosis are reflected in our model of 
heterotopic transplantation in mice. It may also be instrumental in deciphering the formation 
of intestinal fibrosis at the molecular level. The utilization of our new in vivo heterotopic 
transplant animal model of intestinal fibrosis may ultimately lead to novel interventions in the 
prevention of treatment of intestinal fibrosis. We were able to confirm the postulated anti-
fibrotic effects of pirfenidone.Thus pirfenidone may be a new treatment-option to prevent 
intestinal fibrosis formation in IBD. 
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Figure legends 
 
Figure 1:Increased collagen layer thickness in heterotopic intestinal grafts. Histologic 
cross sections of freshly isolated small intestine (A and C) and explanted at day 5 (D) and 21 
(B and E) after transplantation. EvG staining of mouse small heterotopic intestinal grafts 
revealed an increase of collagen deposition in a time-dependent manner. (F) EvGstaining 
revealed significantly increased collagen layer thickness (H, * = p < 0.05, Kruskal-Wallis one 
way analysis of variance on ranks, all pairwise multiple comparison procedures (Tukey test), 
n = 9 for each column). BALB/c were used as donors for allogeneic transplantation, B6 were 
used as donors for isogeneic transplantation. B6 were used as recipients. 
 
Figure 2: Increased TGF-in heterotopic intestinal grafts.IHC for TGF- of mouse small 
intestine allografts.Histologic cross sections of freshly isolated small intestine (A, C and D) 
and explanted at day 5 (E) and 21 (B and F) after transplantation. Transmitted light 
microscopy. In freshly isolated intestinal samples TGF- (brown) was increased along the 
crypt villus axis in mouse intestinal epithelial cells (D). Data revealed increased expression of 
TGF- a potent mediator of fibrosis. Each image is representative for two samples 
investigated. BALB/c were used as donors for allogeneic transplantation, B6 were used as 
donors for isogeneic transplantation. B6 were used as recipients. 
 
Figure 3: Host cells progressively infiltrate the intestinal graft. IHC of lumen-obstructing 
cells of recipient origin. Freshly isolated intestinal resections are negative for GFP (A). 
Increase in infiltration at day 1 (B), 2 (C), 5 (D), 7 (E) and 14 (F) in a time-dependent manner. 
 
Figure 4:TGF-1 mRNA is significantly decreased following administration 
ofpirfenidone in intestinal fibroblasts in vitro. Increased pFAKfollowing administration 
of pirfenidone compared to control. TGF-β, COL1A1, MMP-9 and α-SMA mRNA 
expression is decreased and BCL-XL mRNA expression is increased after treatment with 
pirfenidonecompared to vehicle (*P < 0.05, **P < 0.01, ***P < 0.001, n= 5 each column, 
error bars = SEM, B). Western blotting (left) and densitometric analysis (right) showed 
significant increase in the ratio pFAK/totalFAKafter treatment with pirfenidone (*P < 0.05, 
**P < 0.01, **P < 0.001, n = 4, error bars = SEM,B). 
 
Figure 5: Collagen layer thickness is significantly decreased following administration of 
pirfenidone in grafts from the heterotopic transplantation model.Sirius Red staining.(A) 
Transmission light showed significantly decreased collagen layer thickness after treatment 
with pirfenidone compared to vehicle (** p < 0.001).(B) Polarizing light microscopy 
confirmedsignificantly decreased collagen layer thickness after treatment with pirfenidone (* 
p < 0.05). n = 12 – 14 as indicated. Thickness was calculated from at least eight places in 
representative areas at 10-fold magnification for each single graft. Mean value und standard 
deviation is shown. 
 
Figure 6:TGF-1 is significantly decreased following administration of pirfenidone in 
grafts from the heterotopic transplantation model. (A) Significant decrease in TGF-β 
mRNA expression after treatment with pirfenidone compared to vehicle (*P < 0.05, n = 13 
and 15 respectively). (B) Western blotting confirmed significant decrease in TGF-βfollowing 
administration of pirfenidone (*P < 0.05, n = 3 for each column). Error bars = standard 
deviation.Grafts exhibited a pronounced TGF-β staining (DAB, brown) upon vehicle 
compared to pirfenidone. (C) IHC reveals a significant decrease in TGF-1 positive cellsafter 
treatment with pirfenidone. (D and E) Number of TGF- positive cells (red crosses) was 
significantly increased upon vehicle (*P < 0.05, Kruskal-Wallis One Way Analysis of 
Meier et al.   Decreased fibrogenesis after treatment with pirfenidone16 
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Variance on Ranks, All Pairwise Multiple Comparison Procedures (Holm-Sidak method), D 
and E). Number of TGF- positive cells was normalized to the number of total cells (nuclei 
labeled by yellow and red crosses). 
 
Figure 7:Increased pFAK following administration of pirfenidone compared to control 
in grafts from the heterotopic transplantation model. (A) Western blotting (left) and 
densitometric analysis (right) showed significant increase in the ratio pFAK/total FAKafter 
treatment with pirfenidone (**P < 0.01, n = 4 for each column, error bars = SEM).(B)α-SMA 
mRNA expression is significantly decreased while BCL-XL mRNA expression is significantly 
increased after treatment with pirfenidonecompared to vehicle (*P < 0.05, n= 9 each column, 
error bars = SEM). 
 
Figure 8:MMPs and pro-inflammatory cytokines are decreased following administration 
ofpirfenidonein grafts from the heterotopic transplantation model. MMP-2, -9, -13 and 
TIMP-1 are decreased after treatment with pirfenidonecompared to vehicle (*P < 0.05, 
Kruskal-Wallis One Way Analysis of Variance on Ranks, All Pairwise Multiple Comparison 
Procedures (Holm-Sidak method), A). IL-1β, IL-6 and MCP-1 are decreased after treatment 
with pirfenidone(B). LOXL-2, COL1A1 and COL3A1 are decreased after treatment with 
pirfenidone(C). N = 13-15 for each column, error bars = standard deviation. 
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Supplemental figure 3: Fibrotic model is also effective upon 
stent insertion 
(A) A cobalt chromium coronary stent (white arrows) was inserted into a graft 
before transplantation. Cut surface of the epoxy resin after explantation at day 
7. (B) Paragon and (C) Gimsa staining revealed luminal occlusion. 
A 
B 
1mm 500µm 
100µm 
luminal 
occlusion 
submucosa                 stent                                          luminal occlusion 
100µm 
C 
100µm 
1mm 500µm 
/ 
Supplemental figure 4: Increase of MMP-9 and collagen I mRNA expression levels  
upon TGF-β compared to vehicle in intestinal fibroblasts in vitro 
2 ng/ml TGF-β significantly increased both MMP-9 and COL1A1 mRNA expression (*p < 0.05 and **p < 0.01 
respectively, n = 2) and was used for further stimulations. 
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Supplemental figure 5: CCK-8 assay, increase of viability following treatment with 
pirfenidone compared to vehicle in intestinal fibroblasts in vitro 
CCK-8 colorimetric assay for the quantification of cell viability. Colonic fibroblasts showed an increase in cell 
viability following treatment with pirfenidone in a dose-dependent manner (n = 5 each column). Cell viability 
was also significantly increased upon TGF-β stimulation (162% ± 8%, n = 5) as compared to vehicle (set to 
100%, n = 5, ***p < 0.001) but did not further increase following additional pirfenidone treatment.  
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Supplemental figure 6: Wounding assay, faster wound closure following 
treatment with pirfenidone compared to vehicle 
Gain of migratory potential of colonic fibroblasts shown in a wounding assay. The wounding 
assay revealed an advanced wound closure after 24 and 48h following treatment with 
pirfenidone independent of TGF-β stimulation (representative for two experiments). 
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Supplemental figure 7: Body weight remained unchanged 
following treatment with pirfenidone compared to vehicle 
Pirfenidone, white circle, n = 7 and vehicle, black diamond, n = 8 for each 
time point.  
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